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Abstract 
One in six couples wishing to start a family are infertile. The many causes of 
infertility include genetic defects that can be single gene, multifactorial or 
chromosomal (including Y deletions, karyotype abnormalities and gamete 
aneuploidy). This thesis is concerned with the association between infertility and 
increased sperm aneuploidy. Specific questions are: should males be screened for 
sperm aneuploidy before intracytoplasmic sperm injection (ICSI)? Is there a 
relationship between individual semen parameters and sperm aneuploidy for specific 
chromosome pairs? What is the role of genome organisation in male gametes and its 
association with infertility? Whether use of alternative therapy (in this case, 
traditional Chinese Medicine (TCM)) can be used to improve sperm disomy levels. 
Statistical analysis of questionnaire data revealed that infertility specialists believed 
there to be merit in screening sperm aneuploidy levels before ICSI. Evidence is 
presented for possible chromosome-specific and semen parameter specific 
mechanisms for sperm aneuploidy as is evidence of genome organisation that may 
be perturbed in infertile males. Finally, in six males studied, sperrn aneuploidy 
levels improved significantly coincident with TCM. Closer investigation of the 
biological activity of individual therapeutic herbs and treatment cocktails revealed 
strong anti-oestrogenic and anti-oxidant properties. This suggests a possible 
mechanism of action of the herbs and provides the basis from which future placebo 
controlled clinical trials might continue. Possible criticisms of the work presented 
here include the unavailability of blood samples from many of the patients (thus 
preventing karyotype analysis) and the absence of a second control group in our 
studies on semen parameters. Nevertheless significant steps have been made towards 
establishing the need for, and the implementation of, a pre-ICSI screening test. 
Moreover progress has been made towards further understanding the aetiology of 
sperm aneuploidy and towards the implementation of a new treatment that may, 
ultimately, augment, or even replace ICSI. 
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Chapter 1: Genetic basis of infertility 
1. Introduction 
Infertility is defined as a failure of a couple to conceive after I year of trying, and is 
estimated to affect I in 6 couples wishing to start a family. The term 'infertility' thus 
includes that of not only complete sterility but also that of sub-fertility, (where the 
capacity for producing offspring is diminished). It is estimated that the rate of infertility 
affects males and females equally (Shah et al., 2003). 
Infertility can be caused by a number of factors; including endocrine abnormalities, 
psychological trauma, infection, immunological infertility, lack of ovulation, obesity, 
varicocele, exposure to toxic chemicals and environmental factors including: smoking, 
alcohol, chemotherapy (Martin et al., 1998a; Wyrobek et al., 1995), mechanical 
stoppage, obstruction and age. However more recently a wide range of genetic defects 
have been associated with infertility. Genetic defects are estimated to account for 50% 
of male infertility (13hasin et al., 1994). Although this figure is spurious, it is probable 
that the majority of these factors affecting reduced fertility may have some genetic 
basis, however small. Factors including obesity, endocrine abnormalities, susceptibility 
to infections and psychological problems are likely (Shah et al., 2003). 
1.1 Identification and classification of infertility 
When a couple are having difficulties conceiving GP's will refer them to specialists 
including: andrologists, urologists, endocrinologists and gynaecologists, amongst 
others. In this situation the female partner is sent for a number of tests in order to 
determine levels of FSH (follicle stimulating hormone) and LH (luteinizing hormone) 
important for the development and quality of the eggs and to check for ovulation. A 
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transvaginal ultrasound is used to check uterus lining and monitoring of follicle 
development, also a hysterosalpinogram is undertaken to check for tumours, blockages, 
pelvic adhesions, endornetriosis and a post coital test to ensure that the sperm can 
survive and penetrate the cervical mucus (www. nhsdirect. nhs. uk). 
The male partner undergoes a semen assessment, of which the main factors analysed are 
volume, count, concentration, motility and morphology amongst other tests (See table 
1.1 for nonnal reference values). 
Table LI- reference guide for normal semen parameters 
Wit 
Volume >2mls 
Ph 7.2-8.0 
Sperm concentration > 20 million/ml 
Total sperm count > 40 million 
motility > 50% forward progression (category A and B) or > 25% 
rapid progression (category A) 
Morphology > 14% normal morphology (Strict Kruger criteria) 
According to the results of this semen assessment, males are classified by the following: 
normozoospermia (all parameters are within the normal range), oligozoospermia., 
(sperm concentration of less than 20 million/ml or severe oligozoospennia, less than 5 
million/ml). The classification of asthenozoospennia is used in cases of less than 50% 
forward progression (or less than 25% rapid forward progression), and teratozoospermia 
in males with less than 14% normal morphology (according to the strict Kruger 
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guidelines). Males can have any combination of these semen parameter abnormalities 
for example males with oligoasthenoteratozoospermia, (OAT) have a disturbance in all 
three major categories of count, motility and morphology. Individuals for which no 
sperm is found within the ejaculate are referred to as azoospermic. 
Over the last decade or so research into genetic causes of male and female infertility has 
rapidly expanded and genetic factors have been associated with infertility and assigned 
to specific chromosome locations however, the majority still remain undeciphered. 
1.2 Genetic reasons for infertility 
The genetic basis of infertility can be divided into the following: 
1) Infertility involving a single gene defect. 
2) Infertility involving multifactorial (polygenic) defects. 
3) Infertility involving a chromosomal defect. 
1.2.1 Infertility syndromes due to a single gene defect 
To date a number of infertility syndromes/phenotypes have been attributed to a single 
gene defect and these defects can be inherited in several ways including: sex linked, 
autosomal dominant or autosomal recessive. The most common single gene defects are 
considered in the following section and listed in table 1.2. 
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1.2.1.1 Autosomal recessive syndromes 
1.2.1.1.1 Cystic fibrosis 
Cystic fibrosis is one of the most common genetic disorders affecting Caucasians of 
European descent, estimated to affect I in 2,500 children with a carrier frequency in the 
Caucasian population of I in 25. Among the clinical manifestations around 95% of 
males have been found to be infertile presenting with obstructive azoospennia, 
(Johnson, 1998). Congenital bilateral absence of the vas deferens (CBAVD) has been 
demonstrated in nearly all affected males regardless of the severity of the cystic fibrosis, 
(Lissens et al., 1996). 
Mutations have been found within the cystic fibrosis transmembrane conductance 
regulator gene (CFTR), located on the long arm of chromosome 7 (Hargreave et at., 
1998). Screening for mutations within the CRTR gene is undertaken within infertility 
clinics, to date over 900 mutations within the CFTR gene have been identified 
(www. genet. sickids. on. ca/cftrý. In many cases however, CFTR mutations are not 
identified as only ap proximately 30 of these mutations are screened regularly 
(Hargreave, 2000; Lamb and Lipshultz, 2000). The relationship between the absence of 
the vas deferens and CFTR mutations has been well established, however, there are also 
reports of CFTR mutations in men with severe oligozoospermia, who do not present 
with absence of the vas deferens. The CFTR complex has thus been suggested relate to 
spermatogenesis (van der Ven et al., 1996), although at present its role of the CFTR 
complex remains unclear (Hargreave, 2000). Mutations within the CFTR gene have not 
been directly associated with female infertility, but females with cystic fibrosis are 
subfertile with an increased risk of complications during pregnancy (Cohen et al., 
1980). 
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A correlation exists between those studies reporting a higher incidence of males with 
mutations within CFTR and those that have analysed more mutations. Therefore 
individuals presenting with CBVAD would benefit from increased screening of 
mutations within the CFTR gene. (Hargreave, 2000). 
1.2.1.1.2 Other autosomal recessive syndromes 
Immotile cilia syndrome and Kartagener syndrome (also associated with situs inversus, 
bronchiectasis and chronic sinusitis) both fall into a group of related disorders 
collectively known as primary ciliary dyskinesia (PCD) characterised by immotility or 
dysmotility of ciliary structures, including airway and sperm axonernes. (Carson and 
Collier, 1988). In many cases affected males exhibit infertility due to abnormalities in 
sperm motility. 
Bardet-Biedle syndrome features typically include obesity, retinitis, mental retardation, 
variable cardiac and renal defects and hypogonadism resulting in spermatogenic 
impainnent (Greene et al., 1989). 
Persistent Mullerian duct syndrome (PMDS) is a rare form of male 
pseudohermaphroditisurn, whereby patients have the genotype 46, XY and in the 
majority of cases both external genitalia and secondary sexual characteristics appear 
nonnal. Patients also possess fallopian tubes and a uterus as a result of the failure of the 
regression of the Mullerian duct, due to defects in either the Mullerian inhibitory factor 
(MIF) produced by the Sertoli cells, or the MIF receptor (Imbeaud et al., 1996; 1995; 
1994). 
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Usher syndrome is the most frequent cause of hereditary dual loss of sight and hearing, 
however, some patients have also been identified as having degeneration in the sperm 
axoneme (Hunter et al., 1986). Abnormal microtubular organisation of the axoneme in 
sperm tails and other cell types has also been found, resulting in the production of 
sperm with poor motility. 
Cerebellar ataxia with hypogonadism is rare among the population and is often the 
result of parental consanguinity (as reviewed in Hargreave, 2000; Rushton and Genel, 
1981). Phenotype includes disturbances in speech and gait, lack of secondary sexual 
characteristics, absence of libido, small and firm testes and hypothalamic pituitary 
dysfunction with impaired response and increases in LH and FSH. 
5(x-reductase deficiency, results in a failure to convert testosterone (secreted by the 
foetal testis) to dihydrotestosterone (DHT) due to defects in 5(x-reductase, (responsible 
for the intracellular conversion of testosterone to DHT) (reviewed in Mak and Jarvi, 
1996), and is characterised by male pseudohermaphroditism. The disease phenotype 
includes; perineoscrotal hypospadias, blind vaginal pouch, female habitus without 
breast development and the absence of female internal genitalia (reviewed in Mak and 
Jarvi, 1996). The main cause of infertility however is structural abnormalities of the 
external genitalia, and in some cases decreased spermatogenesis. Less severe forms may 
present with hypospadias and reduced penile size (Imperato et al., 1974). 
There are several disorders, in which androgen function is altered and which are 
associated with adrenal hyperplasia as some of the enzymes involved in these disorders 
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are also involved in adrenal synthesis of androgens (due to a deficiency of androgen 
synthesis). The three following disorders are included in this category. 
3-p-hydroxysteroid dehydrogenase deficiency syndrome, is responsible for the 
conversion of pregnenolone to progesterone. The disease phenotype results in 
incomplete masculinization as a result of point mutations in the gene encoding this 
enzyme (Simard et al., 1996). 
Deficiency of the enzyme 17-cc-hydroxylase perturbs the conversion of progesterone to 
17-hydroxyprogesterone, clinical manifestations include defective virilization due to 
impaired testosterone synthesis in the foetal testis (Geller et al., 1997). 
17-p-hydroxy dehydrogenase is responsible for converting androstenedione into 
testosterone, mutations in this enzyme result in pseudohen-naphrodites with complete or 
incomplete female genitalia, with inguinal or intra-abdominal testes (Andersson et al., 
1996). 
1.2.1.2 Autosomal dominant syndromes 
1.2.1.2.1 Myotonic dystrophy 
Myotonic Dystrophy is transmitted as an autosomal dominant trait with variable 
penetrance affecting males and females. Patients exhibit muscle wasting, frontal 
balding, hypogonadism, testicular atrophy and loss of libido. Male infertility is seen in 
approximately 30% of cases, however some degree of testicular atrophy is seen in at 
least 80% of cases, mainly affecting the seminiferous tubules, with normal Leydig cells 
present and severe tubular sclerosis and spermatogenesis being affected. The genetic 
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defect involves a gene encoding a serine/threonine protein kinase, which contains an 
unstable CTG triplicate repeat pattern. 
1.2.1.2.2 Polycystic kidney disease 
This disorder is characterised by numerous cysts in the kidney, liver, spleen, lung, testis, 
epididymis and seminal vesicle. Two loci have been identified as being involved 
including PKD I (accounting for the majority of cases) and PKD2 (located on 
chromosome 16p 13.3 and 4q respectively) (reviewed in Mak and Jarvi, 1996). Male 
patients often present with infertility due to the multiple cysts found throughout the 
epididymis and seminal vesicles, which can result in obstructive azoospermia. 
1.2.1.2.3 Noonan syndrome 
Noonan syndrome patients exhibit a similar phenotype to that of Turner syndrome (refer 
to section 1.4.2.1), including short stature, webbed neck, cardiovascular abnormalities 
and cryptorchidism and testicular atrophy. Approximately 50% of affected males 
display azoo- or oligospennia and delayed puberty (Elsawi et al., 1994). However 
unlike Turner syndrome (45, XO), patients display a 46, XY karyotype, the locus 
involved being mapped to chromosome 12q22 (Jamieson et al., 1994). 
1.2.1.3 X-linked syndromes 
Kallmann syndrome individuals exhibit hypogonadotrophic hypogonadism, as a result 
of an endocrinological defect whereby there is no hypothalamic secretion of 
gonadotrophin - releasing hormone (GnRH). In these cases follicle stimulating hormone 
(FSH), luteinizing hormone (LH) and testosterone levels are low or undetectable. 
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Patients' fertility can be restored when treated with a combination of FSH or human 
menopausal gonadotrophin (HMG) and human chorionic gonadotrophin (hCG). 
Aarskog-Scott syndrome and is associated with facial, skeletal and genital abnon-nalities 
(Porteous and Goudie, 1991). Affected males often have reduced fertility frequently 
displaying cryptorchoidism, there may also be specific defects involving the sperm 
acrosome related to this syndrome (Meschede et al., 1996). 
Adrenomyelopathy arises as a result of small deletions and point mutations within the 
adrenoleukodystrophy protein (ADLP) gene (Braun et al., 1995). Clinical onset of this 
disease is around 30 years of age, phenotype includes: progressive paralysis, peripheral 
neuropathy, adrenocortical failure. The vast majority of men also exhibit endocrine or 
exocrine testicular failure including: impotence, gynaescomastia, poor androgenization, 
azoo- or oligozoospermia, low ejaculate volume, low testosterone and elevated levels of 
LH and FSH (Assies et al., 1995). 
Androgen insensitivity syndrome (AIS) is attributed to a defect in the androgen receptor 
(AR) gene resulting in quantitative and qualitative receptor binding abnormalities 
(reviewed in Brinkmann et al., 2001; Mak and Jarvi., 1996). Defects within the AR can 
prevent the normal development of both internal and external male structures. Increased 
luteinizing hormone (LH) production results in increased testosterone production by 
leydig cells, which is converted to oestrogens, resulting in ferninisation (reviewed in 
Thielemans et al., 1998). Several types of AIS have been reported including: Complete 
Androgen Insensitivity Syndrome (CAIS), Partial Androgen Insensitivity Syndrome 
(PAIS) and Mild Androgen Insensitivity Syndrome (MAIS). 
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Individuals with CAIS present with female external genitalia, a short blind ending 
vagina, absence of any Wollfian derived structures including the epididymis, vas 
deferens and seminal vesicles, the absence of a prostate and gynaecomastia (reviewed in 
Quigley et al., 1995). During puberty in these patients testosterone and LH levels are 
elevated, the higher levels of testosterone within these individuals act as a substrate for 
aromatase activity, resulting in substantial amounts of estrogens, causing further 
ferninisation of these individuals (reviewed in Brinkmann et al., 2001). 
PAIS (also known as Reifenstein syndrome) is characterised by hypospadias, 
micropenis, with gynaestocomastia, sex reversal or intersex genitalia, the majority of 
patients are brought up as females (reviewed in Thielemans et al., 1998). The severity of 
the disease depends on the degree of androgen insensitivity, individuals germ cells 
display mitotic activity but contain no spermatozoa (reviewed in Brinkmann, 200 1). 
Spinal and bulbar muscular atrophy (SBMA) / Kennedy disease has a clinical age onset 
of 20-30 years, presenting with progressive muscular atrophy and weakness, secondary 
testicular atrophy causing infertility later on in life including defective spen-natogenesis, 
oligo or azoospermia, and gynaecomastia. SBMA is associated with a CAG trinucleotide 
repeat within the androgen receptor, the number of repeats varies in individuals without 
any phenotypic aberrations. However, if the CAG repeat exceeds 40 (normal situation is 
15-3 1) it can compromise the function of the gene (La Spada et al., 1992). 
1.2.1.4 Imprinted genes and uniparental disomy 
In some cases the normal pattern of Mendelian inheritance does not occur, in that 
Mendelian genetics assume that both maternal and paternal copies of a gene are equally 
II 
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expressed. This however, is not always the case, the discovery of certain genes 
(imprinted genes), have been shown to carry a specific molecular modification which 
are specific to the parent from which it originates. This modification causes the 
46silencing" of either the paternal or matemal gene, therefore, loss of any function of 
such genes (whether it be due to mutation or deletion) may result in either over- or 
under expression (reviewed in Meschede and Horst, 1997). This same phenomenon can 
be caused as a result of uniparental disomy (UPD), whereby at least segments if not 
entire chromosome homologues are derived from the same parent. A number of UPD 
and aberrations in imprinted genes have been implicated in infertility. 
1.2.1.4.1 Beckwith-Wiedemann syndrome (BWS) 
Patients with BWS often present with pre- and post natal overgrowth, renal 
abnormalities, are prone to develop embryonic tumours and most males also display "U 
cryptorchidism (Elliot and Maher, 1994). 
1.2.1.4.2 Prader-Willi syndrome (PWS) and Angelman syndrome (AS) 
The lack of expression of imprinted genes within the chromosome region of 15q II -q 13 
result in two clinically distinct syndromes PWS and AS. These syndromes arise through 
several mechanisms including deletions and UPD. PWS and AS syndrome both result 
from a genetic deficiency from paternally and maternally inherited chromosome IS 
(respectively) (Glenn et al., 1997). An estimated 70-75% of individuals with PWS and 
AS are found to contain a deletion within the region of 15ql I -qI 3, with UPD and single 
gene mutations accounting for the remainder (Knoll et al., 1993). PWS individuals are 
characterised by severe obesity, mental retardation, delayed and incomplete 
development in puberty and hypogonadism as a result of deficient hypothalamic release 
12 
( 
of gonadotrophin-releasing hormone, resulting in low levels of testosterone, LH and 
FSH. AS individuals often present with severe mental retardation, problems with 
movement, microcephaly and hypopigmentation (Williams et al., 1995). 
1.2.1.5 Infertility syndromes for which the mode of inheritance is not 
reported or complex 
Bioactive LH (hypogonadism. due to a mutation in LH). LH is a heterodimer consisting 
of two subunits (x and P, alterations within this gene can cause the abnonnal binding 
activity of LH (revicwcd in Thiclcmans ct al., 1998). Hcnce causcs inadcquatc 
stimulation of Leydig cells resulting in testosterone deficiency with poor 
spermatogenesis. Patients homozygous for the mutation do not undergo normal pubertal 
development and are infertile, however, heterozygous patients undergo normal pubertal 
development presenting with sub fertility (Weiss et al., 1992). 
Kearns-Sayre syndrome predominantly affects endocrine and neuromuscular systems, 
phenotypes including: pigmentary degeneration of the retina, cardiac conduction defect 
and cerebellar ataxia. Abnormalities in the reproductive system are reported in 20-30% 
of affected males, including cryptorchidism, pubertal delay, lower testicular volume and 
low gonadotrophin levels (Harvey and Barnett, 1992). Prevalence of sub fertility 
among these individuals has not yet been reported (Meschede and Horst, 1997). Kearns- 
Sayre syndrome is a multisystemic disorder caused by mutations in the mitochondrial 
genome (reviewed in Johns, 1995). 
Young syndrome patients are characterised by chronic sinopulmonary infections and 
obstructive azoospen-nia, however, it should be noted that in these patients 
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spermatogenesis is normal. Histological studies have revealed the obstructive 
azoospertnia as being caused by thickened secretions, resulting in obstructions within 
the epididymis (Handelsman et at., 1984). 
Table L2- List of syndromes caused by single gene defects, frequency, phenotype and inheritance if 
known 
C".. 
Ysticf1brosis 1/2,500 
, m- ". 
Wollfian duct maldevelopment, 
--i. rV" 
Autosomal recessive CFFR 
respiratory infections, pancreatic gene chromosome 7q3l. 2 
insuff icicncy 
Congenital absence of 1/60,000 Isolated abnormalities in wollfian duct CFrR gcne 
the vas deferens 
I 
Imotile cilia 1/10,000- Immotilc spcrmatozoa, chronic Autosomal recessive 
16,000 sinusifis, bronchitis chromosome Ip35.1 
Bardet-Biedle Unknown Hypogonadism resulting in Autosomal recessive 
spcrmatogenic; impairment chromosome 16q2l 
Persistant mullerian Unknown Pseudohermaphrodifism and impaired Autosomal. recessive, two loci 
duct syndrome spermatogcnesis MIF 19p 13 and MIF receptor 
12qI3 
Sci-reductase Unknown Pseudohermaphroditisin and abnormal Autosomal recessive, located I 
external genitalia on chromosome 2 
Usher's 1/30,000 Sperm axonemal dysfunction, hearing Autosomal recessive USHIA- 
loss, retinitis pigmentosa E chromosome I1 q13.5 
Cerebellar ataxia Unknown Lack of secondary sexual 
characteristics, hypothalamic pituitary 
dysfunction 
3-j6hydroxysteroid Unknown Incomplete masculinization Autosomal recessive maps to 
dehydrogenase chromosome I 
deficiency 
17-ahydroxylase Unknown Defective virilization, resulting from Autosomal recessive 
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deflkiency impaired tcstosterone synthesis. 
17-j6hydroxy Unknown Pseudohemaphroditism, with Autosomal recessive 
dehydrogenase complete /incomplete female genitalia 
Myotonic dystrophy 1/8,000 Tcsticular atrophy, muscle wasting, Autosomal dominant variable 
cataract penetrcnce chromosome 
19ql3.3 
Polytystic kidney 1/800 Multiple cysts in seminal vesicles, Autosomal dominant, PKD I 
disease epididymis, liver, kidneys chromosome l6p13.3 
Noonan 1/1,000- Cryptorchidism, testicular atrophy and Autosomal dominant, 
112,500 delayed puberty chromosome 12q22 
Kallmann 1/10,000 Delayed puberty, small testes, anosmia X-linked recessive KAL locus 
cleft palate Xp22.3 
Androgen insensitsity 1/60,000 Different degree of testicular X-linked recessive androgen 
ferninisation, (oligolazoospermia) receptor XqI 1-12 
Aarskog-scoft Unknown Genital abnormalities, reduced fertility, X-link-ed recessive Xp 11.21 
cryptorchidism, defects in sperm 
acrosome reaction implicated 
Adrenomyelopathy Unknown Endocrine/exocrine testicular failure: X-linkcd recessive, ADLP 
impotence, azoololigozoospermia low gene Xq28 
testostcrone levels 
SRHA Unknown Testicular atrophy, defective Trinuclcotide repeat CAG 
spermatogcnesis, oligo- azoospermia 
and gynaecomastia 
Bioactive LH Unknown inadequate stimulation of the leydig Unknown mode of inheritance 
cells, testosterone deficiency results in 19ql3.32 
poor spurnatogenesis 
AKAP-82 Unknown Disturbance of sperm motility Chromosome Xp 11.12 
Kearns-Sayre Unknown Cryptorchidism, delayed puberty, low Unknown mode of inheritance 
gonadotrophin 
Youngs Syndrome Unknown Obstructive azoospermia, as a result of Unknown mode of inheritance 
thickened secretions within the 
epididymas 
I aDle aaaplea ffom male le=ty and miertihty, Fatnzio, F and tiroomlicld, 1) (1999) page 164 
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1.2.2 Genes implicated in infertility 
A vast number of mutations within genes have been reported to impact on fertility, 
through numerous studies carried out in model organisms including drosophila and 
mice. A comprehensive review of over 200 mutations associated with reproductive 
defects in both male and female mice has recently been published (Matzuk and Lamb 
2002 www. nature. com/fertili! y). An adaptation of the table presented in this review 
listing individual genes, sex affected, reproductive phenotype and the fertility status of 
individuals affected can be found in appendix A. It is possible that all fonns of 
infertility may have some kind of genetic component, for example, individuals may 
have a genetic susceptibility to diseases that affect fertility (e. g. chlamydia). 
1.2.3 Multifactorial and Polygenic disorders 
Several approaches, including linkage analysis and positional cloning in recent years 
have seen an explosion in the identification of mutations within genes resulting in 
Mendelian disorders. However, the identification of genes involved in polygenic genetic 
diseases has been less forthcoming. The detection of Polygenic diseases are considered 
to be caused as a result of multiple interacting genes and the environment, and are 
believed to occur at a much higher incidence (Rannala, 2001). 
The advent of the Human Genome Mapping Project (HGMP) has provided researchers 
in the field of human genetics with a powerful resource, that will aid in the 
identification of the genes involved in polygenic disorders. This will be extremely 
useful in male and female infertility enabling research to be undertaken in candidate 
gene screening, homology studies and animal modelling. The majority of male specific 
genes are located on the Y chromosome (refer to section 1.3.3) and therefore the 
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complete mapping of the Y chromosome will enable the functional properties of 
individual genes to be identified through a number of techniques including protein 
binding studies, expression studies and inhibition studies. The results of the HGMP 
serve to increase our understanding of the genome and its interactions and as a result 
aims to elucidate and identify potential polygenic and multifactorial disorders involved 
in infertility. It has also been proposed that the advent of the HGMP could potentially 
alter our current thinking in medical care from that of a treatment approach to a 
prevention based method, dependent on the identification of individual risk (Guyer and 
Collins, 1993). 
1.3 The chromosomal basis of infertility 
1.3.1 Meiosis 
Meiosis is a specialized form of cell division, its main features are to halve the number 
of chromosomes in the gametes, and the generation of genetic variation among the 
population. Meiosis (figure 1.1), unlike mitosis consists of an initial round of DNA 
replication, which is subsequently followed by two rounds of cell division. In short 
these are split into; MI which involves the segregation of homologous chromosomes 
from each other and Mll whereby sister chromatids are segregated. This process results 
in the production of 4 haploid daughter cells from one diploid germ cell. These 
divisions are, however, preceded by a unique meiotic stage (prophase) in which 
homologous chromosomes synapse and undergo recombination. 
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The process of meiosis in males and females is fundamentally similar, however there 
are important differences, these differences include: time of onset, duration and 
outcome. Prenatally germ cells in the developing testis (spermatogonia) and ovary 
(oocytes) both undergo mitotic proliferation. In males, a brief period of mitotic 
proliferation is followed by a period of mitotic arrest. After birth male spermatogonia 
resume mitotic proliferation and once puberty is reached cells continuously undergo 
mitotic and meiotic cell divisions. Sperm production therefore continues throughout the 
lifetime of the male. In females the brief period of mitotic proliferation is followed by 
the entry of all cells into meiotic prophase. Before birth all cells enter meiotic arrest, 
quiescent oocytes are then surrounded by somatic cells forming primordial follicles 
before birth. Once puberty is reached these are stimulated to grow throughout the 
reproductive life of the female, usually one mature oocyte is ovulated once a month. 
Unlike in males this process will only continue until the limited pools of oocytes are 
depleted (subsequently the female enters the menopause at approximately 50 years of 
age). 
Spermatogenesis (figure 1.2) in the male begins at the onset of puberty, and is a 
continual process occurring in the serniniferous tubules within the testes. Spen-natogonia 
(containing a diploid number of chromosomes) develop from primordial germ cells that 
lie within the tubules and at puberty the spermatogonia undergo mitosis. Of these 
progeny some continue to divide indefinitely, however others undergo meiosis and 
hence produce primary spermatocytes (containing a tetraploid configuration). These 
cells continue into division I of mciosis producing secondary spermatocytes and by the 
end of the second meiotic division these cells will have now formed haploid spermatids 
19 
(fillLire 1.2 sperril melosis), which then Linder,, o a series of morphological differentiation 
steps in order to become spermatozoans. 
Figure 1.2- sperin nleiosis 
III O--t( 
all 
Sperm at ogellesis 
Figure 1.2- The lelt hand side illustrates the various stages ol'inciosis during 
spermatogencsis, on the right hand side Is a Sertoll cell, with the ILIIIICII 01'111C IubLIlC 
found at the bottom ol'thc diagram. Various sta. ges ofspci-matogeriesis are illustrated 
embedded in the plasnia membrane ofthe Scrioll cell. Image taken from 
www. luc. edu, depts/bioloi4y/dev/speriiielo. litiii 
1.3.2 Chromosome aberrations 
Given that the formation and movement ot'chromosomes is involved in pre-mciotic 
divisions in mciosts and in fertilisation and in subsequent c1cavage divisions, it is not 
surprising that many infertility phenotypes have been associated with identifiabic 
chromosome abnormalities. Structural anomalies are often the rcSLllt ot'a breakage that 
occurs during ineiosis and in this case a number of outcomes arc possible: loss of 
material (deletion), gain of material (duplication) and chromosome rearrangements. 
These can be ftirther divided into the following: 
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Constitutional inversions (considered in section 1.3.2.1) 
Constitutional translocations (considered in section 1.3.2.2) 
-Y chromosome deletions (considered in section 1.3.3) 
- Constitutional aneuploidy (including mosaicism) (considered in section 
1.4) 
i. Including sex chromosomes (considered in section 1.4.2) 
ii. Autosomes (mainly chromosome 2 1) (considered in section 1.4) 
- Aneuploidy in the gametes 
i. Maternal age effect for the oocytes (considered in section 1.4.4) 
ii. Spenn aneuploidy (considered in section 1.5) 
1.3.2.1 Constitutional Inversions 
An inversion is the result of a single chromosome with two breaks, in which the 
chromosome segment is inverted, subsequently reversing the order of the genes 
compared to the wildtype. This inversion is problematic for the normal continuation of 
mciosis, as synapsis is compromised, due to the re-ordering of the genes along the 
length of the chromosome in inversion heterozygotes. In this case one or the other of the 
chromosomes twists into a loop (inversion loop) in the inverted region. Within the 
inversion loop if no crossing over takes place the homologous chromosomes can 
separate normally, if the crossing over takes place within this loop the chromatids 
involved become joined, resulting in the fort-nation of chromosomes containing 
duplications and deletions (figure 1.3 and 1.4). Individuals are hence at risk of 
producing unbalanced gametes (i. e. may lead to the conception of a foetus with an 
unbalanced amount of genetic material). Inversions are split into two categories; those 
not involving the centromere (paracentric); and those involving the centromere 
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(pericentric). Frequencies of paracentric and pericentric inversions have been found to 
be 8 times higher in severe oligozoospermic mates compared to the normal fertile 
population (Patrizio and Broomfield, 1999). 
There are a number of mechanisms by which inversions result in reduced fertility, 
including the time constraints and mechanics of the formation of a pairing loop imposed 
by the meiotic machinery which can hinder meiosis (Forejt et al., 1982). The use of 
single sperm PCR has also identified a reduced number of cross overs within the pairing 
loop suggesting reduced recombination within the inverted region which in turn can 
result in the breakdown of meiosis (Brown et al., 1998). Chandley et al. (1987) 
observed extensive disturbances of meiotic pairing resulting in failed synapse formation 
during meiosis I across the inverted region in heterozygote carriers, which in turn can 
lead to unbalanced gametes. (Patrizio and Broomfield, 1999). 
Figure 13- Formation of a pairing loop in a pericentric inversion heterozygote, illustrating the results of 
a crossing over within the pairing loop 
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Figure 1.4- Formation of a pairing loop in a paracentric inversion heterozygote, illustrating the 
results of a crossing over within the pairing loop 
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Images taken from http: /twww. med. nyu/Sackler/2003t&i. htm 
1.3.2.2 Constitutional translocations 
Structural anomalies also include translocations (which involves the exchange of non - 
homologous chromosome segments). Rearrangements are described as being balanced, 
(if all genetic infonnation is kept) and unbalanced (if there has been any loss or gain of 
genetic information) (figure 1.5). Balanced translocations are estimated to occur in I in 
500 individuals, the majority of which do not display any abnormal phenotype with the 
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exception of decreased fertility and the risk of chromosome abnormalities in offspring 
due to the mal-segregation of the tmnslocation. 
Translocations interfere with normal chromosome pairing and segregation at MI, and 
therefore are potentially at risk of producing unbalanced gametes and hence 
chromosomally abnormal offspring. Spermatogenesis results in the fonnation of three 
possible combinations including normal, abnormal balanced (both of which are 
phenotypically normal however, the latter will be a carrier of the translocation) and 
abnormal unbalanced spermatozoa (figure 1.5). Offspring conceived with abnormal 
unbalanced spermatozoa will be partially trisomic and monosomic (as a result of 
duplications and deletions (respectively) in the parts of the genome involved). The risk 
of abnormal unbalanced spermatozoa. is difficult to quantify as a number of factors such 
as the size of the chromosome segment involved, the breakpoint location and the type of 
rearrangement all play key roles in the pairing and segregation process of chromosomes. 
In a large percentage of cases any unbalanced conceptions will perish in utero (again 
dependant on the size and chromosomes involved) as they are not viable. The incidence 
of reciprocal translocations has been estimated to be 5 times higher in males with severe 
oligozoospermia. (Patrizio and Broomfield, 1999). 
1.3.2.2.1 Autosomal translocations 
There are a number of reasons as to why autosome-autosome translocations can result in 
a reduction in fertility. In order for these chromosomes to proceed through meiosis it is 
essential for the chromosomes to synapse and must therefore form a pairing cross 
(quadrivalent). The formation of this quadrivalent can affect fertility as the mechanics 
involved and the time constraints imposed in this formation can impede the meiotic 
process (Forejt et al., 1982). The disjunction of the quadrivalent is also susceptible to 
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producing unbalanced gametes, depending on the type of segregation. The gametes will 
either contain the following: adjacent-I and adjacent-2 segregation = extra or missing 
chromosome; alternate segregation = normal and carrier of the translocation (refer to 
figure 1.5). Failure of meiosis can also occur as a result of asynaptic regions within the 
quadrivalent, leading to the elimination of germ cells (Miklos et al., 1974). Lyon et al. 
(1966) have provided evidence of non-homologous pairing between segments of 
translocated chromosomes and the sex chromosomes (X and Y) during meiosis I. This 
interaction can interfere with X inactivation resulting in a lethal gene dosage effect on 
the germ cells (Forejt et al., 1982). Chandley et al. (1984) reported that interactions may 
occur between the translocated segments and other parts of the nucleus which may 
result in errors in meiosis and cell death. 
1.3.2.2.2 Robertsonian translocations 
Robertsonian translocation involves the centromeric regions of two nonhomologous 
acrocentric chromosomes fusing to form a single centromere. The heterozygous carrier 
is usually phenotypically normal but there is a high risk of aberrant segregation in 
meiosis. There is an estimated 10 fold increase in the incidences of robertsonian 
translocations in infertile men, the most common translocation observed in the mate 
infertility population is that of t(13ql4q), followed by t(14q2lq). Meiotic studies of 
infertile carriers of t(13ql4q) and t(14q2lq) have demonstrated the behaviour of the 
autosomes involved in meiosis to be abnormal during spermatogenesis resulting in 
infertility (Luciani et al., 1984; Rosenmann et al., 1985). The heterochromatic short ann 
of acrocentric chromosomes have been found to contain nucleolar organiser regions 
(NOR). These NOR are involved with RNA synthesis, however they are also required to 
associate with the sex chromosome vesicle. Robez et al. (1986) reported that 
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I Fieure 1.5 Illustrates the formation of a (wadrivalent and the vossible seRmation vattems in a heterozvlzous translocation I 
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Robertsonian translocations in which the NOR has been lost are at an increased 
likelihood of cell disruption, and genn cell death, thereby reducing the fertility of the 
individual involved. 
1.3.2.3 Supernumerary marker chromosomes and rings 
Superriumerary chromosomes are extra chromosomes that are too small to characterise 
by standard cytogenetic banding which therefore does not allow identification and as a 
result the origin cannot be discerned. Carriers of marker chromosomes and ring 
chromosomes are at risk for spermatogenic impairment due to meiotic arrest and 
instability that frequently results in maturation arrest at the spermatocyte stage 
(Chandley et al., 1997). 
1.3.3 Y chromosome deletions 
1.3.3.1 The Y chromosome 
In mammals, sex is determined via a chromosomal mechanism, unlike in some 
organisms such as reptiles whereby other mechanisms are in place (e. g. the temperature 
at a certain point of development). In mammals, females are homogametic having two 
X chromosomes and males are heterogametic possessing an X and Y chromosome. The 
male phenotype is determined by the presence of the Y chromosome. The X 
chromosome is larger in size and highly conserved between eutherian mammals, 
whereas the Y chromosome is much smaller, poorly conserved and largely 
heterochromatic. The sex chromosomes undergo pairing and recombination in the small 
pseudoautosomal region at the ends of the p-anns. 
Genes that have been identified on the Y chromosome have been shown to possess X 
linked homologues which, together with the pairing at the pseudoautosomal region 
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suggests that the X and Y chromosomes may have arisen from an autosomal pair in an 
ancestral mammal. Differentiation between chromosomes X and Y is thought to have 
occurred when an allele at a single locus on the proto-Y took over a male determining 
function from either an ancestral genetic or environmental determining system. 
Furthermore, the evolution of a second male determining or differentiating locus on the 
proto-Y may then set up conditions whereby coinheritance of these alleles would be 
advantageous to males. This situation could have resulted in a suppression of 
recombination between these loci (Graves, 1998). Restriction of recombination is likely 
to result in the isolation from the homologue resulting in mutations, inactivation and 
deletions via either genetic drift or the selection of a new allele (Charlesworth, 1991). 
These genetic changes have been demonstrated to be present in the Y chromosome, by 
the comparison of the sequence of genes when compared with their X chromosome 
counterparts (Whitfield et al., 1993). 
It is hypothesised that the formation of the Y chromosome has arisen through various 
cycles of attrition of the X chromosome and the addition of autosomal regions with 
genes on the Y chromosome being under constant threat of mutation, deletion, 
inactivation and degradation. It has been suggested that only favoured genes survive 
over a long evolutionary time, thus selective forces are in operation in retaining those 
that perform male specific functions such as male determination and differentiation 
(Graves, 1995; 1998). 
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1.3.3.2 Deletions in the Y chromosome and incidence 
Until relatively recently, the large majority of infertility was described as idiopathic, 
with no specific known actiological factor being established. One genetic factor 
however, being abnon-nalities within the Y chromosome, which are now attributed to a 
significant proportion of infertility phenotypes. The first breakthrough came in 1976 
when Tiepolo and Zuffardi reported macrodeletions in the chromosome region Yq in 6 
azoospermic males. Since then it has been hypothesised that I or more genes within this 
region may possess important roles in the maintenance of spermatogenesis (Fitch, 1995; 
Patrizio and Broomfield, 1999). Numerous studies have utilised PCR and STS's, 
reporting microdeletions within the Y chromosome in severely oligozoospen-nic males, 
this has lead to the suggestion of a presence of an azoospennia factor (AZF). The AZF 
locus located on Yq and has been mapped to interval 6 of the Y chromosome (within 
the cytological band YqI 1.23), at least three deletion intervals have been defined 
(AZFa, AZFb and AZFc, located in the proximal, central and distal segments of Yq 
respectively), (Patrizio and Broomfield, 1999; Reijo et al., 1996; Vogt et al., 1996) 
(figure 1.6). In many cases deletions in the Y chromosome are thought to arise de-novo 
from fertile fathers with intact Y chromosomes and are rarely cytogenetically visible, 
these deletions represent one of the most frequent structural chromosomal anomalies 
affecting an estimated I in 5,000-10,000 males (Le Bourhis et al., 2000; Kent-First et 
al., 1996). 
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Figure 1.6- Map of the Y chromosome 
A functional map of the Y Chromosome 
(taken from Lahn & Page 1997, Science 278: 675) 
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1.3.3.3 Mechanism of Y chromosome deletions 
The frequency of de-novo Y deletions indicates that the Y chromosome is susceptible to 
spontaneous loss of genetic material (McEireavey and Krausz, 1999). Instability of the 
Y chromosome may be related to high levels of repetitive elements clustered along the 
length of the chromosome, deletions may occur through the aberrant recombination 
events (either between areas of homologous or similar sequence repeats, between the X 
and Y chromosomes, Y chromosome unbalanced sister chromatid exchange) or by 
slippage during DNA replication. It is also possible that particular sequences may 
promote deletion of the AZF regions and as a consequence individuals may be more 
susceptible to de-novo deletions than others (McElreavey and Krausz, 1999). 
The deletions reported so far are, however, variable in extent and location and at present 
no pattern has been identified and may be attributed to a number of factors including: 
ethnic variation, geographical variation, patient selection and experimental design. The 
incidence of deletions in the AZF region is estimated to affect approximately 15% of 
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men with azoospen-nia and 10% of men with severe oligozoospermia (Kent-First et al., 
1996; Reijo et al., 1995). 
1.3.3.4 Identified genes in Y chromosome microdeletions 
A number of studies have investigated the incidence presence and location of these 
deletions, and a number of candidate genes have been identified. Current knowledge 
about the biochemistry or the biology of Y chromosomes proteins is very limited with 
the exception of two genes which have been the subject of extensive research: RBM 
(RNA binding motif) and DAZ (deleted in azoospermia) and will be discussed further in 
subsequent sections. In recent years a number of other candidate genes have also been 
identified, but as of yet there is limited information on function and association with 
infertility, however, their location falls within the AZF region of the Y chromosome. 
Within the AZFa region genes such as DFFRY (Drosophila fat facets related Y), DBY 
(dead box Y) and UTY (ubiquitous transcribed tetratricopeptide repeat gene Y) have 
been identified. Deletions within this region have been implicated in infertility, 
including oligozoospermia (DFFRY alone) and Sertoli cell only syndrome (DFFRY and 
DBY together) (McElreavey and Krausz, 1999). These genes are involved in general 
'housekeeping' functions and are not specifically expressed in the testes, as are other 
genes within this region, for this reason they may not be directly involved in 
spermatogenesis but may be involved in control of protein turnover required for 
successful spen-natogenesis (Affara, 2001). Within the AZFb region PRY (protein- 
tyrosine phosphatase BAS like (PTP-BL)- related Y) and RBM have been identified. 
Mapped to the AZFc region, genes CDY (chromodomain Y), BPY (basic proteins Y) 
and DAZ are found. Stuppia et al, (1998) reported deletions within the AZFc region that 
do not encompass DAZ genes but may involve other genes located in this region such as 
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CDY and BPY, suggesting that other loci may contribute to fertility, and this in turn 
may partially explain the variation seen in phenotype, as these may be associated with 
different deletions. 
1.3.3.5 RBM (RNA binding motif) 
RBM (Ma et al, 1993) is part of a family estimated to contain 40 members of genes and 
pseudogenes, spread across the entire length of the Y chromosome with clustering in the 
AZFb region (Chandley et al., 1998). RBM has been shown to be expressed specifically 
within the testes and antibodies to the RBM protein illustrate that localisation is 
confined to the nucleus of germ cells and is present in all stages of spermatogenesis 
with the exception of elongating spermatids, (Elliot et al., 1997). The function of RBM 
has been suggested to be in RNA binding protein and localisation factors associated 
with splicing factors (Elliot et al., 1998). Comparative analysis of RBM and related 
genes in different eutherian mammals and marsupials suggest that these genes have an 
important function as they are conserved on the Y chromosome and is consistent with 
these genes having an essential function such as spennatogenesis, (Affam, 2001). Due to 
the fact that RBM genes are a multicopy family it is difficult to provide direct genetic 
and functional evidence that they are critical to spermatogenesis and if this is the case 
whether one or multiple copies are required for normal spermatogenesis (Ma et al., 
2000). Nevertheless there is indirect evidence for the requirement of RBM for normal 
spennatogenesis these include: the location within the AZFb region, testes specific 
expression and the protein association with genn cell nuclei. (Elliot et al., 1997). 
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1.3.3.6 DAZ (deleted in azoospermia) 
The second candidate gene "DAZ" was isolated in 1995 (Reijo et al., 1995), and, as in 
RBM, was found to encode an RNA binding protein specifically expressed in the testes, 
and is a multi gene family containing at least 7 copies clustered in the distal region of 
interval 6, located within the AZFc region. Unlike other gene families on the Y 
chromosome DAZ genes are not dispersed along the Y chromosomes, but are all 
locatedwithin the commonly- deleted DAZ region (Krostiner et al., 1998). Deletions 
encompassing the DAZ region of the Y chromosome have been identified as the most 
common molecularly defined cause of infertility in men. This occurs at an estimated 
rate of 13% of azoospermic men and 6% of severely oligozoospermic men (<5 
million/mi) (Reijo et al., 1995; Stuppia et al., 1996; Foresta et al., 1997; Simoni et al., 
1997). The identification of genes critical to fertility has been extensively researched 
with several putative genes mapping to the DAZ region (Ma et al., 1993; Reijo et al., 
1995; Latin and Page, 1997). No specific point mutations, however have yet been 
identified, thus evidence linking deletions within the DAZ genes and infertility as in 
RBM is indirect. Nevertheless, no deletions have so far been identified in men with 
non-nal sperm counts, whereas in men with low or complete absence of sperm cells, 
deletions removing all or most of the DAZ gene cluster are found in 6-13% (Reijo et al., 
1995; Pryor et al., 1997; Simoni et al., 1997). Also the fact that DAZ genes are not 
dispersed along the Y chromosome, suggests that the DAZ region is of importance as 
deletions of single genes or a subset of genes in this case may lead to phenotypically 
silent or mild defects in spermatogenesis, whereas anomalies have been reported in 
severe defects only. DAZ genes have also been highly conserved despite the tendency 
for degradation of genes on the Y chromosome (Saxena et al., 1996), suggesting the 
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involvement in an important function. Homologues of the DAZ genes in model 
organisms have also been identified and disruption of these causes infertility in 
drosophila by arresting MI at the pachytene stage and in mice no functional copy results 
in sterility, and one copy in sub fertility (reduced numbers of spermatozoa). Deletions 
within the DAZ gene cluster in humans have been found to produce similar phenotypes 
compared to those of the model organisms, sterility and greatly reduced numbers of 
spennatozoa (Reijo et al., 1995). 
13.3.7 The future of Y chromosome microdeletions 
The function of these genes in the AZF region and their expression during 
spennatogenesis is still uncertain and knowledge of genetic control remains limited but 
it is reasonable to assume that the regulation will be through the expression of a number 
of genes. The pattern of Y chromosome deletions is currently inconclusive, although 
there is a definite cause and effect relationship between Y chromosome deletions and 
male infertility. A definite prognosis will only be made when one genotype is strongly 
correlated with a particular phenotype and there is a known function for the gene and its 
role in spen-natogenesis (Liow et al., 2001). Attempts to correlate genotypes and 
phenotypes have been largely inconclusive, a number of studies have not included 
histological findings and those that have, often have not correlated deletion findings 
with phenotype. Studies that have attempted to do this have found that similar or 
identical deletions in patients can cause different impairments in spermatogenesis 
(Affara, 2001). 
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1.4 Aneuploidy 
1.4.1 Aneuploidy as a result of non-disjunction 
Aneuploidy arises as the result of the failure of chromosomes to segregate properly at 
meiosis resulting in a process called non-disj unction. Non-disjunction results in the loss 
(monosomy) or gain (trisomy) of chromosomes from the normal diploid number, this in 
turn is the most commonly identified chromosomal abnormality in humans, occurring in 
at least 5% of all clinically recognized pregnancies (Griffin, 1996a; Hassold et al., 
1993). In the majority of cases an aneuploid conceptus will not survive full term, as a 
result it is the most common genetic cause of pregnancy loss, however, it is also the 
leading cause of mental retardation in humans in those that do survive full term 
(Hassold et al., 1993; 1996). Despite the clinical ramifications caused by aneuploidy, 
relatively little is currently known about how aneuploidy originates in humans. 
Analysis of aneuploidy within the female gametes is difficult to undertake in humans, as 
female gametes are only obtainable through the hyperstimulation of the ovaries and 
surgical removal of the gametes as occurs in lVF and ICSI treatment (refer to section 
1.6). Male gametes on the other hand do not require surgical removal and hence are 
more amenable for analysis, therefore it is not surprising to find that most studies 
investigating aneuploidy have been carried out in spermatozoa. 
1.4.2 Sex chromosome aneuploidy 
1.4.2.1 Turner Syndrome 
Turner Syndrome is a sex chromosome abnormality that affects females. These 
individuals usually present with monosomy of the X chromosome (45, XO) in 55% of 
35 
cases with other karyotypes including 46, X, I(Xq), 46, XX/45, X and various structural 
abnormalities including deletions and ring X chromosomes (Shah et al., 2003). The 
incidence is estimated to be around 115,000-1110,000 females. Individuals often present 
with ovarian dysgenesis with hypoplasia and are often short in stature and do not 
undergo sexual maturation as a result of the haplo-insuff iciency of the XY homologous 
genes critical for gonadal development (Witters et al., 2001). The majority of 45, X 
individuals are due to paternal origin with the following possible mechanisms acting: 
meiotic non-disjunction at meiosis I or II, or anaphase lag resulting in a spenn. with a 
missing sex chromosome in an estimated 75% of cases (Hassold et al., 1993). The 
generation of a 45, X karyotype in a 46, XY or 46, XX zygote may also arise through 
anaphase lag of the patemal X or Y chromosome (Jacobs et al., 1997). 
1.4.2.2 Triple X syndrome (47, XXX) 
The incidence of 47, XXX is estimated to occur at an incidence of 1/1,000 females, the 
additional X chromosome is maternal in origin and associated with increasing maternal 
age in approximately 95% of cases (Hassold et al., 1996). Individuals often present with 
normal phenotypes including weight, mental function and pre-pubertal development, 
individuals are usually fertile but display an early onset of the menopause at around 30 
years of age compared to the general population (around 50 years of age) (May et al., 
1990). However, individuals with four or more X chromosomes have been reported to 
present with clinical features and is attributed to the increased dosage of gencs, that 
escape X inactivation and as a result the severity of the clinical features reported 
increase in proportion with the number of X chromosomes (Shah et al., 2003). 
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1.4.2.3 Klinefelter Syndrome (47, XXY) 
In this syndrome affected males, prior to puberty are phenotypically normal, with the 
exception that they are generally tall with disproportionately long and thin legs. After 
puberty however manifestations include small atrophic testes that are severely depleted 
or absent of germ cells, and impaired secondary sexual characteristics, educational 
disorders especially that of dyslexia, normal intelligence or some mild retardation with 
the majority of patients being infertile. 
There are two main karyotypes found in these cases: 
1) Non-mosaic 47, XXY 85% 
2) Mosaic 46, XY/47, XXY 15% 
(in some rare cases, others variants of the syndrome are found: 48, XXXY, 48, XXYY, 
49, XXXXY, and in mosaicism more than two cell lines are found). The incidence of 
Klinefelters is estimated to be around I in 1,000 live male births, I in 300 spontaneous 
abortions, 1-2 in 100 infertile men and 7-13 in 100 azoospen-nic men (Mak and Jarvi, 
1996). Klinefelter syndrome is caused by the meiotic non-disjunction of the XY 
bivalent at male meiosis 1 (50%), or of the X chromosome in female meiosis 1 (33%), 
with the remainder of cases as a result of errors in female meiosis 11 or from postzygotic 
mitotic error leading to mosaicism. The severity of Klinefelter syndrome varies, some 
tubules may contain Sertoli cells whereas others may be completely devoid. The range 
of spermatogenesis and the production of mature spermatozoa is sometimes seen, 
however, this is often when a mosaic karyotypc is present. The severity of the syndrome 
is associated with which karyotype is presented, those with a mosaic karyotype 
generally have less severe abnormalities than those with the non-mosaic karyotype, also 
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the increasing number of X chromosomes present the greater the severity of the 
phenotype. 
1.4.2.4 XYY syndrome 
47, XYY syndrome, has an estimated incidence of 1-4 in 1,000 of all live male births 
(Mak and Jarvi, 1996). These men are often phenotypically tall and the origin of this 
syndrome is as a result of non-disjunction of the Y chromosome at paternal Mll 
resulting in YY disomic spermatozoa. In the majority of cases these men are severely 
oligozoospermic or azoospermic. The mechanism of reduced sperm production in 
affected individuals appears to be secondary to spermatogenic arrest of most YY germ 
cells due to abnormal meiotic pairing during meiosis, (Speed et al., 1991). The severity 
of the damage to the germ cells has been shown to correlate with higher FSH and LH 
levels (Mak and Jarvi, 1996). 
1.4.2.5 Noonan syndrome 
Noonan syndrome is the male equivalent of Turner syndrome, the incidence is found to 
be around I in 1,000-2,500, the phenotype presented is similar to that of Turner's 
syndrome. Karyotype analysis of these patients reveals a 46, XO/XY mosaicism, in most 
cases males have compromised testicular function and elevated gonadotrophins, 
cryptorchidism and testicular atrophy. 
1.4.3 Autosomal trisomies 
1.4.3.1 Trisomy 21 (Down syndrome) 
The incidence of Down syndrome occurs at an estimated rate of I in 700, in rare cases, 
female patients with Down syndrome may become pregnant and bear children. The 
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majority if not all males, however have impaired spermatogenesis, males are almost 
exclusively sterile, presenting with spermatogenetic arrest, reduced number of germ 
cells, and hyalinized tubules. The mechanism by which trisomy 21 affects testicular 
histology is unclear, the prevailing hypothesis is that there may be a reduced 
proliferation of the primordial germ cells during their migration to the gonadal ridge, 
perhaps associated with an accelerated rate of apoptosis. (Patrizio and Broomfield, 
1999). 
1.4.4 Maternal age effect 
The relationship between reduced fertility in women and increasing matemal age is long 
established (Hassold et al., 1996). Increasing maternal age has been significantly 
correlated an increased risk of producing trisomic offspring such as Down syndrome, 
however, increasing age has also been found to be the most common cause of 
pregnancy loss. An estimate of 25% of first trimester spontaneous abortions have been 
found to be trisomic. This may be a conservative estimate as it is likely that many other 
aneuploid conceptuses are spontaneously aborted prior to reaching the stage of clinical 
recognition (including autosomal monosomies and trisomies of chromosomes I and 19) 
(Shah et al., 2003). Several models have been put forward to explain the effect of 
matemal age, the first of which is the "production line hypothesis" and is based on the 
findings of Henderson and Edwards (1968) in rabbit eggs. This model proposes that 
oocytes that enter meiosis first are the first to be ovulated, with those entering meiosis 
last being ovulated last, and that these are more prone to non-disj unction. This therefore 
suggests that the depletion of oocytes within the ovaries results in the remainder being 
more prone to mal-segregation (Peters and McNatty., 1980). There are however, some 
difficulties with this particular model, in that mammalian eggs all enter meiosis 
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prenatally proceeding to diplotene whereby they then arrest until ovulation when the - 
eggs resume meiosis (Griffin, 1996a). Secondly, it has been hypothesised that it is 
unlikely that such a significant effect on chromosome segregation could occur years 
later as a result of events initiated prior to birth (Griffin et al., 1996a; Koehler et al., 
1996; Speed and Chandley et al., 1983). As a result, the Local factors Hypothesis was 
proposed (Crowley et al., 1979; Eichenlaub-Ritter et al., 1988; Sugarawa and Mikarno 
et al., 1983), suggesting that the effect seen may be due to extrinsic factors within the 
ovary that occur with increasing age that directly affect the eggs. This suggests that the 
ovarian environment itself becomes compromised as a woman ages and that the eggs in 
the ovary become more prone to the mal-segregation of chromosomes. A number of 
changes within the ovary have been associated with increasing age and subsequently 
affecting chromosome segregation including that of hon-none levels, pH and oxygen 
concentration (Gaulden., 1992). In fact several studies have demonstrated that the 
spindle apparatus in older women with a lower intracellular pH is less well-formed (Van 
Blerkorn et al., 1997; Van Blerkorn-, 1998; 2000; Van Blerkorn and Davis., 2001). This 
hypothesis has been backed up further by several studies that have compared the non- 
disjunction of human chromosome 21 and the Drosophila NOD DTW mutation (Hawley ct 
al., 1994; Koehler et al., 1996). These studies have proposed that older and younger 
eggs with proximal (or two) chiasmata have fewer problems segregating chromosome 
bivalents whereas older eggs that have either no or distal chiasmata are more likely to 
have difficulties with the segregation of the bivalents compared to younger eggs. 
Secondly it has been suggested that the human homologue of the NOD gene product in 
Drosophila plays a central role and is a kinesin like protein, which is believed to be 
involved in maintaining contact between chromosome homologues and between the 
centromeres and the kinetochores (Shah et al., 2003). At present this seems to be the 
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prevailing hypothesis, however the lack of human material to experiment with and few 
comparable mammalian systems have made it difficult to identify whether this is the 
mechanism involved to explain this phenomenon as being the mechanism involved. 
1.4.4.1 Differential aneuploidy rates in human male and female gametes 
As discussed previously the process of meiosis (section 1.3.1) is responsible for the 
generation of haploid gametes and genetic variation among the population. The correct 
segregation of chromosome homologues requires the fon-nation of reciprocal genetic 
exchanges a process known as recombination that results in the formation of chiasmata 
(the physical manifestations of genetic recombination) along the length of the 
chromosome (reviewed by Smith and Nicolas, 1998). Errors within mciotic 
chromosome segregation result in aneuploid gametes and have been found to occur at 
different rates within females and males. The rate of aneuploidy that occurs within 
female gametes is difficult to estimate, primarily due to the difficulties in obtaining 
female oocytes. Hassold and Hunt, (2001), reviewed studies investigating the levels of 
aneuploidy in IVF-derived pre-implantation embryos and that of 'control' oocytes, these 
studies have indicated that the overall aneuploidy rate may be in excess of 20%. In 
contrast it has been estimated that male gametes have a much lower incidence of 
aneuploidy with estimates placing this at around 2% (Hassold, 1998). Errors in mciotic 
chromosome segregation occur frequently in human females, particularly in the first 
meiotic division (MI). Matemal. MI segregation errors predominate amongst almost all 
trisomies (reviewed by Hassold and Hunt, 2001). This is not surprising however, when 
considering the differences in the process of meiosis in males and females (section 
1.3.1). In contrast to males, females undergo a protracted arrest of meiosis in which all 
oocytes enter meiosis prenatally and are arrested at MI prior to ovulation, as a result the 
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completion of MI could take 40 years or longer (reviewed by Hunt and LeMarie- 
Adkins, 1998). 
1.4.4.2 Possible mechanisms for this disparity in aneuploidy rates 
The mechanisms for this disparity between aneuploidy rates in males and females are 
not yet clear, however the use of genetic mapping techniques used to study the 
inheritance of DNA polymorphisms in human trisomic conceptions has uncovered an 
association of aberrant recombination and non-disjunction in humans by comparing the 
frequency and distribution of meiotic exchanges in trisomy-generating meioses 
(Hassold et al., 2000). These studies are reviewed by Hassold and Hunt, (2001), the 
general findings of these studies suggest that all MI-derived trisomies studied to date 
exhibit significant reductions in recombination and include paternally derived cases of 
trisomy 21 and 47, XXY, and maternally derived cases of 15,16,18,21 and sex 
chromosome trisomies. The extent of reduced recombination is variable, with the most 
marked reduction seen in paternally derived 47, XXYs, in which a reduction of around 5 
fold is seen in the genetic map of the XY pairing region between normal meioses and 
trisomy-generating meioses (around 50 cM compared to 10- IS cM) (Thomas et al., 
2000). The effect seen for other chromosomes varies, however it is probable that 
decreased recombination is associated with all human trisomic conditions (reviewed by 
Hassold and Hunt, 2001). The reduced map lengths seen in different trisomic conditions 
are believed to arise through failure of the chromosomes to recombine (hence the 
chromosome bivalent was achiasmate), or a reduction in the number of chiasmata. In this 
case it would involve a bivalent that in the normal situation contains 2 or more 
chiasmata, however only a single sub-optimally placed chiasma was present (reviewed 
by Hassold and Hunt, 2001). These reports suggest that both decreased and aberrantly 
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situated recombination events are risk factors for meiotic: non-disjunction (Koehler et 
al., 1996). 
The identification of meiotic division checkpoints have also provided possible reasons 
for the disparity in aneuploidy rates between males and females, in particular a spindle 
assembly checkpoint mechanism that operates at the metaphase/anaphase transition 
(Wells and Murray, 1996). This checkpoint ensures that there are no defects in spindle 
assembly or chromosome alignment at the spindle equator prior to the initiation of 
anaphase. In the mouse, there is evidence of a gender specific effect of an achiasmate 
chromosome on meiotic cell division. For example in the male mouse, the existence of a 
univalent chromosome results in the metaphase arrest and as a consequence the animal 
is sterile (Sutcliffe et al., 199 1). LeMarie-Adkins et al. (1997) however, investigated 
mciotic cell cycle progression in murine oocytes from XO females and control siblings. 
The results from this study demonstrated that even though the X chromosome did not 
align at the metaphase plate in the majority of cases no delay was detected in the onset 
of anaphase. The results of this study lead LeMarie-Adkins et al. (1997) to suggest that 
mammalian female meiosis may lack this stringent chromosome-mediated checkpoint 
control that operates in male meiosis and hence provide an explanation for the disparity 
in gamete aneuploidy rate between males and females. 
1.4.5 Aneuploidy in human sperm 
Sperm aneuploidy and its association with male infertility is considered within the 
following sections on chromosomes in human sperm. 
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1.5 Chromosomal studies on human sperm 
1.5.1 Techniques used to analyse chromosome complement of 
spermatozoa 
1.5.1.1 Hamster oocyte-human sperm fusion assay 
Whole, G-banded sperm chromosome complements can be analysed by karyotyping 
sperm using the hamster oocyte-human (Humster) spenn. fusion system, this system has 
advantages as it generates information on both numerical and structural abnormalities of 
all the chromosomes. Disadvantages however, include the fact that it is a technically 
demanding method that requires a considerable amount time and is a costly procedure, 
hence is only capable of analysing a few cells and therefore is only able to generate a 
small amount of data. Results using this system are also potentially biased, whereby 
only spermatozoa that are able to fertilise hamster oocytes can be karyotyped, 
potentially excluding spen-natozoa with morphological disadvantages or genetic 
mutations (Jacobs et al., 1992; Martin et al., 1993). The Hurnster assay has however, 
provided a useful benchmark for which data generated from subsequent assays can be 
compared against (Downie et al., 1997). 
1.5.1.2 In-situ hybridisation (ISH) 
The technique in-situ hybridisation enables the hybridisation of a chromosome specific 
DNA probe to bind to complementary sequences on a target chromosome, following 
this the bound probe is then detected, and hence the chromosome (Downie et al., 1997). 
Early studies utilising this technique to study the chromosome complement of 
spermatozoa used isotopic detection methods, however this technique was quickly 
replaced with non-isotopic detection methods as long autoradiography times were 
required and the signals produced were often indistinct (Downie et al., 1997). The major 
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drawback of early ISH techniques is that they only enabled one colour to be used and as 
a result could not provide reliable estimates of disomic spermatozoa as it is not possible 
to distinguish disomic cells from that of diploid cells. 
1.5.1.3 Fluorescent in-situ hybridisation (FISH) 
Since the use of isotopic ISH in the study of aneuploidy in spennatozoa, the non- 
isotopic method used in subsequent studies has been fluorescent in-situ hybridisation 
(FISH) a technique that utilises fluorochromes in the detection of probes (in either red, 
green, blue or a combination of these). The advent of FISH has revolutionised studies 
on chromosomes, and the development of this technique has been rapidly adopted in an 
attempt to identify chromosomal abnormalities in spermatozoa. Two methods of FISH 
have been used in these studies, including indirectly labelled FISH and directly labelled 
FISH. Indirectly labelled FISH involves the hybridisation of a DNA probe labelled with 
either biotin or digoxigenin to the target chromosome(s). Following hybridisation the 
DNA probe is then detected using a fluorochrome-conjugated protein for example 
avidin, for biotinylated probes or a fluorochrome-conjugated antibody for the detection 
of digoxigenin labelled probes. This technique is advantageous as it is a highly sensitive 
technique and enables the intensity of the signals produced to be increased by the 
consecutive amplification of the signal using antibodies. This method however, is costly 
and also produces higher background labelling and is more time consuming compared 
to directly labelled FISH. Directly labelled FISH technique uses probes in which 
fluorochromes including Cy3, Cy5, FITC, TRITC and Texas Red have been 
incorporated within the probe. This is advantageous over indirectly labelled FISH as it 
does not require post hybridisation detection of the haptens and reduces the non-specific 
binding of probes. 
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The use of FISH has many advantages over previous techniques (Humster sperrn fusion 
and ISH) as the technique itself is rapid, taking 2-3 days, and enables the analysis of 
thousands of spen-natozoa to be undertaken for 2-4 chromosomes at any one time. It is 
imperative that if autosomes are being investigated that a dual colour FISH is carried 
out and if the gonosomes are being analysed at least one autosome should also be 
investigated. This enables the distinction of disomic and diploid cells, and is required to 
provide estimates of accurate disomic frequencies (Griffin et al., 1995; 1996b). Thus 
enabling a large number of men to be screened for investigated chromosomes, and has 
proved to be a reliable technique for establishing the frequency of chromosome 
abnormalities in spermatozoa. The main disadvantage with the use of FISH over 
previous methods is that unlike the Hurnster assay it does not allow the detection of 
structural chromosomal abnormalities. 
At least 100 studies have used FISH to examine the chromosome complement in 
spermatozoa, in order to address a number of issues: 
- At what frequency do chromosome abnormalities in spermatozoa occur 
in the normal fertile population? 
Is there any age effect associated with increases in non-d isj unction? 
- Are certain chromosome pairs more susceptible to non-disj unction, than 
others? 
- Is there any increased frequency of chromosome abnormalities in the 
spermatozoa of the infertile population? 
- Are there any phenotypes that confer any increased risk of chromosome 
abnonnalities in spennatozoa? 
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- Is there any increase in the frequency of chromosomally abnormal 
spen-natozoa in men whose karyotype carries a numerical or structural 
abnonnalities? 
- Are there lifestyle/environmental factors that may be associated with 
increases in aneuploid frequencies in spen-natozoa (will be considered in 
section 1.5.9)? 
- Are there intrinsic factors such as DNA polymorphisms that may confer 
increased risks of chromosomally abnonnal spermatozoa? 
Studies addressing these points will be considered in subsequent sections. 
During the early to mid 1990's at least 10 studies investigated the incidence of 
chromosome aneuploidy within the spermatozoa of non-nal fertile men using FISH. 
These studies, taken collectively, have examined the frequency of disomy and diploidy 
of both the autosomes and the gonosomes. These studies examined the rate of 
aneuploidy using single colour FISH or dual colour FISH for the sex chromosomes 
only, therefore disomic cells cannot be distinguished from diploid cells. These studies 
hence, almost certainly produce inaccurate high estimates of disomy levels as it is 
impossible to tell if the spermatozoon is truly disomic or if it is in fact a diploid cell. 
Since these early investigations the majority of studies now use a minimum of two 
colour FISH when investigating autosomes or three colour FISH when analysing 
gonosomes, thereby producing more accurate informative results. Studies have only 
been considered if dual or triple colour FISH has been utilised in the study depending 
on whether autosomes or gonosomes have been investigated. 
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1.5.2 FISH studies analysing the spermatozoa of normal fertile males 
The identification of estimates of aneuploidy in the spermatozoa is of particular interest 
as chromosome abnon-nalities are known to cause infertility and are a leading cause of 
pregnancy loss and the birth of children with mental and physical handicaps (Hassold et 
al., 1993; 1996). Studies into aneuploidy frequencies in male gametes have been heavily 
investigated over the past decade, particularly as female gametes are not so easily 
accessible. Studies have investigated the rates of aneuploidy of the autosomes and 
gonosomes in the spermatozoa of normal fertile males and taken collectively all the 
chromosomes have been analysed by at least one study. Studies vary in the number of 
subjects analysed and the number of spermatozoa analysed per subject, however the 
majority of studies have analysed a minimum of 5,000 sperm nuclei per donor and per 
probe set. 
The reported frequencies of disomic sperrn found in normal fertile males for both the 
autosomes and gonosomes vary considerably from study to study for example for 
chromosome 16, the lowest frequency reported was in the region of 0.05% (Spriggs et 
al., 1996) with the highest being around 0.54% (Bischoff et al., 1994). A similar degree 
of variation was reported for the sex chromosomes from study to study, with the lowest 
reported frequency for XY disomy being around 0.1% (Griffin et al., 1995) and the 
highest frequency 0.79% (Chevret et al., 1995). 
Studies investigating the chromosome complement of spermatozoa within the normal 
fertile population have been undertaken to answer several questions including an 
assessment of the baseline frequency of chromosome abnormalities in sperm, the 
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distribution of disomy in order to establish if non-disjunction occurs at a similar rate 
identifying if any chromosomes are more prone to non-disj unction. 
1.5.2.1 Studies addressing the question as to whether particular chromosomes are 
more susceptible to non-disjunction 
Rives et al. (1998), analysed aneuploidy frequencies for all the autosomes and 
gonosomes in 4 individuals, reporting all chromosomes were equally susceptible to non- 
disjunction, with disomy levels for the autosomes to be around 0.24%. Bischoff et al. 
(1994) investigated chromosomes 3,4,6,7,8,10,12,16,17,18, X and Y in two 
individuals, one individual showed no significant difference in the rate of non- 
disjunction for the chromosomes investigated in agreement Rives et al. (1998). A 
significant difference however, in the rate of non-disjunction was observed for the 
autosomes in the other subject enrolled in the study. There may be a degree therefore of 
variability in non-disjunction and some individuals may be predisposed to higher or 
lower frequencies of non-disjunction (Bischoff ct al., 1994). In contrast to Rives et al. 
(1998) several studies have demonstrated increased rates of non-disjunction for 
chromosomes investigated. Spriggs et al. (1995) reported significant increases in the 
disomy rates of chromosome 21 and the sex chromosomes in five subjects compared to 
chromosomes 1,2,4,9,12,15,16,18 and 20. Subsequently the same group (Martin et 
al., 1999a) analysed the same five individuals for chromosomes 13 and 22 to establish if 
all acrocentric chromosomes have an increased rate of non-disj unction, or whether 
chromosome 21 is an exception. In this study the frequency of non-disjunction for 
chromosome 13 (0.19%) was not significantly different to that of the other autosomes 
investigated previously by Spriggs et al. (1995), however, chromosome 22 showed a 
significant increase with a disomy rate of 1.2 1 %, suggesting that the G- group 
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chromosomes are potentially more prone to non-disj unction. In agreement Blanco et al. 
(1996) analysed the levels of non-disjunction for chromosomes 6 and 21 and found that 
chromosome 21 demonstrated a significantly higher rate of non-disjunction compared to 
chromosome 6. Williams et al. (1993) reported the frequency of sex chromosome 
disomies to be up to 2 fold greater than that of chromosomes 16 and 18. Increased 
frequency of sex chromosome disomies have also been reported in two studies (Downie 
et al., 1997, Scarpato et al., 1998). However, Downie et al. (1997) also reported a 
significant increase in the disomy frequency of chromosome 3. 
In summary a number of studies have found evidence that certain chromosomes are 
more susceptible to non-disjunction than others in the normal fertile population. 
Including chromosome 3 (Blanco et al., 1996); chromosome 18 (Bischoff et al., 1994); 
chromosome 21 (Blanco et al., 1996; Spriggs et al., 1996); chromosome 22 (Martin et 
al., 1999) and the sex chromosomes particularly the XY bivalent (Scarpato et al., 1998; 
Spriggs et al., 1996; Williams et al., 1993). 
1.5.2.2 Gonosome ancuploidy levels within normal fertile males 
The vast majority of studies have investigated the frequency of aneuploidy in the sex 
chromosomes and these studies report the mean frequencies to lie between 0.02% and 
0.38% for XX disomy, 0.06% and 0.34% for XY disomy and finally 0.01%- 0.21% for 
YY disomy (Abruzzo et al., 1996; Bautmanger et al., 1999; Bischoff et al., 1994; 
Chevret et al., 1995; Downie et al., 1997; Goldman et al., 1993; Griffin et al., 1995; 
Martin et al., 1995; Rives et al., 1998; Shi et al., 2000; Spriggs et al., 1996; Williams et 
al., 1993). Five of these studies noted significant increases in the frequencies of XY 
disomy compared to XX and YY disomy (Chevret et al., 1995; Downie et al., 1997; 
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Goldman et al., 1993; Shi et al., 2000; Rives et al., 1998) with levels ranging from 
0.13%-0.34%. Bischoff et al. (1994) however, reported a significant increase in XX 
disomy (0.3 8%) compared to XY (0.12%) and YY disomy (0.09%). Several studies 
have reported no significant difference between the disomy frequencies of XX, XY or 
YY, these studies also reported lower incidences of these disomies compared to the 
studies taken collectively with values ranging from 0.02%-0.07% for XX, 0.06%-0.16% 
for XY and 0.03%-0.2 1% for YY disomy (Abruzzo et al., 1996; Bautmanger et al., 
1999; Griffin et al., 1995; Martin et al., 1995; Spriggs et al., 1996; Williams et al., 
1993). 
The following studies: Goldman et al., 1993; Griffin et al., 1995; Martin et al., 1995; 
Martin et al., 1996; Rives et al., 1998; Spriggs et al., 1995 investigated disomy rates in 
the autosomcs and gonosomes with three groups (Goldman et al., 1993; Martin et al., 
1996; Spriggs et al., 1995) reporting the incidence of sex chromosome disomy to be 
significantly higher than that of autosome disomy. 
Griffin et al. (I 996b), carried out a study investigating whether there is any evidence 
that the sex chromosomes preferentially segregate with chromosome 18 or 21, to 
establish whether this would explain why with trisomy 18 there is an excess of females 
and with trisomy 21 there is an excess of males. No evidence of a preferential 
segregation of chromosome 18 with chromosome X was provided, however there was 
evidence of a preferential segregation with chromosome 21 and chromosome Y. 
Scarpato et al. (1998) also reported evidence of a preferential segregation in spenn 
disomic for chromosome 2 and chromosome X. These results suggest that autosomal 
aneuploidies may be preferentially associated with either chromosome X or Y. 
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1.5.3 FISH studies on the spermatozoa, investing the effect of donor 
age 
To date there have been a number of studies that have investigated the effect of 
increasing paternal age and semen parameters. These studies have generally indicated a 
correlation between increasing paternal age and a reduction in quality of non-nal semen 
parameters. In a review study (Kidd et al., 2001) investigating studies published over 
the last 20 years, a general consensus indicated that increasing age is associated with a 
decline in semen volume and sperm motility and an increase in morphologically 
abnon-nal spermatozoa, and a decrease in sperm motility, however, no reliable effect 
was identified for sperm concentration. Increasing age may not only have a 
consequence on semen quality but may also affect the genetic integrity of spermatozoa. 
Such a relationship between advancing maternal age and significant increases in the 
generation of aneuploid conceptuses has been well established (refer to section 1.4.4). 
Studies investigating paternal age have analysed chromosomes 1,6,8,9,12,13,14,17, 
18,21 and the sex chromosomes. 
1.5.3.1 Autosomes investigated for paternal age effect 
Martin et al. (1995) conducted a study examining the aneuploidy frequencies for 
chromosomes 1,12 and the sex chromosomes in 10 normal men aged 21-52, providing 
evidence of a significant association between an increase in disomy for chromosome I 
and an increase in donor age. In contrast several other studies have found no such age- 
related increase for chromosome I (Guttenbach et al., 2000; Kinakin et al., 1997; 
McInnes et al., 1998). Evidence for this association and chromosome 21 was also 
investigated in several studies, Rousseaux et A (1998) analysed the chromosome 21 
disomy frequencies in 3 men aged over 60 and 8 men aged under 30. In two out of the 
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three individuals aged over 60 significantly higher levels of disomy 21 were found 
compared to controls, suggesting there is evidence of a small age effect on the non- 
disjunction rate of chromosome 21. In contrast Bosch et al. (2001) and McInnes et al. 
(1998) identified no such age for chromosome 21. The following autosomes have also 
been investigated including chromosomes 6, (Bosch et al., 2001); 8, (Robbins et al., 
1995); 9, (Luetjens et al., 2002); 12, (Asada et al., 2000; Martin et al., 1995); 13, 
(McInnes et al., 1998) 14, (Rousseaux et al., 1998); 17, (Guttenbach et al., 2000) and 
chromosome 18 (Asada et al., 2000; Griffin et al., 1995; Guttenbach et al., 2000; 
Luetjens et al. 2002). These studies have revealed no association between increasing 
donor age and increasing aneuploidy for these autosomes investigated. 
1.5.3.2 Sex chromosomes investigated for paternal age effect 
The majority of studies investigating the effect of paternal age on non-disjunction of 
sperm have analysed sex chromosomes due to the contribution of paternally derived sex 
chromosomes trisomies these include XYY - 100%, XXY - 50% and XXX 5% (Griffin, 
1996b). 
Griffin et al. (1995) investigated disomy frequencies for chromosomes 18, X and Y in 
24 men aged 18-60. Significant associations with increasing age and XX, XY and YY 
disomy was identified. Robbins et al. (1995) analysed 4 individuals aged 42-50 and 
compared these against 10 younger individuals, the chromosomes investigated included 
8, X and Y in agreement with Griffin et al. (1995) a significant association was found 
with XX and YY disomy, with a borderline effect found for XY disomy. Conversely an 
association with XY disomy was reported in two studies (Asada et al., 2000; 
Guttenbach et al., 2000) however, these studies found no association for XX or YY 
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disomy. Kinakin et al. (1997) and Martin et al. (1995) revealed evidence of a paternal 
age effect and YY disomy, but no evidence for XX or XY disomy. One study (Bosch et 
al., 2001), however reported no such association in sex chromosome disomy levels and 
increasing paternal age in 18 individuals aged 24-74. On the contrary a number of 
studies have demonstrated associations with chromosome I (Martin et al., 1995), 
chromosome 21 (Rousseaux et al., 1998) sex chromosome disomies XX (Griffin et al., 
1995; Robbins et al., 1995); XY disomy (Asada et al., 2000; Griffin et al., 1995; 
Guttenbach et al., 2000) and YY disomy (Griffin et al., 1995; Kinakin et al., 1997; 
Martin et al., 1995; Robbins ct al., 1995). 
At present there is no consensus of opinion amongst studies investigating paternal age 
effects and non-disj unction. There is evidence, however to suggest that older men like 
older women have increased risks of producing aneuploid. offspring, especially for the 
sex chromosomes. 
1.5.4 FISH studies on the spermatozoa of infertile men 
The results of the studies investigating aneuploidy frequencies (mean values are 
presented for patient groups unless stated otherwise) in the sperm of infertile males, 
aneuploidy frequencies are also presented in table 1.3 (page 70). 
1.5.4.1 Chromosomes 1-5 (Groups A and B) 
At least ten studies have investigated the incidence of disomy I in infertile males. The 
majority report a significant increase in the frequency of disomy I when compared with 
fertile controls (Finkelstein et al., 1998; Lahdetie et al., 1997; Moosani et al., 1995; 
Pfeffer et al., 1999; Rives et al., 1999; Viville et al., 2000) with levels ranging from 
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0.18%- 1.35%. Rives et al. (1999) examined 50 patients with various compromised 
semen parameters and 10 males with proven fertility. Patient levels (0.34%) were 
significantly higher than controls (0.22%). Moosani et al. (1995) also reported an 
approximate two fold increase in 5 males with idiopathic infertility (0.18% in patients 
compared to 0.09% in controls) however it is noteworthy that the patient levels in the 
second study were lower than the control levels in the first. In order to distinguish the 
motile from the immotile fraction (a common procedure in infertility clinics) Pfeffer et 
al. (1999) examined the pellet and supernatant of "swim-up" preparations in 10 males 
with severe OAT (as defined by Pang et al. (1999) and four healthy control donors. The 
patients had significantly higher disomy frequencies in both the pellet and swim up 
preparation (0.62% and 0.57% respectively) compared to the control individuals (0.28% 
and 0.17% respectively) but no significant difference between pellet and supernatant. 
Lahdetie et al. (1997) investigated three groups of individuals: four OAT patients 
(group 1), eight with normal/intermediate semen parameters (group 2) and 18 healthy 
fertile males (group 3). A significant increase was found in group 1 (0.22% compared 
to 0.08% and 0.1% for groups 2 and 3 respectively). Finkelstein et al. (1998) enrolled 
12 subjects with poor quality semen as a result of a varicocele; a significant increase 
(1.35%) was noted, compared to eight controls (0-08%). Viville et al. (2000) 
concentrated their efforts on four patients exhibiting 100% teratozoosperrnia. Three had 
similar levels to controls, however, one (presenting with 100% macrocephalic 
spermatozoa) presented with a markedly significantly higher rate of disomy I (17.7% 
compared to 0% in controls). 
While the majority report an association between increased disomy levels for 
chromosome I and infertility, several studies (Guttenbach et al., 1997; Harkonen et al., 
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200 1; Miharu et al., 1994) found no evidence of such an increase. Guttenbach et al. 
(1997), examined 45 males with varying compromised semen parameters (and 8 
controls) reporting no significant difference between them (0.13% and 0.12% 
respectively). Similarly Miharu et al. (1994), analysed 9 patients and 12 controls; 
reporting frequencies of 0.14% and 0.13% respectively) and Harkonen et al. (2001) 
(studying 20 teratozoospermic males) found no evidence of an association between 
disomy I and male infertility with control frequencies of 0.07% and infertile 
frequencies of 0.12%. 
As far as we are aware, only one study (Pang et al., 1999) has examined a chromosome 
apart from I in chromosome groups A and B. Disomy analysis of chromosome 4 in nine 
OAT males and four control donors revealed a significant increase in the patient cohort 
(1.58% versus 0.15%). 
1.5.4.2 Group C autosomes (chromosomes 6-12) 
Pang et al. (1999) is unique in having analysed all of the C group chromosomes. Each 
were found to have significantly higher disomy levels in nine OAT males compared to 
controls. The mean frequencies obtained follow for patients and controls respectively: 
chromosome 6 (1.3 8%, 0.13%); 7 (1.83%, 0.3 1 %); 8 (1.74%, 0.23%); 9 (1.68%, 0.2%); 
10 (1.63%, 0.2%); 11 (1.68%, 0.13%); and 12 (0.69%, 0.05%). 
In keeping with their results for chromosome 1, Lahdetie et al. (1997) reported a 
significant increase in disomy 7 levels in OAT individuals (0.13% compared to 0.06%), 
partially supporting Pang et al. (1999) but suggesting a more modest increase. Similar 
findings were reported by Harkonen et al. (2001) with a significant increase in disomy 
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frequencies of tcratozoospcrmic individuals of 0.12% versus 0.06% within the control 
group. Guttcnbach ct al. (1997) ho%%, cvcr. as for chromosomc 1. found no such cvidcnce 
for chromosome 7 (0.1211) in patients and 0.15% in controls). 
Calogcro ct al. Q 1001 a) studied chromosome 8 disomy levels in spcnnatozoa of 3 
groups (19 OAT individuals (group 1). 9 tcratozoospermic men (group 2) and 13 
controls (group 3) groups I and 2 displayed significantly higher disomy frequencies 
with values of 0.49%, 0.46% and 0.15% respectively. Bun-clio ct al. (2002) focussed 
their attention on azoospcrmic individuals, extracting spermatozoa from the testes (six 
donors) or epididymis (tcn donors); there were 14 normally fertile controls. 
Significantly higher frequencies of chromosome 8 disomy were observed in the two 
azoospcrrnic groups with levcls of 0.68% for epididymal spcrinatozoa and 1.03% for 
testicular spermatozoa versus 0.18% in the control group. Acar ct at. (2000) however 
reported no such increase within the six infertile males (all of whom had at least one 
compromised semen parameter) compared to controls with frequencies of 1.33% and 
0.69% respectively. Guttcnbach ct al. (1997), extended their analyses to chromosome 10 
and, again, found no significant difference between the infertile and control group 
(frequencies of 0.12% and 0.14% respectively). In agreement Acar et al. (2000) reported 
no significant difference between disomy 10 frequencies between the infertile and 
control groups with frequencies of 1.45% and 0.95% respectively. 
Several authors have asked the same question of chromosome 12 (Asada et al., 2000; 
Burrcllo et al., 2002; Calogero et al., 2001 a; Moosani et al., 1995). In contrast to the 
findings of Pang et al. (1999) no significant difference was observed between infertile 
(group 1) and control (group 2) individuals in any of these studies. (Group 1 -0.19%, 
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group 2-0.15% (Nloosani ct aL. 1995). Calogcro, et al. (200 1 a) and Burrello, ct al. 
(2002) 0% in both groups. Asada et al. (2000) examined three groups of men including; 
ten men over the age of 39 with idiopathic infertility and nonnozoospcn-nia (or with a 
spcrin concentration of > 20 million1ml), five maics with oligozoospcrmia (with a spcn-n 
concentration of < 20 million/ml) and ten control donors aged 25 or less. No significant 
difference was observed between the three groups for disomy 12. 
ISAJ Group D (chromosornes 13-15) 
Group D is a clinically significant group as approximately 10- 15% of Patau syndrome 
cases arise as a result of disomy 13 sperm and because uniparental disomy of paternal 
chromosome 15 is a cause of Angelman syndrome (Griffin, 1996b). To date at least 10 
studies have investigated the incidence of disomy for chromosome 13 and they suggest 
a significant increase in infertile individuals compared to controls (Hristova ct al., 2002; 
Martin ct al., 2003a; McInnes ct al., 1998; Pang et al., 1999; Pfeffer ct al., 1999; Rives 
et al., 1999; Templado et al., 2002; Ushijima ct al., 2000; Vegetti et al., 2000). Pang et 
al. (1999) reported levels of 1.86% in OAT men compared to 0.2% for controls and, 
consistent with these findings, Pfcffcr ct al. (1999) reported frequencies of 0.88% and 
1.03% in OAT men in pcllct and swim up preparations respectively and 0.3% in 
controls. Carrell ct al, (2003) investigated 24 patients with a history of recurrent 
pregnancy loss (RPL) (; >- 3 pregnancy losses) and two control groups 16 males from the 
general population and 10 fertile donors. Disomy 13 frequencies in the RPL patients 
were found to be signi f icantly higher than in the two control groups with levels of 
1.02%, 0.44% and 0.39% respectively. Martin et al. (2003a) investigated 30 infertile 
males split into three groups of 10 exhibiting mild, moderate and severe 
106 Sperm/ 1" 1.9 X 106 e Oligozoospermia (10-19 xm sperm/mland '106 sperm/ml, 
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rcspectivcly) with disomy 13 ratcs of 0.17%, 0.24% and 0.3% in rcspective groups. 
Martin et al. (2003a) rcport a marginal trcnd of incrcased chromosomc abnormality with 
decreased sperm conccntration for chromosonic 13. McInnes ct al. (1998) analysed nine 
infertile men presenting with either oligozoospcrmia or tcratozoospcrmia and found a 
sigmificant increase in both groups compared to 18 controls (0.28% versus 0.13%). 
Rives ct al. (1999) reported levels of 0.32% in patients versus 0.21 % in controls and 
Tcmplado et al. (2002) analysed asthcnotcmtozoospcrtnic patients and 18 controls 
finding a significant increase in the patient cohort (0.23% compared to 0.13% in 
controls. Hristova ct al. (2002) reported similar findings in tcn infertile patients and 
controls (0.24% versus 0.13%) while Ushijima ct al. (2000) studied eight OAT patients 
and ten controls finding much lower levels overall but nevertheless a significantly 
higher rate of chromosome 13 disomy (0.13%) compared to controls (0.09%). Vegetti et 
al. (2000) analysed four groups of men: group I contained 15 individuals with abnormal 
semen parameters but normal karyotypes; group 2 contained 13 individuals with 
abnormal karyotypes-, group 3 contained 4 karyotypically normal individuals with 
abnormal semen parameters that had undergone ICSI resulting in a child/ foetus with 
chromosome abnormalities, and group 4 normal fertile control donors. They established 
a significantly higher mean frequency of disomy 13 in groups 1 (0.23%) and 2 (0.2 1 %) 
but not group 3 (control rate was 0.08%). 
In contrast to the above, two studies reported no significant association between infertile 
males and any increase in sperm disomy for chromosome 13. Martin et al. (2000) 
studied three patients with non-obstructive azoospcn-nia, no significant increase was 
found with levels of 0.2% compared to 0.13% in the controls. Rubio ct al. (200 1) 
reported no significant difference between disomy 13 frequency within infertile males 
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(0.17%) comparcd to control frcqucncics (0.14%). Schultz ct al. (2000) also found no 
significant increase but made use of the alpha-satcllitc probe that hybridiscs to both 
chromosomcs 13 and 21 and thus the validity of the rcsults may bc callcd into qucstion 
whcn drawing conclusions about chromosomc 13 alonc. 
The remainder of group D chromosomes (14 and 15) have been examined to a lesser 
extent with only one study investigating chromosome 14 disomy (Rives et al., 1999) 
and one for chromosome 15 disomy (Finkelstein et al., 1998). Rives et al. (1999), 
observed significantly higher frequencies of chromosome 14 disomy (0.43%) compared 
to that of controls (0.22%). Finkelstein ct al. (1998) reported highly significant increases 
in disomy 15 in their infertile population (1.6711,0) compared to controls (0.09%). 
1.5.4.4 Chromosomes 16-20 (groups E and F) 
In these groups, chromosomes 16 and 18 arc the most clinically significant. Trisomy 16 
is the most common trisomy among spontaneous abortions however we are not aware of 
a convincing report of a trisomy 16 that has arisen as a result of a disomy 16 sperm. 
Approximately 10% of trisomy 18 conceptuscs (including those that go to term and lead 
to Edwards syndrome babies) arise as a result of disomy 18 sperm. Miharu ct al. (1994) 
analysed disomy rates of chromosome 16, no significant differences were observed 
between infertile and control groups with values of 0.16% and 0.17% respectively. 
Chromosome 17 disomy and its association with infertility has been investigated by two 
sets of authors (Guttcnbach ct al., 1997; Pang ct al., 1999). As with the other 
chromosomes studied, Pang et al. (1999) reported a significant increase in OAT men 
(1.62% versus 0.2% in controls). Similarly Guttenbach ct al. (1997) were consistent in 
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their findings for other chromosomes recording no significant difference in patients and 
controls (0.13% and 0.16110 rcspccti,., cly). 
Chromosome 18 is a commonly studied chromosome partly because of its clinical 
significance and partly because of the early availability of the reliable alpha satellite 
probe. The vast majority of studies investigating the incidence of chromosome 18 
disomy within selected infertile populations and control donors found statistically 
significant increases in infertile males compared to controls. Pang et al. (1999) reported 
a significant increase in the frequency of disomy in OAT patients compared to controls 
(1.67% versus 0.11%). Colombcro ct al. (1999) suggested significant increases in 
infertile patients with chromosome disomy 18 levels of 0.6%, however, they do not give 
control frequencies. Carrell ct al, (2003) reported increased frequencies of disomy 18 in 
RPL (recurrent pregnancy loss) patients compared to fertile control donors with rates of 
0.5 1% and 0.25% respectively. Rivcs ct al. (1999) also found an increase in disomy rate 
with 0.5 1% compared to control levels of 0.24%. Pfcffer ct al. (1999) reported rates of 
0.77% and 0.96% (pellct and swim up preparation respectively) versus 0.18% and 
0.17% in OAT males and controls respectively. Finkelstein ct al. (1998) and Calogcro ct 
al. (2001 a) (2 groups) reported increased disomy levels within the infertile cohort with 
infertile malc rates of 0.85%, 0.641.1, ý and 0.39% with control levels of 0.12% and 0.2% 
respectively. Vegetti et al. (2000). found significantly increased levels compared to 
controls (0.06%) in two infertile groups (including males with abnormal semen 
parameters and normal karyotypes and males with abnormal karyotypes) (frequencies of 
0.22% and 0.19% respectively). flarkoncn ct al. (2001) and Rubio et al. (2001) reported 
a significant increase in disomy 18 in infertile males with frequencies of 0.1% and 
0.05% compared to control frequencies of 0.05% and 0.02% respectively. A significant 
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increase in disomy 18 was also reported in spermatozoa surgically extracted from the 
testes and epididymis of patients with levels of 1.23% and 0.37% respectively versus 
0.2% in the control group. (Burrello et al., 2002). Mateizel et al. (2002) investigated the 
rates of disomy 18 in testicular sperm derived from 17 patients with spermatogenic 
failure and 26 patients with non-nal spermatogenesis (considered as the control group). 
A significantly higher frequency of disomy 18 was reported in patients with 
spermatogenic failure (1.3% versus 0.3% within patients with normal spermatogenesis). 
Levron et al. (2001) reported a significant increase in disomy 18 in three groups of 
infertile males compared to controls, nonobstructive azoospermia, obstructive 
azoospermia and severe oligozoospennia with frequencies of 0.65%, 0.55% and 0.86% 
respectively. Control frequencies were not given for individual chromosomes however 
the total frequency for all the investigated chromosomes was reported to be 1.5%. 
In contrast, the following studies found no evidence of a significant increase in the 
disomy levels of chromosome 18 within the spermatozoa of infertile males. Aran et al. 
(1999) investigated the frequencies of disomy 18 in the spermatozoa of nineteen 
infertile patients and five control donors, reporting a rate of disomy of 0.05% and 0.09% 
respectively. Damri et al. (2000) investigated twelve individuals undergoing ICSI and 
three fertile controls, the rates of 0.06% versus 0.11% in the control group were 
obtained. Ohashi et al. (2001) reported disomy frequencies in ten severely 
oligozoospermic males (0.2%), ten ol igozoospermic males (0.13%) and seven control 
males (0.17%). Nishikawa et al. (2000) reported frequencies of 0.15% within the ten 
infertile individuals analysed. 
To the best of our knowledge no studies published to date have analysed the F group 
chromosomes (19 and 20) in this context. 
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1.5.4.5 Group G chromosomes (21-22) 
Chromosome 21 is perhaps the most clinically significant of the chromosomes. 
Although predominantly of maternal origin, trisomy 21 arises -7% of the time as a 
result of disomic sperm (Griffin, 1996b). Thus approximately I in 10,000 babies are 
paternally derived Down Syndrome cases and, despite the absence of a reliable alpha- 
satellite probe to detect the chromosome, a large number of studies (at least eleven) 
have examined chromosome 21 sperm disomy in this context. The majority noted a 
significant increase in the rate of disomy 21 in the infertile populations analysed 
compared to that of the controls enrolled in their studies. Pang et al. (1999) reported a 
mean frequency of 1.94% in OAT men and 0.18% in controls. Rives et al. (1999) noted 
higher levels of disomy in the infertile population analysed (0.5% compared to 0.22%), 
similarly Pfeffer et al. (1999) reported comparable frequencies of 0.48% and 0.46% in 
infertile males and control levels of 0.18% and 0.17% (in the pellet and swim up 
preparation respectively). Carrell et at, (2003) reported increased rates of chromosome 
21 disomy in RPL patients compared to the general population and fertile control 
donors with levels of 0.47%, 0.28% and 0.24% respectively. Martin et al, (2003a) 
reported a marginal trend of increased chromosome 21 disomy frequencies with 
decreased sperm concentration 0.22% (mild oligozoospermia), 0.44% (moderate 
oligozoosperinia) and 0.58% (severe oligozoospermia). Ushijima et al. (2000) reported 
a significant increase in the rate of disomy in infertile individuals (0.24%) compared to 
0.19% observed in the controls while McInnes et al. (1998) recorded frequencies of 
0.48% compared to controls (0.37%). Vegetti et al. (2000) identified a significant 
increase in disomy for chromosome 21 in two infertile groups (including males with 
abnormal semen parameters and normal karyotypes, and males with abnormal 
karyotypes) with frequencies of 0.29% and 0.22% respectively compared to control 
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frequencies of 0.07%. Rubio et al. (200 1) also reported a significant increase in disomy 
21 with frequencies of 0.24% and 0.17% in infertile males and controls respectively. 
Finally Colombero et al. (1999) reported a significant increase of 1.2% in patients 
compared to control levels. 
As with most autosomes, several studies found no such evidence of an increase. Martin 
et al. (2000) observed frequencies of 0.46% in sperm extracted from the testes of 
azoospermic men, however, this was not significantly different to control levels 
(0.37%). Consistent with these findings Hristova et al. (2002) found frequencies of 
disomy to be similar to that of Martin et al. (2000) with infertile levels of 0.37% and 
control levels of 0.36%. Templado et al. (2002) reported frequencies of disomy 21 in 
infertile males to be 0.23% versus 0.36% within the control group. Guttenbach et al. 
(1997) reported lower frequencies of disomy although authors were in agreement 
finding no evidence of any difference between the infertile and control groups (0.14% 
and 0.12% respectively). 
Not surprisingly, studies for chromosome 22 are less common in the literature and we 
are aware of only one. Rives et al. (1999) reported a significant increase in infertile men 
with a frequency of 0.42% compared to 0.25% observed in the controls. 
1.5.4.6 Sex chromosomes 
While chromosome 21 is perhaps the most clinically significant because of the severity 
of Down Syndrome, it is in the sex chromosomes where an increase in sperm disomy is 
more likely to have a effect on the frequency of trisomic conceptuses. Sex chromosome 
trisomies present with far milder clinical features than those of the autosomes, 
64 
nevertheless, they are, collectively more frequent among liveborns (0.45% of live births 
compared to 0.3% for Down Syndrome) and, unlike the autosomes, arise approximately 
50% of the time in the spenn. That is nearly 50% of XXY, 5% of XXX, 25% of XO and 
100% of XYY cases arise as a result of an aneuploid sperm (Griffin et al., 1995; 1996a). 
This, coupled with the availability of reliable FISH probes has made them the most 
studied chromosomes in this context. A further advantage of analysing the sex 
chromosomes is that it is possible to identify whether the disomic sperrn has arisen as a 
result of a meiosis I (XY) or meiosis 11 error (XX or YY) (Griffin et al., 1995; 1996a). 
This is not usually possible in autosomes except where DNA polymorphisms have been 
identified (O'Keefe et al., 1997). Studies can be split into those that specify individual 
disornies (XX disomy, XY disomy and YY disomy) and those that do not specify the 
individual disomy results but report on the sex chromosome disomies as a whole. 
These studies will be split into several groups those that found increases in XY disomy, 
XX disomy and YY disomy and those that do not specify the individual disomy results 
but report on the sex chromosome disomies as a whole. All the studies within these 
sections have been described previously in earlier sections as at least one autosome has 
also been analysed in conjunction with the sex chromosomes to enable disomic sperm to 
be distinguished from that of diploid. 
1.5.4.6.1 XY Disomy 
The XY bivalent is thought to be most prone to non-dis unction in the male gametes. j 
Moreover most studies found statistically significant increases in the rate of XY disomy 
within infertile individuals analysed compared to levels obtained from control males. 
Pang et al. (1999) report a mean rate of 1.05% in OAT men versus 0.08% in controls. 
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Finkelstein et al. (1998) reported rates of 0.74% in the infertile males and 0.1% in 
control donors. Martin et al, (2003a) reported significantly increased rates of XY 
disomy coincident with decreasing sperm concentration with disomy rates of 0.25% 
(mild oligozoospermia), 1.04% (moderate oligozoospen-nia) and 0.68% (severe 
oligozoospermia). Three studies (Martin et al., 2000; Rives et al., 1999; Templado et al., 
2002) established similar XY disomy frequencies for cohorts of infertile males 
investigated, with disomy levels of 0.62%, 0.54% and 0.5% respectively, compared to 
control levels of 0.3%, 0.35% and 0.3% respectively. Nishikawa et al. (2000) reported 
significantly higher frequencies of XY disomy in infertile males (0.36%) compared to 
controls (0.14%). Studies carried out by Moosani et al. (1995), Ushijima et al. (2000) 
and Vegetti et al. (2000) recorded the disomy frequency of the infertile individuals to be 
lower than that of the previous studies mentioned, nevertheless a significant increase 
was observed between the infertile and control males. That is 0.34%, 0.23%, and 0.2% 
compared to 0.16%, 0.14% and 0.05% respectively in their control groups. Harkonen et 
at. (2001) reported lower frequencies of 0.13% and 0.05% in infertile and control males 
respectively, nonetheless the rates were significantly increased within the infertile 
group. Ohashi et al. (2001) divided infertile males into two groups: severe 
oligozoospermic men (<5 million/ml) and males with oligozoospermia (5-20 
million/ml). They found a significant increase in XY disomy only in the males with 
severe oligozoospennia (0.41%) whereas the frequency of disomy for the 
oligozoospermic males was found to be comparable to the control frequency (0.16% 
and 0.18% respectively). Levron et al. (200 1) reported significant increases in the 
frequency of XY disomy compared to controls with frequencies of 3.27% 
(nonobstructive azoospennia), 2.18% (obstructive azoospennia), 0.17% (severe 
oligospermia), 1.5% (control frequency for all investigated chromosomes). 
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In contrast several studies have not demonstrated significantly increased levels of XY 
disomy in infertile males compared to controls (Calogero et al., 2001 a, Hristova et al., 
2002; Schultz et al., 1998; Acar et al., 2000; Burrello et al., 2002), 0% and 0.15% 
patients versus 0% controls (Calogero et al., 200 1 a), 0.41 % patients versus 0.3% 
controls (Hristova et al., 2002); 0.44% patients versus 0.36 % controls (Schultz et al., 
1998); 0.94% patients versus controls (Acar et al., 2000) and 0.5% and 0% patients 
versus 0% controls (Burrello et al., 2002). The latter study examined azoospermic 
males. 
1.5.4.6.2 XX and YY Disomy 
The following studies have all reported a significant increase in XX disomy in infertile 
males versus control populations: Pang et al. (1999) reported 0.7% disomy in OAT men 
versus 0.04% in controls. Calogero et al. (2001a) - 0.33% and 0.48% versus 0.2% in 
controls; Ushij ima et al. (2000) and Finkelstein et al. (1998)- 0.16% versus 0.12% in 
controls, Templado et al. (2002) - 0.13% versus 0.05% in controls; Hristova et al. 
(2002) - 1% and 0.05% in controls. Vegetti et al. (2000) reported a significant increase 
in two groups of infertile men, namely those with abnormal semen parameters and 
normal karyotypes and those with abnormal karyotypes. XX disomy frequencies were 
0.17% and 0.09% respectively compared to a control rate of 0.03%. Martin et al, 
(2003a) reported a significant increase in XX disomy in correlation with decreased 
sperm concentration, with rates of 0.04% (mild oligozoospermia), 0.08% (moderate 
oligozoospennia) and 0.10% (severe oligozoospermia). Burrello et al. (2002) reported a 
significant increase in XX disomy in spermatozoa. extracted from the testes and 
epididymis of azoospermic men compared to controls (1.23%, 0.56% and 0.2% 
respectively). Frequencies of 2.61% (nonobstructive azoospermia), 1.63% (obstructive 
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azoospermia), 2.0% (severe oligospermia), 1.5% (control frequency for all investigated 
chromosomes) were reported in the study carried out by Levron et al. (200 1). 
XX disomy is the only one where the majority of studies have not found an increase in 
the infertile patient cohort compared to controls. Ohashi et al. (2001) examined males 
presenting with severe oligozoospermia and oligozoospermia-, the rates for both these 
groups were reported as 0.07%, not significantly different from that of the control 
(0.11%). In the following list, the reported frequencies of infertile patients, fertile 
controls followed by the reference are given: 0.79%, 0.44% (Acar et al., 2000), 0.15%, 
0.07% (Schultz ct al., 2000), 0.1%, 0.15% (Nishikawa ct al., 1999), 0.09%, 0.08% 
(Moosani et al., 1995); 0.06%, 0.05% (Martin et al., 2000), 0.22%, 0.2% (Rives et al., 
1999) and 0.3%, 0.3% (Harkonen et al., 2001), 
At least seven studies have provided evidence for an effect for YY disomy. Pang et al. 
(1999) recorded the most dramatic increase with levels in OAT men of 0.77% versus 
0% within the controls. The remainder found lower but comparable frequencies. That is 
Calogero et al. (2001a) recorded 0.48% and 0.33% YY disomy in the infertile groups 
versus 0.16% controls. Rives et al. (1999) recorded 0.24% versus 0.17%, Ushij ima et al. 
(2000) reported infertile levels of 0.2 1% versus 0.12%, Finkelstein et al. (1998) 
reported infertile frequencies of 0.18% versus 0.12%, Harkonen et al. (200 1) reported 
infertile frequencies of 0. IS% compared to 0.05% (all figures, infertile patients versus 
fertile controls (usually sperm donors). Vegetti et al. (2000) reported a significant 
increase in two groups (including males with abnormal semen parameters and normal 
karyotypes and males with abnormal karyotypes) (0.18% and 0.12% respectively) 
compared to controls (0.05%). Martin et al, (2003a) reported a significant increase in 
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YY disomy coincident with decreased sperm concentration with rates of 0.04% (mild 
oligozoospermia), 0.06% (moderate oligozoospermia) and 0.09% (severe 
oligozoospen-nia). Burrello et al. (2002) recorded a significant increase in the rate of YY 
disomy in both testicular and epididymal spermatozoa with an incidence of 0.77% and 
0.59% versus control levels of 0.16%. Levron et al. (200 1) reported significantly 
increased frequencies of YY disomy in males with nonobstructive azoospermia 
(1.3 1 %), obstructive azoospermia (0.55%), severe oligospennia (1.6%), compared to 
the control frequency of 1.5% (total for all investigated chromosomes). 
Equally there have been a number of studies whereby no difference was observed 
between the rate of YY disomy in the spermatozoa of infertile men compared to that of 
control donors. Asada et al. (2000); Hristova et al. (2002); Martin et al. (2000); Moosani 
et al. (1995); Nishikawa et al. (2000); Ohashi et al. (200 1); Schultz et al. (2000) and 
Templado et al. (2002) collectively all report values of disomy within a similar range 
(0%-0.18%) for both patients and controls with no significant difference between the 
groups. Acar et al. (2000), are in agreement with these studies in not identifying any 
significant increase in YY disomy between infertile males and controls, however report 
a higher incidence with frequencies of 0.98% versus 0.41% respectively, although in 
this case only 400 sperm were analysed. 
1.5.4.6.3 Studies that have considered sex chromosome disomy as a whole 
A number of studies that have investigated the sex chromosome disomy collectively i. e. 
have not presented the results of the disomy rates for the individual chromosomes (i. e. 
XX, XY and YY disomy). These studies are clearly less infon-native but nevertheless 
significant. The majority have indicated increases in sex chromosome disomy in 
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infertile patients compared to fertile controls (Amn et al., 1999; Carrell et al., 2003; 
Colombero et al., 1999; Pfeffer at al., 1999). Carrell et al, (2003) reported a significant 
increase in sex chromosome disomy (0.77%) compared to the general population 
(0.40%) and fertile control donors (0.31%). Colombero et al. (1999) observed the 
disomy frequency of the infertile population studied to be 0.64% with control 
frequencies of 0.46%. Aran et al. (1999) reported similar sex chromosome disomy 
levels within the infertile males analysed to be 0.53% versus 0.37% in the control 
subjects. Pfeffer et al. (1999) analysed spermatozoa of infertile males prior to and after 
swim up preparation. This study concluded no significant difference in the rate of 
disomy prior to or post swim up preparation, however, they did note a significant 
increase in disomy of the sex chromosomes in both preparations (1.08% and 1.13% 
respectively) compared to that of the control (0.48% and 0.25% respectively). Mateizel 
et al. (2002) reported no significant difference in sex chromosome disomy in the 
infertile males and control males analysed with levels of 2.4% and 2.2% respectively. 
Damri et al. (2000), report sex chromosome frequencies of 0. IS% in infertile and 0.28% 
in the control. 
Miharu et al. (1994) and Guttenbach et al. (1997) report the disomy frequency of the sex 
chromosomes in two groups (X and Y), but do not as far as we can determine 
distinguish XX, YY and XY disomy, these studies found no statistical difference 
between the rates of disomy in the infertile and control individuals for chromosome X 
(0.16% versus 0.13%) (Miharu et al., 1994), (0.14% versus 0.12%) (Guttenbach et al., 
1997) or chromosome Y (0.11 % versus 0.08%) (Miharu et al., 1994), (0.1 % versus 
0.11%) (Guttenbach et al., 1997). 
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1.5.5 Studies that have investigated the rates of disomy in recurrent miscarriages/ 
implantation failure 
Several studies have addressed the question as to whether patients with a history of 
recurrent miscarriages or implantation failure after ICS1 are at risk of having a higher 
incidence of chromosomal abnormalities within the spermatozoa of the male partners 
(Rubio et al., 1999; Rubio et al., 200 1). In the study carried out by Rubio et al. (1999) 
semen samples were obtained from twelve couples undergoing IVF, all of which 
previously had two or more spontaneous abortions within the first trimester. The 
findings of this study suggest that there is evidence of increased sperm chromosome 
aberrations in couples with a history of recurrent spontaneous abortions particularly for 
the sex chromosomes with frequencies two-three fold higher within the population 
analysed compared to control frequencies. Blanco et al. (2001) subsequently carried out 
a larger study, investigating nineteen couples undergoing ICSI that had experienced 
repeated implantation failure and forty couples whom had repeated miscarriages of 
unknown actiology. These patients were further split into groups according to semen 
parameters, a significant increase in the frequency of sex chromosome disomy was 
found in the spermatozoa of the males in both the repeated miscarriage and ICSI 
implantation failure groups compared to controls. However, individuals within these 
groups for which semen parameters were classified as oligoasthenoteratozoospermic 
also demonstrated a significant increase in the frequency of disomy for not only the sex 
chromosomes but that of chromosomes 18 and 21 compared to normozoospermic 
individuals. Several studies suggest that individuals with a history of recurrent 
miscarriages (Rubio et al., 1999; Rubio et al., 2001) and those with repeated ICSI 
implantation failures (Rubio et al., 200 1) have a significantly increased rate of sperm 
disomy particularly for the sex chromosomes (Rubio et al., 1999; Rubio et al., 200 1). 
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Individuals identified as having OAT semen parameters were also reported to have 
much higher incidences of sperm disomy incidences for chromosomes 18,2 1, X and Y 
compared to normozoospermic individuals. These results suggest that cases couples 
with a history of pregnancy failures in some cases are likely to in part be due to the 
increased frequency of chromosomal abnormalities found within the spermatozoa of 
these individuals. 
1.5.6 Conclusion for all the FISH studies on infertile males 
Despite some significant differences between studies, there is a general consensus that 
suggests there is evidence of an increased risk of aneuploidy within the spermatozoa of 
infertile males with the significant majority of studies reporting an increase in the rate of 
disomy in at least one chromosome with the exception of a few studies (Guttenbach et 
at., 1997; Martin et al., 2000; Miharu et al., 1994; Shultz et al., 2000). It is also clear 
that particular chromosomes may be more prone to non-disjunction including 
chromosome 21 and the sex chromosomes particularly XY disomy. The differences in 
the rates of disomy and whether or not a significant increase was observed between 
infertile males and controls between studies are vast as can be seen from this section. A 
number of factors/ differences exist between studies, which may account for some of the 
differences observed between studies and these are now considered. 
1.5.6.1 Patient Differences 
There are a number of obvious differences that may affect results when comparing 
studies, for example the number of patients enrolled in studies differs, with this varying 
from 1-50 individuals. Patient number is an important factor as if too few patients are 
analysed in one study the results may be skewed or biased by one or two individuals 
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with particularly higher aneuploid frequencies within their sperm. Certainly one key 
factor involved is differences in the criteria used in patient selection. Firstly the age 
ranges of patients vary significantly between studies and may contribute towards the 
differences observed. Secondly there are studies that give no indication as to whether 
the controls were age-matched, which given the reports of the presence of a paternal age 
effect may alter the results depending on the age ranges of individuals (Asada et al., 
2000; Griffin et al., 1995; Guttenbach et al., 2000; Kinakin et al., 1997; Martin et al., 
1995; Robbins et al., 1995; Rousseaux et al., 1998). If both age and infertility 
phenotypes are affecting sperm disomy then it is clear that there is a complex 
relationship between them. 
Infertile males are classified (based on analysis of semen parameters, refer to section 
1) as having defects in count, motility, morphology or any combination of the three 
with OAT males being the severest affected (with all three parameters impaired). It is 
difficult to draw direct comparisons between studies as often more than one type of 
infertility is analysed within studies and the results are not presented for each type. Also 
even in studies investigating the same infertility the severity varies from individual to 
individual. It is possible or even likely that specific infertility phenotypes are more 
likely to confer an increased risk for aneuploidy than others and at levels of severity. 
Many studies do not clearly define the semen parameters of individuals or in some cases 
even specify the impainnent involved reporting no further details other than infertile. It 
is therefore feasible that in some cases the differences seen are a reflection of the 
different andrological phenotypes of the males studied and that certain criteria may 
correlate more closely with chromosome abnormalities of certain chromosome pairs. 
Clearly there are other problems even if studies have reported patient details there are 
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potentially differences in the classification of semen parameters either individual or the 
use of a different classification system. 
Several other variables amongst the patients analysed within studies include differences 
in days of abstinence prior to assessment, which may result in differences in disomy 
levels. Differences in the type of spermatozoa utilised including immature (testicular 
extracted spermatozoa) or mature spermatozoa (ejaculated). There is much concem over 
the use of testicular spermatozoa in ART. This may be justif ied as these are not yet fully 
formed differentiated and the risk is hard to establish as only a handful of cells can be 
analysed. Similarly lifestyle differences are not always considered. It is well established 
that sperm counts can vary according to exercise, alcohol consumption, caffeine intake, 
smoking etc and some of these factors (e. g. smoking) have been associated with 
increased levels of spenn aneuploidy (Robbins et al., 1997; Rubes et al., 1998; Shi et 
al., 2001). Indeed the effect of extrinsic factors is an area that requires further 
investigation, for instance few papers have reported the association between pollution 
and sperm disomy and the area of endocrine disruption is one that has yet to be 
investigated in this context. 
1.5.6.2 Technical Differences 
FISH on human sperm is a more involved procedure than on metaphase preparations. 
The major difference lies in the fact that it is necessary to decondense the sperm nuclei 
prior to denaturation and probe hybridisation. This step is critical in that the DNA in 
sperm nuclei is tightly packed through interprotarnine disulphide bridges. The method 
and quality of the decondensation treatment between studies is thus critical, as it is 
likely to effect the hybridization and interpretation of the results (Rives et al., 1998). 
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Inadequate or absent decondensation of sperm nuclei will result in reduced access of the 
probes to the nucleus and thus may result in an underestimate of disomy levels (Miharu 
et al., 1994). Excessive decondensation results in a highly diffuse signal as a result of 
the over decondensation of the chromatin within the sperm nucleus, potentially resulting 
in an over estimate of disomy levels through "split spots" (Rives et al., 1998). Between 
studies there are considerable differences in the type of decondensation procedure used. 
To date there are three main types of incubations used in the decondensation procedures 
these include: NaOH, Dithiothreitol (DTT) and finally DTT subsequently followed by 
an incubation in Lithium salt (LIS). The differences between studies also extend to 
formamide concentration, pH, duration and temperature of the denaturation solution and 
stringency washes. For the most part studies utilise the DTT only or DTT and LIS 
combined. 
The type of probe used for the experiments is also critical. The most commonly used 
probes for sperm FISH studies are those that bind to the peri-centromeric regions of 
chromosomes (usually alpha-satellite probes) or, in the cases of chromosomes 1,9,16 
and Y to the dark C-bands (Downie et al., 1997). With the use of these particular probes 
it is especially important to ensure that adequate decondensation is carried out as the 
centromeres are more condensed within the nuclei than the p and q arms (Rives et al., 
1998). Clearly the smaller the signal from the probe, the more likely it is to detect 
disomy as larger probes may give overlapping signals in disomic cells. Signals vary in 
size in proportion to the size of the tandem repeat array (indeed alpha satellite and this is 
particularly apparent for the Y chromosome. Most studies investigating the Y 
chromosome use a satellite III probe that recognises a large proportion of the long arm 
(Griffin et al., 1995; 1996b). There is a probe that recognises the centromere of the Y 
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chromosome that gives a much more punctate signal but, as the Y chromosome alphoid 
array is the smallest in the human karyotype, signals can often be unreliable. For 
chromosome 21, as the alpha satellite probe also recognises chromosome 13, it is 
necessary to use single locus probes (e. g. BACs). These probes frequently give bright 
signals and, for chromosome 21, a number of studies have made good use of it. A 
further point of note is that, when establishing the levels of XY disomy, it is much more 
easy to tell apart two signals of different colour than two of the same. XY disomy and 
21 disomy are often quoted as the most frequent among human sperm (Griffin et al., 
1996b; Spriggs et al., 1995; 1996) in our opinion, the extent to which this reflects the 
fact that the small size of the probe (for chromosome 21) and the use of two differently 
coloured probes (for XY) remains to be determined. 
Differences are likely to arise between studies dependent on the stringency applied to 
the scoring criteria. It is clear that in order to produce results that are comparable 
between studies the same strict scoring criteria should be utilised between studies. 
Sperm nuclei are scored as normal if they contain I signal for each of the chromosome 
pair investigated, as disomic if they contain two signals for the same chromosome, and 
diploid if they contain two signals for all chromosomes investigated. Griff in et at. 
(1995; 1996a) established scoring criteria that include: Only scoring sperm of similar 
size (approximately 1.5-2 times normal size after decondensation), not scoring 
overlapping sperm nuclei, in order to score a cell as disomic the signal intensity and size 
most be similar, the distance between the two signals must be separated by at least I 
signal domain and not scoring signals that appear outside the cell nucleus. While the 
majority of studies have adhered to such criteria, the stringency to which they are 
applied may well vary from lab to lab and from individual to individual. Thus we 
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cannot rule out the possibility of a small but potentially significant difference in disomy 
frequencies between studies as a result of observer bias. 
Given the complexities of sperm preparation techniques, scoring criteria, intrinsic inter- 
individual differences and the involvement of extrinsic factors it is perhaps not 
surprising that results have varied from study to study. Nevertheless, it is clear that with 
a few exceptions (Acar et al., 2000; Damri et al., 2000; Guttenbach et al., 1997; Martin 
et al., 2000; Miharu et al., 1994; Schultz et al., 2000) a general agreement in favour of 
significant increases in sperm disomy has been established for all chromosomes 
analysed. As with many studies however more questions are raised than are answered, 
for instance, if the inter-laboratory differences are real then what is the cause of them? 
Are particular andrological, phenotypes more associated with mal-segregation of 
specific chromosome pairs than others? In an ideal world therefore future studies would 
use a range of males, each with one, two or three perturbations in their andrological 
criteria and each with at least three repeat samples. The problem of differing signal sizes 
could be circumvented by use of equally sized BACs for all of the chromosomes 
analysed. Scoring of very large numbers of sperm (e. g. more than 20,000) would be 
necessary in order to minimise statistical anomalies and a standard protocol for scoring 
criteria would have to be established. Moreover, a consensus needs to be reached among 
chromosome researchers and statisticians as to the most appropriate test to use. It is 
likely that such demands are unlikely to be fulfilled without the use of automation. 
Fortunately automated dot counters (after many false dawns) are now becoming 
commonplace and reliable; their use and implementation will enable the generation of a 
large volume of data on chromosome disomy. It is also likely that the use of these 
automated counters will reduce observer bias. 
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As there is so much variability between all the studies, it is an difficult and time 
consuming task to directly compare studies against each other. Ideally detailed patient 
accounts must be included in all studies, specifically the parameters mentioned earlier 
and technical differences mentioned above need to be discussed and specific levels/ 
parameters should be agreed for future studies. Future studies should therefore be 
required to adhere to all the parameters set although this will be difficult to accomplish 
it is only then that studies will be directly comparable in order to elucidate potential 
increased risks of higher disomy levels in infertile men and any particular subsets that 
are predisposed to an increased rate of disomy. There also needs to be further studies 
investigating chromosomes including 2,3,4,5,6,7,8,9,10,11,14,15,16,19,20,22 
where few or no studies have analysed these chromosomes. Also it would be 
advantageous to study large numbers of infertile males, studies such as these are likely 
to be published in the near future as a result of the development of automated dot 
counters. 
1.5.7 FISH studies on the spermatozoa of men carrying structural or 
numerical abnormalities within their karyotype 
As discussed in section 1.3 a number of chromosome numerical and structural 
abnormalities have been associated with infertility including: numerical abnormalities 
such as Klinefelter syndrome in which the majority of patients are found to be infertile 
and XYY syndrome in which there is a variable phenotype ranging from fertility to 
severe infertility. Structural abnormalities including chromosome translocations and 
inversions, which again are variable in phenotype depending on the chromosomes 
involved and the size of the affected region. However, the recent advent of 
intracytoplasmic sperm injection (ICSI) has now given some of these patients who were 
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previously deemed infertile the opportunity to conceive. The use of ICSI in the 
treatment of infertility in these patients has been questioned due to the concern of the 
genetic composition of the spermatozoa to be used in this procedure. In order to assess 
whether these patients are at any increased risk of producing children with chromosome 
abnormalities a number of studies have used FISH to establish the rates of chromosomal 
abnonnalities within the spermatozoa of these patients. 
1.5.7.1 FISH studies in the spermatozoa of translocations carriers 
Translocations and their involvement in infertility have previously been discussed in 
section 1.3.2.2. Reciprocal translocations often forrn quadrivalents at meiosis I (figure 
1.5 section 1.3.2.2), which segregate in a number of ways resulting in gametes that are 
either normal, abnon-nal balanced and abnormal unbalanced. FISH has been utilised to 
identify the frequency at which these types of segregation occur in the spermatozoa of a 
number of translocation carriers involving various chromosomes (table 1.4). 
These studies are of importance for identifying the mechanisms of meiotic segregation 
of such translocations and are hence able to estimate the risk of pregnancy loss and birth 
defects within these individuals (Van Hurnmelen et al., 1997). It is important to note 
that the rates of balanced and unbalanced spermatozoa between translocation carriers 
may not be equal. The segregation pattern of the quadrivalent is different dependent on 
a number of factors including; the chromosomes involved, the size of the translocated 
segments, the likelihood of crossing-over within the translocated region and the position 
of the chromosome breakpoints (Oliver-Bonet, 2001). It is interesting to note (table 1.4) 
the few cases for which translocations involve the same chromosomes, the frequency of 
the different types of segregation are similar e. g. t(3; 9)(p25; q32) and t(3; 9)(q26.2; q32) 
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(Honda et al., 1999). When the segregation frequencies however are compared when 
only one chromosome is the same involved the translocation e. g. chromosome 8 in 
t(7; 8)(q 11.2 I; cen) and t(8; 9)(q24; q32) the segregation patterns have different 
frequencies. Hence the risk of chromosomally imbalanced gametes and hence the 
potential risks to a foetus and chance of survival is very much dependant on the 
chromosomes involved. 
Several studies have investigated whether there is an interchromosornal effect within 
these individuals by assessing aneuploidy frequencies for other chromosomes not 
involved in the translocations and comparing them to karyotypically normal control 
males. To date several studies have suggested evidence of an interchromosomal effect 
for several chromosomes including that of chromosome 18 (Mercier et al., 1998; 
Oliver-Bonet et al., 2001; Rousseaux et al., 1995), evidence for such an effect involving 
the sex chromosomes has also been documented (Cifuentes et al., 1999; Oliver-Bonet et 
al., 200 1). The study carried out by Cifuentes et al. (1999) investigated the 
interchromosomal effect on chromosomes 1,8,6,12,15,17,2 1, X and Y in up to 29 
reciprocal translocation carriers. Over 50% of the translocation carriers demonstrated a 
significant increase for at least one chromosome, particularly that of chromosome 1,21 
but also that of the sex chromosomes, no significant difference was observed for the 
other chromosomes investigated. These studies currently suggest that the non- 
disjunction of chromosomes 1,18,2 1, X and Y may be more frequently affected by the 
presence of a translocation. It is clear however, that more studies investigating this 
finding are required. 
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1.5.7.2 Aneuploid frequencies in the spermatozoa of Klinefelter syndrome males 
Studies have analysed the frequencies of aneuploidy in the spermatozoa of non-mosaic 
and mosaic Klinefelter syndrome for the sex chromosomes and autosomes including: 1, 
8,12,18,21 (Hennebicq et al., 200 1; Bielanska et al., 2000; Hennebicq et al., 2000; 
Rives et al., 2000; Lim et al., 1999; Kruse et al., 1998; Foresta et al., 1998; Morel et al., 
2000) to establish whether these patients through the use of ICSI are at any increased 
risk of producing aneuploid progeny specifically for the sex chromosomes. 
1.5.7.3 Aneuploid frequencies in mosaic Klinefelter males 
The majority of studies investigating aneuploidy rates in the spermatozoa, of Klinefelter 
individuals have done so in mosaic individuals exhibiting a 47, XXY/46, XY karyotype 
(Bielanska et al., 2000; Lim et al., 1999; Morel et al., 2000; Rives et al., 2000) and one 
study a 47XXY/48, XXXY/46, XY individual (Kruse et al., 1998). All studies 
investigated aneuploidy levels for the sex chromosomes and at least one autosome with 
the exception of the study carried out by Kruse et al. (1998) who utilised a dual-colour 
approach. This particular study reported a high frequency of XX, XY and XXY 
aneuploidy in the spermatozoa prior to ICSI, although, it should be noted that only 202 
spermatozoa were available for analysis and that disomy frequencies reported are 
unlikely to be accurate as only chromosomes X and Y were investigated (which does 
not enable disomic cells to be distinguished from diploid cells). Morel et al. (2000) 
reported a significant increase in XX, XY and YY disomy in one of the two Klinefelter 
individuals involved in this study, in agreement with these results significant increases 
for these disomies were also reported by other studies (Bielanska et al., 2000; Rives et 
al., 2000). In some cases studies have found no such evidence of an increase in YY 
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disomy, however, document significant increases in both XX and XY disomy (Lim et 
al., 1999; Morel et al., 2000). 
1.5.7.4 Aneuploid frequencies in non-mosaic Klinefelter individuals 
To date there have been a handful of studies that have investigated the chromosome 
complement of spermatozoa from non-mosaic Klinefelter individuals (47, XXY) 
(Forcsta et al., 1998; Hcnnebicq et al., 2000; Henncbicq et al., 2001; Rivcs et al., 2000). 
Each study has reported significant increases in hyperhaploid levels in the Klinefelter 
patients investigated for at least one of the sex chromosomes. All studies demonstrated 
significant increases in XY disomy (Foresta et al., 1998; Hennebicq et al., 2000; 
Hennebicq et al., 2001; Rives et al., 2000) with up to a ten fold increase compared to 
controls (Hennebicq et al., 2000). Of these four studies, two studies also reported 
significant increases in XX disomy (Hennebicq et al., 2001; Rives et al., 2000) 
however, none of these studies reported any increases in YY disomy. 
All authors suggest that it is possible for at least some 47, XXY cells to proceed through 
meiosis to produce mature hyperhaploid spermatozoa (Bielanska et at., 2000; Foresta. et 
al., 1998; Hennebicq et al., 2000; Lim et al., 1999; Morel et al., 2000). Foresta ct al. 
(1998) have suggested there is evidence of this as the frequency of 24, XY disomic 
spenn was significantly higher in the absence of the 22,0 hypohaploidy that would be 
expected in the event of meiosis I non-disjunction in a normal 46, XY cell. It is clear 
from these studies that Klinefelter syndrome patients have been shown to be at an 
increased risk of producing offspring aneuploid for the sex chromosomes (Bielanska et 
al., 2000; Foresta et al., 1998; Hennebicq et al., 2000; Hennebicq et al., 200 1; Kruse et 
al., 1998; Lim et al., 1999; Morel et al., 2000; Rives et al., 2000) through ICSI, 
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compared to fertile controls and infertile males with normal karyotypes (Rives et al., 
2000). A number of these studies however, have revealed the possibility that Klinefelter 
syndrome may also be associated with an increased risk in producing offspring 
aneuploid for autosomes. At present the existence of this association needs further 
investigation, however, reports suggest a significant increase in the following 
autosomes chromosomes 12 (Rives et al., 2000), chromosome 18 (Lim et al., 1999) and 
chromosome 21 (Hennebicq et al., 200 1). Hennebicq et al. (200 1) hypothesised that the 
increase seen in chromosome 21 disomy is likely to be due to the abnon-nal sex 
chromosome content, resulting in the disturbance of the meiotic segregation of some 
chromosomal pairs. This may be attributed to the presence of an abnormal or absent sex 
chromosome vesicle. Disturbance of the segregation of chromosome 21 may arise as a 
result of a close association with one or both sex chromosomes during meiosis, which in 
turn could result in abnormal segregation. Some studies have found no association with 
significant increases in autosome aneuploidy in the spennatozoa of Klinefelter 
individuals for chromosomes I (Hennebicq et al., 2001; 2000), 8 (Foresta et al., 1998; 
Morel et al., 2000), 15 (Morel et al., 2000) or 18 (Bielanska et al., 2000; Morel et al., 
2000). 
It has also been suggested that if Klinefelter individuals decide to undertake ART that 
FISH should be used to determine the risk of transmission of sex chromosome 
(Hennebicq et al., 2000; Hennebicq et al., 2001; Kruse et al., 1998; Lim et al., 1999; 
Rives et al., 2000) and autosomal aneuploidy particularly for chromosome 21 
(Hcnnebicq et al., 2001) to future children in order to provide additional information for 
genetic counselling and also indicating if preimplantation or prenatal genetic diagnosis 
may be advisable depending on the potential risk. 
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1.5.7.5 Aneuploid frequencies in the spermatozoa of XYY syndrome males 
Males with 47, XYY phenotypes have varying semen parameters ranging from 
normozoospen-nia to severe oligozoospermia (Johnson, 1998), at present it is unclear 
why such different effects are seen in these individuals although these facts suggest that 
this condition may have a deleterious effect in some individuals but not others. Early 
studies suggested that the extra Y chromosome in these men was lost during the 
premeiotic stage, thereby leaving an XY bivalent to proceed with normal meiosis 
(Chandley et al., 1976; Evans et al., 1970; Melnyk et al., 1969; Thompson et al., 1967). 
More recent reports however, have suggested that there is increasing evidence that XYY 
cells can enter, and eventually complete meiosis (Blanco et al., 1997; Blanco et al., 
200 1; Burgoyne., 1979; Burgoyne and Biddle., 1980; Speed et al., 199 1). Support for 
this theory has been produced utilising FISH, indicating that some 47, XYY individuals 
have increased frequency of aneuploid spermatozoa compared to controls (Blanco et al., 
1997; Han et al., 1994; Lim et al., 1999; Martin et al., 1999; Wang et al., 2000). 
The rate of aneuploidy in the spermatozoa of males with mosaic and non-mosaic XYY 
karyotypes has been investigated in a series of studies. The study carried out by Han et 
al., 1994 utilised two colour FISH for the sex chromosomes to establish the aneuploid 
frequencies in one XYY male, a significant increase in XY (0.35%) an YY (0.43%) 
disomy was found compared to control levels (0.11 % and 0.16% respectively). These 
results may be overestimated due to the usage of a dual probe for the sex chromosomes 
only. The remainder of the studies have utilised three colour FISH; two studies have 
investigated the effect of an XYY mosaic karyotype and the chromosome complement 
of spermatozoa in these individuals. In both studies mosaic individuals were identified 
through the karyotyping of peripheral lymphocytes, in total three XYY mosaic patients 
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have been investigated by these studies. Of the three patients investigated two patients 
had similar levels of mosaicism of 19% and 20% with the third having a substantially 
higher level of 90%. The two patients exhibiting similar frequencies of mosaicism both 
demonstrated significant increases for XY disomy alone. Specifically, the patient 
exhibiting the 47, XYY[20%]/46, XY[80%] karyotype had reported levels of 0.61% 
compared to control the control frequency of 0.22% (Wang et al., 2000); with 
frequencies of 0.23% identified for the 47, XYY[ I 9%]/46, XY[79%] patient compared to 
0.2% recorded from the control (Lim et al., 1999). However, the patient with the higher 
level of mosaicism 47, XYY[90%]/46, XY[ 10%] was demonstrated to have a significant 
increase in both XY and YY disomy with levels of 1.02 and 0.44 respectively compared 
to the control levels of 0.1% found for both types of disomy (Lim et al., 1999). 
Significantly higherfrequencies of sex chromosome disomies have been reported within 
studies of 47, XYY non-mosaic patients. Five studies have investigated the chromosome 
constitution of spermatozoa from six 47, XYY individuals. However two of these studies 
analysed two individuals with dual-colour FISH (hence frequencies found may be 
inaccurate) only one study reported an increase in aneuploid sperm for YY and XY 
(Mercier et al., 1996), whereas Han et al. (1994) found no evidence of an increase. 
Studies identified a significant increase in XY disomy for both patients with frequencies 
of 0.55% (Martin et al., 1999) and 0.3% (Blanco et al., 1997). Blanco et al. (1997) and 
Chevret et al. (1997) also reported a significantly higher level of YY disomy associated 
in a 47, XYY patient compared to controls. In contrast Mennicke, et al. (1997) found no 
such evidence of an increase in disomy rate for any of the chromosomes investigated in 
three 47, XYY individuals. 
89 
At present there is limited information available on the effect of an XYY karyotype on 
the germ cells of these individuals. Investigations though are contradictory, although 
recent evidence would suggest that in mosaic XYY patients the higher the percentage of 
the XYY karyotype the higher the levels of disomy. Increased rates of YY disomy as 
found in three papers (Blanco et al., 1997; Chevret et al., 1997; Lim et al., 1999) 
provide evidence that some of these hyperdiploid cells found in men with XYY 
syndrome can indeed undergo meiotic division. The majority of studies have provided 
evidence that XYY cells appear to be able to complete meiosis. These studies however, 
suggest that a large proportion of abnonnal cells are arrested at various stages of 
spermatogenesis, thereby resulting in the continuous elimination of abnormal cells, 
resulting in a small but significant increase in aneuploid spermatozoa (Blanco et al., 
1997; Blanco et al., 2001; Lim et al., 1999; Martin et al., 1999; Martini et al., 1996). A 
number of investigations have suggested that due to this increase in sex chromosome 
disomies within these patients, and that assessment of the frequencies of chromosome 
abnon-nalities within the spermatozoa of these patients may be warranted prior to the 
commencement of ART. This enables specific individual risks of transmitting the extra 
sex chromosome and pre-implantation diagnosis to be recommended in patients with 
increased frequencies compared to the normal population (Lim et al., 1999; Martin et 
al., 1999; Martini et al., 1996; Wang et al., 2000). 
1.5.8 FISH studies on the spermatozoa of karyotypically normal males 
who have fathered karyotypically abnormal children 
1.5.8.1 Fathers with Klinefelter syndrome offspring 
Lowe et al. (2001) analysed the frequency of disomy 21 and the sex chromosomes in 
thirty-eight fathers of boys with Klinefelters syndrome (47, XXY). This study provided 
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evidence of a significant correlation between the increased incidence of XY disomy 
within the spermatozoa of fathers and increasing paternal age. Increasing age (measured 
in this study by decades) demonstrated a significant increase of around 10% in XY 
disomy in fathers in their thirties, over a 30% increase was found in those men within 
their forties and an increase of 160% in fathers aged over fifty compared to those within 
their twenties. The results suggest that men fathering children latter on in life are at a 
substantially increased risk of producing offspring with Klinefelter syndrome. 
1.5.8.2 Fathers with Turner syndrome offspring 
Martinez-Pasarell et al. (1999), investigated the sperm disomy rates for chromosomes 6, 
X and Y in four fathers of Turner syndrome individuals, (in all these cases monosomy 
X was paternal in origin). The mean frequency of XX disomy (0.04%) and YY disomy 
(0.07%) in these individuals was not significantly different from levels obtained from 
the control (0.04% and 0.06% respectively). Nevertheless, a significant increase in the 
rate of XY disomy was recorded between these patients, (0.22%) versus control levels 
1%). Based on these results, Martinez-Pasarell et al. (1999) suggested an increase of 
non-disjunction of the sex chromosomes occurs as a result of errors in meiosis 1, thereby 
producing more XY bearing and as a result an increase of spermatozoa nullisomic for 
the sex chromosomes. In a further study carried out by the same group Soares et al. 
(2001 a) investigated the disomy frequency for chromosomes 4,13,18,21 and 22 in the 
same four Turner syndrome fathers. In order to establish whether these individuals had 
a general increase in chromosome disomy within the spen-natozoa. or whether this 
increase was restricted to the sex chromosomes only. This study revealed no significant 
difference between the disomy rates for chromosomes 4 (0.06%) and 18 (0.05%) in the 
Turner syndrome fathers compared to that of the control levels with levels of 0.06% and 
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0.04% respectively. A significant increase in the rate of disomy however, was found for 
chromosomes 13,21 and 22, with levels of 0.14%, 0.14% and 0.12% respectively 
versus the control frequencies of 0.10%, 0.07% and 0.06% respectively. Soares et al. 
(2001 a) suggest an association between the fathering of aneuploid offspring and an 
increased incidence of disomic spen-natozoa, and that this increase does not appear to be 
restricted to the chromosome pairs involved in the production of the aneuploid 
offspring. Soares ct al. (2001 a; 2001b) hypothesised that this may affect the acrocentric 
chromosomes and sex chromosomes, due to having only one chiasma during meiosis 
therefore more susceptible to malsegregation. 
1.5.8.3 Fathers with Down syndrome offspring 
Blanco et al. (1998b) investigated sperm disomy rates for chromosomes 6 and 21 in 
fifteen fathers with children affected with Down syndrome and compared the rates 
against those found in nine control males. In ten out of the fifteen cases the extra 
chromosome 21 was matemal in origin with only two cases being paternal in origin (the 
origin of the remainder were mitotic, with one case due to a translocation). In both the 
control group and the patient group a significant increase in the rate of disomy for 
chromosome 21 was observed compared to that of chromosome 6. No significant 
difference was observed between the two groups for the two chromosomes investigated. 
Comparison of each individual with the controls revealed a significant increase in the 
rate of disomy for chromosome 21 in the two fathers (DP-4 and DP-5) for which the 
extra chromosome 21 in their offspring was paternal in origin (compared to the controls 
and the remaining individuals in this group), 0.75% and 0.78% versus 0.37% in the 
controls. In light of this data Blanco et al. (1998b) also investigated the disomy 
frequencies of chromosomes 18, X and Y in the same two individuals DP-4 and DP-5 in 
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an attempt to establish if the increase of disomy 21 was due to disruptions in meiosis. 
The disomy frequencies of these chromosomes in DP-4 did not show any significant 
increase compared to the control levels. In patient DP-5 however, a significantly higher 
frequency of sex chromosome disomy, particularly XY disomy was recorded which 
may suggest the existence of a generalised susceptibility to the disruption of the 
synaptic process resulting in an increased incidence of chromosomal anomalies (Blanco 
et al., 1998b). Soares et al. (200 1 b) carried out a follow up study on these two patients 
DP-4 and DP-5 investigating the disomy frequencies of chromosomes 4,13 and 22, 
using the same nine control donors in the previous study. A significant increase in the 
rate of disomy 13 and 22 but not chromosome 4 was found in both of these patients 
compared with the controls. Soares et al. (200 1 b) suggested that it is possible that both 
of these individuals may have a susceptibility to meiotic non-disjunction and that 
acrocentric chromosomes may be more susceptible to non-disjoin than other 
chromosomes. In contrast Rubio et al. (2001) analysed the disomy frequency for 
chromosomes 13,18,2 1, X and Y in the spermatozoa of three fathers, all of which had 
pregnancies that were affected by Down syndrome. This study found no evidence of any 
significant difference between the study group and the control donors for any of the 
investigated chromosomes, however, the origin of the extra chromosome 21 was not 
determined. The determination of parental origin is of importance as Blanco et al. 
(1998b) only found evidence of an increase in spen-n. disomy in individuals for which 
the extra chromosome was paternal in origin. It is therefore possible that no significant 
difference was identified by Rubio et al. (2001) as the origin of the extra chromosome 
21 may not have been paternal in origin. However, more studies for which the parental 
origin of the extra chromosome 21 is known needs to be undertaken to deten-nine if this 
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is the case. Therefore more studies need to be carried out in individuals in which the 
extra chromosome 21 is determined to be paternal in origin. 
1.5.9 Studies investigating environmental and lifestyle factors on 
aneuploidy frequencies in spermatozoa 
To date studies have investigated a wide range of lifestyle and environmental factors in 
order to examine whether any of these may contribute to increased frequencies of 
aneuploidy within spen-natozoa and include some of the following: 
o caffeine 
o alcohol 
o Smoking tobacco 
o environmental exposures 
o chemotherapy 
1.5.9.1 Lifestyle effects 
In modem society there are a number of stresses that are placed on our bodies, these 
include lifestyle choices such as alcohol and caffeine consumption, smoking tobacco 
and recreational drug use. These lifestyle choices have often been associated with health 
problems, however, what remains unclear is what effect these lifestyle habits are having 
on the reproductive health of individuals. The excessive consumption of alcohol has 
been implicated as a possible cause of a reduction in the quality of semen parameters, 
chronic alcoholics have been shown to have a decrease in spenn concentration and 
forward motility and an increase in abnormal morphology (Goverde et al., 1995; Nagy 
et al., 1986). Chronic alcoholics have also been found to have decreased serum 
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concentrations of testosterone and increased levels of oestrodiol (Gomanthi et al., 
1993). 
Smoking has been demonstrated to have damaging effects on semen parameters 
including sperm concentration, morphology and motility (Little and Vainio., 1994; 
Stillman et al., 1986; Vine et al., 1994; Vine., 1996; Vogt et al., 1986). Electron 
microscopy has shown that smokers have an increased incidence of abnormalities 
involving the sperm axoneme, including changes in number and arrangement of 
axoneme microtubules in smokers. These abnormalities could result in significant 
effects on the progressive motility of spen-natozoa (Zavos et al., 1998). Smoking could 
also potentially bring about significantly higher numbers of genetically abnormal 
spermatozoa, as smoke has been shown to contain at least 30 chemical agents known to 
be mutagens, clastogens, aneugens or carcinogens (Claxton et al., 1989; Lofroth., 1989). 
A handful of studies have investigated the relationship between aneuploid frequencies 
in spen-natozoa and a number of lifestyle factors including smoking, alcohol and 
caffeine consumption, chromosomes analysed include 1,8,13,18,21, X and Y 
(Robbins et al., 1997a, Rubes et al., 1998; Shi et al., 2001). For the most part studies 
have analysed more than one lifestyle factor per study. Shi et al. (200 1) analysed 
chromosome 1,13, X and Y in 31 Chinese men who were split into 3 groups, non- 
smokers; light smokers (<20 cigarettes per day) and heavy smokers (>20 cigarettes a 
day). Both light and heavy smokers were found to have significantly higher levels of 
disomy 13 compared to the group of non-smokers, but no significant increase was found 
for any of the other chromosomes investigated. The authors however, comment on a 
significant amount of inter-donor heterogeneity for all chromosomes analysed in both 
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the light and heavy smokers groups. Rubes et al. (1998) investigated aneuploidy for 
chromosomes 8, X and Y in 25 men all aged 18, these were split into two groups, those 
that have smoked 20 cigarettes a day for at least two years and a group of non-smokers. 
The smoking group exhibited reduced semen quality for count and displayed a 
significantly higher percentage of round-headed sperin. compared to the control group, 
and a significant increase in YY disomy. The group of smokers however, was also 
recorded to consume a greater quantity of alcohol and twice the amount of caffeine 
compared to the control group. Hence the causative agent for increase in YY disomy 
cannot be attributed to smoking alone but also in conjunction with the consumption of 
alcohol. Robbins et al. (1997a) carried out a study in 45 men investigating the effect of 
smoking, consumption of alcohol and caffeine on the incidence of chromosomal 
aneuploidy for chromosomes 18, X and Y. This study has reportedly controlled for age 
and the consumption of the two factors alcohol, caffeine or smoking by using poisson 
regression statistical analyses. After controlling for these effects the following 
associations were identified between increases in disomy and the three exposures 
investigated including caffeine consumption and XX and XY disomy, alcohol 
consumption and XX disomy and an unstable association with smoking and XX 
disomy. This unstable association between smoking and sperm aneuploidy was also 
reported by Shi et al. (200 1), suggesting that smoking cigarettes potentially increases 
the risk of aneuploidy for specific chromosomes, but due to the inter- donor differences 
that some individuals may be more susceptible than others to increases in aneuploidy. 
Several studies have investigated the effect of common lifestyle exposures including 
smoking, consumption of alcohol and caffeine and the presence of any causal effect 
between such lifestyle factors and spenn aneuploidy and have found a significant 
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adverse effect on spen-n aneuploidy. The results have however, been largely 
inconclusive in producing direct evidence of a relationship between individual factors 
and sperm aneuploidy. Understandably this has been a difficult task as there are a 
number of potential confounding factors that may be involved including smoking, 
alcohol and caffeine consumption, diet, exercise, stress, geographic differences, 
environmental and occupational exposures. Occupational exposures have also been 
implicated in a reduction in semen quality. In the study carried out by Figa-Talamanca 
et al. (1996) the effects of prolonged automobile driving in taxi drivers was 
investigated. Evidence of prolonged automobile driving as a risk factor for reduced 
semen quality, especially for morphology was described. It is possible that any one of 
these lifestyle factors mentioned above may exert an individual effect or that any of 
these may act in a synergistic manner. Authors attempting to correlate the effect of 
individual lifestyle factors and spenn aneuploidy are in a difficult position, as it is 
difficult to isolate non-nal healthy individuals that only have exposure to one type of 
lifestyle exposure such as smoking. This is especially true for smokers, which have been 
reported to consume greater quantities of alcobol and caffeine compared to non-smokers 
(Rubes et al., 1998). Studies investigating this phenomenon ideally need to have age 
matched individuals who are from the same region, and for which samples are taken at 
similar time periods in order to minimise the risk of different environmental exposures, 
and comprehensive information is required about lifestyle, diet, exercise and potential 
occupational and envirom-nental exposures such as pesticides. This is an enormous task 
as studies ideally require a large number of individuals and can often only rely on the 
details patients have given with regards to lifestyle exposures and cannot take into 
account environmental exposures for which individuals may have no knowledge. 
Previous reports have however, indicated that a number of these lifestyle factors have 
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been associated with a decline in semen quality and an increase in sperm aneuploidy. 
Future work will hopefully identify potential effects of individual types of exposures 
and levels capable of causing adverse effects on the reproductive health of individuals 
and elucidate the mechanisms involved. 
1.5.9.2 Environmental exposure 
A number of questions have been posed as to whether environment contaminants induce 
any genetic damage in humans especially within the gametes, this has far reaching 
public health perspectives. Within recent years there have been several controversial 
reports of a significant reduction in sperm counts over the past 50 years or so (Auger et 
al., 1995; Carlsen ct al., 1992; De Mouzon and Thonneau, 1996; Irvine et al., 1996). 
The debate as to whether this observation is in fact the case still rages on however 
studies have been undertaken in order to detect any such association between 
environmental contaminant exposures and alterations in genn cells. 
Robbins et al. (1999) analysed the aneuploidy frequencies in the spermatozoa of 32 
healthy 18 year olds for chromosomes 8, X and Y due to reports of poor conception 
rates, high rates of congenital malformations reportedly related to air pollution in the 
Czech region of Teplice. This study used individuals previously recruited in another 
study investigating air pollution and health (Srarn et al., 1996). All individuals gave 
information on exposure data for both occupations and hobbies as well as lifestyle 
information including reproductive health, alcohol and cigarette consumption, passive 
smoking and medication. This study only considered males with normal semen 
parameters and non-smoking individuals. Robbins et al. (1999) analysed semen samples 
collected from the same region at two different times of year, one which had record high 
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levels of air pollution with the other having low level of air pollution. This study 
concluded that there was a significant increase of approximately five fold in the levels 
of YY disomy in the individuals tested in the season with high air pollution compared to 
those in tested when air pollution levels were low. The authors checked for associations 
between semen parameters, the period of abstinence and lifestyle factors including: 
caffeine and alcohol consumption, no effect was found. This provides evidence of a 
possible association between increased aneuploidy and high levels of air pollution, 
nevertheless it is a near impossible task to determine if this is the cause of the increase 
in disomy found, as there are potentially many confounding factors. 
Padungtod et al. (1999), analysed aneuploidy frequencies for chromosomes 18, X and Y 
in 13 individuals working in a pesticide-manufacturing plant in China, the aneuploidy 
, L%;; quencies were compared with 16 individuals working in a textile factory that was not 
exposed to any pesticides. Those that worked within the pesticide plant were exposed to 
ethyl parathion or methamidophos (both of which are potent organophosphate 
pesticides) were found to have significant increases in chromosome disomy levels 
compared to those working in the textile factory. 
There is preliminary evidence to support the hypothesis that exposures to environmental 
contaminants, whether it is through everyday exposure such as air pollution or whether 
it is through occupational activities, can cause significant increases in genetic 
abnormalities in the spermatozoa of men. 
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1.5.9.3 Chemotherapy 
Chemotherapy is widely used in the treatment of cancer, during such treatment fertility 
is reduced within these patients, there is also concern raised by both patients and 
specialists on the potential of causing detrimental genetic damage after chemotherapy. 
In male rodents it has been well documented that treatment with chemo- and radio- 
therapeutic drugs prior to mating can cause genetic defects in the germ line (Miestrich et 
al., 1982; Robbins et al 1997). Recently laboratories have addressed the risks of genetic 
damage in the gametes of human mates treated by chemotherapy and the possibility of 
passing on abnormalities to future offspring. A number of studies have investigated the 
use of chemotherapy regimes used in the treatment of testicular cancer and Hodgkins 
disease (both of which are often diagnosed during the patients reproductive years). The 
genetic effects on the gametes of men undergoing these treatments, have been 
investigated for the following chromosomes: 1,2,4,7,8,9,12,13,15,16,18,20,2 1, X 
and Y (De Mas et al., 2001; Frias et al., 2003; Martin et al., 1997; Martin et al., 1999; 
Robbins et al., 1997). 
1.5.9.3.1 Testicular cancer 
Several studies have investigated the genetic composition of spermatozoa in patients 
with testicular cancer before and after chemotherapy treatment with bleomycin, 
etoposide and cisplatin. Following an azoospennic period, spenn cell recovery is 
generally observed after treatment delivery, in order that the genetic consequences on 
new spermatozoa could be assessed, De Mas et al. (200 1) analysed aneuploidy 
frequencies in 5 patients for chromosomes 7,16,18, X and Y prior to treatment and at 
6-18 months after treatment. In this study 20,000 spermatozoa were scored per patient, 
moderate differences in the sperm count before and after treatment were noted and a 
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significant increase in disomy for chromosomes 16,18, XY and diploidy was found. 
However Martin et al. (1997) analysed the frequency of aneuploidy for chromosomes 1, 
12, X and Y in four patients treated with the same chemotherapy agents 2-13 years after 
treatment. In this particular study no such increase in disomy or diploidy was reported 
for the investigated chromosomes. This study also used sperm karyotyping to check for 
both numerical and structural abnormalities for all chromosomes. Concluding that there 
was no significant increased risk of structural or numerical abnormalities in the 
spermatozoa of patients undergoing chemotherapy for testicular cancer two or more 
years after treatment. Subsequent work however, (Martin et al., 1999) analysing sperm 
chromosome complements before during and after treatment reported a significantly 
increase in aneuploidy particularly for XY disomy and that of diploid cells in one 
patient within 18 months after treatment. At present results suggest that the use of 
chemotherapy agents in the treatment of testicular cancer causes a significant increase in 
ancuploidy in the newly generated spermatozoa after treatment, however these 
increased frequencies may fall to levels found prior to treatment after 2 or more years. 
1.5.9.3.2 Hodgkins Disease 
Hodgkins Disease is often diagnosed within the reproductive years of patients, as a 
result there is interest in the effect of the treatment on the reproductive system of mate 
patients. Several studies have analysed samples before, during and after treatment (Frias 
et al., 2003; Robbins et al., 1997). In an effort to establish whether any effects seen in 
aneuploidy levels occur only in those cells undergoing spermatogenesis (transient 
defect) during treatment or whether any persistent defects are induced are affecting the 
germ line stem cells. Robbins et al. (1997) analysed the frequency of aneuploidy for 
chromosomes 8, X and Y in eight patients, before, during and after treatment with 
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Novanthrone, Oncovin, Vinblastine, Prednisone (NOVP) chemotherapy. A significant 
increase in aneuploid frequencies of approximately five fold, including disomy, 
diploidy and hyperhaploidy for all chromosomes investigated during treatment 
compared to pre-treatment levels, with the exception of YY disomy. Samples analysed 
after treatment suggest that the increased level of aneuploidy in the spermatozoa of 
these patients declined to levels comparable to the pre-treatment samples around 100 
days after treatment finished. Frias et al. (2003), examined the use of NOW in the 
treatment of eight male patients, analysing the aneuploidy levels in the spermatozoa for 
chromosomes 18,21, X and Y. This study analysed patients before during and 1-2 years 
after treatment, aneuploidy frequencies were found to be significantly elevated for all 
chromosomes investigated during treatment. Levels of disomy 18 increased 7 fold, with 
disomy 21 rising by 3 fold. Sex chromosome disomy levels increased two fold for XX 
and YY disomy, with XY disomy having the largest increase of all chromosomes 
investigated (14 fold). In contrast Robbins et al. (1997) reported no increase for YY 
disomy however in agreement with Robbins et al. (1997) patients tested post treatment 
no longer demonstrated these increases in aneuploidy for the chromosomes tested. 
1.5.9.4 Conclusions of investigations into the effect of chemotherapy and sperm 
ancuploidy 
It is certain that more studies need to be carried out, as only a handful of studies have 
investigated the potential association between chemotherapy and aneuploidy. This 
information is of importance as it will enable accurate information to be passed on to 
the patients about the genetic risks to potential offspring. There are many types of 
cancer and modes of treatment, until studies are carried out it will remain unknown as to 
whether these treatments cause transient chromosomal defects or persistent defects 
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(Robbins et al., 1997). Therefore it is important that future studies look at patients with 
the same type of cancer and treatment and that these patients should be followed prior 
to, during, and at regular intervals for the following 0-2 years after treatment. This 
would enable the identification of any adverse effects on cells actively undergoing 
spermatogenesis and the stem cell population of individual treatments for specific 
cancers (Martin et al., 1997). Studies to date suggest that the chemotherapy regimes 
analysed including bleomycin, etoposide and cisplatin and NOW in the treatment of 
testicular cancer and Hodgkins disease appear to result in the production of transient 
(non-persistent) chromosomal defects (De Mas et al., 2001; Frias et al., 2003; Martin et 
al., 1999; Robbins et al., 1997). In these cases there is evidence for an increase in 
aneuploidy levels therefore increasing the risk of producing aneuploid offspring for a 
period for an amount of time after treatment with chemotherapy (De Mas et al., 200 1; 
Frias et al., 2003; Robbins et al., 1997). It has therefore been suggested that an 
appropriate period of contraception should be recommended to patients (established by 
studies such as these to determine the time required for aneuploid frequencies to return 
to pre-treatment levels). It is also suggested that patients should also undertake genetic 
counselling if a pregnancy does occur within this time (De Mas et al., 200 1; Frias et al., 
2003; Robbins et al., 1997). 
1.6 Assisted reproductive techniques (ART) 
A large volume of research has gone into assisted reproductive techniques (ART), the 
first major development came with the advent of in-vitro fertilisation (IVF), the first 
baby born using the technique of IVF came in 1978 (Steptoe and Edwards 1978). IVF 
has subsequently become a widespread technique, primarily used for treating female 
infertility. Until recently however, it was rarely possible for couples to reproduce in the 
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case of male factor infertility. Within the last decade the advent of intracytoplasmic 
spenn, injection (ICSI) has enabled such couples to procreate. ICSI has been an effective 
method used to assist fertilisation with sperm from an infertile male and has been 
heralded as the biggest advancement in ART since IVF enabling couples previously 
unable to conceive due to male factor infertility to now do so. The birth of the first ICSI 
baby came in 1992 (Palermo et al., 1992). Recent estimates suggest that lVF accounts 
for just over half of ART treatment cycles with ICSI being undertaken in approximately 
46% of ART cycles (Fraser., 2002 www. nature. com/fertility). 
1.6.1 IVF treatment cycle 
In brief the most common IVF technique used involves the following: 
The female partner is administered fertility drugs to hyperstimulate the ovaries to 
produce multiple eggs, (including a GnRH agonist used in conjunction with hMG, or 
FSH to produce multiple mature ova). The female is then regularly monitored by 
ultrasounds and blood tests enabling the appropriate time to harvest the ova to be 
determined. Prior to this, an injection of hCG is administered to induce the final 
maturation of the ova, following this oocyte retrieval is performed, most commonly 
through the use of ultrasound guided aspiration where a needle is guided through the 
vaginal wall into the ovary where the ova can then be aspirated. Embryologists will then 
identify and grade the maturity of the ovum. Ova are then transferred to a culture dish 
with medium and are placed into an incubator. Spermatozoa from the ejaculate of the 
male is then placed in the culture dish containing the ovum and left to fertilise 
(http: Heastcoastivf com). Much like unassisted conception, spen-natozoa are in 
competition with each other, the hurdles that sperm have to overcome that are in place 
in natural conception are similar to those encountered by sperm used in IVF. In both 
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these cases the spermatozoa that fertilise the eggs are those that swim well, can undergo 
the acrosome reaction and fuse with the plasma membrane of the egg. The following 
day the ova are examined for evidence of fertilisation and are incubated further to 
enable the development of an embryo following this period the embryo is then 
transferred to the uterus. 
1.6.2 ICSI treatment cycle 
In the case of ICSI, the female partner is treated in much the same way as in IVF, 
ovaries are hyperstimulated and the eggs are surgically removed. Sperm is collected 
from the male partner either through ejaculation or surgically. Oocytes are then cleansed 
of all surrounding cells and the spermatozoa are prepared separately. The egg is held in 
place with a glass pipette while a sharp hollow needle is used to immobilise and capture 
a single sperm. Unlike in IVF and natural conception there is no selective pressure on 
the sperm as the spermatozoa selected for fertilisation is chosen by the embryologist. 
The needle containing the spermatozoa. is then carefully inserted through the zona 
pelucida (taking care not to disturb the meiotic spindle) into the cytoplasm of the oocyte 
(figure 1.7). As in IVF the oocyte is then incubated and checked the following day for 
evidence of fertilisation. Any oocytes that have been successfully fertilised and appear 
to be dividing normally are then transferred to the females uterus either 2 days later (at 
the two-cell stage) or after five days (at the blastocyst stage) (Winston and Hardy., 2002 
www. nature. com/fertility). 
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Figure 1.7- shows the process of ICSI, panel A, sharp hollow needle picks up a single sperm, 13- 
egg is held in place and the needle carrying the sperm is injected into the egg, C- the needle is 
clearly seen in the cytoplasm, D- the needle is withdrawn and the egg is left to see if fertilisation 
has taken place. Image taken from ", %%, w. acrm. conVART/ART. htm 
1.6.3 How safe is ICSI? What are the risks involved with this 
technique? 
The development of ICSI has revolufionised. the management of male factor infertility 
and because of enormous patient demand has been rapidly adopted by infertility clinics 
all over the world with little regard for the potential genetic problems for future 
generations (Bhasin et al., 1994; Johnson, 1998). Many have criticised the procedure of 
ICSI, in the treatment of male infertility, as it is believed that the use of ICSI 
theoretically increases the risk of propagating disorders associated with male infertility, 
thereby increasing the fitness of these infertile genotypes (Johnson., 1998). These views 
on ICSI may well have good standing as the procedure itself bypasses the biological 
mechanisms of sperm selection, which are in place in natural conception. The use of 
ICSI has been criticised, as it has not undergone proper cell culture experiments or 
extensive research trials in other mammals prior to being used in a clinical setting. The 
concern is that pressure to treat male infertility has meant that vital infon-nation that 
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could be gleamed from these types of experiments has been bypassed. Although in 
recent years ICSI has been tested in rhesus monkeys, however, this has been many years 
after the use of ICSI in the treatment of humans (Winston and Hardy., 2002 
www. nature. com/fertility). Therefore the human experience with ICSI is the 
experimental record, (Johnson., 1998; Tornaye., 1999; Winston and Hardy., 2002 
www. nature. com/fertility). In part the problem stems from the fact that technological 
solutions to male infertility are developing substantially faster than our understanding of 
the underlying causes (Johnson, 1998). Due to this uncertainty it is important to develop 
an understanding of the genetic risks and possible consequences that may be associated 
with ICSI. Assessment of such risk is unlikely to adversely affect the practice of ICSI, 
but will enable couples to be fully aware of any risks associated with the procedure 
(Fraser., 2002 www. nature. com/fertility; Griffin et al., 2003). Moreover, investigations 
of the genetic causes of the infertility may lead to subsequent treatment regimes that are 
alternative to ICSI without the potential risks involved. 
With the development of IVF came major concerns about the safety of this technique. 
Despite this, the few controlled studies have been performed, that do suggest that the 
r- 
nequency of congenital malformations compared to naturally conceived babies is not at 
any increased rate. Research currently suggests that ICSI has similar fertilisation and 
conception rates as IVF (Van Steirteghem., 2002). The advent of ICSI brought about 
similar concerns, although the IVF situation does not seem to cause any perturbations, 
the use of ICSI is more invasive as the sperm cell is injected directly into the egg. These 
include concerns that selective mechanisms against physiologically or genetically 
abnormal spermatozoa are bypassed; immature spermatozoa that previously would not 
of been able to be used in fertility treatment can now be used including sperm extracted 
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from the epididymas and testes, abnormal oocytes may be fertilised; altered 
environment, mechanical or chemical damage to the oocyte may lead to perturbations of 
meiosis and mitosis; various chemical or environmental exposures may also lead to 
point mutations, resulting in genetic diseases visible at birth or later in life, (Bonduelle 
et al, 1996). 
1.6.3.1 Chromosomal aberrations within couples undergoing ICSI 
Concerns have arisen as several studies have published evidence that infertile couples 
specifically infertile males have a significant increase in chromosomal aberrations 
compared with their fertile counterparts. 
1.6.3.2 Reports on the rates of congenital malformations and chromosomal defects 
in children born with the use of ICSI 
At present only a handful of studies have been published, looking at the outcomes of 
ICSI, in an attempt to identify the risks of congenital malformations, abnormal 
karyotypes, growth parameters and developmental outcome in children born through 
ICSI, (Aboulghar et al., 2001; Bonduelle et al, 2002a 2002b; 1999; 1998; 1996; Hansen 
et al, 2002; Loft et al, 1999; Schieve et al, 2002; Zech et al, 2000). The Belgian group 
that pioneered the technique of ICSI has carried out the largest studies to date 
(Bonduelle et al., 1996; 1998; 1999; 2002a and 2002b). An assessment of the risks 
involved with ICSI is difficult to estimate from the results of these studies as in many 
cases this procedure is often combined with others that may also exert an effect 
including that of cryopreservation and pre-implantation genetic diagnosis (PGD) 
(Winston and Hardy., 2002 www. nature. com/fertility). Nevertheless, these studies have 
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noted some negative effects on the children bom by ICSI when compared to lVF and 
naturally conceived children, these studies will now be considered. 
The first studies to be considered will be those carried out by Bonduelle et al. (1996; 
1998; 1999; 2002a 2002b) as these are the largest studies to date. Bonduelle et al. 
(1996) reported no significant increased incidence of major or minor congenital 
malformations in live births, reporting around 2.6% compared to the incidence in lVF or 
the naturally conceived population. They do however suggest significantly increased 
risk in the transmission of paternal chromosome aberrations (including translocations 
and inversions), with 1.2% of children (out of 877), all of which were transmitted by the 
fathers and also that of de-novo aberrations, mainly that of trisomy involving the sex 
chromosomes the incidence of which was 1% in 877 children. This increased incidence 
in trisomy of the sex chromosomes was approximately five times higher than observed 
within the general population (Jacobs et al, 1992; Hook and Hamerton, 1977; Nielson 
and Wohlert et al, 1991). This finding may be attributed to the use of gametes from men 
with infertility as a large number of studies have reported a high proportion of 
aneuploidy in the spermatozoa of these individuals compared to their fertile 
counterparts (refer to section 1.5.4) rather than problems with the actual technique 
(Bonduelle et al., 1996). 
Bonduelle et al. (1999) investigated a total of 1,987 conceived by ICSI. Prenatal 
diagnosis was undertaken in 1,082 cases, revealing abnormal karyotypes in twenty eight 
individuals (2.6%) ten were inherited structural aberrations, the remainder were de-novo 
with chromosomal aberrations affecting the autosomes in nine cases and the gonosomes 
in nine cases. The rate of major congenital malformations were found to be 2.3% at 
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birth however, this rate increased to 2.9% when stillbirths and those picked up by 
prenatal ultrasound were included. 
The largest study carried out to date is that reported by Bonduelle et al. (2002a), this 
study collected data on 2889 children bom after ICSI and 2995 children bom after IVF. 
This study presented data on birthweight, still birth rate and prematurity amongst others, 
the rates obtained were comparable between both the ICSI and IVF groups. The rate of 
major malformations in liveborn children (defined as needing a surgical correction or 
causing a functional impairment) was estimated to be 3.4% in the ICSI population and 
3.8% in the lVF group. This rate of major malformations within the ICSI population is 
significantly higher than that found within the general population, however the rates 
found were similar to those obtained with IVF pregnancies. 
Bonduelle et al. (2002b) also reported data collected on the prenatal testing of a total of 
1586 ICSI pregnancies over the past decade, this study presents the findings and their 
relation to the semen parameters in the male partner. In an attempt to determine whether 
utilising the gametes of chromosomally normal parents leads to an increased risk of 
chromosomal aberrations in their children and whether these are as a result of the 
technique itself or the gametes used in the technique. In total 47 abnormal karyotypes, 
(3%) were found out of the 1586 foetuses tested. These included 25 de-novo 
abnormalities (1.6%) (10 sex chromosome abnormalities, 8 numerical autosome 
anomalies and 7 structural autosome aberrations), 22 abnormal karyotypes (1.4%) were 
transmitted to the offspring by the parents. These inherited abnormalities comprised of I 
unbalanced karyotype and 21 balanced, it is of interest to note that 17 of these 22 were 
paternally inherited. Of the 47 abnormal foetuses II were aborted, 2 miscarried as a 
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result of the prenatal test and 3 de novo abnormalities were stillborn, a total of 31 
children were born. The maternal age was taken into account and de-novo abnormalities 
were shown to occur in 1.2% when the maternal age was: 535, significantly higher than 
the general population (Bonduelle et al., 2002b). Approximately 50% of the 
abnormalities found were transmitted (mainly paternally derived sex chromosome or 
structural abnormalities), with a total frequency of 1.4% this is significantly higher than 
that found within the general population (Hook and Hamerton, 1977). Bonduelle et al. 
(2000b) presented evidence of an association particularly with poor spenn concentration 
and also poor motility, therefore males presenting with reduced semen quality for these 
particular semen parameters may be at an increased risk of producing a chromosomally 
abnormal child through ICSI. 
Loft et al. (1999) investigated the outcome of 730 individuals born after ICSI from 
thirteen infertility clinics in Denmark. This study sent out questionnaires to the couples 
involved enquiring about pregnancy outcome, prenatal diagnosis, mode of delivery and 
the health of the child, a total of 665 returned the questionnaire and allowed further 
contact to the departments where the children were treated, hence not all abnormalities 
may have been reported within this study. Similar levels of abnormalities were found 
within this population compared to previous studies with a rate of major malfon-nations 
estimated to be 2.2%. Prenatal karyotyping was carried out in 209 cases, 2.9% were 
found to have a major chromosome aberration including: trisomy 18, trisomy 2 1, 
triploidy and an unbalanced translocation, however Loft et al. (1999) suggest that up to 
2 /3 of these may be attributed to maternal age as the mothers were aged over 35. One 
individual (0.5%) was found to have inherited a chromosome structural abnormality. 
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Six postnatal karyotypes were carried out revealing one deletion 13 and one case of 
tri somy 2 1. 
Aboulghar et al. (2001) analysed the karyotypes postnatally of a total of 430 children 
conceived via ICSI and 430 children conceived naturally, the rate of chromosome 
abnornialitics within the ICSI population was reported as 3.4% (15 individuals). This 
included six individuals with sex chromosome abnormalities, eight individuals with 
autosomal abnormalities and one individual with a combination of a sex chromosome 
and autosome abnormality. The control population of naturally conceived children had 
no observed cytogenetic abnon-nality within their karyotype and as a result a statistically 
significant increase in the rate of chromosomal abnormalities was reported within the 
ICSI population analysed when compared to individuals conceived naturally and the 
risk appears to be equal between the gonosomes and autosomes. 
In contrast the recent study carried out by Hansen et a]. (2002) reported a two fold 
increase in the incidence of major birth defects within their ICSI (301 individuals) and 
lVF (837 individuals) groups compared to individuals conceived naturally (reporting 
frequencies of around 8.6%, 9% and 4.2% respectively). 
1.6.3.3 Studies looking at testicular extracted sperm (TESE) and cryopreserved 
embryos 
Bonduelle et al. (I 998b) also analysed three groups of children bom with the assistance 
of ICSI, these groups were split as follows: group 1,57 individuals whereby epididymal 
spermatozoa was utilised; group 2,50 individuals whereby testicular spermatozoa, was 
used and group 3,58 individuals in which cryopreserved embryos were used. Prenatal 
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diagnosis identified 5.8% of the cryopreserved embryos had a 47, XXY karyotype. The 
rate of major malformations was estimated to be around 2.4% for all groups, with group 
I recorded as having a rate of 3.6%, group 2 rates of 2% were recorded and 1.8% for 
group 3, minor malfon-nations were also recorded in 8.7% of all groups. Major 
malformations included ureteral dialation, leg and hip malformation and cleft lip and 
palate; minor malformations included facial, cardiac and dermatological abnon-nalities. 
However approximately 1/3 of individuals were lost for follow-up at the age of two 
months, therefore these values may be under-reported. 
A small case study analysing the ICSI outcome of four pregnancies utilising elongated 
spermatozoa obtained from TESE (Zech et al., 2000), reported two pregnancies out of 
the four resulted in major malformations. The ultrasound diagnosed a hydrocephalus in 
one pregnancy that was terminated, cytogenetic analysis of the foetal tissue revealed a 
male with trisomy 9 (47, XY + 9), the foetus also exhibited spina bifida and 
diaphragmatocele. In the second case the malformation was not picked up prior birth but 
was found to have a neural tube defect. It is not yet clear whether the malfonnations that 
occurred arose as a result of the injection of the immature testicular cells, or the 
procedure itself or if these events were unrelated. Zech et al. (2000) have reported to 
have at present stopped carrying out such treatment due to the potentially high rate of 
malformation and the poor success rate that has been observed even within this small 
number of individuals, and suggest any such treatment should be managed carefully and 
any resultant pregnancy should have an amniocentesis. 
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1.6.3.4 Studies investigating parameters including mental and growth parameters 
Concerns over the use of ICSI were raised when the study carried out by Bowen et al. 
(1998) who analysed the medical and development outcome of children at the age of 
one bom with the assistance of ICSI (84 children) and IVF (80 children). No significant 
difference was observed between the two treatments for congenital malformation and 
major health problems. This study did observe a significant risk of mild delays in 
development for children bom with the assistance of ICSI when compared to lVF and 
naturally conceived children. Following this report, several studies have since 
investigated the development of children conceived by ICSI (Bonduelle et al., 1998b, 
2003; Sutcliffe, 2001,2003). These studies have each investigated at least 200 
individuals with mean ages of 15 months to 28 months and have found no evidence of 
any significant differences in the development of children conceived by ICSI compared 
to controls. The studies, at present, are reassuring as there is little evidence of any 
difference in the developmental outcome of ICSI children, although few individuals 
have been analysed. However, Bower et al. (1998) have provided evidence that ICSI 
individuals may carry a small risk of developmental abnormalities and in light of this 
information it would seem pertinent to continue to observe many more ICSI individuals, 
and possibly into adulthood to ensure that these individuals are not at risk of intellectual 
impainnent or leaming difficulties throughout school (Bower et al., 1998; Fraser., 2002 
www. nature. com/fertility). 
1.6.3.5 Genomic imprinting and ICSI 
Recent studies have indicated that possible adverse effects may arise form 
cryopreservation and the culturing of embryos that may lead to epigenetic alterations of 
the nuclear genome, including DNA integrity, gene expression and genomic imprinting 
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(Schatten., 2002 www. nature. com/fertility; Winston and Hardy., 2002 
www. nature. com/fertility). Concerns have been raised with the use of testicular 
extracted spermatozoa in ICSI, as this may result in less complete imprinting than if 
ejaculated spermatozoa had been utilised (Van Steirteghern et al., 2002). Imprinting 
defects are unlikely to affect fertilisation but abnormalities may be found at birth or later 
on in life (Van Steirteghern et al., 2002). 
1.6.4 Conclusions on the safety of ICSI 
It is still not apparent as to whether any increased risk of abnormalities with ICSI is due 
to the use of genetically abnormal spermatozoa or whether the procedure itself is the 
cause. It is clear that the actual technique itself may lead to a number of problems 
including the injection of aneuploid spermatozoa but also incorporation of harmful 
contaminants within the egg, leakage of the cytoplasm and membrane damage as well as 
damage to the meiotic spindle, resulting in aneuploidy as a result of mitotic errors in 
early cleavage divisions (Bonduelle et al., 2002b; Winston and Hardy., 2002 
www. nature. com/fertility). This increase is likely to be related to the increase in 
chromosomal abnormalities found within the males presenting with severe infertility 
(Meschede et al., 1998; Peschka et al., 1999; Scholtes et al., 1998; Tuerlings et al., 
1998; Van Assche et al., 1996). Indeed Bonduelle et al (1996) reported that at least two 
of the semen parameters in the fathers of offspring trisomic for the sex chromosomes 
were found to be abnormal. Preliminary results confirm that the higher frequency of 
chromosomal aberrations reported in the spermatozoa of infertile men especially OAT 
males and those with abnormal karyotypes may confer an increased risk of 
chromosomal abnormalities in ICSI offspring. 
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Results in the follow-up studies of ICSI children are reassuring with the number of 
major congenital malformations found being higher than found in natural conceptions 
but comparable to those of lVF pregnancies. Comparisons between individuals 
conceived with the assistance of ART techniques and control populations are difficult to 
undertake as any increase in congenital malformations may be as a result of over- 
reporting as naturally conceived children are unlikely to be analysed as thoroughly as 
ICSI children in follow-up studies, differences in the definition of congenital 
malformations between studies may account for some discrepancies. The rate of 
abnormalities may however be lower if neonates are analysed by individuals untrained 
in this area, this can be the case when follow-up studies are augmented by the 
examination of subsequent hospital records or through telephone contact (Van 
Steirteghern et al., 2002), as in the study carried out by Loft et al. (1999). It is important 
to note that the figures reported may not represent the total rate of malformations as 
these arc not only reported at birth but also in early childhood up to six years old, (Loft 
et al., 1999) and therefore may result in under-reporting. The recent study carried out by 
Hansen et al. (2002) reported a significant increase in the rate of major congenital 
abnormalities within ICSI and lVF conceived children, with an approximate two-fold 
increase compared to the normal population. It is clear that from the studies published to 
date that there is a increase in the risk of major malformations compared to offspring 
conceived naturally. However, data collected to date indicate that this increase is 
comparable to that found within lVF populations. 
The use of ICSI has been shown to increase the risk of transmission of chromosomal 
abnormalities particularly that of paternal origin, mainly that of sex chromosome 
trisomy and autosomal rearrangements. Studies have revealed that in approximately 
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50% of cases chromosomes aberrations are de-novo in origin, with the remainder being 
parentally inherited, of these a significant majority are paternal in origin. Although the 
small body of literature available implies that these approaches are relatively safe (the 
incidence of chromosomal anomalies has been reported as ranging from 2.6% to 3.6%, 
higher than that of IVF pregnancies 2.1 % (Bonduelle et al., 1996; 1999; 2002). It is 
apparent that there is an increased risk of de-novo aberrations involving the sex 
chromosomes anomalies among the offspring conceived by ICSI (Bonduelle et al., 
1996; 1999; 2002b) but also potentially that of the autosomes also (Aboulghar et al., 
2001). At present the detection of any increases in autosome trisomy within ICSI 
conceived children has not been reported, however this is to be expected as too few 
individuals have been analysed in follow-up studies. This is evident when considering 
Trisomy 21 for example, which has an occurrence of I in 800, however 90% of cases 
are matemally derived. 
The fact that the significant increase in aneuploid spermatozoa in infertile males does 
not seem to be reflected in pregnancies established with ICSI may be due to the sample 
size analysed. Millions of spennatozoa, have been analysed for aneuploidy but in 
comparison only a few thousand children born from ICS1 have been analysed. It is also 
difficult to obtain adequate controls to compare the rates of abnon-nalities. 
In the majority of studies, parameters such as postnatal growth and development have 
all been shown to be within normal ranges although some studies have revealed 
differences requiring further investigation. These findings are reassuring although it is 
important to realise that only a small number of patients have been analysed and not all 
ICSI individuals have extensive clinical follow up. Therefore the reported figures of 
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abnormalities in children conceived with ICSI may not reflect the true frequency of 
abnon-nalities within this population. The full risks and effects of ICSI are still 
unknown, primarily as none of these children have yet to reach reproductive age 
therefore there is still the question of the long-tenn reproductive health of these 
individuals. The limited studies carried out to date on the risks of ICSI has clearly 
identified a high risk of transmitting chromosomal anomalies, and producing de-novo 
chromosome aberrations mainly involving the sex chromosomes and imprinting defects 
and are therefore at risk of transmitting infertility. Further investigation needs to be 
continued in this area in order to fully ascertain the safety of this procedure with much 
larger patient cohorts being analysed (if not all) children conceived by ICSI and all 
findings documented. 
1.7 What are the perceived risks of ICSI according to infertility 
0. specia ists. 
Given the information presented within sections 1.5 and 1.6, there is clearly a concern 
about the genetic risks and invasiveness involved in the procedure of ICSI in the 
treatment of male infertility. There has been considerable research analysing sperm 
aneuploidy levels in infertile males and the outcome of ICSI pregnancies. Despite this 
there are a number of questions that have so far been poorly investigated: firstly how 
these results are perceived and its relevance to ICSI by both infertile couples and the 
infertility clinics treating them. Secondly whether there is any consensus of opinion 
regarding the safety of ICSI in infertility clinics across the UK, and thirdly whether 
patients attending different infertility clinics are provided with similar information on 
the risks of ICSI (if this is not the case it may be that stricter guidelines should be put in 
place to ensure that patients receive the same information). 
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In an attempt to address some of these unanswered questions, P. Hyland, an MSc 
student undertaking her dissertation within our group designed a questionnaire based 
study that was sent out to all the infertility clinics around the UK, with the aim of 
establishing the following: 
- What, if any, genetic tests do clinics regularly undertake in male patients prior 
to ICSI? 
- Do all clinics offer genetic counselling prior to ICSI? 
- Is aneuploidy in the spermatozoa of infertile men undergoing ICSI a concern in 
infertility clinics? 
- Do infertility clinics currently screen the spermatozoa of these men for 
aneuploidy levels prior to ICSI? 
- Do infertility clinics feel there is any merit in doing such aneuploidy studies 
prior to ICSI? 
The results of this study have been published in Human Reproduction (Griffin et al., 
2003) a copy of this paper can be found in Appendix A. The results of this questionnaire 
suggest that this uncertainty surrounding the safety of ICSI is not just of concern to the 
scientific community, but is also mirrored within the infertility clinics that are directly 
involved in treating infertile couples. A significant majority of infertility clinics 
acknowledge the benefits of screening spermatozoa for the frequency of aneuploidy 
prior to ICSI. This opinion appears to stem from the belief that specialists believe there 
to be an increased risk of congenital abnormalities associated with ICSI compared to 
IVF, which was mainly felt to be due to sperm aneuploidy, despite this, no participants 
felt that the risks of ICSI outweighed the benefits. 
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The results generated from this study indicate that the majority of infertility clinics do 
not screen spermatozoa for aneuploidy levels prior to ICSI and those that do may do so 
for research purposes only. At least twice as many infertility clinics however, feel that 
there is merit in pre-screening spennatozoa, compared to those that do not. Screening 
sperm will also initiate a much larger research study to evaluate the risks of ICSI, in 
particular the risk of transmitting Down syndrome and trisomy of the sex chromosomes. 
Given the results of this questionnaire the majority of participants agree that an 
aneuploidy screening test should be implemented prior to embarking on ICSI treatment 
along with the existing genetic tests. With this in mind we proceeded to develop such a 
test. 
1.8 General conclusions 
It is clear from the data presented within this chapter that there is a relationship between 
sperm aneuploidy and infertility, and that this affects the safety of current regimes used 
to treat it. The review of the literature has raised a number of questions that remain 
unanswered. Firstly, the majority of studies investigating sperm aneuploidy in infertile 
males have reported increased disomy frequencies, however significant intcr-laboratory 
differences have been reported. It is unclear as to whether these are "true" differences or 
whether these are due to the patient and technical specific differences between studies 
identified in section 1.5.6. Secondly, what has been hitherto poorly investigated is 
whether particular infertility phenotypes are associated with the mal-segregation of 
specific chromosomes. Thirdly, the use of ICSI has been shown to result in the 
transmission of chromosome abnormalities but also that of de-novo aberrations 
including increased incidences of sex chromosome trisomies. Questions remain, as to 
whether this is the case for autosomal trisomies, and also regarding the future 
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reproductive health of ICSI conceived children. These questions can only be answered 
in years to come with more detailed monitoring of much larger numbers of individuals. 
Fourthly, given the evidence of the transmission of chromosomal abnormalities and the 
increase in sex chromosome trisomy in ICSI conceptuses, should infertility clinics offer 
a screening test for spenn aneuploidy frequencies prior to undertaking ICSI? Finally, 
ICSI is currently the only treatment currently available for male infertility, however it is 
a radical and invasive technique that has raised the concern of many individuals within 
the scientific community. To the best of our knowledge little research has been carried 
out investigating other forms of treatment that are less radical and invasive without the 
potential risks involved with ICSI. Only through a clearer understanding of the 
mechanisms involved in the aetiology of infertility and non-disl-i unction can safe 
pharmocogenomic strategies be implemented. 
1.9 Objectives 
This thesis is primarily concerned with the questions surrounding male factor infertility. 
Specifically, investigations have been undertaken examining the issue of whether the 
aneuploidy frequencies in men should be screened prior to ICSI. With regard to the 
aetiology of this phenomenon this study has been particularly interested in the 
relationship between individual semen parameters and sperm aneuploidy of specific 
chromosome pairs. In addition, preliminary evidence as to the role of genome 
organisation in the aetiology of spenn aneuploidy is presented. Finally, to the best of 
our knowledge, there are no reports of any medical intervention improving the rates of 
sperm aneuploidy. With this in mind, this study has investigated the role of a particular 
type of alternative therapy and its influence on sperm aneuploidy. Therefore this thesis 
had the following aims: 
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1) To development of a reliable protocol for the screening of sperm aneuploidy for 
chromosomes 21, X and Y prior to ICSI, for use within infertility clinics 
(chapter 2). 
2) To determine the levels of chromosome aneuploidy for chromosomes 2 1, X and 
Y in infertile males to establish if particular infertility phenotypes were 
correlated were with the non-disjunction of the investigated chromosomes 
(chapter 3). 
3) To investigate an alternative treatment to ICSI for male factor infertility, in 
particular the effect of traditional Chinese herbal medicine (TCM) on the 
aneuploidy rates for chromosomes 21, X and Y in six males (chapter 4). 
4) To investigate the biological activity of TCM herbs used in the treatment of 
male infertility, specifically that of endocrine activity (oestrogenic, anti- 
oestrogenic, androgenic and anti-androgenic) and anti-oxidant activity (chapter 
5). 
5) To analyse genome organisation for chromosomes 18, X and Y within the 
nucleus of spermatozoa from control and infertile males to deten-nine if the 
elevated frequency of sperm aneuploidy is related, in part, to changes in genome 
organisation (chapter 6). 
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Chapter 2 
Devefopment of a spenn aneupfoidy 
screening kitfor estab(ishing leve& of 
aneupfoid I in ICSI men y 
Results of this chapter have attracted the interest of Stretton Scientific Ltd who wish to 
market a pre-ICSI sperm aneuploidy kit. 
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Chapter 2: Development of a sperm aneuploidy screening kit for establishing levels 
of ancuploidy in ICSI men 
2.1 Introduction 
Taking into consideration the results of the study produced by Griffin et al. (2003) 
located in Appendix A, the aim of this study was to develop a FISH sperm aneuploidy 
screening kit that could ultimately be made commercially available to infertility clinics, 
enabling the implementation of such screening. The key features of the screening kit 
method developed are that it would have to be: reliable, robust, reproducible, able to 
generate data rapidly, simple to use and that it should contain all the components 
required. That is any screening kit developed with a view to being used in a clinical 
setting would have to be reliable ensuring that it works every time (as it will be carried 
out in patient samples), the kit would also have to be robust ensuring that the technique 
works in a range of patient samples (including poor quality semen) and that it will work 
in a range of conditions. The other main features of the kit are that it has to be highly 
reproducible in that it would be transferable between labs. The technique should also be 
rapid enabling infertility clinics to carry out the technique and analysis in as short as 
time as possible so that couples can receive the results as soon as possible. The kit will 
also have to be made as simple as possible, so that individuals without previous training 
in FISH techniques would be able to carry out the technique. 
2.2 Objectives 
The aim of this study was to develop a screening kit ensuring that the requirements of 
the method were met; for the purpose of this study the chromosomes used in the 
development of the screening kit were chromosomes 2 1, X and Y. These specific 
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chromosomes were chosen as they are clinically significant, hence aneuploid 
conceptuses involving any of these chromosomes can survive full terrn giving rise to 
various syndromes including Down syndrome, Klinefelters syndrome, XYY amongst 
others (refer to section 1.4). 
FISH involves the denaturation of chromosomes and fluorescent labelled chromosome 
probes (carrying a specific target sequence of the chromosome of interest), these are 
then hybridised in situ. Once hybridised the chromosomes are then stained with a total 
DNA counterstain for relocation purposes (Griffin, 1994). The critical steps in sperm 
FISH include: sperm nuclei decondensation, denaturation of the sperm nuclei and post 
hybridisation washes. As previously stated in section 1.5.6.2 decondensation of sperm 
nuclei is critical as it allows demembranation and decondensation. of the DNA and 
protamines in the tightly packaged spenn nuclei. Absent or inadequate decondensation 
of spenn nuclei will result in reduced access of the probe to the sperrn head, however 
excessive decondensation will result in highly diffuse probe signals. The denaturation of 
the chromosomal DNA and probe DNA is also of importance as under denaturation will 
result in the probe not being incorporated in to the chromosome and excessive 
denaturation will result in "fuzzy" looking chromosomes due to the spooling out of 
DNA (Bridger et al., 1997). The stringency of the post hybridisation washes arc also 
important as if washes are not stringent enough excess probe will remain resulting in 
high background levels, however, if washes are over stringent it will result in probes 
being removed. When comparing reports published investigating sperm disomy levels, 
these have often report many technical differences with reference to the key factors 
required for successful FISH (refer to section 1.5.6.2). Section 8.2.3 within the materials 
and methods reports the sperm FISH procedure developed and utilised, however this 
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was the result of testing various methods, incubation times and temperatures within 
previously published work (refer to section 1.5), to detennine the best method, that also 
incorporates all of the requirements of the kit. The adjustments in the sperrn FISH 
technique will now be considered, with the optimised conditions being tested on semen 
samples from individuals with semen quality varying from normal to severely 
compromised semen parameters. 
2.2.1 Probe protocol methods tested within the sperm screening kit 
Two methods in these studies have been utilised, the first of which was a four probe 
approach (probe protocol 1) that used two probes labelled with two different 
fluorochromes. With the third probe produced by a combination of two probes spanning 
the same region (chromosome X centromere) labelled in two different fluorochromes to 
produce a third colour (figures 2.1,2.2 and 2.3). This four probe (probe protocol 1) 
approach was used for the majority of the tests (98 out of the 128 cases tested), 
primarily due to the lack of appropriate filter sets on the Leica, microscope utilised for 
the majority of the studies. This microscope system only enabled the detection of three 
different fluorochromes including that of the counterstain, therefore a different 
fluorochrome for each of the 3 probes and that of the counterstain was not possible. 
Latterly we were able to utilise a second probe protocol (protocol 2) that utilised a three 
probe approach (figure 2.4), in which the three probes and the DNA counterstain for the 
investigated chromosomes were labelled with four different fluorochromes. The use of 
this probe approach eliminated the need for a combinatorial approach that was made 
possible with the acquisition of a multi-colour FISH microscope system. 
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Specifically probe protocol I Will ses a locus-specific probe for chromosome 2 1, 
spanning 2lq22.13-q22.2 region, directly labelled with Spectrum Orange (LSI 21, 
Spectrum Orange) (figure 2.1). The probe for chromosome Y utillsed encompassed the 
Yql2 region and was labelled in Spectrurn Green (CEP Y, satellite 111) (figure 2.2). For 
chromosome Xa combination of a two different colour probes with Spectrum Green 
and Spectrum Orange spanning the Xp 11.1 -ql 1.1 region (CEP X, Spectrum Green and 
CEP X, Spectrum Orange) (figure 2.3). 
sp 
Spectrum Orange 
Spectrum Green 
Yq12 CEP Y 
j--4*-21q22.13-q22.2 LSI 21 satellite I// 
Chromosome 21 Chromosome Y 
igure 2.1 illustrates the ideogram for 
hromosome 21, the region the LSI 21 
pectrum Orange probe hybridises to used in 
rotocol I (adapted from www. N, ysis. com). 
Xpll. l-qll. ICLPX 
Spectrum Green 
Chromosome X 
, 'iguiv 2.2 illustrates the ideogram for 
hromosome Y, the region the CEP Y 
pectrum Green probe hybridises to used in 
rotocol I (adapted from www. vysis. com). 
Xpil. 1-qll. ICLPX 
Spectrum Orange 
Chromosome X 
C 
Xpll. l-qll. ICLPX 
Spectrum Green 
Spectrum Orange 
Chromosome X 
Figure 2.3 image A, B and C each show the ideogram for chromosome X and the region that the CEP 
X probe spans, image A illustrates the CEP X probe labelled in Spectrum Green and image B 
illustrates the CEP X probe labelled in Spectrum Orange. In probe protocol I both of these probes (A 
and B) are utilised resulting in a CEP X probe that is yellow in colour (image Q (adapted from 
www. vysls. com). 
Probe protocol 2 utilised the same probe for chromosome 21 (LSI, Spectrum Orange) 
and chromosome X (CEP X Spectrum Green only) as in protocol I and a CEP Y probe 
labelled in Spectrum Aqua spanning the region Yq 12 was utilised for chromosome Y 
(figure 2.4). 
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Figure 2.4 illustrates the ideograms for chromosomes 2 1, Y and X, along with the region to which 
each of the probes hybridise too and fluorescent label that each of these are labelled with. Image A: 
LSI 21 Spectrum Orange, image B: CEP Y Spectrum Aqua and image C: CEP X Spectrum Green 
(adapted from www. vysis. com). 
2.3 Results 
2.3.1 Sample preparation 
Semen samples and slides were prepared as specified in the materials and methods 
section 8.2.3 and section 8.2.3.1 respectively 
2.3.2 Decondensation of sperm nuclei 
Two main protocols were used for sperm nuclei decondensation prior to denaturation, 
protocol I consisted of two swelling buffers and included the use of Tris buffer 
containing DTT and Tris buffer containing LIS, with protocol 2 only using the Tris 
buffer containing DTT (refer to section 8.2.3.3). 
2.3.2.1 DTT decondensation of sperm nuclei 
The first stage was to determine the required concentration of the first swelling buffer 
containing DTT for adequate decondensation, reported to be approximately 1.5 - 2.5 
times the original size of the spenn nuclei (Wyrobek et al., 1990). To determine the 
appropnate concentration of DTT to use in the decondensation step we tested the effect 
of a range of concentrations of DTT and incubation times, (in all cases a 0.1 M Tris 
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buffer pH8.0 was utilised as reported in the study published by Griffm et al., 1995). In 
total 3 concentrations of DTT were tested for 3 different incubation periods, each test 
has been assigned a letter A-1. For this test slides were prepared as specified in section 
8.2.3 and left overnight at room temperature (RT) to age, these were subsequently 
transferred to their respective swelling buffers (A-1), rinsed briefly in 2x SSC and 
dehydrated through an ethanol row. Slides were then air dried and counterstained with 
DAPI to enable the degree of decondensation to be visualised, several samples of 
varying semen quality were tested in each, table 2.1 displays the concentration and 
incubation times of DTT, and figure 2.5 show the result of each type of treatment. 
Table 2.1- Concentration and incubation times tested for the DTT swelling buffer 
A B c D E F G H I 
c 5mM I OmM 20mM 5mM I OmM 20mM 5mM lOmM 20mM 
IT 15 15 15 30 30 30 45 45 45 
concentration, IT = incubation time 
Figure 2.5- provides examples of the effect of the several different types of DTT treatment on the 
decondensation of sperm nuclei. 
Panel A- sperm with no decondensation treatment, Panel 13- sperm incubated in 5mM DTT, Panel 
C- sperm incubated in I OmM DTT and Panel D- sperm incubated in 20mM DTT, (all incubations 
were carried out for 30 minutes). 
From the results presented in figure 2.1 it was deduced that the following methods 
(table 2.1) A, B, D and G produced inadequate decondensation with the sperm nuclei 
remaining similar to pre-decondensation size with methods C, F, H and I producing 
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excess decondensation with the nuclei approximately 2-3 times larger than nuclei not 
decondensed. Method E (figure 2.5-C) repeatedly gave the appropriate decondensation 
of approximately 1.5 -2 fold size increase, irrespective of the sample quality 
decondensation of the sperm heads were similar in each patient (for the same methods). 
2.3.2.2 LIS decondensation of sperm nuclei 
The I OmM DTT (30 minute incubation) that produced the best results was then used in 
conjunction with a second swelling buffer containing LIS, to determine the effect of 
LIS. As with the DTT swelling buffer previous publications have specified a variety of 
concentrations and incubation times for LIS swelling buffers, as a result we tested 
several concentrations and incubation times (table 2.2). The same procedure as carried 
out for the DTT swelling buffer test was used however with the slide being transferred 
straight from the DTT swelling buffer into the LIS buffer prior to being rinsed and 
counterstained with DAPI. 
Table 2.2- Concentration and incubation times tested in conjunction with DTT 
1 2 3 4 5 6 
c lomm 25mM lomm 25mM lomm 25mM 
IT 
1 
Ihr 
1 
Ihr 
1 
2hr 
1 
2hr 
1 
3hr 
1 
3hr 
11 
When comparing the results of the DTT alone and the use of LIS in addition to DTT, 
the degree of decondensation remained comparable, with no significant difference in the 
degree of decondensation of the sperm nuclei. It would appear from these results that 
the use of LIS does not cause sperm nuclei to undergo further decondensation, however, 
the role of both of these buffers is to enable the DNA probes to access the tightly 
packed DNA of the sperm nucleus and therefore it may have a role in facilitating access 
of the probe to the nucleus. We tested the two protocols DTT and LIS (DTT- I OmM, 30 
minutes and LIS 25mM, I hour) and DTT alone (I OmM) in several FISH experiments 
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to determine which protocol at which concentration and incubation time produced the 
best results. 
Figurc 2.6 - image panel A illustrates the effects of DTT swelling buffer alone, image panel B 
illustrates the effect of DTT and LIS combined 
The results from these experiments revealed no significant difference between the two 
treatments (A- I OmM DTT alone, and 13- 1 OmM DTT and 25mM LIS) in the degree of 
decondensation of spenn nuclei, or hybridisation efficiencies (both of which produced 
hybridisation efficiencies of >95%). Each protocol produced reliable and reproducible 
results, with no obvious differences in the results obtained for each test the DTT 
swelling buffer alone was utilised for the majority of the sperm FISH studies. On a few 
occasions however, there were individual samples that were not adequately 
decondensed with weak/absent hybridisation signals, these particular samples were 
tested on a number of occasions and with other samples that were successful. After 
several attempts we utilised a combination of the DTT and LIS swelling buffers to 
determine if the addition of the LIS buffer could better enable the probe to access the 
sperm nuclei than DT-F alone. In 8 out of 14 samples exhibiting this problem the 
addition of the LIS swelling buffer made analysis possible (previously not possible with 
DTT treatment alone), producing clear hybridisation signals with hybridisation 
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efficiency levels of around >90%. In the remaining six samples tested the degree and 
quality of the hybridisation signals was not good enough for analysis.. 
2.3.3 Denaturation 
The denaturation of the spenn nuclei is a key-factor in the reliability of the screening 
kit, we tested several denaturation times in 70%fonnamide/2xSSC, and included 7,8,9, 
10,11,12 and 13 minutes. The results of repeated tests revealed that the denaturation 
times of 7-9 minutes often-resulted in under-denaturation (hence absent or weak signals, 
denaturation times of over 12 minutes often resulted in over-denatured sperm nuclei. 
The most reliable and reproducible results were obtained using denaturation times of 
10- 11 minutes, for all FISH procedures the denaturation times of 10/ 11 minutes were 
utilised. 
2.3.4 Probe protocol development 
2.3.4.1 Development of probe protocol 1 
Throughout this study two main chromosome probe protocols were used, both 
commercially available and directly labelled probes obtained from Vysis (Downers 
Grove 111. USA). As mentioned previously the chromosomes chosen for this 
investigation were chromosomes X, Y and 21. In order to distinguish the individual 
chromosomes they have to be labelled with different fluorochromes, figures 2.1,2.2 and 
2.3 displays ideograms for these chromosomes and the region for which these 
chromosome probes are specific for. In order to investigate the sex chromosomes Probe 
protocol I is described in section 8.2.1.5.1 (materials and methods) briefly involves a 
chromosome 21 probe labelled in Spectrum Orange, aY chromosome probe labelled in 
Spectrum Green. Chromosome X was produced by combining two probes specific for 
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the same chromosome region labelled with two different fluorochromes (Spectnun 
Orange and Spectrum Green) to produce a yellow colour enabling the distinction of the 
individual chromosomes. The manufacturers recommendations suggest that when using 
multiple probes 10 of each probe should be added to an eppendorf along with 7gl of 
the hybridisation buffer. This protocol was followed for the first few experiments, the 
results of these experiments produced hybridisation signals for each of the 
chromosomes. However, several problems with this protocol were encountered the first 
of which was the chromosome 21 probe was weak and difficult to visualise down the 
microscope, and the second of which was the inability to distinguish between the 
chromosome Y and X probe. Using this protocol the colour of the X was not 
sufficiently different to that of the Y. To solve these problems we set up an experiment 
with different probe ratios (table 2.3) to determine if we could make the chromosome 21 
probe more intense and if we could differentiate between the X and Y probes. 
Table 2.3- Probe volumes tested for each of the four probes used in this approach 
" (Orange) 
k7m 
1.250 1.0pi 1.00 
" (Green) 0.5pl 0.5pl 0.75ýT- 
Y (Green) 0.50 0.5pl 0.75pl 
21 (Orange) 1.25pl 1.5td 1.250 
Hybridisation buffer 70 70 70 
Total 10.50 10.50 10.5pi 
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Figure 2.7- Panel A- (test A table 3.3), each chromosome (X, Y and 21) are indicated, the results show 
chromosome X to be orange in colour similar to that of chromosome 21. 
Panel 13- (test B table 3.3), chromosomes X, Y and 21 are indicated, in this case chromosome X has the 
desired yellow colour, hence it is distinguishable from that of chromosomes 21 and Y. 
Panel C- (test C table 3.3), indicated are chromosomes X, Y and 21, in this probe protocol chromosome 
X was a green colour making it difficult to distinguish from that of chromosome Y. 
Analysis of each of the slides (figure 2.7) revealed that for test A and C the 
chromosomes X and Y were not easily distinguished, and the signal for chromosome 21 
was also still weak. However test B had a clearly visible chromosome 21 and the X 
chromosome was distinguishable from that of the Y chromosome as it was yellow- 
orange in colour. All subsequent FISH studies utilised this probe protocol, however 
there were problems with the reproducibility of this protocol. The chromosome X was 
not always yellow-orange in colour, with occasions where it would be greener in colour 
(hence indistinguishable from chromosome Y), or more orange in colour (hence 
indistinguishable from chromosome 2 1). 
2.3.4.2 Development of probe protocol 2 
As a result we tried a second probe protocol, to try to resolve the reproducibility issues, 
for this protocol we utilised chromosome probes labelled with three different 
fluorochromes. The probes were obtained from the same commercial company (Vysis, 
134 
Downers Grove, 111, USA). Ideograms for each chromosomes along with the regions for 
which the chromosome probe are specific for are found in figure 2.4. In the probe 
protocol 2 chromosome 21 is labelled in Spectrum Orange; the X chromosome is 
labelled in Spectrum Green and the Y chromosome labelled in Spectrum Aqua. Initial 
experiments were carried out in accordance with manufacturers recommendations 
(utilising I ýLl of each chromosome paint and 7ýtl of hybridisation buffer). As before 
there were technical difficulties with the ability to visualise the weak chromosome 21 
signal, this was rectified by using 1.5 ýd of the chromosome 21 probe and I ýd of the X 
and Y probe. The new probe protocol and the adjusted probe ratios resulted in a reliable 
reproducible assay for which the intensity of chromosome 21 was clearly visible down 
the microscope. This protocol also resulted in the elimination of analysis problems 
arising due to the inability of distinguishing chromosome X from that of chromosome Y 
or 21 (due to the fact that different fluorochromes were utilised for all chromosomes 
figure 2.8). 
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Figure 2.8- illustrating the three 
colour approach, chromosome 21 - 
orange, X- green and Y- aqua 
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2.3.5 Aneuploidy screening kit results 
The aneuploidy screening kit was tested in 165 samples, of which 128 samples 
successfully yielded results (defined as able to accurately score the frequency of 
aneuploidy in at least 5,000 spermatozoa). In some of these cases the probes were easily 
distinguished from that of the other chromosome probes and DAPI counterstain, in this 
situation scoring of sperm cells was rapid and easily undertaken, ideal for use within a 
clinical setting. There were however, cases in which the FISH was successful, but that 
the probes were difficult to distinguish from each other. For example with probe 
protocol I chromosomes X was sometimes difficult to distinguish from chromosomes 
21 or Y, or with probe protocol 2 chromosome Y was sometimes difficult to distinguish 
from the DAPI counterstain. In these cases slides could still be scored however, it 
required significantly more time. This is a result of each area having to be checked with 
individual filter sets rather than dual or triple filter sets that enable all probes to be 
visualised simultaneously. These slides are thus, amenable for analysis however, this 
situation is not ideal for a clinical setting, as slides can take between 1.5-5 times longer 
to analyse. The results generated for these 128 individuals, including the probe protocol 
and swelling treatments used are presented in table 2.4. 
Table 2A X- indicates the type of swelling buffer utilised, A- probes easily distinguished from 
each other and the DAPI counterstain, B- chromosome X not easily distinguished from 
chromosome Y, C- chromosome X not easily distinguished from chromosome 21, D- 
chromosome Y not easily distinguishable from the DAPI counterstain. 
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Table 2.4- Results produced by the screening kit including that of the type of swelling buffer, probe 
protocol used along with details on the ability to distinguish the three probes and the DAN counterstain. 
Mt! -, l TCLIT'1ý2'ý 
In addition to this karyotype analysis was carried out in 57 patients, in all cases at least 
10 metaphases were karyotyped and the number of chromosomes in over 30 metaphases 
were counted to rule out chromosome mosaicism (Hook, 1977). All individuals were 
found to have no karyotype abnon-nalities (46, XY). Out of these 57 individuals spen-n 
FISH analysis was only possible in 10 individuals, we believe that this is due to the fact 
that the blood and semen samples were sent through the post; as a result we received 
them up to three days later. In 8 cases however, the addition of the LIS decondensation 
buffer to the protocol enabled FISH analysis, with the remaining 2 patients recruited 
from another study (for which samples were received same day). 
2.5 Discussion 
We have undertaken a series of experiments to determine the appropriate concentrations 
and incubation times for various key stages in the sperrn FISH assay in order to ensure 
that the technique and probe protocols are reliable, robust and reproducible, suitable for 
use in a clinical setting. Our experiments have shown that the concentrations of DTT 
and LIS found to be the most effective were I OmM and 25mM respectively at 
incubation times of 30 minutes and 1-2 hours respectively. The use of LIS as a swelling 
buffer was also found not to be essential (with the exception of a few circumstances). 
The most effective denaturation of sperm nuclei occurred between 10 and II minutes. 
Two probe protocols were utilised the first of which utilised a combination of two 
fluorochromes to produce a third colour, however their were reproducibility problems 
arising with the inability to distinguish between the other investigated chromosomes. As 
a result this was subsequently changed to a three-colour approach resolving this 
problem. This approach has also proved problematic as in many situations the aqua Y 
was not distinguishable from the DAPI counterstain. 
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Within the literature the concentration of DTT and length of incubation is one of the 
principal technical differences between studies, for example within FISH studies DTT 
concentrations ranged from between 0.0 1 mM -25mM (Acar et al., 1999; Calogero et 
al., 2001), with incubation times of 30 minutes to overnight (Acar et al., 1999; Shultz et 
al., 2000). In the vast majority of samples the 30 minute DTT (I OmM) swelling buffer 
treatment alone was more than adequate producing reliable and reproducible rates of 
decondensation with clear distinct punctate signals required for scoring analysis in over 
120 patient samples, however, in 14 cases DTT swelling alone did not appear to be 
adequate enough to produce results amenable for analysis. Upon further investigation it 
was discovered that these 14 samples included ones processed the following day (refer 
to section 8.2.3 in the materials and methods) or processed several hours later than in 
the normal situation. For these samples the addition of the LIS swelling buffer step 
enabled analysis to be performed in 57% (8/14) of cases. It is apparent that samples 
need to be processed as soon as possible (preferably within 1-3 hours after production). 
If this does not occur it may be possible that DTT swelling alone is not capable of 
producing adequate dernembranation or decondensation of the nucleus, thus not 
enabling the probes to enter the nucleus. The addition of the LIS step in the protocol 
however, (shown not to have any effect on the swelling of the nucleus) may in fact have 
an additional role in causing further demembranation of the spenn nucleus, enabling the 
DNA probes to access the spenn nucleus. We suggest therefore that the addition of the 
additional swelling buffer step of LIS (concentration for I hour) is optional however 
should be recommended as it has no negative effects and has proved to aid in situations 
where for whatever reason samples have not been processed in the sperm buffer within 
several hours of production. 
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Within this study denaturation times of 10-11 minutes produced the most reliable results 
with times below this often resulting in under-denaturation and times above this 
resulting in over-denaturation. 
Initial studies used a combinatorial approach for chromosome X, however this produced 
a great deal of difficulty in the collection of data, due to difficulties in distinguishing 
individual chromosomes. This approach rarely produced reproducible results and hence 
was not suitable for the inclusion in a clinical screening kit. Therefore a different three- 
colour approach (red 2 1, green X and blue Y) was put in place eliminating the 
reproducibility problem. This protocol also required only three fluorescent-labelled 
probes rather than four (as in the previous protocol) and will be less costly and more 
suitable for inclusion in a screening kit. 
In conclusion we have developed a protocol for an aneuploidy screening kit, this 
protocol has been successfully used by researchers and undergraduate students to screen 
over 150 control and patient samples (with varying semen quality) with few problems. 
The results of our initial testing of the various parameters required have ensured that 
this FISH technique is reliable, robust, reproducible, easy to follow and given the 
appropriate microscope filter sets will enable the probes to be easily distinguished from 
each other. The data generated from this kit has resulted in the interest of a company 
(Stretton Scientific Ltd). Stretton Scientific Ltd are interested in commercialising this 
kit for sale and distribution to infertility clinics for the use of screening sperm 
aneuploidy levels prior to ICSI and are currently working with us to achieve that goal. 
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Chapter 3: The association between male infertility and sperm disomy: Evidence for 
variation in disomy levels among individuals and a correlation between particular 
semen parameters and disomy of specific chromosome pairs 
3.1 Introduction 
The relationship between male infertility and elevated proportions of aneuploid sperm in 
any given ejaculate is now extensively documented (refer to section 1.5). Over 30 studies 
have investigated this effect with the ma ority suggesting a highly significant relationship j 
between decreased semen quality parameters and increased sperm disomy (refer to section 
1.5.4). Differences between the frequencies reported between studies may be due to 
technical and patient specific differences (refer to section 1.5.6). An alternative explanation 
however is that, among individuals and individual patient cohorts, some men have elevated 
levels of sperm disomy associated with infertility whereas others do not. It is possible that 
perhaps environmental influences could play a role, if this is the case it may account for 
patient specific differences observed between studies. Indeed, a number of synthetic 
chemicals have been shown to be able to mimic endogenous hormones and affect the 
normal pattern of reproductive development in wildlife (Tyler et al., 1998). In humans, 
levels of sperm disomy can be increased by environmental factors including: alcohol abuse 
and heavy smoking (refer to section 1.5.9.1). Intrinsic factors such as age, have been well 
established (refer to section 1.5.3) and DNA polymorphisms have also been implicated. 
Abruzzo et al. (1996) found no effect of Y chromosome alphoid array size on Y 
chromosome non-disj unction, however Hobbs et al. (2000) recently identified a genetic 
polymorphism involved in folate metabolism as a significant risk factor for trisomy 2 1. 
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To date a handful of studies have been published investigating the possible existence of a 
direct relationship between individual semen parameters and aneuploidy (e. g. are specific 
semen parameters associated with aneuploidy for particular chromosome pairs). Several 
studies have reported a correlation between teratozoospermia and sperm disomy (Calogero 
et al., 2001b; Templado et al., 2002; Viville et al., 2000). However Viville et al. (2000) 
were the only study to investigate teratozoospermia. alone, analysing four males presenting 
with different types of total teratozoospermia (including shortened flagella syndrome, 
globozoospermia, irregular acrosomes and macrocephalic sperm). In that study no 
significant difference was reported for three patients however one patient with 100% 
macrocephalic spermatozoa had a total aneuploidy rate (including nullisomy, disomy and 
diploidy) of around 90% demonstrating a significant correlation with morphology for 
patients with macrocephalic spermatozoa. Further studies, demonstrated a negative 
correlation between sperm disomy and sperm concentration (Rives et al., 1999; Vegetti et 
al., 2000; Calogero et al., 2001b). Correlations were also found between disomy and 
progressive motility (asthenozoospermia) (Vegetti et al., 2000; Hristova et al., 2002). In the 
majority of the above studies either semen parameters and or aneuploidies for individual 
chromosome pairs were grouped together and thus not considered individually with the 
exception of the study carried out by Viville et al. (2000). 
3.2 Objectives 
Given the above information, the purpose of this study was to deten-nine the following: 
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- To investigate the sperm aneuploidy levels for chromosome 21, X and Yin repeat 
samples from the same individual to investigate potential variations within the rates 
of disomy. 
- To compare the individual specific semen parameters on a sample-by-sample basis. 
To establish if particular infertility phenotypes were associated with specific 
chromosome aneuploidy for the investigated chromosomes. To determine 
chromosome-specific and parameter-specific correlations between mate infertility 
and percentage of aneuploid sperm in an ejaculate as a preliminary step towards 
understanding the mechanisms of the association between male infertility and 
chromosome segregation 
3.3 Patient cohort and experimental design 
A series of males undergoing infertility treatment with a range of andrological phenotypes 
were assessed for conventional semen parameters and for sperm disomy. All patients were 
attending IVF clinics in the central London area. Semen samples were taken, with patients' 
informed consent, from 19 different men on 43 occasions from infertility clinics in central 
London. None had known constitutional karyotypic abnormalities or Y chromosome 
deletions (however the majority declined permission to have blood samples taken). We 
received I sample each from 12 men, 2 samples from one man, 3 samples from 2 men, 4 
samples from one man, 6 samples from 2 men and 7 samples from one man. In some men 
one, two or three of the semen parameters measured (concentration, motility and 
morphology) were within the normal range; these were hence placed in a control group. In 
other cases (test group) individual parameters were in the abnormal range (refer to 
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subsequent section for andrological criteria). Given that some samples were taken from 
individual patients on several occasions, these males sometimes appeared within the control 
group for some samples and in the test group for others. We restricted our molecular 
cytogenetic studies to chromosome 21 and the sex chromosomes for three reasons. Firstly, 
according to previous studies (Blanco et al., 1996; Hassold et al., 2001; Scarpato et al., 
1996; Spriggs et al., 1996) these are the most prone to non-disjunction in sperm and hence 
the most likely to give significant results. Secondly, the large number of sperm that needed 
to be scored per individual to establish statistically significant results precluded the study of 
large numbers of chromosome pairs. Finally these pairs are the most clinically significant 
as they lead to common mutant phenotypes among liveborns. That is, unlike most 
trisomies that abort in the first trimester, trisomies of the sex chromosomes and 
chromosome 21 frequently go to term and can lead to Klinefelter syndrome and Down 
syndrome respectively. 
3.3.1 Semen analysis 
Patients were assessed for sperm quality, the same operator perfon-ned all analyses. 
Individual samples were then placed in three occasions (for concentration, motility and 
morphology) into a "tesf 'or "control" group based on the results of the semen assessments. 
For the studies investigating sperm concentration individuals were placed in the control 
group if there semen assessment revealed a sperm concentration of ; ->20 million/ml, those 
individuals with <20 million/ml were placed in the test group. When investigating motility 
individuals were placed into the control groups if individuals had forward motility of ; ->20% 
and those with <20% forward motility were placed in the test group. Finally when 
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investigating sperm morphology the control group consisted of individuals who had a 
normal morphology of ýA% and those with <4% normal morphology placed in the test 
group. The cut-off Points for considering individual samples as being in the test or control 
groups were based on VMO guidelines for oligozoospermia, severe asthenozoospermia, 
and severe teratozoospermia and were comparable to those used in other studies for sperm 
disomy (Pang et al., 1999). In each case the sample was assessed by fluorescent in-situ 
hybridisation (FISH) for the proportion of disomic sperm for chromosomes X, Y and 21. 
3.3.2 Statistical Analysis 
The hypotheses of interest were whether the rate of disomy was significantly different for 
the test and control groups in terms of sperm concentration, morphology or motility. Data 
on the rate of disomy were generated for chromosome 21 and the sex chromosomes. 
Initially linear regression was utilised to determine if a correlation could be found between 
individual semen parameters and chromosome disomy levels for X, Y and 2 1. The 
distribution of the data (refer to table 3.1) however, did not lend itself to this particular 
analysis, as the data points were not normally distributed. This is illustrated for example 
when considering abnormal morphology (table 3.1), in total 43 semen samples were 
obtained with a range of abnormal forms (%) of between 86-100%, of these over 70% of 
the data points were skewed to one side (i. e. between 96 and 100%). In consultation with 
statistician Dr. D. Wright it was decided that the data would be more suitable for analysis 
with logistic regression. To test the hypotheses six logistic regression models were fitted in 
the statistical software package SAS (Version 8.2). Logistic regression is a statistical model 
that examines the relationship between one or more independent variable and is used to 
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determine the probability of whether an event occurs by chance or not. For each model an 
Odds Ratio, a 95% confidence interval and a p-value were calculated. A confidence 
interval that does not contain I implies that there is evidence that the disomy rates were 
significantly different for that comparison and hence has a corresponding p-value of < 0.05. 
3.4 Results 
In total for the 43 samples analysed for chromosomes X, Y and 21 a total of 209,188 
spermatozoa were scored (approximately 5,000 per sample). The results of the sperm 
disomy rates calculated for these chromosomes and the semen assessments for each of the 
43 samples analysed are presented in table 3.1. The total rate of disomy for the sex 
chromosomes and chromosome 21 was found to be 0.3% (633/209,188) and 0.19% 
(398/209,188) respectively. In agreement with previous studies published (refer to intro) 
we report a high degree of inter-individual differences with disomy levels ranging from 
0.02% - 2.00% for the sex chromosomes and 0.00% - 1.46% for chromosome 2 1. We also 
found a surprisingly large variation in aneuploidy frequency in patients for which multiple 
samples were received. Including patient 5, who gave 4 samples, had sex chromosome 
disomy rates between 0.06% and 0.22% and chromosome 21 disomy rates between 0.1% 
and 0.24%). Patient 9 (6 samples) ranged from 0.1% and 0.73% for the sex chromosomes, 
0.12% and 0.25% for chromosome 21. Patient 10 (3 samples) 0.02%-0.24% (sex 
chromosomes) and 0.04%-0.38% (chromosome 21). Patient 12 (7 samples) 0.12%-0.44% 
(sex) and 0.11%-1.46% (21). Patient 14 (6 samples) 0.08%-0.65% (sex) and 0.04%-0.37% 
(21). Patient 17 (3 samples) 0.08%-0.24% (sex) and 0.04%-0.24% (21) (Table 3.1). 
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Table 3.1 Sperm disomy for the sex chromosomes and chromosome 21 and the semen analysis in 43 men. 
1 0.50% 0.43% 5097 6.9 26 97 OT 
2 1.02% 0.10% 5000 6.6 48 98 OT 
3 0.29% 0.29% 4864 128 63 86 N 
4 0.35% 0.201/6 4790 13.5 17 98 OAT 
Sa 0.17% 0.24% 5400 61 24 95 N 
5b 0.22% 0.100/0 5092 37.5 7 95 A 
5C 0.12% 0.10% 5000 22 45 99 T 
5d 0.06% 0.14% 5000 63 13 94 A 
6a 0.14% 0.08% 5000 48 44 98 T 
6b 0.12% 0.04% 5000 40 50 99 T 
7 0.18% 0.20% 5000 4.8 <10 95 OA 
8 0.74% 0.00% 544 <0.01 <10 100 OAT 
9a 0.73% 0.25% 5066 17 18 96 OAT 
9b 0.45% 0.24% 5056 12 11 97 OAT 
9C 0.30% 0.14% 5084 21 30 96 T 
9d 0.10% 0.22% 5000 80 8 98 AT 
9e 0.18% 0.12% 5063 13.3 26 97 OT 
9f 0.24% 0.12% 5004 7.9 42 98 OT 
10a 0.24% 0.38% 5000 25 48 99 T 
10b 0,02% 0.04% 5000 8 38 97 OT 
10C 0.16% 0.12% 5000 22 41 98 T 
11 0.17% 0.09% 5275 41 46 93 N 
12a 0.96% 1.46% 4050 69 10 91 A 
12b 0.44% 0.11% 5449 10.3 26 87 0 
12c 0.30% 0.12% 5048 9.5 11 97 OAT 
12d 0.24% 0.14% 5019 63 17 97 AT 
12e 0.18% 0.08% 5031 32 41 96 T 
12f 0.12% 0.06% 5061 57 37 96 T 
12g 0.14% 0.18% 5000 24 58 87 N 
13 0.06% 0.02% 5000 96 60 92 N 
14a 0.65% 0.20% 3521 12 36 97 OT 
14b 0.24% 0.08% 5009 7.5 53 99 OT 
14C 0.14% 0.10% 5001 37 27 97 T 
14d 0.08% 0.14% 5037 16 45 98 OT 
140 0.20% 0.04% 5000 30 40 100 N 
14f 0.27% 0.37% 4108 16 38 94 0 
is 2.00% 0.5wo 5293 14 57 96 OT 
16 0.31% 0.21% 5120 47 49 89 N 
17a 0.24% 0.24% 5000 18 53 92 0 
17b 0.08% 0.04% 5000 49 44 96 T 
17c 0.08% 0.04% 5000 44 56 92 N 
18 0.10% 0.26% 5000 123 10 96 AT 
19 0.30% 0.18% 5107 52 46 89 N 
Patient number. Letters after patient number indicate consecutive samples from the same patient e. g. 10b is the second sample from patient 
10, Semen Analysis: 0- oligozoospen-nia-, A- severe asthenozoosper mia; T- severe terato7oospe rmia-, N- normo7ompermis 
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3.4.1 The relationship between chromosome aneuploidy and sperm concentration 
Each of the 43 samples from 19 different individuals were placed either into a control 
group or a test group dependent on the results of the sperm concentration of sperm in the 
ejaculate as determined by the semen assessment (Table 3.1). In total 25 individuals were 
placed in the control group (those with a spenn concentration of ý! 20 million/ml) with the 
remaining 18 samples placed into the test group (those with a spenn concentration of < 20 
million/mi). The mean rate of disomy for the control group and test group for the sex 
chromosomes and chromosome 21 were 0.19% and 0.46%, and 0.18% and 0.21 % 
respectively (Figure 3.1). 
Figure 3.1 Graph to show the mean sperm disomy frequencies for the sex chromosomes and chromosome 21 
in two groups with sperm concentration of ýý! 20 million/n-A and <20 million/n-d, error bars represent SEM. 
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Type of disomy 
Statistical analysis using logistic regression analysis clearly demonstrate that men with 
oligozoospermia (sperm concentration of < 20 million/ml) have significantly elevated 
levels of sex chromosome disomy (Odds Ratio 2.39, p<0.0001) (table 3.2) in their sperm 
compared to men with normal spen-n count levels (sperm concentration > 20 million/ml). 
148 
As the lower limit of the 95% confidence interval for the Odds Ratio is 2.04 these data 
suggest that the rate of sperm disorny is likely to be at least twice as high in test patients 
compared to controls. Further analysis revealed that this increase was largely accounted for 
by an increase in XY disorny (with around 72% of the sex chromosome disorny rate 
attributed to XY disomy), which is usually associated with non-disjunction errors of 
meiosis 1. Conversely there was no evidence of a significant association between 
oligozoospermia and sperm disorny for chromosome 21 with disomy rates of 0.18% within 
the control group and 0.2 1% in the test group. 
Table 3.2 Logistic regression analysis ofindividual disomy rates compared to semen parameters. a. Sperm 
concentration. b. spemi motilitN. c. spen-n morphology, 
a. Spenil concentration 
Chromosome disomy Odds Ratio (95% Confidence Interval) p-value 
21 1.14 (0.94,1.40) (Hs 
Sex 2.39 (2.04,2.81) 0.0001 
b. Motility 
Chromosome disomy Odds Ratio (95"/o Confidence Interval) p-value 
21 1.75 (1.43,2.14) 0.0001 
Sex 1.12 (0.95,1.34) 0.19 
c. Morphology 
Chromosome disomy Odds Ratio (95Yo Confidence Interval) l)-value 
21 1.54 (1.26,1.89) -- 0.0001 
I ex 
1 1.22 (1.04,1.43) 1 0.01 
Chromosome disomy Odds Ratio (95% Confidence Interval) p-value 
21 1.14 (0.94,1.40) (Hs 
Sex 2.39 (2.04,2.81) 0.0001 
Chromosome disomy Odds Ratio (95%, Confidence Interval) p-value 
21 1.75 (1.43,2.14) 0.0001 
Sex 1.12 (0.95,1.34) 0.19 
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3.4.2 The relationship between chromosome aneuploidy and sperm motility 
As for sperin concentration each of the 43 samples from 19 different individuals were 
placed either into a control or a test group dependent on sperm motility as determined by 
the semen assessment (Table 3.1). In total 31 individuals were placed in the control group 
(those with sperm motility of ý: 20%) with the remaining 12 samples placed into the test 
group (those with sperm motility of < 20%). The mean rate of disomy for the control group 
and test group for the sex chromosomes and chromosome 21 were 0.30% and 0.37%, and 
0.16% and 0.28% respectively (Figure 3.2). 
Figure 3.2 Graph to show the mean sperm disorny frequencies for the sex chromosomes and chromosome 21 
in two groups with percentage of motility of ý-20% motility and <20% sperm motility, error bars represent 
SEM. 
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These results provide evidence of a difference between sperm disomy and motility 
however, the opposite situation to that of spenn concentration pertained. That is, there was 
no significant difference between sperm disomy levels for the sex chromosomes (XY, XX 
or XY disomy) whereas men with motility of < 20% (asthenozoospermia) had significantly 
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elevated levels of chromosome 21 disomy compared to controls (Odds Ratio 1.75, p 
0.0001) (Table 3.2). 
3.4.3 The relationship between chromosome aneuploidy and sperm morphology 
As for sperm concentration, each of the 43 samples from 19 different individuals were 
placed either into a control or a test group dependent on sperm motility as determined by 
the semen assessment (Table 3.1). In total 21 individuals were place in the control group 
(those with normal sperm morphology of ý: 4%) with the remaining 22 samples placed into 
the test group (those with normal sperm morphology of < 4%). The mean rate of disomy for 
the control group and test group for the sex chromosomes and chromosome 21 were 0.33% 
and 0.27%, and 0.23% and 0.15% respectively (Figure 3.3). 
Figure 3.3 Graph to show the mean sperm disomy frequencies for the sex chromosomes and chromosome 21 
in two groups with ýA% abnormal morphology and <4% abnormal morphology, error bars represent SEM. 
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Finally (and surprisingly) men with severe teratozoospermia (less than 4% abnormal forms) 
had significantly reduced levels of sperm disomy for both pairs of chromosomes compared 
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to controls. (Sex chromosome disomy, Odds Ratio 1.22 (p = 0.013), Chromosome 21 
disomy, Odds Ratio = 1.54 (p < 0.0001) (Table 3.2). 
3.5 Discussion 
The results generated by this study particularly that of the repeat patients were surprising in 
that there was marked variation between semen samples produced by the same individual 
on separate occasions. It is clear from previous studies that many factors can influence both 
that of sperm aneuploidy (refer to section 1.5) and semen parameters including: the number 
of days abstinence, possible environmental effects for example variations within semen 
parameters may be due to the climate, seasonal changes and environmental factors for 
example Centola et al. (1999) reported no changes in volume, count motility or motile 
count associated with climate changes, however found a significant reduction in the 
percentage of rapid sperm and progressive straight-line velocity in the Spring and also 
found relationship between age and decreased semen parameters and an increase in tail 
defects in older males. This may be of particular relevance, as if climate and seasonal 
changes do affect semen parameters, the variation noted in these repeat patients may be in 
part due to these factors as many of patients were treated for 3 months to 1.5 years 
therefore encompassing seasonal changes. It is also probable that there may be differences 
in ancuploidy levels and semen parameters between patients due to geographic and ethnic 
differences. Thirdly it is clear from previous studies (refer to section 1.5) that many factors 
can influence sperm aneuploidy and semen parameters including: increasing paternal age; 
alcohol; tobacco; caffeine; stress; chemotherapy; drugs and exposure to chemicals for 
example whether it is through occupational exposure or through environmental exposure. 
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To date there have been few studies that have addressed these points and those that have, 
have been poorly designed, not taking into account other factors that may be involved and 
not analysing a large enough patient cohort for example. It is clear that these questions are 
difficult to address (and may even be impossible) to prove any existence of a relationship 
between reduced semen parameters and aneuploidy with any of these questions, as there are 
so many compounding factors involved. Hopefully, future studies will be able address these 
questions without the pitfalls of previous studies. 
This study revealed the existence of a possible relationship between individual clinically 
defined semen parameters and segregation of specific chromosome pairs. The relationship 
between sex chromosome disomy and the failure of spermatocytes to complete 
spermatogenesis is manifested by significantly higher sex chromosome disomy levels in 
oligozoospermic men. These results are similar to those of Rives et a]. (1999), Vegetti et al. 
(2000), Calogero et al. (2001b) who also reported a relationship between sex chromosome 
disomy and sperm concentration for investigated chromosomes. However the study carried 
out by Vegetti et al. (2000) investigated total aneuploidy (hence nullisomy and disomy) and 
considered chromosomes 13,21 and 18, X and Y as a group. Here however we report on 
individual chromosomes and also report the absence of such an effect for chromosome 21 
which leads us to propose the hypothesis that this effect may be restricted to the sex 
chromosome bivalent. Further studies on other chromosome pairs will allow us to test this 
hypothesis further (refer to section 7.3). 
Our results also suggest a significant association between asthenozoospermia (poor 
motility) and non-disj unction of chromosome 2 1. This is similar to reports by Vegetti et al. 
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(2000) but in this case, we found no such association with the sex chromosomes. This study 
however is not in agreement with the study published by Hristova, et al. (2002) in which 10 
males with asthenoteratozoospermia were investigated, we report that asthenozoospermia is 
correlated with chromosome 13 and XX disomy but not that of chromosome 2 1, XY and 
YY disomy. One possible explanation for the association within our patient cohort is that 
over expressed genes on chromosome 21 significantly impair the formation of the sperm 
midpiece through which sperm motility is mediated. This seems unlikely however since 
chromosome 21 is a gene-poor chromosome and there are thought to be few genes 
expressed in the spermatocyte itself that impact on spermiogenesis. It is also possible that 
there are gene products (e. g. micro tubular or motor proteins) common to both normal 
chromosome segregation of chromosome 21 (or the acrocentric (non-Y) chromosomes, or 
the autosomes in general) and normal formation of the structures that mediate sperm 
motility. A final possibility is that our results represent a statistical anomaly. While 
correlations for individual males who have given multiple (four or more) samples are 
relatively consistent for sperm concentration, they are less so for motility (see table 4.1). If 
disomy were related to motility by a genetic cause, then would expect a consistency in 
chromosomal aneuploidies from individual patients who gave multiple samples. In patient 
5 however, his highest motility sample of 45% also had the lowest proportion of autosomal 
disomy (0.1%) and the highest (0.24%) in a "normal" motility sample. Moreover in patient 
9, the lowest motility sample (8%) had a disomy frequency of 0.22% and the 18% motility 
sample had 0.25% disomy frequency. There was also considerable evidence of varying 
disomy levels when motility remained relatively constant, for instance, patient 10, had 
normal motility in all samples, the disomy frequency ranged from 0.12 - 0.3 8%. In patient 
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12 the sample with 10% motility had an disomy rate of 1.46%, the sample with I I% 
motility had a 0.12% rate and the 17% motility sample had 0.14% disomy. A similar 
situation pertained for patient 14, in which samples of 16% motility had disomy rates of 
both 0.14 and 0.3% and patient 17 had >40% motility throughout but disomy rates of 0.24, 
0.04 and 0.04% respectively. Clearly therefore further studies are necessary before a 
stronger relationship between autosomal sperm disomy and asthenozoospermia can be 
established. 
The apparent inverse association between sperm morphology and chromosome segregation 
was surprising and it is, again, possible that this is a statistical anomaly. Indeed although a 
number of studies have found no significant correlation between morphology and disomy 
for the investigated chromosomes (In't Veld et al., 1997; Colombero et al., 1999; Vcgetti et 
al., 2000; Ryu et al., 2001), others suggest a positive correlation between disomy and 
abnormal morphology for disomy 8,18, XX and YY (Calogero et al., 2001b), disomy 13 
and XX and YY (Hristova et al., 2002; Templado et al., 2002), but do not suggest a 
correlation for disomy 12 or XY (Calogero et al., 2001b), disomy 21 or YY (Hristova et al., 
2002; Templado et al., 2002). The high level of statistical significance reported, the fact 
that the effect is clear in two separate chromosome pairs, and the fact that different effects 
were seen for concentration and morphology would argue that this is a genuine 
phenomenon. Moreover this is one of the few studies that has used repeat samples from 
individual patients and, in some cases, the same individual appeared in different groups 
depending on his semen parameters at the time of donation. In other words disomy levels 
appear not to be consistent among individuals, rather they relate more to their semen 
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parameters on any given day, perhaps as a result of extrinsic factors. Other studies have 
reported that teratozoospermic males have elevated levels of sperm disomy. Calogero et al. 
(200 1 b) found a correlation between increased sperm disomy levels and teratozoospermia 
as did Viville et al. (2000) but only an association with 100% macrocephalic spermatozoa. 
For the most part however these individuals were defined as "'OAT" i. e. also 
oligozoospermic and asthenozoospermic and thus it is possible that the association of 
teratozoospermia alone was not measured fully. Future studies warrant investigating this 
further, perhaps investigating more chromosome pairs and individuals who display severe 
teratozoospermia but normal levels of sperm concentration and motility. 
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Data presented in this chapter were previously published as a poster abstract, Tempest et 
al., (2001). Looking to the East: Evidence that traditional medicine can significantly 
reduce the rates of sperm aneuploidy in infertile males. Chromosome Research., Vol 9, 
pg 146. 
Results from this chapter and chapter 5 are in preparation for publication 
1! tAvl-i -! 'Crlne, ýt I 
Chapter 4: Evidence of an improvement in the genetic quality of sperm coincident 
with infertility treatment by traditional Chinese medicine (TCM) 
4.1 Introduction 
To date a number of causes of infertility have been identified (reviewed in chapter 1); 
however, at present our understanding of the causes of infertility is limited, with many 
cases diagnosed as "unexplained". Currently the only widely used treatment of male 
factor infertility is that of ICSI. As mentioned in chapter 1, there are a number of 
concerns over the safety of this technique, the aim of this study was to investigate 
another possible treatment regime that may, ultimately provide an adjunct or alternative 
to ICSI. Within the past decade more and more Westerners are turning to alternative 
therapies also known as complementary and alternative medicine (CAM) for the 
treatment of illnesses and general well being. CAM includes a wide range of treatments 
including: herbalism, aromatherapy, osteopathy, chiropractic, massage, meditation, 
reflexology, reiki, hypnotherapy, homeopathy, acupuncture and traditional Chinese 
medicine (TCM) amongst others (New Scientist., 2001). Figures released by the British 
Medical Association reveal that specialists in alternative medicine outnumber GPs in 
the UK with around 50,000 practioners of CAM compared to 36,600 GPs in 1999 (New 
Scientist., 2001). 
4.2 Why are Westerners turning to CAM therapies 
Individuals often turn to CAM when Western medicine fails to provide a diagnosis, they 
have exhausted all that it has to offer and as CAM treatment is often less radical and 
invasive. This is of relevance when considering infertility, as in many cases Western 
medicine fails to provide a diagnosis. CAM therapies offer alternative models of disease 
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and hence may offer diagnosis and possible cures for these individuals (New Scientist., 
2001). Many individuals are turning to CAM therapies for chronic and degenerative 
conditions that Western medicine has had little success in treating such as asthma, 
eczema, cancer and infertility. In these cases individuals are often treated indefinitely 
with potentially serious side effects. CAM is often undertaken to alleviate the serious 
side effects or in some cases for sole treatment escaping the invasiveness of Western 
treatment (Bensoussan, 1999). 
4.3 Traditional Chinese medicine (TCM) 
Studies in this chapter were carried out to investigate the effectiveness of traditional 
Chinese herbal medicine (TCM), in the treatment of male factor infertility. TCM 
originated from Taoism over 4,000 years ago in China and has been developed and 
practised over thousands of years. Treatment includes both acupuncture and 
individualised prescriptions (the components of which are mainly plant based). In recent 
years the practice of TCM within Western countries has increased significantly and 
Chinese herbalists are now commonly found UK high streets. Western medicine as a 
whole has been very sceptical towards the use of TCM, largely in part due to views that 
it is an unscientific approach. Traditionally Western drugs contain a single active 
compound, whereas TCM uses on average 10-20 different herbs within prescriptions, 
therefore it is likely that in many cases the activity of these plants are based on the 
interactions of different compounds (Yuan and Lin, 2000), TCM uses an estimated 
8,000 plants; 400 of which are commonly used (Pach et al., 2002). 
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4.3.1 Principles of TCM 
The philosophy of TCM is different to that of Western medicine, in that Western 
medicine often targets specific biochemical pathways. Western medicine has 
methodically looked at the relationship between structure and function and designed 
specific drugs to target pathogens and/ or diseased cells and tissues (Yuan and Lin, 
2000). TCM differs in diagnostic techniques and therapeutic principles. The theoretical 
system of TCM is based around the doctrines of Yin-Yang, the Five Elements, 'Zang' 
and Tu' organs (viscera) and 'Meridians' (energy channels that flow through the body, 
Channels and Collaterals). TCM suggests that the human body is an organic entity in 
which tissues and sense organs are connected through a network of channels and 
collatemls (blood vessels), and that the body is unified with nature. TCM defines health 
in terms of balance and the principles suggest that the body and the environment should 
be in a balanced state in order to perpetuate good health, and any alteration results in 
disease. 
4.3.2 Zang-Fu theory of TCM 
Zang and Fu theory comprises of five zang organs including: the heart, lung, spleen, 
liver and kidney, and six fu organs including: the gall bladder, stomach, small and large 
intestine, bladder and sanjiao (the trunk of the body). The theory proposes that these 
Zang-Fu organs are not just organs but represent the physiology and pathology of a 
number of systems within humans. The zang organs produce and store essence 
including: qi, blood and bodily fluids, whereas the fu organs primarily receive and 
digest food absorbing any nutrients, transmit and excrete any waste products. 
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4.3.2.1 Zang organs in TCM 
Table 4.1 reports the main functions and indicators (leading to diagnosis) of the five 
Zang organs according to TCM principles. 
According to TCM theories the Iddney in particular plays a vital role in growth, 
development and reproduction, its main fimction is involved in the storing of essence 
(termed kidney qi) and is of importance in reproduction terms, as it is believed that 
kidney qi becomes abundant when a male reaches the age of sixteen causing him to 
have sexual energy and semen. However, kidney qi is said to decrease with increasing 
age causing a decline in sexual energy and semen quality resulting in infertility, 
abnormalities can also cause maldevelopment and infantile underdevelopment. 
Table 4.1: List of the 
Heart - Domination of blood, vessels and facial complexion 
- Control of the mind 
- Opening into the tongue 
Lung - Dominating qi and controlling respiration 
- Dispersion and descent of qi 
- Regulating water passage 
- Connecting externally with skin, hair and internally with the large intestine 
Spleen - Governing transportation and transformation 
- Controlling blood 
- Dominating muscles and limbs 
- Opening into the mouth and the complexion of the lips 
Liver - Storing blood 
- Creating unrestrained conditions for qi 
- Controlling tendons and luster reflected in the nails 
- Opening into the eye 
Kidneys - Controlling human reproduction, storing essence, growth and development 
- Controlling water metabolism 
- Receiving qi 
- Producing marrow, filling up the brain, controlling bones, manufacturing blood and hair luster 
- Opening into car, and the bladder which is connected both internally and externally 
4.3.2.2 Fu organs in TCM 
Table 4.2 reports the main functions and potential disease types that may result due to 
abnormalities within the six Fu organs according to TCM principles. 
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Table 4.2: List of the Fu organs, function and associated diseases 
Gall bladder (attached to the liver, stores bile), mental disorders, insomnia and emotional symptoms such as 
fear 
Stomach (receives and digests food, associated with the spleen), anorexia, fullness, nausea and distension 
of the upper abdomen 
Small intestine (connects with the stomach, receives partially digested food and continues with digestion), 
affect digestion and can lead to urinary problems 
Large intestine (receives waste material and absorbs fluid coverts its to faeces), diarrhoea and constipation 
Bladder (associated with the kidney, stores and discharges urine), dysfunction in qi will result in urine 
retention or incontinence 
Sanjiao (split into upperjiao: contains heart and lungs; middlejiao: spleen and stomach, lowerjiao: 
kidney and bladder) 
In summary it is proposed that the heart and lung distribute qi and bodily fluid, the 
spleen and stomach are responsible for the digestion, absorption and transference of the 
qi, blood and body fluids transformed form essential substances and the kidney and 
bladder transport fluids and water. Hence if any of the sanjiao areas are affected by 
pathological problems the organs located within these will be affected. 
4.3.4 Yin-Yang theory of TCM 
Yin-Yang theory in TCM is important for both diagnosis and treatment, Yin and Yang 
represent two polar pairs/opposites (e. g. night and day, hot and cold etc). Yin and Yang 
are said to be found in all things, and are not independent of each other (e. g. day is 
Yang and night is Yin, however morning is believed to be Yang within Yin and 
afternoon is Yin within Yang). In summary they are two fundamental principles that 
oppose and complement each other. In TCM it is postulated that the body's functional 
activities are perceived to be Yang and the consumption of nutrient substances is Yin, if 
Yin is decreased Yang increases and when nutrients are metabolised (Yin) functional 
energy is decreased (hence Yang). In the normal situation the body is thought to 
undergo mutual increases and decreases in Yin and Yang, however, a relative balance is 
maintained. In contrast disease is said to result if there is either an excess or deficiency 
in either Yin or Yang, therefore normal vital activities of the human body are the result 
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of a balance between Yin and Yang. The Yin-Yang theory is also used in TCM 
treatment, for example properties, flavour and action of the Chinese herbal medicine 
(e. g. herbs that are bitter are Yin and those that are sweet are Yang). The treatment aims 
are supposed to restore a balance between Yin and Yang in individuals. 
4.3.5 The Five Elements theory 
This theory is based upon the fact that the "main elements" of the material world are 
fire, water, wood, earth and metal. The characteristics of each element is assigned to 
humans and anything within the world, for example characteristics of wood are 
gemination, extension, softness and harniony, and hence anything that falls into this 
category is identified as a wood element. This theory is utilised to express the mutual 
relationship between humans and the environment including that of seasons, climates 
and flavours amongst others. Wood is associated with such things as the spring and 
wind but also with the liver and the eyes of humans. The diagnosis and treatment of 
disease according to this theory is made possible, as any changes in the internal organs 
function are hypothesised to be detected in the external appearances of individuals; 
including complexion, voice sense of taste and pulse. Any changes therefore within 
these parameters are measured by TCM practioners through the careful monitoring and 
examining of individuals by four diagnostic methods: inspection ausculation and 
olfaction, inquiring and palpitation. 
4.3.6 Diagnostic methods of TCM 
Normally an individual consulting a TCM specialist will undergo a number of 
diagnostic methods, these include: inspection, olfaction, palpation and interrogation. 
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4.3.6.1 Inspection 
( h: ' 
This technique is used to observe vitality (thought to enable prosperity, decline of vital 
essence and energy of the body, enabling the seriousness of the disease to be 
established); complexion (changes in colour and lustre of the face, believed to indicate 
the type and severity of the disease), general appearance and observation of changes in 
secretions and excretions for example analysis of the seminal fluid including colour and 
volume. 
4.3.6.1.1 Inspection of the tongue 
Inspection of the tongue is of key importance in TCM theory, tongue colour and tongue 
coating being analysed as this is thought to establish the location of the disease. The 
thinness/thickness and colour of the coating is thought to indicate the prosperity and 
decline of Qi factors, the colour indicates cold and heat of pathologic changes, if the 
coating is moist or dry allegedly denotes an insufficiency of body fluids. 
4.3.6.2 Ausculation and olfaction 
Ausculation (listening) and olfaction (smelling) are also two key methods used in 
diagnosis. Listening to the voice, breathing and coughing can help indicate the type of 
syndrome and deficiency of Qi. Olfaction, (smelling) of individual's breath, secretions 
and excretions such as faeces, urine is thought to indicate the location, type of syndrome 
and discase. 
4.3.6.3 Meridians 
Analysing meridians, is based on a complex pulse-taking method (over twenty pulse 
characteristics have been described in TCM) which analyses the energy channels that 
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flow through the body. These meridians are believed to identify vitality and health and 
when these are balanced the individual is healthy. However if one or more of these 
meridians is unbalanced, it will present itself as illness. 
4.3.7 Differentiation of syndromes according to the Eight Principles 
In TCM syndromes can be differentiated according to the eight principles, which 
include: yin and yang, cold and heat, exterior (biao) and interior (li) and finally 
deficiency (xu) and excess (shi). Yin and yang are the general principles that are used to 
categorise the other six principles (as listed previously). Exterior and interior are used to 
indicate the depth and development of disease, exterior syndromes relate to pathological 
changes in the body surface resulting from pathogenic factors. 
The syndromes of each of the mentioned principles are varied but are postulated to be 
linked with each other, in many cases for example when differentiating syndromes of 
deficiency (xu) and excess (shi), other syndromes are often also involved including 
exterior (biao), interior (li) and cold and heat. 
4.3.8 Conclusion on the principles of TCM 
TCM is based on the theories and relationships of the Zang-Fu organs and tissues of the 
human body, but also that of the relationship between the environment and the human 
body. One key factor in TCM theory is that all these elements remain in a relatively 
balanced state for the body to function normally; any alteration in this balance will 
result in disease. 
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4.4 Studies investigating the efficacy of TCM treatments 
The practice of TCM has met with much scepticism particularly within the Western 
world. However, some argue that it would be unlikely that the practice and theory of 
TCM would have continued over these thousands of years if no positive effects were 
noted. There are currently a number ofjournals published based around TCM, however 
the majority are published in Chinese and hence are not easily accessible. It is clear that 
definitive literature is scant and as a result has not been integrated within the 
mainstream medical community (Cohen et al., 2002). To the best of our knowledge no 
reports have been published within Western literature investigating the role of TCM in 
the treatment of mate infertility. There are however, reports of both open tube 
experiments and randomised clinical trials within the literature proving the effectiveness 
of TCM in the treatment of a wide range of diseases including: asthma; atopic 
dermatitis; atopic eczema; cancer; diabetes mellitus; heart disease; irritable bowel 
syndrome (IBS); pneumonia; rheumatoid arthritis and viral hepatitis. Several of these 
studies demonstrating the effectiveness of TCM in the treatment of some of the diseases 
mentioned previously will now be considered. Sheehan and Atherton (1992) 
investigated TCM treatment of atopic dermatitis in 40 adults, split into two groups, each 
group was administered either a standardised TCM mixture (consisting of a mixture of 
ten herbs) or a placebo for a period of two months. Both groups were then given a four 
week wash-out period and subsequently switched to the opposite treatment. A clear 
decrease in the severity of the dermatitis was observed after TCM treatment, identified 
by both patient and specialist evaluation. Sheehan et al. (1992) carried out a similar trial 
investigating TCM treatment of atopic eczema in 47 children. As before specialists 
analysing erythema and surface damage and parental observations monitored the 
progress of patients. As oýserved in the atopic dermatitis, patient's conditions 
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significantly improved with TCM treatment and in both studies the patient's conditions 
returned to its original state when the placebo was administered. In a follow-up study 
Sheehan and Atherton. (1994) further investigated 37 of the 47 children enrolled in the 
previous study for the following year. A total of 18 children demonstrated a 90% 
reduction in eczema symptoms and 5 had lesser degrees of improvement. Within this 
study 14 individuals dropped out, 4 due to difficulties in preparation and or ingestion of 
the TCM treatment and 10 due to no response. However, 7 patients were able to stop 
treatment as their symptoms returned to normal and 16 were able to control their 
eczema through treatment. 
At least two studies have investigated the efficacy of TCM treatment in bronchial 
asthma, one study evaluated the effects on childhood bronchial asthma (Hsieh, 1996) 
and will be considered first, with the second study investigating the effects in adults 
(Egashira and Nagano, 1993). 
A multi-centre, double-blind, placebo controlled trial was carried out in 3 10 children 
over a period of 6 months (Hsieh, 1996). This study split patients into three groups, 
dependent on the diagnosis by TCM specialists. Each of these three groups were 
divided further into 2 groups, with one receiving a TCM treatment specific to the type 
of deficiency found by the TCM specialists, with the other group receiving a placebo. 
The authors reported an improvement in all groups, therefore suggesting some evidence 
of a placebo effect, however, those individuals treated by TCM demonstrated better 
results. Egashira and Nagano, (1993) investigated 90 adults with steroid-dependant 
bronchial asthma for a 12 week period, patients were administered either a TCM 
treatment or a placebo. All groups also received steroid (prednisolone) treatment, this 
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study reported an improvement in the bronchial asthma of individuals treated with TCM 
compared to that of the placebo group. Two patients were reported to have stopped their 
steroid usage with eleven patients reducing their steroid levels by over 50%, compared 
to only three patients reducing their steroid levels by 50% in the placebo group. 
Egashira and Nagano, (1993), suggest that TCM is effective in the treatment of 
bronchial asthma and that when used in conjunction with steroid treatment may result in 
the stoppage and reduction of steroid usage, and as a result may lead to a reduction in 
the side effects of steroid use. 
Bensoussan et al. (1998) investigated the use of TCM in the treatment of irritable bowel 
syndrome (which at present, no Western drug treatment has been identified). 116 
patients participated, these were split into three groups (group I- received individualised 
TCM treatments, group 2- received a standardised TCM treatment with group 3- 
receiving a placebo for 16 weeks). This study interestingly reported significant 
improvements in both groups I and 2 (individualised and standardised treatment) 
compared to group 3. The results of this study suggest that standardised treatments are 
as effective as tailored treatments, however a follow-up study was carried out 14 weeks 
after treatment completion. The authors suggest from these results that the continued 
improvement of the condition was only found in those individuals administered the 
tailored treatment. 
4.5 Objectives 
To the best of our knowledge no empirical studies have been performed to assess sperm 
aneuploidy levels as a result of, or coincident with, any medical intervention. Moreover 
we are not aware of studies in the Western literature that have investigated the role of 
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TCM in the treatment of infertility. Finally we are not aware of any study that has 
reported the efficacy of any alternative treatment of a disease with a genetic basis. With 
this in mind we investigated the role of TCM as a possible means of improving 
ancuploidy frequencies and semen parameters within the sperm of infertile males. 
- To do this we established a patient cohort of males undergoing TCM treatment 
in conjunction with the Zhai Clinic (112 Harley Street), for each patient repeat 
semen samPles were obtained and semen assessments performed in each case. 
We carried out investigations into the rates of aneuploidy for chromosomes X, 
Y and 21 within this patient cohort to detennine if there is any difference/ 
improvement in aneuploidy frequencies over repeat semen samples. 
4.6 Materials and Methods 
4.6.1 Patient cohort 
In total 10 individuals were enrolled in this study and comprised of four control males 
(defined as males with proven fertility and semen parameters within the normal range) 
and six patients (with a history of fertility problems and reduced semen parameters) 
undergoing TCM treatment at the Zhai clinic for male infertility. In each of these 
individuals the aneuploidy frequencies for chromosomes X, Y and 21 were established, 
(in each case an average of 5,000 sperm nuclei were scored). Due to difficulties in 
recruiting control individuals repeat semen samples were only received from one 
individual on five occasions, with semen samples obtained on one occasion for-the 
remaining three control individuals. Semen samples from all six patients undergoing 
TCM treatment were received on a minimum of three; up to seven occasions, over a 
period of eighteen months, with repeat samples being received on average at 6 weekly 
intervals. In all cases semen assessments were carried out as standard according to 
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World Health Organization and Kruger's strict scoring criteria, all assessments were 
also carried out by the same operator (Dr. S. Homa), ensuring any observed differences 
in semen assessments between patients was not accountable to different operators. The 
sperm FISH method used can be found in section 8.2, all slides were coded and scored 
blind, details of the scoring criteria can be found in section 8.3. 
4.6.2 Statistical analysis 
Within this section of work the statistical test Chi squared was utilised to detennine if 
there was any evidence of a statistically significant difference between the control males 
and the six infertile male patients undergoing TCM treatment. Firstly Chi squared 
analysis was performed to establish whether any of the six patients enrolled in the study 
exhibited statistically significant increases in disomy rates for the investigated 
chromosomes compared to controls. The mean value obtained for the chromosome 
disomy investigated (e. g. X, Y or 2 1) within the control group was used in Chi squared 
calculations to establish whether sperm aneuploidy levels in each of the six patients was 
significantly higher than those obtained for the controls. The results of this analysis are 
presented in table 4.4, which show significant increases in the rate of disomy for at least 
one of chromosome investigated in the six patients compared to controls. Chi squared 
analysis of this type, has previously been published spenn aneuploidy studies 
investigating the levels of aneuploidy in control and infertile males (refer to table 1.3). 
Secondly Chi squared analysis was performed for each individual patient to establish if 
there was evidence of a significant difference in sperm aneuploidy in the initial sample 
from each patient and subsequent samples received during the TCM treatment for male 
infertility. The analysis of this data revealed a significant difference (reduction) in 
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sperm disomy coincident with treatment and these aneuploidy rates were found to 
decline to levels comparable to controls. 
Ideally Chi squared analysis is not the most appropriate test to use, in particular with 
reference to the second analysis performed, however due to the small sample size and 
the wide variation in repeat samples obtained in both the control and infertile group, 
makes applying a more powerful statistical test difficult. Such a test for example is the 
student's West, however this analysis revealed no significant difference between the 
groups (this however, was borderline) and is most likely due to factors mentioned 
previously. These factors suggest that in this case Chi squared is the most appropriate 
test to use in this situation and describes the interesting trends shown within the data. 
4.7 Results 
Detailed semen assessments from each of the patient samples enrolled in the study can 
be found in the appendix section C. In six patients analysed either prior to treatment or 
early on in the treatment regime, all had disomy levels significantly higher than that of 
the control group for at least one of the investigated chromosomes (X, Y or 21). Semen 
samples from the patient cohort were received at intervals of approximately 8 weeks. 
4.7.1 Control Group 
Four males with semen parameters all within the normal range were recruited to this 
study. Semen samples were obtained for CI on five separate occasions, with one sample 
received for each of the other control males C2-4. 
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4.7.1.1 Aneuploidy frequencies for chromosomes X, Y and 21 in the spermatozoa 
of control subjects as determined by three colour FISH 
In this study the aneuploidy frequencies for chromosomes 21, X and Y were established 
in four control subjects with 5,000 spermatozoa scored per sample. The number of 
normal spermatozoa monosomic for the tested chromosomes scored (and the 
percentage), along with the disomy frequencies for each of the sex chromosomes XX 
(figure 4.3), XY (figure 4.4) and YY (figure 4.5), the sex chromosomes as a whole 
(figure 4.2) and chromosome 21 (figure 4.1) are displayed in table 4.3. 
4.7.2 Patient Group 
In this study a total of six patients (NLCL, IDSS, PHEH, ALTAL, JFEF and SGSW) 
were recruited, from each of these patients repeat semen samples on different occasions 
were obtained, (approximately at 8 weekly intervals). We received between 3-7 repeat 
semen samples from each patient, for each sample the semen parameters were assessed 
(semen assessment results for each patient can be found in appendix Q. Each of these 
six patients were undergoing TCM treatment for infertility, with the first sample 
analysed either being prior to any TCM treatment or early on within the treatment 
regime (within 1-4 weeks). The six patients enrolled within this study were aged 
between 33 and 39 years with a mean age of 35.5 years at the time of their first semen 
assessment. 
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1: 1 4.7.2.1 Ancuploidy frequencies for chromosomes X, Y and 21 in the spermatozoa 
of patient group as determined by three colour FISH 
In this study aneuploidy frequencies for chromosomes X, Y and 21 were established in 
twenty-eight semen samples from six patients undergoing TCM treatment for male 
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infertility. The average number of cells scored per sample per patient was as follows: 
NLCL- 4,945; IDSS- 5,046; PHEH- 4,714; ALTAL- 5,123; JFEF- 5,000 and SGSW- 
5,000. The rates of disomy for all twenty-eight samples from the six patients 
investigated was established. The number of normal spermatozoa, monosomic for the 
tested chromosomes scored (and the percentage), along with the disomy frequencies for 
each of the sex chromosomes XX (figure 4.3), XY (figure 4.4) and YY (figure 4.5), the 
sex chromosomes as a whole (figure 4.2) and chromosome 21 (figure 4.1) are displayed 
in table 4.4. 
Table 4.3- showing number of normal X and Y bearing spermatozoa, scored (0/o), and the rates of disomy 
for the sex chromosomes individually and totalled as well as disomy rates for chromosome 21 in all four 
control su 
Patient 
bjects (each 
Alormal 
li x 
with three re 
Aormal 
peat s mQle 
V,. V + 
21 
s). 
'Y' I' + Y, Y+ 21 Sex chr Chr 21 Total 
l . di . 21 Iý di 
cl-I 
p) C 
2656 2332 1 
)) id C( soill. j ( voill. ) 
81 10 2 5UUU 
(53.12) (46.64) (0.02) (0.16) (0.02) (0.2) (0.04)_ 
CI-2 2532 2459 1 4 1 6 4 5000 
(50.64) (49.16) (0.02) (0.08) (0.02) (0.12) (0.08) 
C 1-3 2603 2380 1 7 0 8 9 5000 
(52.06) (47.6) (0.02) (0.14) (0) (0.16) (0.18) 
1 C14 2553 2443 0 3 0 3 1 5000 
1 (51.06) (48.86) (0) (0.06) 1 (0) (0.06) (0.02) 
cl-5 2497 2498 0 2 0 2 3 5000 
(49.94) (49.96) (0) (0.02) (0) (0.04) (0.06) 
1 C2 2539 2454 1 3 0 4 3 5000 
(50.78) (49.08) (0.02) (0.06) (0) (0.08) (0.06) 
1 C3 2593 2401 0 2 0 2 4 5000 
(51.86) (48,02) (0) (0.04) (0) (0.04) (0.08) 
C4 2603 2392 1 2 0 3 2 ()00 1 
(52.06) ) 
1 
(47.84 
1 
(0. 02 (0 ) . 04 ) 
1 
(0 (0 ) . 06 
(0.04) 
1 
173 
Helen Tempest Chapter 4 
Table 4.4- showing number of normal X and Y bearing spermatozoa scored (%), and the rates of disomy 
for the sex chromosomes individually and totalled as well as disomy rates for chromosome 21 in the six 
natients enro 
Patient 
lled in the 
Normal 
TCM studv. 
Normal Y 
I I 
X, X+ 21 N, Y+ 21 Y, 17 + 21 Sex chr Chr 21 Total 
. ý'i di di (Date) 
11 1 
X 
1957 
( I ;, ) 
1 
,) sont. l CO ( som ,r 
6 29 39 59 40 
(8112199) 9 (48.3) (48.8) (0.15) (0.72) (0.10) (0.96) (1.461 
NLCL 2 2 2730 2638 2 16 6 24 6 5449 
(19/1/00) ýO )0 
J 
(50.1-1. ) (49.3%) (0.04) (0.30) (0.11) (0.44) (0.11) 
NLCL 3 2337 2670 4* 10- 1 is* 6 5048 
0 (813100 46.3 (52.8) (0.08) (0.20) (0.02) 0.30 (0.12) 
NLCL 4 2408 2578 2 10- 0 12- 7 5018 
(1615100) (47.9) (51.4 (0.04) (0.20) (0.00) (0.24) (0.14) 
NLCL 5 2414 2599 3- 6 0 9 4 5031 
(8/, VOO (47.9) (51.6) (0.06) (0.12) (0.00) (0.18) (0.08) 
NLCL 6 2340 2699 0 6 0 6 3 5016 
(7111100) (46.2) (53.3) (0-00) (0.12) (0.00) (0.12) (0.06) 
NLCL 7 2538 2436 2 5 0 7 9- 5000 
(317101) (50.8) (48.7) (0.04) (0-10) (0-00) (0.14) ALI-81 
IDSS 1 2511 2457 3~ 28 * 6* 37 * 13 * 5066 
(8112199) (49.6) (48,5) (0.06) (0.55) (0.12) (0.73) (0.26) 
IDSS 2 2500 2556 0 16 * 7* 23 * 12 * 5056 
(1911100) (49.4) (50.5) (0.00) (0.32) (0.14) (0.46) (0.24) 
IDSS 3 2478 2517 1 14 * 0 15 * 7 5084 
(2317100) (48.7) (49.5)-- (0.02) (0.28) (0-00) (0.30) (0.14) 
- - IDSS 4 2373 2577 1 3 1 5 11 1 5000 
(2913100) (47.5) (51.5) (0.02) (0.06) (0.02) (0.10) (0.22) 
IDSS 5 2121 2858 2 6 1 9 3 5063 
(215100) 
. 
(41.9) (56.4) (0.04) (0.12) (0.02) 
. 
(0.18) 
-1 
(0. 
IDSS 6 2295 2641 , 1 10- 1 12- 6 5004 
(1316100) (45. n (52.7) (0.02) (0.20) (0.02) (0.24) (0.12) 
PHEH 1 1658 1779 9* 13 * 1 23 * 7 3521 
(1211100) (47.1) (50.5) (0.26) (0.37) (0.03) (0.65) (0.2) 
PHEH 2 2218 2753 1 11 * 0 12 ~ 4 5009 
(1612100) 
. 
(44.3) (55.0) (0.02) (0.22) (0-00) (0.24) (0.08) 
PHEH 3 2389 2574 0 7 0 7 5 5001 
(2213100) (47.8) (51.5) (0-00) (0.14) (0,00) (0.14) (0-10) 
PHEH 4 2415 2594 0 3 1 4 7 5037 
(1615100) (47.9) (51.5) (0-00) (0.06) (0.02) (0.08) (0.14) 
PHEH 5 2398 2564 0 10- 0 10 2 5WO 
(3016100) 
. 
(47.9) (51.3) (0-00) (0.20) (0.00) (0.20) (0.04) 
ALTAL 1 2686 2672 0 8 1 9 13 * 5400 
(15112199) (49.8) 49.5 (0-00) (0.15) (0-02) (0.17) (0.24) 
ALTAL 2 2565 2503 2 7 2* 11 - 5 5092 
(1911100) (50.4) (49.2) (0.04) . 14) (0.04) (0.22) 
(0-10) 
ALTAL 3 2495 2482 2 4 0 6 5 5000 
(Mwoo) 
. 
(49.9) (49.6) (0.04) (0.08) (0-00) (0.12) (0.10)- 
ALTAL 4 2550 2421 1 2 0 3 7 5000 
(2 0) (51.0) (48.4) 
- 
(0.02) (0.04) (0-00) (0.06) (0.14) 
JFEF 1 2511 2422 2 8 2* 12- 190 5000 
(514100) (50.2) (48.5) (0.04) (0.16) (0.04) (0.24) (0.38) 
JFEF 2 2537 2458 0 1 0 1 2 5000 
(1/8/00) 
. 
(50.7) (49.1) (0-00) (0.02) (0. ) (0,02) (0.04) 
JFEF3 2379 2592 40 4 0 8 6 5000 
(2 0) (47.6) (51.8) (0.08) (0.08) (0-00) (0.16) (0.12) 
SGSWI - 2427 2515 1 8 3* 12- 12 * 5000 
fI612100) (48.6) (50.3) (0.02) (0.16) (0.06) (0.24) (0.24) 
SGSW2 2502 2457 2 2 0 4 2 
(2213100) 1 (50.0) 
. 
(49.5) 
1 
(0.04) 
1 
(0.04) (0-00) 0.0 0.04) 
SGSW3 
1 
1 2367 2328 0 2 2 
- 
(1817100) 1 (52.7) 
1 
(46.6) (0 . 
00) (0.04) 
, 
0.04 8) (0.08) (c (C. ) 
Chi squared analysis was pcrfonned to dctcnninc if the levels of ancuploidy in the patients were significantly 
higher than that of the controls (refer to section 4.5.3). Ancuploidy frequencies significantly higher am controls 
are highlighted in bold, * denotes a sigafficanc-c level of <0.0005 and - denotes a significance level of <0.005 
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4.7.3 Chromosome 21 disomy frequencies in the spermatozoa of both control and 
patient group. 
The chromosome 21 disomy rates within the control group ranged from 0.02- 0.18% 
(table 4.3) (with an average of 0.07%), the rate of disomy 21 within the infertile group 
ranged from 0.04-1.46% (table 4.4) (with a mean rate of 0.19%). The disomy 21 rates 
for individual patients ranged from 0.06-1.46% (NLCL), 0.06-0.26% (IDSS), 0.04-0.2% 
(PHEH), 0.1-0.24% (ALTAL), 0.04-0.38% (JFEF) and 0.04-0.24% (SGSW). The 
chromosome 21 disomy frequencies for all semen samples investigated for both control 
and infertile males are presented in figure 4.1. 
Figure 4.1 chromosome 21 disomy levels in repeat samples for controls and patients undergoing TCM 
treatment 
Levels of chromosome 21 disomy in sperm within control* 
and patients undergoing TCM treatment 
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The Chi squared statistical analysis (table 4.4) revealed that significantly higher 
frequencies of chromosome 21 disomy compared to control levels (p=<0.0005) were 
found in the initial samples received for all patients with the exception of PHEH. Of 
significance is the fact that in all cases the levels of chromosome 21 disomy decreased 
to levels not significantly different to that of the controls, by the second sample (NLCL, 
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ALTAL, JFEF and SGSW) or the third sample (IDSS). When analysing figure 4.1 and 
table 4.4 we can say that in all patients disomy 21 levels have declined to rates 
comparable to controls coincident with TCM treatment, with all patients found to have a 
significant reduction from the first to last sample. 
4.7.4 Sex chromosome disomy frequencies (including XX, XY and YY) in the 
spermatozoa of both control and patient group. 
The sex chromosome disomy rates within the control group ranged from 0.04- 0.20% 
(table 4.3) (with an average of 0.095%), the rate of sex chromosome disomy within the 
infertile group ranged from 0.02-0.96% (table 4.4) (with a mean rate of 0.27%). The sex 
chromosome disomy rates for individual patients ranged from 0.12-0.96% (NLCL), 
0.10-0.73% (IDSS), 0.08-0.65% (PHEH), 0.06-0.22% (ALTAL), 0.02-0.24% (NEF) 
and 0.08-0.24% (SGSW). The sex chromosome disomy frequencies for all semen 
samples investigated for both control and infertile males are presented in figure 4.2. 
Figure 4.2 sex chromosome disomy levels in repeat samples for controls and patients undergoing TCM 
treatment 
Levels of sex chromsome disomy in controls and repeat 
patients undergoing TCM treatment 
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The Chi squared statistical analysis (table 4.4) revealed that significant increases in sex 
chromosome disomies were found in the initial samples of each of the patients 
compared to controls (p=<0.0005 or p=<0.005 refer to table 4.4 for individual patient p- 
values). As reported for chromosome 21 in all cases these frequencies were found to 
drop to levels not significantly different to the control group, after the first sample (in 
patients ALTAL, JFEF and SGSW), second sample (PHEH), third sample (IDSS) and 
fourth sample (NLCL). Figure 4.2 and table 4.4 demonstrates that coincident with TCM 
treatment, levels of disomy were all found to decline to rates reported within the control 
group. 
4.7.5 Sex chromosome disomy rates broken down into the individual types of 
disomy (XX, XY and YY) 
4.7.5.1 XX disomy frequencies in the spermatozoa of both control and patient 
group 
The XX disomy rates within the control group ranged from 0- 0.02% (table 4.3) (with 
an average of 0.0 125%), XX disomy within the infertile group ranged from 0.00-0.26% 
(table 4.4) (with a mean rate of 0.04%) The XX disomy rates for individual patients 
mnged from 0.00-0.15% (NLCL), 0.00-0.06% (IDSS), 0.00-0.26% (PHEH), 0.00- 
0.04% (ALTAL), 0.00-0.08% (JFEF) and 0.00-0.04% (SGSW). The XX disomy 
frequencies for all semen samples investigated for both control and infertile males are 
presented in figure 4.3. 
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Figure 4.3 YCX disomy levels in repeat samples for controls and patients undergoing TCM treatment 
Levels of XX disomy in controls and repeat patients 
undergoing TCM treatment 
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Chi squared analysis revealed significant differences in the rates of XX disomy in the 
first samples for patients NLCL (p=<0.0005), IDSS (p=<0.0005), and PHEH (p=0.005) 
compared to the mean rate of aneuploidy for chromosome X. Patients IDSS and PHEH, 
both dropped to levels not significantly different to that of the controls. Whereas NLCL 
was found to have significantly higher levels in 3 of the 7 sarnples analysed (table 4.4). 
It is clear that XX disomy frequencies in the majority of cases are within control levels 
with the vast majority of samples displaying rates ranging between 0.00-0.04% (except 
in 6 samples). 
4.7.5.2 XY disomy frequencies in the spermatozoa of both control and patient 
group. 
The XY disomy rates within the control group ranged from 0.04- 0.16% (table 4.3) 
(with an average of 0.0775%), XY disomy within the infertile group ranged from 0.02- 
0.72% (table 4.4) (with a mean rate of 0.20%) The XY disomy rates for individual 
patients ranged from 0.10-0.72% (NLCL), 0.06-0.5 5% (IDSS), 0.06-0.37% (PHEH), 
0.04-0.15% (ALTAL), 0.02-0.16% (JFEF) and 0.04-0.16% (SGSW). The XY disomy 
178 
frequencies for all semen samples investigated for both control and infertile males are 
presented in figure 4.4. 
Figure 4.4 XY disomv levels in repeat samples for controls and patients undergoing TCM treatment 
Levels of XY disomy in controls and repeat patients 
undergoing TCM treatment 
0.9 13sample 1 
0.8 Msample 2 
0.7 OsamPle 3 
0.6 0 sample 4 
0.5 a sample 5 0.4 
4) 
CL 0.3 
93sample 6 
L 
0.2 MsampIe7 
0.1 - IA 0 n nn 
Cý 6ý 0 Cý 40 Patient 
Chi squared statistical analysis (table 4.4) has established that three out of the six 
patients (NLCL p=<0.0005, IDSS p=<0.0005 and PHEH p=<0.005) were found to have 
significantly higher levels of XY disomy in their initial samples compared to controls. 
As reported for the other investigated chromosomes these levels declined to those 
within the control group after the second (PHEH), third (IDSS) and fourth (NLCL) 
sample (table 4.4) Figure 4.4 and table 4.4 demonstrates that coincident with TCM 
treatment, levels of disomy decline to levels found within the controls in the 3 patients 
with significantly higher levels of XY disomy. 
4.7.5.3 YY disomy frequencies in the spermatozoa of both control and patient 
group. 
The YY disomy rates within the control group ranged from 0- 0.02% (table 4.3) (with 
an average of 0.0005%), YY disomy within the infertile group ranged from 0.00-0.14% 
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(table 4.4) (with a mean rate of 0.03%) The XY disomy rates for individual patients 
ranged from 0.00-0.11%(NLCL), 0.00-0.14%(IDSS), 0.00-0.03% (PHEH), 0.00- 
0.04% (ALTAL), 0.00-0,04% (JFEF) and 0.00-0.06% (SGSW). The YY disomy 
frequencies for all semen samples investigated for both control and infertile males are 
presented in figure 4.5. 
Figure 4.5 YY disomy levels in repeat samples for controls and patients undergoing TCM treatment 
Levels of YY disomy in controls and repeat patients 
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Chi squared analysis (table 4.4) revealed statistical differences between the control 
group and initial samples in all patients with the exception of PHEH refer to table 4.4 
for levels of significance in each case. As reported for the other investigated 
chromosomes these levels were found to decline in the majority of cases to those 
reported in the controls. 
As previously mentioned (refer to section 1.5) analysis of aneuploidy for the sex 
chromosomes can enable the stage of origin of the segregation error to be determined. 
Errors within the segregation at the MI stage results in a XY bearing spermatozoa. and 
an error at the Mll stage results in either an XX or YY bearing spermatozoa. As can 
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been seen when comparing the individual sex chromosome disomies (figures: 4.3,4.4 
and 4.5) it is clear that in the majority of cases MI errors (figure 4.4) form a significant 
proportion of the total sex chromosome disomy rates with M11 errors (figures: 4.3 and 
4.5) contributing to a lesser extent. For example in the first sample analysed from 
patient NLCL the levels of XY disomy are 0.72% compared to 0.15% and 0.1 % for XX 
and YY disomy respectively. This holds true for all patients investigated, all of which 
were found to have increased frequencies of MI errors compared to Mll errors with the 
exception of patients: JFEF 3 with levels of 0.08% for both XX and XY disomy and in 
patients SGSW 2 and SGSW 3, XY disomy levels in both these samples were recorded 
as 0.04% which was equal to that of XX disomy (SGSW 2) and YY disomy (SGSW 3). 
4.8 Analysis of the effect of TCM on semen parameters for repeat patients (NLCL, 
IDSS, PHEH, ALTAL, JFEF and SGSW) 
Utilising the data obtained in the semen assessments for each of the patients (NLCL, 
IDSS, PHEH, ALTAL JFEF and SGSW) presented in appendix C it was possible to 
determine if there was any improvement within the three main semen parameter 
categories. These include sperm concentration, percentage of motility and finally the 
percentage of abnormal forms. In order to investigate the effect of TCM on semen 
parameters the appropriate values for each category was plotted onto a graph to enable 
any relationship to be established using Chi-squared statistical analysis. 
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4.8.1 Investigation into the effect of TCM on sperm concentration in patients 
NLCL, IDSS, PHEH, ALTAL, JFEF and SGSW 
The sperm concentration for each of the samples received from the patients enrolled in 
this study as determined by their semen assessments (appendix Q, this information can 
also be found in table 4.5 and figure 4.6. 
Table 4.5: - sperm concentration in patients NLCL, IDSS, PREH, ALTAL, JFEF and SGSW and 
their corresponding sample number as determined by semen assessments 
Sperm concentration per million/ml 
Patient Sample I Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 Sample 7 
NLCL 69 10 9.5 63 32 57 24 
IDSS 17 12 21 80 13 7.9 
PHEH 12 7.5 37 16 30 
ALTAL 61 37 22 63 
JFEF 25 8 22 
SGSW 18 49 44 
Figure 4.6- sperm concentration 
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patients undergoing TCM treatment 
90-1-- Usample 1 
80 NSample 2 
Mample 3 
70 Mample 4 
ElSample 5- 60 
E USample 6, 
-C 50 
_01 
Sample 7 
4) 2 40 
30 
C; ------- z 20 
10 
0 
NLCL IDSS PHEH ALTAL JFEF SGSW 
Patient 
Analysis of the data in figure 4.6 shows no clear improvement in spenn concentration in 
the patients undergoing TCM treatment, however there is marked variation between 
samples derived form the same patients at different time points. This is most notable in 
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paýents NLCL, IDSS and ALTAL, in which ranges of 9.5-69 million spermatozoa/ml, 
7.9-80 million spermatozoa/ml and 22-63 million spermatozoa/ml recorded 
respectively. 
4.8.2 Investigation into the effect of TCM on sperm motility in patients NLCL, 
IDSS, PHEH, ALTAL, JFEF and SGSW 
The sperm motility for each of the samples received from the patients enrolled in this 
study as determined by their semen assessment (appendix Q, table 4.6 and figure 4.7 
displays the results obtained for sperm motility in these patients. 
Table 4.6: - percentage of sperm motility in patients NLCL, IDSS, PHEH, ALTAL, JFEF and SGSW and 
their carresnondino ,. qmnI, - ntimhor n-z AptPrminpd hv qP. rnenqqP. -, -zme. nts 
Percentage of motility (%) 
Patient Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 Sample 7 
NLCL 10 26 11 17 41 37 58 
IDSS 18 11 30 8 26 42 
PHEH 36 53 27 45 40 
ALTAL 24 7 45 13 
JFEF 48 38 41 
SGSW 53 44 56 
Figure 4.7- Percentage motility 
Graph to show motility (%) of patients undergoing TCM treatment 
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It is clear that as in figure 4.7 (sperm concentration) there is a marked variation in 
percentage of motility within samples at different time points from the same patient. 
The percentage of motility within patient JFEF and PHEH appears less varied with 
percentages ranging from 38-48% and 27-53%. However, despite the fluctuation in rate 
of motility there is a general significant trend in the improvement of motility observed 
in patient NLCL with values of 10%, 26%, 11%, 17%, 41%, 3 7% and 5 8% 
(p=<0.0005). 
4.8.3 Investigation into the effect of TCM on percentage of abnormal forms within 
the spermatozoa of patients NLCL, IDSS, PHEH, ALTAL, JFEF and SGSW 
The percentage of abnormal forms for each of the samples received from the patients 
enrolled in this study as deten-nined by their semen assessment can be found in 
appendix C. Table 4.7 and figure 4.8 present the results obtained from these semen 
assessments. 
Table 4.7: - percentage of abnormal forms in patients NLCL, IDSS, PHEII, ALTAL, JFEF and SGSW 
and their correspondina samnle number as deten-nined bv semen assessments 
Percentage of abnormal forms (%) 
Patient Sample I Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 Sample 7 
NLCL 91 87 97 97 96 96 87 
IDSS 96 97 96 98 97 98 
PIIEII 97 99 97 98 100 
ALTAL 95 95 99 94 
JFEF 99 97 98 
SGSW 92 
1 
96 
1 
92 
1 
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Figure 4.8- Abnormal forms 
Graph to show the percentage of abnormal forms in the 
spermatozoa of patients undergoing TCM treatment 
gn 
tu 
,e 
ag 
Patient 
13 Sarr; Ae 1 
M Sample 2 
(3 Sample 3 
(3 Sample 4 
M Sample 5 
a SarqAe 6 
0 Sarroe 7 
Analysis of the semen assessment data (can be found in appendix Q within these 
patients has enabled the investigation into the effect of TCM on the percentage of 
abnormal forms as individuals undergo treatment. Unlike in figure 4.6 and 4.7 analysing 
sperm concentration and motility respectively there is less variation within individuals 
with levels remaining at similar levels with the exception of NLCL in which there was a 
wide variation in the levels ranging from 87-97%. There is no significant relationship 
with TCM treatment and any improvement in the percentage of abnormal forms. 
4.9 Discussion 
Our results show a clear association between a reduction in disomy levels for the sex 
chromosomes (in all patients), chromosome 21 (in 5 patients) and XY disomy (in 3 
patients) coincident with TCM treatment compared to our control group. The levels of 
XX and YY disomy were also found to be significantly higher than that of the controls 
in a number of patients (table 4.4), however the reported frequencies are much lower 
than that of the other investigated chromosome disomies. In the majority of cases it is 
likely that the significant difference between the control group and these patients may, 
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in part, be due to the low levels found in the control group for XX and YY disomy 
(0.0 125% and 0.0005%). On several occasions the level of chromosome disomy within 
the patient group rose to levels significantly different to those obtained in the control 
group after having a reduction in disomy levels. In the most part, these levels were 
substantially lower than those found within initial samples. For example in patient 
NLCL the initial sample was found to have disomy 21 levels of 1.46% chromosome 21 
disomy levels, which by the second sample had reduced to control levels, however in 
the seventh sample the disomy 21 rate was significantly higher than that of the controls 
with a rate of 0.18%, clearly however this is still significantly lower than that found in 
the initial sample (p=<0.0005). In contrast no such effect was observed for conventional 
semen parameters except for a weak correlation with an improvement in sperm motility 
in patient NLCL. In some ways this is surprising given the results of chapter 3, however 
the existence of any strong correlations may be due to the small sample size analysed. 
Although there are potentially many factors involved, the results presented in this 
chapter, demonstrate the significant decrease in aneuploidy frequencies for 
chromosomes 21, X and Y in six infertile males with compromised semen parameters 
undergoing TCM treatment. Evidence of an effect on the semen parameters of these 
individuals is less clear, there may be the existence of a possible weak correlation 
between improved semen parameters including motility for specific patients. We have 
nevertheless provided some strong preliminary evidence for the effectiveness of TCM 
treatment and improving sperm quality. It remains difficult to unequivocally identify 
any strong positive correlations with TCM treatment, aneuploidy frequencies and semen 
parameters due to the vast number of compounding factors including lifestyle and 
environmental factors mentioned in chapter 1. The outcome of this open tube 
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experiment fon-ns a good basis of evidence in the effectiveness of TCM in the treatment 
of male infertility. This study however is not comparable to a double-blind placebo 
controlled trial, nevertheless studies such as these are crucial in providing the necessary 
preliminary evidence of the efficacy of treatment but can also play important roles in 
designing comprehensive clinical trials (Yuan and Lin, 2000). To the best of our 
knowledge this is the first report of a study demonstrating an association between an 
improvement in a disorder with a clear genetic basis, specifically that of a decline in 
aneuploidy in the spermatozoa of infertile males in association with TCM treatment. As 
mentioned previously we are not the first to report evidence of the efficacy of TCM. 
Within the literature there have been reports of at least 450 clinical trials (reviewed in 
Pach et al., 2002) undertaken investigating the efficacy of TCM in a wide range of 
diseases including: asthma; atopic dermatitis; atopic eczema; cancer; diabetes mellitus; 
heart disease; irritable bowel syndrome (113S); pneumonia; rheumatoid arthritis and viral 
hepatitis (Pach et al., 2002; Tang et al., 1999; Yuan and Lin. 2000). The majority of 
these studies however, are Chinese, Japanese and Taiwanese in origin and hence are not 
easily accessible, it is also important to note that in the large majority of cases these 
trials were not randomised or double-blind placebo controlled trials (Tang et al., 1999; 
Yuan and Lin. 2000). There have been, however several well designed randomised, 
placebo controlled clinical trials investigating several diseases including: atopic 
dermatitis; atopic eczema; bronchial asthma and irritable bowel syndrome within the 
literature (reviewed in section 4.2.8). 
The conventional method of male infertility treatment within Western medicine is ICSI 
(rcfcr to section 1.6). As mentioned in section 1.6.3 there have been concerns raised 
over the potential risks of this technique, in particular the increased risk of generating 
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aneuploid offspring especially for the sex chromosomes attributed in part to the 
increased proportion of aneuploid sperrn in infertile males (refer to section 1.5). As 
reported in chapter I one partial solution to this issue would be the implementation of 
an aneuploidy screening kit prior to ICSI, (chapter 2 reports on the development of such 
a kit). Clearly this can only inform a couple of their specific risks, but will not result in 
a reduction of those risks. What is required in the case of individuals who have been 
identified as having an increased risk is a treatment that has been shown to reduce the 
levels of aneuploid sperm. If such a treatment was identified it could be used instead of 
or in conjunction with ICSI to reduce such risks. Whilst we are not suggesting that we 
have found such a treatment, we have shown that high aneuploidy levels in sperm can 
be reduced. Clearly, this is a subject that warrants further comprehensive investigations 
in order to identify the biological activities of the treatments used. 
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Chapter 5: Investigations into the biological activities of the TCM herbs used in 
the treatment of male infertility 
5.1 Introduction 
In light of the data presented in chapter 4, a question that remains to be addressed is 
whether the improvements in aneuploidy levels, coincident with TCM treatment in the 
six patients investigated were the result of a placebo effect or a result of the treatment 
itself. While this would take some years to address in full, evidence of any relevant 
measurable biological activity of the herbs used in the treatment of these individuals 
might provide some evidence supporting the latter hypothesis. It would stand to reason 
that if these herbs are in fact having a positive effect on sperrn aneuploidy they would 
be likely to exert an effect on the process of spermatogenesis. Spen-natogenesis is a 
process that is under strict hormonal control (refer to section 5.3), and operates through 
a delicate balance and negative feedback mechanisms. Any disruption to the hormonal 
balance can result in a number of disease phenotypes. Thus we might expect any effects 
of therapeutic treatment to target the endocrine control processes. 
5.2 Spermatogenesis 
The adult male testis has two main functions, firstly the testes is responsible for 
spermatogenesis (the production of mature male gametes) and secondly steroidogenesis 
(the production of steroid hormones). Both these functions are reliant on stimulation by 
pituitary gonadotrophins, follick-stimulating hormonc (FSH) and luteinizing hon-none 
(LH), that are part of a family of peptide hormones (derived from amino acids) that 
phosphorylate other proteins, which leads to altered cell function. Gonadotrophins are 
heterodimers that consist of a (x- and P-subunit, the (x-subunit is common in FSH and 
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LH and are identical. These are non-covalently bound to the specific P-subunits that 
confer there activity (Achermann and Jameson., 1999). Steroid hormones on the other 
hand are synthesised from cholesterol. Both of these types of hormone are intimately 
involved in the process of spermatogenesis. 
Spennatogenesis is a process that is initiated when males reach puberty and continues 
throughout their life. Spennatogenesis takes place within the seminiferous tubules of the 
testes. The process of spermatogenesis occurs over 60-70 days, and is of importance to 
note that at any one time, all stages of spermatogenesis will be found within the 
seminiferous tubules. The regulation of spen-natogenesis is under endocrine control, 
which involves the hypothalamic-pituitary-gonadal (HPG) axis, and is of importance as 
any imbalance/disruption occurring within the HPG results in infertility: (Klinefelter 
syndrome, hypopituitarism, primary testicular failure, hypothroidism, 5cc-reductase 
deficiency, AIS and PAIS amongst others). Briefly this process requires the 
hypothalamus to secrete gonadotrophin-releasing hormone (GnRH). This then acts on 
the anterior pituitary (adenohypophysis) and that in turn causes the release of both FSH 
and LH. LH subsequently acts on the Leydig cells of the testes stimulating the 
production of testosterone by these cells. FSH acts on the Sertoli cells stimulating 
spermatogonia division. Figure 5.1 illustrates this pathway along with feedback 
mechanisms in place, these will be considered later. 
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5.3 Endocrine control of spermatogenesis 
Figure 5.1 illustrating the HPG axis, the honnones involved and the feedback controls that are in place and where 
these act. 
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Figure 5.1: GnRH= gonadotrophin-releasing hormone, T= testosterone, FSH= follicle- 
stimulating hormone, LH= luteinizing hormone, I= inhibin, A= activin. 
All hormones are indicated in yellow boxes and feedback controls are indicated by dashed 
lines. Adapted from Endocrine Reviews. 
Figure 5.1 illustrates the endocrine control of spermatogenesis, the hypothalamus 
releases GnRH in pulses, the frequency that this occurs varies from hourly to several 
times a day (varying with age and hormonal status). This in turn binds to receptors on 
the anterior pituitary that stimulate the release of FSH and LH, both of which are only 
known to exert effects in the gonads. These two hormones will now be considered 
individually starting with LH. 
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5.3.1 The role of luteinizing hormone (LH) in spermatogenesis 
LH is released in pulses, and the frequency of these varies depending on GnRH release. 
The primary function of LH is to stimulate steroid production in the testes, this is done 
so by stimulating the interstitial Leydig cells to synthesise testosterone from cholesterol. 
Approximately 95% of testosterone is synthesised in the Leydig cells with the 
remainder being derived from the adrenal cortex, in both situations the precursor to 
testosterone is cholesterol. There are a number of stages involved in the conversion of 
cholesterol to testosterone, firstly LH activates adenylate cyclase via a G-protem linked 
LH receptor, stimulating cyclic AMP which activates protein kinase A. Subsequently a 
number of enzymes are activated which result in the conversion of cholesterol to 
pregnenolone to testosterone. Testosterone itself, has two major metabolites including 
dihydrotestosterone (DHT) and I 7p-oestradiol. (Figure 5.2 Illustrates the pathway of 
testicular androgen and oestrogen synthesis including the enzymes involved). 
Figure 5.2- pathways of testicular androgen and oestrogen synthesis 
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Figure 5.2 taken from Endocrine Physiology. 
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5.3.2 The role of testosterone in spermatogenesis 
The testosterone produced by the Leydig cells is secreted, however infonnation on the 
mechanism of testosterone action on spermatogenesis is limited. At present it is thought 
that testosterone exerts its effects via the Sertoli cells. One function identified is that 
testosterone stimulates the Sertoli cells to produce of androgen-binding protein (ABP), 
which binds both testosterone and DHT (McLachlan et al., 1996). ABP acts as a 
transport protein in both the Sertoli cell and following its release into the lumen of the 
reproductive tract, sequestering testosterone preventing its free diffusion out of the 
serniniferous tubules (Martinez-Zaguilian, 2002). DHT has double the binding affinity 
for the androgen receptor (AR) than that of testosterone and as a result is considered to 
be a more potent androgen than testosterone. Despite this increased affinity to the AR, 
research suggests that testosterone is likely to be the main ligand as concentrations are 
approximately five fold greater than that of DHT. Testosterone appears to have an 
important function in spermatid maturation, studies in testosterone-suppressed rats 
revealed that steps 1-7 round spermatids were maintained with low levels of 
testosterone. The conversion of round spermatids to spermatids, however, occurred at 
around 15% of nonnal efficiency. When testosterone levels were restored the 
production of spennatids returned to non-nal within 4 days (O'Donnell et al., 1994). In 
addition it was noted that adhesion of round spennatids to Sertoli cells (in the presence 
of low testosterone levels) was lost, consequently these cells were shed into the lumen. 
As a result these round spermatids did not undergo further maturation (O'Donnell et al., 
1995). In the normal situation prior to spermatid elongation a junction (the ectoplasmic 
specialisation) forms between Sertoli cells and round spermatids, however in the 
absence of testosterone this junction is disrupted hence resulting in the loss of the 
majority of round spermatids (Muffly et al., 1994). As can be seen in figure 5.1 (HPG 
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axis) the testosterone produced by the Leydig cells also functions as a negative feedback 
to both the hypothalamus and the anterior pituitary resulting in a decrease in GnRH and 
LH secretion. 
5.3.3 The role of Follicle- stimulating hormone (FSH) in spermatogenesis 
The primary target of FSH is the Scrtoli cell within the seminifcrous tubules of the 
testes. The biochemical pathway of FSH binding to Sertoli cells is similar to that 
described in LH, with the activation of cyclic AMP. As in the case of the mechanism of 
testosterone action on spermatogenesis, knowledge on the roles FSH play in this process 
is also limited. To date research suggests that FSH is likely to have a role stimulating 
spermatogonial division and meiosis as well as potentially having an 'anti-apoptotic' 
function resulting in an increase in genn cell survival. FSH and testosterone are likely to 
also act in a synergistic manner it is hypothesised that FSH stimulates spermatogonia 
division and meiosis but it appears that testosterone is required for later maturation steps 
into spennatozoa (McLachlan et al., 1996). Muffly et al. (1994) also suggest that FSH 
and testosteronc may both play a role in the formation and maintenance of the junction 
required for round spermatid adhesion to Sertoli cells. FSH has been shown to be 
responsible for the alignment of actin and vinuclin filaments of the Sertoli cell, which 
are involved in the specialised junctions leading to round spen-natid adhesion for which 
testosterone is believed to be required for the adhesion (Muffly et al., 1994). 
5.3.4 The role of inhibin in spermatogenesis 
Yet to be mentioned is the role of the two non-steroidal hormones produced in the 
gonads, inhibin and activin, within the HPG axis (figure 5.1). FSH stimulates the Sertoli 
cells to produce the hormone inhibin, which in turn acts as a feed back mechanism on 
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the anterior pituitary to reduce the rate of FSH release (Plant and Marshall, 2001). At 
present the only known role of activin in spermatogenesis is that activin is secreted from 
the Leydig cells and acts as a negative feedback mechanism on the anterior pituitary to 
reduce the rate of FSH (Plant and Marshall, 2001). 
5.3.5 The role of oestrogens in sperm atogenesis. 
To date the role of oestrogen in spermatogenesis is unclear, for several decades it has 
been established that oestrogens are involved in the negative feedback mechanisms in 
place in spermatogenesis (Santen, 1975; Winters et al., 1979). The administration of 
oestrodiol in males exhibiting idiopathic hypogonadotropic hypogonadism, was found 
to suppress LH, by reducing the pulse frequency of GnRH from the hypothalamus 
(Finkelstein et al., 1991). The opposite situation pertained when individuals were 
administered testolactone (an inhibitor of aromatase), resulting in an increase in LH 
secretion and a reduction in the inhibitory effects of testosterone (Bagatell et al., 1994). 
In recent years several discoveries including the finding of two oestrogen receptor (ER) 
isoforms (ERa and ERP), that are expressed throughout the male reproductive system. 
At present there are conflicting reports as to where these receptors are localised within 
the reproductive system, however the majority of studies find little expression of the 
ERa receptor (except in the Leydig cells). The ERP receptor, however has been found 
to be expressed in a variety of cells including Sertoli cells and various stages of germ 
cells (spermatogonia, spermatocytes and round spermatids) (Bremner et al., 1994; 
Turner et al., 2001). This indicates that the role of oestrogen in the testis is not restricted 
to a feedback mechanism alone. There is evidence that oestrogen is also required for 
non-nal fertility, this is apparent in the mice knockout (KO) models ERKO (targeted 
inactivation of ERa) (Eddy et al., 1996). In the ERKO model male mice were found to 
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be infertile due to the accumulation of fluid in the seminiferous tubules resulting in the 
dilution of sperm and testicular atrophy (thought to be attributed to the accumulation of 
fluid). This provides evidence of a potential role of ERct in the regulation of fluid 
transport in the reproductive system of males (Zhou et at., 2001). The following mouse 
KO models have also been generated BERKO (targeted inactivation of ERP); apERKO 
(inactivation of ERcc and ERP) and ArKO (inactivation of aromatase), however the 
fertility in these individuals were not found to be grossly altered, although there is 
evidence in some KO that fertility decreases with age (Couse et al., 1999; Krege et al., 
1998; Roberton et al., 1999). The role of oestrogen in the maintenance of normal 
fertility is uncertain, the molecular mechanisms behind the infertility phenotypes within 
the mouse KO models is unclear, however the problem also lies in the lack of 
information about genes that are directly regulated by oestrogens within the male 
reproductive system (Tumer et al., 200 1). 
5.4 Concern over possible decline in sperm counts and possible causes 
Within recent years there has been considerable debate over several studies reporting a 
decline in spenn counts of up to 50% over the last 50 years (Auger et al., 1995; Carlscn 
et al., 1992; De Mouzon and Thonneau, 1996; Irvine et al., 1996), and the apparent 
increased occurrence of disorders of the male reproductive tract (reported to have 
doubled) within the last 30-50 years (Sharpe and Skakkebaek, 1993). These issues are 
yet to be resolved, however if this is the case these dramatic changes have occurred over 
a relatively recent period of time and have been reported in a number of countries. It is 
possible that these reflect adverse effects of environmental or lifestyle factors (Sharpe 
and Skakkebaek, 1993). There have been a number of reports within the literature on 
endocrine disruption in wildlife affecting the fertility of animals (reviewed by Tyler et 
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al., 1998). There is some evidence that environmental factors may be responsible in 
humans also. During 1945 and 1970 some women were administered a synthetic 
oestrogen (diethylstilboestrol) during pregnancy. The sons of these women have been 
found to have decreased sperm counts, semen volume and increased incidence of 
cryptorchidism and hypospadias. Spen-natogenesis in the adult testis is also vulnerable 
to adverse environmental effects, there are environmental chemicals including 
chemicals used in the home, workplace and agriculture as well as certain drugs (refer to 
section 1.5.9) that can interfere the process of spermatogenesis. Occupational exposure 
to heat or radiation has also been shown to impair spen-natogenesis (Sharpe, 1992). 
There is currently some evidence to suggest that hormonal disruption resulting in 
decreased fertility is occurring in wildlife, however at present, despite receiving much 
attention there is little evidence to support this theory in humans. There is growing 
circumstantial evidence however, that in certain cases particularly those for which no 
cause has been identified for infertility that these factors may play a role. One study 
providing circumstantial evidence of this was carried out by Rozati et al. (2002), in this 
study the lcvcls of polychlorinatcd biphcnyls (PCBs) and phthalatc estcrs (PEs) in 
seminal plasma of infertile males was significantly higher than that found in controls, 
the highest concentrations were identified in fish eaters and vegetarians. The infertile 
males with the higher concentrations of PCB's and PE's were found to have 
significantly lower sperm: volume, concentration, progressive motility, normal 
morphology and fertilising capacity. 
5.5 The role of oxidative stress in infertility 
Oxidative stress has also been implicated in infertility with significant levels of reactive 
oxygen species (ROS) detected in the semen of 25% of infertile males, however normal 
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fertile counterparts have no detectable levels of ROS (Iwasaki and Gagnon, 1992). 
Sperm is susceptible to oxidative stress as a result of the abundance of unsaturated fatty 
acids in the sperm plasma membrane, required for sperm motility and fusion events 
(including the acrosome reaction and the spenn-egg interaction) essential for 
fertilisation. The unsaturated fatty acids are targets for free radical attack and ongoing 
lipid peroxidation throughout the sperm plasma membrane resulting in the accumulation 
of lipid peroxides on the sperm surface causing spenn dysfunction and cell death. 
Oxidative damage to the sperm DNA is also found as a result of the adverse reaction of 
ROS in spenn. This has relevance to our study in that given the infonnation it would 
seem prudent also to assess for anti-oxidant activity, in the herbs used. The anti-oxidant 
potential of the herbs used in the treatment of male infertility was therefore assessed, 
primarily as medicinal plants have been shown to exhibit high anti-oxidant activity 
(Rice-Evans et al., 1995). This is of importance as oxidative stress can be reduced by 
the intake of additional anti-oxidants, and have been related to the prevention of 
degenerative diseases including that of degenerative diseases such as cancer, oxidative 
stress dysfunctions, cardiovascular and neurological diseases (Szollosi and Varga, 
2002). 
5.6 Objectives 
The results presented in chapter 4 have raised a number of questions, primarily whether 
the improvements in disomy levels observed in the six infertile patients coincident with 
TCM treatment represent a genuine effect of the herbal prescriptions administered or if 
they are as a result of a placebo effect. If these herbs were exerting a genuine effect on 
chromosome segregation we might expect them to have a biological activity. Given the 
fact that the process of spen-natogenesis is under strict hormonal control and is subjected 
on 
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to the effects of oxidative stress, these herbs may possess endocrine or anti-oxidant 
activity. 
The aim of this study was to test the 37 individual herbs and 7 patient 
prescriptions (mixtures of the 37 individual herbs) in biological assays to 
determine if this hypothesis is true. 
Each of the individual herbs and herbal prescriptions were tested for endocrine 
activity (including that of oestrogenic, androgenic, anti-oestrogenic and anti- 
androgenic activity) utilising a recombinant yeast based assay (refer to section 
8.3 within the materials and methods). 
- The individual herbs and herb prescriptions were also tested for anti-oxidant 
activity using the ferric reducing anti-oxidant assay (FRAP) assay (refer to 
section 8.6). 
5.7 Validation of assays chosen to test for endocrine and anti-oxidant activity 
In order to establish if any herbs exhibited endocrine activity a recombinant yeast screen 
was utilised (refer to section 8.4), this assay was chosen as there are a number of reports 
within the literature stating that this assay is capable of responding to oestrogens, xeno- 
oestrogens and androgens (both that of steroidal and non-steroidal oestrogens and 
androgens). All assays used in this section of work have been fully validated and 
published (Routledge and Sumpter, 1996; Sohoni and Sumpter, 1998). 
5.7.1 Principles behind the recombinant yeast screen assay: 
The yeast cells used in this assay have been genetically modified with the human 
oestrogen receptor gene (hER) or a human androgen receptor gene (hAR) inserted 
within the yeast genome. In the yeast cells there is also an expression plasmid that 
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contained oestrogen responsive sequences (ERE) (Routledge and Sumpter, 1996), or 
androgen response elements (Sohoni and Sumpter, 1998), within a strong promoter 
sequence and also a reporter gene lac-Z, (encoding the enzyme P-galactosidase, which 
enables the activity of the receptor to be measured). 
The yeast-based assay was developed to test compounds that can interact with the 
human oestrogen or androgen receptor, and works through the following 
reaction/principle. For example in the oestrogen based assay, when an active ligand that 
has occupied the hER, this in turn causes the hER to bind to ERE (located within the 
expression plasmid), which in turn results in the initiation of transcriptional factors 
resulting in gene transcription. In turn this causes the expression of reporter gene lac-Z 
to secrete P-galactosidase into medium. In the normal situation the medium is yellow in 
colour, however, in the presence of a chromogenic substrate such as chlorophenol red- 
B-D-galactopyranoside (CPRG), P-galactosidase metabolises CPRG causing a colour 
change to a red product. This colour change (yellow-red) can then be measured at an 
absorbancc of 540nm (Routledge and Sumpter, 1996). A schematic representation of the 
modified yeast and the process that is undertaken is represented in figure 5.3. 
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ure 5.3 Schematic diagram of the oestrogen-inducible expression system in yeast. The human oestrogen 
eptor gene is integrated into the main genome and is expressed (1) in a form capable of binding oestrogen 
ponse elements (ERE) within a hybrid promoter on the expression plasmid (2). Activation of the receptor (3), 
binding of ligand, causes expression of the reporter gene Lac-Z (4) which produces the enzyme 0- 
actosidase. This enzyme is secreted into the medium (5) and metabolises the chromogenic substrstrate CPRG 
)rmally yellow) into a red product (6) which can be measured by absorbance (taken from Routledge and 
mpter., 1996). 
Figure 5.4 provides an example of an oestrogen yeast-based assay, illustrating the colour change 
response seen with this assay. 
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urc 5.4 is an example of a oestrogen yeast-based assay plate at the end of the assay, as stated 
ve a positive response is obtained when the medium within the wells changes from a yellow to a 
colour (this colour change is read on a spectrophotometer at 540nm). This assay plate shows 
ples serially diluted with the highest concentration found in the first well (on the left-hand side) 
h the lowest concentration in the final well (on the right-hand side). As can be seen from this plate 
F display oestrogenic activity whereas the remaining rows do not display any oestrogenic 
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5.7.2 Antagonist assays 
Using the same yeast based assay it is also possible to detect not only agonist activity 
(any substance responsible for initiating a cellular response) but also that of antagonist 
activity (a substance that inhibits the action of one substance on another). This is 
achieved by the addition of an agonist to the medium (in the case of the anti-oestrogen 
assay 17p-oestrodiol, and in the case of the anti-androgen assay DHT). The addition of 
the agonist to the medium elicits a response, the concentration of the agonist added to 
the medium should produce a sub-maximal response (preferably of around 50-75%). 
The addition of the agonist to the medium will cause a colour change yellow to red, 
however in the presence of an antagonist the activity of the agonist will be inhibited in a 
dose dependant fashion. Hence the antagonist will compete for the receptor and inhibit 
the medium from changing from yellow to red (therefore in the antagonist assays a 
positive response is found for samples tested in which the medium remains yellow). 
Figure 5.5 provides an example of an anti-androgen assay plate. The antagonist assay 
protocol was carried out as before (refer to section 8.5) with the exception of the 
addition of the agonists to elevate the background. 
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Figure 5.5 provides an example of an anti-androgen yeast-based. assay. illustrating the colour change 
response seen NNith this assay. 
Figure 5.5 is an example of a anti-androgen yeast-based assay plate at the end of the assay, as 
stated above a positive response is obtained when the medium within the wells remains a velloNN 
colour (this colour change is read on a spectrophotometer at 540nm). This assay plate sho%N s 
samples serially diluted with the highest concentration found in the first well (on the left-hand 
side) with the lowest concentration in the final well (on the right-hand side). As can be seen from 
his plate rows B, E and H display anti-androgenic activity whereas the remaining ro"s exhibit no 
ti-androgenic activity at the concentrations investigated. 
5.8 Anti-oxidant assays 
The ferric reducing antioxidant potential (FRAP) assay was utillsed to detern-iine the 
anti-oxidant potential of the plant-based herbs due to its reproducibility, the inexpensive 
cost, simplicity and speed (Benzie and Strain, 1996). This technique has also been 
successfully utilised in a number of studies investigating the anti-oxidant potential of 
various plants hol-nogenates and phan-nacological plant products including a variety of 
herbal teas (including green and black), medicinal plants (including 6 members of the 
Labiatae plant family) (Szollosi and Varga, 2002), and common vegetables (Ou et aL, 
2002). 
5.8.1 Principles behind the FRAP assay 
The FRAP assay (refer to section 8.6) works on the pnnciple that the presence ofa ii 
anti-oxidant results in ferric to ferrous ion reduction at a low pH resulting in a COlOLII_Cd 
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ferrous-tripyridyltriazine complex to form. The FRAP assay values are obtained by 
comparing the absorbance at 593 nrn in test reactions to those with a known 
concentration of ferrous ions (Benzie and Strain, 1996). 
5.9 Results 
5.9.1 Herbs 
In total 37 individual herbs (used in the TCM preparations used in the treatment of male 
infertility) were tested for endocrine and anti-oxidant activity, (refer to figure 8.8 and 
table 8.1 for a list of all the 37 herbs including the Chinese name known as the Pin Yin 
name and the Latin name and common name of the herb where possible). As well as 
testing the individual herbs, a total of 7 herb mixtures (4 prescribed to patient NLCL, 
and three prescribed to patient IDSS), the herb mixtures containing between 10 -20 of 
the 37 individual herbs were tested using the same assays, the individual herbs within 
these mixtures cannot be revealed due to confidentiality agreements. These herbs were 
prepared as described in section 8.3. 
5.9.2 Endocrine activity 
The assay (refer to section 8.4) was set-up using the two plate formats including the 
dilution plate (which covered a range of 5xI 0-3_ 10 ýd of the herb extract) and the "'spot 
plate" (which covered a range of 1.25-40gl). In each case the assay was repeated for 
each herb to ensure that the results produced were representative. For each assay a plate 
containing a dose response curve was set-up: the following standards were used in each 
assay: 17P oestrodiol (oestrogen assay), DHT (androgen assay), OHT (anti-oestrogen 
assay) and flutamide (anti-androgen assay) thereby testing the assay system is 
responding to substances of known activity and enabling the response of any activity 
205 
produced by the herbs to be measured (refer to section 5.9.3). Several negative controls 
were also set-up in each assay to ensure that any response was not seen as a result of 
contamination. The controls set-up included: a row of the yeast media only (to give a 
baseline value and ensure that there was no contamination during the preparation of the 
media); a row of ethanol blanks and boiled ddH20 (serially diluted in ethanol in the 
same manner as the herbal extracts) used in the preparation of the herbal extracts 
(ensuring there was no contamination in the ethanol used to set-up the dilution plates 
and ddH20 used to prepare the herbs). In all cases (for each of the 37 individual herbs 
and the 7 herb mixes tested) experiments were repeated a minimum of two times with 
appropriate standards each time, similar responses were generated in each case. Figures 
5.7,5.8,5.9 and 5.10 display representations of the results generated for each standard, 
individual herb and herb mixes. 
5.9.3 Conversion of results to oestrodiol, DHT, OHT and flutamide equivalents. 
Using the data generated in the yeast-based endocrine activity assays it is possible to 
establish estimates of the oestrogenic, androgenic, anti-oestrogenic and anti-androgenic 
activities of the herbs directly with those of the known standard assays. 
In each case the appropriate standards for each agonist and antagonist assays were 
plotted with the concentration (ng/1) against Absorbance measured at 540nm, whilst for 
the herb samples the volume of herb extract (in pl) within the yeast was also plotted 
against the Absorbance (540rim). 
From the graphs produced for each of the individual herbs and the herb mixtures an 
absorbance and its corresponding volume of extract were noted for each herb. The 
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absorbance used was in the mid response range, along a linear section, in order to make 
extrapolation of the results more accurate. Using that same absorbance the appropriate 
standard graph was used and reading from the dose response curve the equivalent 
concentration of the standard found. 
The standard's concentration (ng/1) was then used to calculate the mass of standard in 
each assay well (containing 200pl). From this we were able to calculate the activity of 
the four standards used in each assay, in tenns of the amount of standard (ng/1) required 
to cause the response seen in each assay, it is therefore possible to determine the 
equivalent amount of herb required to elicit the same response. This task however, is 
not an easy one as we have a set of herbs with of unknown constitution, however we do 
know the initial amounts of herb added to a known volume of ddH20 to generate the 
herbal infusion tested in the assay. The conversion of standard equivalents from the 
responses exhibited from the herb are difficult as we do not know the herb components 
and their concentrations, and the fact that a known mass of herb was not added directly 
to the assay plates but boiled in water to create an aqueous extract that was used in the 
assay. One method to be able to determine an estimate of herb activity (compared to that 
of a known standard) is to go back to the initial starting amounts of herb and ddH20 
added to create the aqueous extract, from this we can determine the mass of herb used to 
produce the aqueous extract. As a result we determined that each I ýd of herb extract 
1.5 x 10-4 grams of herb was present to create the aqueous extract, thus we can deduce an 
approximate idea of the amount of herb (in grams) that is boiled in the infusion that 
elicits a response, enabling a standard equivalent to be calculated. From this it is 
possible to extrapolate the daily intake (of standard equivalent) that take places when 
the herbs are taken as prescribed by Dr. P. Zhai. This is clearly not going to produce 
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accurate equivalent values, however this will provide an indication of the activity of the 
herbal extracts. 
5.9.4 Endocrine activity of individual and prescription herbs 
The results generated for each assay (oestrogenic, androgenic, anti-oestrogenic and anti- 
androgenic) are presented in figures 5.7-5.10 for each of the individual herbs, 
prescription herbs and dose response curves. The endocrine activity of each herb is 
determined from these graphs. In the case of the oestrogen screen, for example, the 
results obtained for the standard (in this case 17p-oestrodiol) and the negative control 
(the assay readings in the wells that contained only yeast) were plotted onto a graph. 
The graph plot for the standard illustrates the assay response in the presence of a 
substance possessing oestrogenic activity (in this case the standard 17p-oestrodiol). The 
negative control (yeast medium only) illustrates the response of a substance with no 
oestrogenic activity (see figure 5.6A). Figure 5.6B shows the results of the individual 
herbs 9-14. Clearly we can see that all the herbs, with the exception of herb 14, 
exhibited responses similar to the control yeast (with spectrophotometer readings at 
540nm of around 1). It would therefore indicate that these herbs do not exhibit any 
oestrogenic activity. Herb 14 however, exhibits a similar response observed in the 
standard with spectrophotometer readings (at 540nm) of around 2.5. The results of the 
androgen screen are determined in the same manner. 
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Figure 5.6- Illustrates an example of the response given by a standard of known activity and an example 
of the responses given by 6 individual herbs. 
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Figure 5.6 A- this provides 
an example of the response 
seen on the yeast screen of 
the control yeast (yeast 
media, with the addition of 
nothing), which acts as a 
negative control (indicated 
by the green arrow). The 
absorbance measured at 
540nm gives a value of 
approximately 1.0. The red 
arrow indicates the response 
of the standard of known 
activitv (in this case 
oestrodiol), the maximal 
response gives an absorbance 
of approximately 2.3 at 
540nm. Figure 5.6 B shows 
the response of six herb 
extracts on the oestrogen 
yeast screen. The blue arrow 
indicates that the majority of 
the herbs produces no 
oestrogenic response with an 
absorbance comparable to 
the control yeast. The pink 
arrow however illustrates 
that herb 14 displays 
oestrogenic activity 
displaying a similar result to 
the standard oestrodiol. 
The results of the anti- screens are determined in much the same way with samples that 
exhibit no activity having levels similar to the control yeast (with absorbance readings 
of around the 2-3, as the background has been elevated), and samples exhibiting a 
positive response shown to have activities similar to standards, with absorbance 
readings dropping below the control yeast. 
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5.9.5 Oestrogenic activity of TCM herbs used in the treatment of male infertility 
From figure 5.7 it can be seen that the majority of the individual herbs and all herb 
mixes NL 1 -4 (the four herb mixtures prescribed to patient NLCL) and ID 1-3 (the three 
herb mixtures prescribed to patient IDSS) exhibited no oestrogenic activity. In total 2 
individual herbs, herbsl4 and 20 were found to have oestrogenic activity, using the 
procedure described in section 5.9.3 the responses seen in these herbs were compared to 
that of the standard (table 5.1). 
Table 5.1- showing the herbs that exhibited a response on the oestrogen yeast screen, the amount of herb 
used in each daily prescription and an estimated equivalent 17p-oestrodiol daily intake (gg), (data 
extrapolated from assay results). 
5.9.6 Androgenic activity of TCM herbs used in the treatment of male infertility 
The individual and prescription herbs tested for androgenic activity (figure 5.8) showed 
that in all cases for both the individual herbs and the herb mixtures none were found to 
exhibit any androgenic activity. 
5.9.7 Anti-ocstrogenic activity of TCM herbs used in the treatment of male 
infertility 
The results presented in figure 5.9 illustrate the results of the anti-oestrogenic assay, 
from these results we can see that the vast majority of the individual herbs and all of the 
herbal mixtures displayed an anti-oestrogenic; response (29 out of 37), with all herb 
mixtures also exhibiting anti-oestrogenic activity (table 5.2). 
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Table 5.2- showing the herbs that exhibited a response on the anti-oestrogen yeast screen, the amount of 
herb used in each daily prescription and an estimated equivalent of OHT daily intake (gg), (data 
extrapolated from assay results). 
Herb 
1 
Equivaleut tlaiýj- intake qfolff 
Ot. ") 
0,466 
Amoutitt? f1lerbadded It) (111112() 
fi)r each prescription (in grants) 
9- 
4 0.3 10 
5 0.16 9 
6 1.25 12 
7 6.6 9 
8 1.06 9 
9 3.3 9 
10 3.3 9 
11 10.8 10 
12 2.2 12 
13 18.0 6 
Is 0.053 9 
16 3.0 12 
17 0.08 12 
18 0.024 15 
21 0.048 5 
22 1.4 12 
23 2.4 10 
24 1.2 10 
27 0.4 12 
28 1.06 9 
29 1.3 9 
30 2.0 6 
31 0.8 15 
32 2.0 12 
33 8.0 6 
34 0.3 12 
35 1.6 9 
36 1.6 6 
ID MLr 1 1.6 126 
ID Mv 2 0.055 110 
ID Mv 3 0.05 128 
NL MLv 1 0.8 117 
NL Mix 2 0.17 140 
NL M& 3 0.34 105 
NL Mix 4 0.18 132 
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5.9.8 Anti-androgenic activity of TCM herbs used in the treatment of male 
infertility 
Figure 5.10 presents the results generated in the anti-androgenic yeast-based assay, a 
total of 9 individual herbs displayed anti-androgenic activity (table 5.3). 
Table 53- showing the herbs that exhibited a response on the anti-androgen yeast screen, the amount of 
herb used in each daily prescription and an estimated equivalent of flutamide daily intake (gg), (data herb use 
Oexa oll 
1 
d in each daily prescription and an estimated equivalent of flutamide daily intake (ýLg), 
ated from assay results). 
"1111H 
UM 
0.07 9 
2 10.5 10 
5 0.12 9 
6 0.006 12 
10 0.0006 9 
13 10.0 6 
14 1.16 9 
16 3.0 12 
20 3.6 5 
5.10.1 Anti-oxidant activity of TCM herbs used in the treatment of male infertility 
The anti-oxidant potential of each of the individual herbs and the herb mixtures 
prescribed to patients NLCL and IDSS were tested using the FRAP assay as described 
in section 8.6. The herbs tested in this assay covered a range of 1.25-400, the activities 
of these herbs were compared to a known anti-oxidant (ascorbic acid ImM) covering 
the same range of 1.25-400. Within this assay herbs exhibiting similar responses as 
ascorbic acid were determined to have anti-oxidant activity, whilst those comparable to 
the negative control (ddH20) were established to not possess anti-oxidant activity. The 
results produced in this assay are presented in figure S. 11. 
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5.10.2 Anti-oxidant activity of the TCM herbs used in the treatment of infertility 
The results presented in figure 5.12 reveal that using the FRAP assay only four out of 
the 37 individual herbs tested for anti-oxidant activity were not found to exhibit any 
such activity. In the vast majority of cases, at the highest concentration of the herbal 
extract (400) a similar response to that found in the ascorbic acid (400) was produced. 
In figure 5.12 the absorbance (measured at 593nm) recorded for ascorbic acid (40gl) in 
all four graphs was found to be in the range of 1.55-1.62. Herbs were considered to 
exhibit similar anti-oxidant activity to that of the ascorbic acid if at the extract volume 
of 40pl absorbance measured at 593nm was recorded at <1.4 of herbs. Herbs that 
produced activities of >1.4 but <0.8 were considered to be weaker anti-oxidant with 
herbs producing activities of >0.8 considered as possessing very weak/ no anti-oxidant 
activity at the investigated concentrations of herbal extract. Table 5.4 indicates the anti- 
oxidant activity generated for each individual herb and herb mixtures. 
Table 5.4- anti-oxidant activity of TCM herbs used in the treatment of male infertility 
7 
2 1 26 
1 7 4 28 
15 9 5 30 
37 13 6 32 
17 8 33 
27 10 34 
29 12 35 
31 14 36 
16 NL-1 
18 NL-2 
19 NL-3 
20 NL-4 
21 ID-1 
22 ID-2 
23 ID-3 
24 
25 
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5.11 Discussion 
In this study we report on data generated into the investigation of the activities of TCM 
herbs used in the treatment of infertile males, for which significant improvements in 
chromosome 2 1, X and Y aneuploidy levels in several patients were observed. 
Specifically we investigated the endocrine and anti-oxidant activity of these herbs. Of 
the 37 individual herbs commonly used in the TCM prescriptions administered to 
infertile males by Dr Ping Zhai, the following endocrine activities were found: 2 
ocstrogenic, 29 anti-ocstrogenic and 9 anti-androgenic. Moreover, of the 37 individual 
herbs, 8 were found to be weak anti-oxidants and 25 were found to be strong anti- 
oxidants. As part of this study we were also able to investigate the activities in seven of 
the herb mixtures prescribed to two of the six patients (NLCL and IDSS) at the time of 
the semen assessments investigated for aneuploidy frequencies (data presented in 
chapter 4). Of these 7 herb prescriptions (four administered to patient NLCL and three 
administered to patient IDSS) all were found to be strong anti-oxidants, none were 
found to be oestrogenic or androgenic, however all prescriptions displayed anti- 
oestrogenic activity. 
We have investigated the endocrine activities, not only that of oestrogenic but also that 
of androgenic, anti-oestrogenic and anti-androgenic. We are not the f irst study to report 
anti-oxidant activity of plants used for medicinal purposes, however in contrast to 
previous studies we have investigated the anti-oxidant activities in a large number of 
individual plants. This study has also investigated the anti-oxidant potential of plant 
mixtures, to the best of our knowledge we are the first to report on the activities of each 
of the individual herbs analysed but also that of these particular herb mixtures (within 
the English literature). 
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There have been a number of studies that have investigated the chemical constituents of 
a variety of plant matter used in TCM, some of these studies have also investigated the 
effects of these herbs in in-vitro models to establish potential biological activities that 
may have a physiological effect on humans. The most commonly investigated herb is 
that of Ginseng, the constituents of this include triterpcnc, saponins, essential oils and 
polyacetylenes (Bisset et al., 1994), animal studies have revealed that it has a potential 
role as a immunostimulant (Singh et al., 1983; 1984). The majority of studies have 
investigated the mixtures used in TCM treatment, many of which have revealed anti- 
thrombotic, anti- inflammatory, anti-allergic, anti-tussive and anti-bacterial effects 
(Gong and Sucher, 1999). 
On the basis that this is a small pilot study, we have determined that these herbs possess 
biological activity, however given time it is beyond the scope of this study to identify 
the routes by which these may be acting if the improvement in chromosome aneuploidy 
and semen parameters is as a result of this treatment. We have suggested possible 
pathways as to where these may be acting i. e. through endocrine or anti-oxidant activity 
both of which play key roles in fertility, as any imbalance/ disturbance results in 
decreased fertility, and tested the herbs for each of these biological activities. Given the 
results it is clear that a larger study investigating the efficacy of TCM treatment in male 
infertility needs to be carried out. 
On the basis of the evidence provided within this chapter and chapter 4, we feel that 
there is strong preliminary evidence in the efficacy of TCM treatment in male infertility, 
specifically improved levels of aneuploidy and that the results provided in this chapter 
provide evidence of strong endocrine and anti-oxidant activity. Given these findings we 
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suggest that there is sufficient evidence to warrant progression to a double-blind 
placebo controlled clinical trial with the aim to detennine if these treatments are having 
an effect or whether the results demonstrated are due to a placebo effect or lifestyle 
improvements. Such a trail however, would not be simple to perform as there are a 
number of difficult issues to resolve in initiating a clinical trial involving TCM these 
include: 
- The chemical constituents of these herbs must be identified and the herbs used in 
the trial standardised, this is of particular relevance given the results of the study 
carried out by (Drew and Myers, 1997; Yuan and Yin, 2000) analysis of the 
chemical constituents of herbs harvested at different times of year and within 
different geographical regions all herbs revealed very different results. 
- Whether the skill of the TCM practitioner in tailoring the herbal treatments to 
each patient and the individual visits have a significant effect on the outcome, or 
whether a standardised treatment would be sufficient in the majority of patients. 
If improvements seen are as a result of the tailor made treatments, it would not 
be suitable for pharmaceutical development; a standardised treatment for such 
development would be vital. It is also clear that future studies require a larger 
control group. 
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Chapter 6 
Investigations into Me genome 
00 
organuation of chromosomes 18, XandT 
in human sperm 
A manuscript containing the results from this chapter has been invited for submission 
by the Editor of Cytogenetics and Genome Research and is in preparation. 
_________ jJ 
Chapter 6: Investigations into the genome organisation of chromosomes 18, X and 
Y in human sperm 
6.1 Introduction 
Within recent years there have been a number of studies published that have 
investigated the organisation of the genome within the interphase nucleus, these studies 
suggest that in interphase individual chromosomes tend to occupy discrete territories 
rather than intermingling with each other (reviewed by Bridger and Bickmore, 1998). 
To date there have been several studies that have investigated the organisation of 
chromosomes (i. e. chromosome position) within interphase nuclei of different cell types 
(including lymphoblastoid cells and dermal fibroblasts). These studies have provided 
evidence that the genome is highly organised within the nucleus and that correct 
organisation is critical for normal nuclear function. In humans, for example it has been 
demonstrated that gene-rich chromosomes tend to be located towards the interior with 
gene-poor chromosomes found in a more peripheral location in the nucleus (Bridger and 
Bickmore et al., 1998; Boyle et al., 2001; Croft et al., 1999). There is evidence that the 
organisation seen within human nuclei is conserved through evolution, as reported by 
Tanabe et al, (2002) who have undertaken genome organisation studies within primates. 
It has been suggested that the position of chromosomes within nuclei may play a vital 
role in gene expression and function, and that any change in chromosome location 
within the nucleus may be significant in some diseases (Greaves et al., 200 1). As a 
result chromosome positioning is being used to investigate genome organisation in 
normal and diseased individuals to determine if there is a link between abnormal cell 
function and altered genome organisation. In one such study (Meabum and Bridger, 
2001) investigated the genome organisation in individuals found to have missing or 
mutated proteins implicated in genome organisation, specifically individuals presenting 
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with Emery Dreifuss Muscular Dystrophy (EDMD), evidence was provided for altered 
genome organisation in EDMD patients compared to non-nal controls. 
Several studies have provided also evidence of preferential localisation of chromosome 
X within the spermatozoa of humans (Luetjens et al., 1999; Sbracia et al., 2002), 
monotremes, (Watson et al., 1996) and marsupials (Greaves et al., 200 1). The results 
published within these studies suggest that the position of chromosome X within the 
sperm nucleus corresponds to the point of first contact with the egg at the time of 
fertilisation (Greaves et al., 2001). This observation has lead several authors to believe 
that this may explain the increase of sex chromosome aneuploidy seen within ICSI 
derived conceptions (Luetjens et al., 1999; Sbracia et al., 2002; Terada et al., 2000). 
Terada et al. (2000) demonstrated that during ICSI the sperm nucleus undergoes 
atypical decondensation at the anterior end of the sperm nucleus upon injection within 
the egg. This is hypothesised to be due to the fact that in natural conception the 
acrosomal cap (located at the anterior of the sperm nucleus) begins to break down upon 
incorporation into the egg. This atypical decondensation is believed to hinder the onset 
of the first mitosis in the zygote, leading to an increased incidence of sex chromosome 
aneuploidy in ICSI derived embryos (Luetjens et al., 1999). 
As detailed within section 1.3, correct chromosome segregation is vital for both fertility 
and survival, and failure of chromosome segregation to proceed normally is the leading 
cause of mental retardation and pregnancy loss within humans. During gametogenesis 
this process of chromosome segregation is highly organised (refer to figure 1.1), thus it 
would seem reasonable to suggest that it is likely that genome organisation plays a role 
in ensuring that correct segregation takes place and that genome organisation may also 
have a critical role in the post-fertilisation stages of development (Greaves et al., 1999). 
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6.2 Objectives 
Given the above infon-nation the purpose of this study was to investigate whether there 
is evidence of a relationship between infertility phenotypes and genome organisation in 
male germ cells. 
- In order to do this we investigated the position of chromosomes 18, X and Y in 
spermatozoa of 3 control males with semen parameters all within the normal 
range and 4 patients with reduced semen parameters. 
We investigated whether chromosomes 18, X and Y are preferentially located in 
sperm nuclei as they are in other somatic cells. 
In order to address these questions we carried out two types of analysis: 
1) We investigated the position of chromosomes 18, X and Y in sperni nuclei 
relative to the centre of the nucleus in both patient and control groups. 
2) We analysed the position of chromosomes 18, X and Y in sperm nuclei relative 
to the polarity of the sperm nucleus (in reference to head middle or tail. 
6.3 Materials and Methods 
The sperm FISH protocol and detailed explanation of the method of analysis (Bridger, 
personal communication) can be found within the materials and methods section 
(8.7.4.1). 
Chromosome positioning analysis was undertaken for chromosomes 18, X and Y within 
the sperm of three control individuals with semen parameters within the normal range 
(refer to section 1.1) and four individuals with compromised semen parameters. For 
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each investigated chromosome (18, X and Y) a minimum of 100 spern nuclei (50 nuclei 
analysed on two different slides, and are referred to as repeat samples from herein), 
were analysed per individual, to determine if there is a relationship between infertility 
phenotypes and genome organisation in sperm cells. 
6.3.1 Statistical analysis carried out for the investigations into the location of 
chromosomes 18, X and Y 
Data produced from this study was analysed using the students Mest, this test was 
choosen due to its ability to determine any significant differences between the 
population means of two samples. Data was analysed using the Microsoft Excel 
statistics package. For all FISH experiments for each chromosome investigated and 
each individual enrolled in the study were carried out in duplicate (50 nuclei were 
scored on each occasion). In order to determine whether there was a significant 
difference between the results gathered in the first sample and the repeat sample a Mest 
(two-sample) assuming equal variance was utilised (as the two samples being tested 
were sperm cells from the same person). T-tests were also performed for each 
investigated chromosome, comparing each of the control males to each other and each 
of the patients to each other, to establish if there was any significant difference in the 
location of the chromosome territories within the control and that of the patient group. 
In each patient the results were also compared against each of the controls to determine 
any significant difference in chromosome territory location between the control 
population and the patients. When controls were compared against other controls, 
patients against other patients and controls against patients a West (two-sample) 
assuming unequal variance was utilised as the sperm cells were dervived from different 
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individuals. For both Mests assuming equal or unequal variances two-tailed tests were 
utilised with cut off point for significance set at <5%. 
6.4 Results 
6.4.1 Genome organisation relative to the centre of sperm nuclei for chromosomes 
18, X and Y in the control group 
All analyses were repeated to ensure results were representative of the sample 
population. Statistical analysis for each control revealed no significant difference 
between the two sets of data collected for each chromosome, (results are presented in 
figure 6.1). Statistical analysis was also perfon-ned to establish if the location of 
individual chromosomes were significantly different between the control individuals. 
Statistical analysis revealed that for chromosomes 18, X and Y there was no statistical 
difference in the location of the chromosome territory between C I, C2 or C3, except for 
chromosome 18 for which a statistical difference was identified between CI and C3 
(p=0.00 1; t-stat= -3.39) with C I's mean chromosome 18 position located more towards 
the periphery compared to that found in C3. The data recorded was also investigated to 
establish if there was any difference in the location of the chromosome territory within 
the sperm nucleus (in terms of whether territories are located more towards the 
periphery or interior) for the investigated chromosomes 18, X and Y. This was 
determined by comparing the location of chromosome 18 to that of X and Y, and the 
location of X to Y in the same control patient. Analysis of the location of each 
chromosome in each control revealed that for CI there was a significant difference in 
the location of chromosome 18 and Y (p=2.6x 10-5; t-stat= -4.44) and that of 18 and X 
(p=2.34xl 0-7; t-stat= -5.56). No difference in location however, was identified between 
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chromosome X and Y, with chromosomes X and Y found more towards the interior 
than that of chromosome 18. For C2 no significant difference was established between 
chromosome 18 and Y or chromosome X and Y, however chromosome X was found to 
be located more towards the interior than that of chromosome 18 (p=0.00398; t-stat= - 
2.97). In the case of C3 no significant difference in chromosome location was observed 
between any of the investigated chromosomes. 
6.4.2 Genome organisation relative to the centre of sperm nuclei for chromosomes 
18, X and Y in the patient group 
As in the control group all sperrn analysis for the investigated chromosomes were 
repeated in the four patients investigated (P I, P2, P3 and P4). As with the control group 
the repeat data was compared to the first set of data obtained. For all four patients no 
significant difference was observed between the recorded data of the initial samples and 
that of the repeat samples. Statistical analysis was also performed to establish if the 
location of individual chromosomes were significantly different between the patients. 
Statistical analysis revealed that in the case of PI the location of chromosome 18 was 
significantly different from that of P3 (p=0.0 19; t-stat= 2.39) and P4 (p=0.008; t-stat= 
2.69) (both of which were found to be more peripheral) however, no significant 
difference was found in any other patients. Analysis of the data generated for 
chromosome X revealed a significant difference of territory position between PI and P4 
(p=0.013; t-stat= 2.55) and P2 and P4 (p=0.017; t-stat-- 2.43), with P4 located more 
peripherally than that of PI and P2. No significant difference was found in the location 
of the Y chromosome territory between patients with the exception of PI and P4 
(p=0.036; t-stat= 2.13) with PI located more towards the interior. Analysis of the data 
was also investigated to establish if there was any difference in the location of the 
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chromosome 18, X and Y territory within the sperm nucleus between each of the 
patients (in terms of whether territories are located more towards the periphery or 
interior). The results of the statistical analysis found that there was no significant 
difference in the location of chromosome 18, X or Y in PI or P4, however significant 
differences were identified in P2 and P3. The location of chromosome X was found to 
be more towards the interior compared to that of chromosome 18 in both P2 (p=0.0 II*, 
t-stat= -2.60) and P3 (p=0.003; t-stat= -2.99). 
6.4.3 Comparison of chromosome territory location relative to the centre of sperm 
nuclei found in controls versus patients 
Statistical analysis was also carried out to compare the location of chromosome 
territories of chromosome 18, X and Y in controls and patients to determine if there is 
any significant difference in territory position between males with normal and 
compromised semen parameters. The three control individuals were grouped together 
and compared to each patient using a Mest to test for any significant differences in the 
location of chromosomes 18, X and Y. The results of the statistical analysis revealed 
that there was no significant difference in the location of chromosome Y in sperm nuclei 
between the control group and the four patients investigated. In the case of chromosome 
18 a significant difference in chromosomal location was identified between the control 
group and PI (p=0.007; t-stat= -2.74), however no other patients were found to exhibit 
any significant differences. Comparisons of the X chromosome between the control 
group and patients revealed no significant difference for P I, P2 or P3 however a 
significant difference was observed in P4 (p=0.041 -, t-stat-- 2.07). 
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Figure 6.1 the location of chromosome 18, X and Y territories in the sperm nuclei of controls and 
patients (error bars represent SEM). 
Chromosome territory postion for chromosomes X, Y and 18 
in human sperm of control and infertile males 
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In order to deten-nine if there was any difference in the location of the chromosomes in 
the patients (in tenns of peripherally or interiorly located) compared to the control 
group the following were compared and analysed using t-test statistics: chromosome 18 
(grouped controls) to chromosome X for each patient; chromosome 18 (grouped 
controls) to chromosome Y in each of the patients and chromosome X (grouped 
controls) to chromosome Y in each patient. The results revealed significant differences 
in chromosome location between chromosome 18 in the controls and chromosome X in 
pl (P=1.1, Xlo-5; 0-6. t-stat= -4.66), P2 (p=8.98xl , t-stat= -4.69) and P3 
(p=0.0003, t- 
stat= -3.67). With chromosome 18 within the control group located more peripherally 
than that of chromosome X with the exception of P4 for which no significant difference 
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was identified. When comparing chromosome 18 data from the control group to 
chromosome Y in each of the patients no difference was found in location for P3 or P4, 
however, significant differences were recorded for PI (p=0.0002; t-stat= -3.79) and P2 
(p=0.044; t-stat-- -2.04), with chromosome Y located more towards the interior. In the 
comparisons between chromosome X in the control group and chromosome Y in each 
of the patients, significant differences were noted for P3 (p=0.027; t-stat= 2.24) and P4 
(p=0.008; t-stat= 2.71) with chromosome Y being located more peripherally. No 
significant difference was observed in PI or P2. 
6.4.4 Chromosome territory position for chromosome 18, X and Y in terms of 
polarity, within the control and patient groups. 
Analysis of the location of chromosome territory was made, with reference to the 
polarity of the sperm nucleus in some cases, (in those for which the FISH procedure had 
not resulted in the removal of the spen-natozoa tails). The presence of the sperm tails 
enabled further analysis of the chromosome territories to be carried out (as described in 
section 8.7.4.1.2) these sperm nuclei were split into three regions (head, middle and 
tail). The location of the majority of the chromosome territory within these three regions 
were recorded for 50 sperm nuclei and duplicated in all investigated individuals with the 
exception of chromosome X in C2 for which only one slide was able to be analysed 
(due to the absence of sperm tails in the repeat sample). The results of these studies are 
presented in figure 6.2. 
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Figure 6.2- the location (in terms of head, middle or tail) of chromosome 18, X and Y territories in the 
sperm nuclei of controls and patients (* denotes the mean of two samples). 
Chromosome territory position vAthin sperm nuclei in control and 
infertile males for chromosomes X, Y and 18 
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6.4.4.1 Statistical analysis of chromosome 18, X and Y position in sperm nuclei in 
terms of polarity 
Chi squared statistical analysis was perforined in each of these individuals for all 
chromosomes to detennine if chromosome territories were randomly positioned within 
sperm nuclei (hence equally distributed throughout), or preferentially located within the 
regions investigated. Chi squared analysis was utilised to deten-nine which situation 
pertained, to do this we assumed that if chromosome territories were equally distributed 
throughout sperm nuclei we would expect a third (33.3%) located in the head, a third 
(33.3%) located in the middle and a third (33.3%) located in the tail region. In the chi- 
squared calculations we therefore used 33.3 as the expected frequency, therefore if the 
observed frequencies were not found to be significant we would accept the hypothesis 
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of equal distribution within the nucleus. If observed frequencies were found to be 
significantly different we would reject the hypothesis providing evidence of preferential 
location of chromosome territories. The cut off point for significance was set at 
p=<0.05. The observed frequencies (displayed graphically in figure 6.2) are presented in 
tables 6.1,6.2 and 6.3 (for chromosomes Y, X and 18 respectively). In each case any 
observed frequencies found to be significant are highlighted in bold text. 
Table 6.1 displaying the results for the analysis of the location of the Y chromosome territory in terms of 
oian 
cl 
-x r ssea as 2, orcen ex ressea as a percen 
39 
ia , ta e 
49 * 12- 
C2 47 49 * 4A 
Cc 3 43 50 * 74 
Pi 37 50 * 13- 
P2 38.5 45 16.5 * 
P3 574 32 119 
* deno tes simificance level o f <0.025. - sianificance level of <0.005 
significance level of <0.0005. 
; 4, significance level ofo. 
001; 
The results from the Chi-squared analysis have revealed that, in the case of chromosome 
Y (table 6.1) there was evidence to suggest that the Y chromosome territories were not 
equally distributed throughout the nucleus. Controls Cl, C2 and C3 and patient PI were 
found to have significantly more chromosome territories within the middle region, and 
significantly less within the tail region if territories were equally distributed. P2 was 
also found to have significantly less chromosome territories within the tail region. 
Significantly greater and less proportions of the chromosome territories were found in 
the head and tail region respectively in P3. 
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Table 6.2 displaying the results for the analysis of the location of the X chromosome territory in terms of 
nolaritv eXDressed as a Dercentage 
C2 1 38 52 # 101, 
0 550 
1 
39 6A 
P2 33 500, 17 
P3 56 A 38 6A 
* denotes significance level of <0.025; # significance level of <0.01; * significance level of 0.001; 
significance level of <10.0005 
Chi-squared analysis revealed that in the case of chromosome X, in all individuals 
analysed there was evidence to suggest that X chromosome territories are not equally 
distributed throughout the spemi nucleus. C2 and P3 were found to contain significantly 
higher and lower proportions of chromosome territories in the head and tail region and 
C2 and P2 were found to have significantly higher and lower proportions within the 
middle and tail region respectively, than would be expected if chromosome position was 
equally distributed throughout the sperm nucleus. 
Table 63 displaying the results for the analysis of the location of the chromosome 18 territory in terms of 
volaritv exvressed as a t)ercentaae 
P2 45 1 29 26 
P3 24 1 35 41 
Statistical analysis of the location of chromosome 18 within the sperm nucleus in terms 
of polarity has found no evidence to suggest that the position of chromosome 18 within 
the sperm nucleus is not equally distributed throughout the three regions investigated. 
Table 6.4 summarises the results of the investigations into the position of chromosomes 
18, X and Y with regards to the two types of measurements carried out, (with reference 
to the centre, and with reference to the polarity of the sperm nuclei). 
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Table 6.4- sunimarises the results of the investigation into the location of chromosome territories within 
sperm nuclei in terms of relation to the centre an polarity. 
Chromosome Position relative rip the head and Ittil Position relatire to the centre qfthe 
nucleus 
18 Equally distributed throughout the Found to be the most peripherally located 
nucleus 
I 
of the three investigated chromosomes 
Y Evidence to suggest preferential location Location similar to that of 18 with 
within the head and middle region evidence of more interior location in 
several individuals 
x Evidence to suggest preferential location Location of chromosome X was found to 
within the head and middle region be the most interiorly located 
chromosome compared to Chromosomes 
18 and Y 
6.5 Discussion 
In this study, we found only limited evidence for our initial hypothesis that men with 
compromised semen parameters have increased levels of genome disorganisation for the 
chromosomes examined. With significant differences in the location of chromosome 18 
and X (in PI and P4 respectively) compared to the data obtained in the control group. 
Due to the small sample size for both the control group and infertile group, it is possible 
that these may be attributted to normal variation in genome organisation. Nevertheless, 
even in such a small sample population these results provide some evidence to support 
the hypothesis that in some individuals with compromised semen parameters there may 
be perturbed levels of genome organisation. Clearly ftuther studies need to be 
performed with the recruitment of a much larger sample population and, in particular, a 
correlation between the level of sperm aneuploidy and the degree of genome 
organsiation. for a wider range of chromosomes needs to be established. Our results 
indicate, that as in lymphoblastoid cells, and human dermal fibroblasts there appears to 
be some degree of genome organisation (Boyle et al., 2001) and preferential location for 
chromosomes 18, X and Y within sperm nuclei. 
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Further analysis of chromosome territory position was also made possible in sperm cells 
retaining there tails after FISH analysis. This enabled the location not only to be 
determined as peripherally or interiorly located, but also in terms of head middle or tail 
position. The results from these studies suggest that the sex chromosomes were not 
equally distributed throughout all three regions. In the case of the Y chromosome, 
significantly higher levels were found in the middle region and significantly lower 
levels in the tail region in all three controls, the same situation pertained in P I. In P2 
significantly lower levels were found in the tail region than would be expected if 
chromosome Y was equally distributed with the remainder of territories roughly equally 
spread over the head and middle regions. Whilst in P3 significantly higher and lower 
levels were found in the head and tail region respectively. Analysis of chromosome X in 
the four individuals analysed revealed that in two cases significantly higher levels were 
found in the head region with the remaining two cases having significantly higher levels 
within the middle region. All four individuals were found to have significantly lower 
levels found in the tail region than expected if chromosome X was equally distributed. 
In the case of chromosome 18 we found no significant evidence of a preferential 
localisation; analysis revealed chromosome 18 to be equally distributed throughout. 
Previous reports have demonstrated delayed nuclear dccondensation of the apical region 
of the sperm nucleus after ICSI (Terada et al., 2000). In studies in Rhesus monkeys after 
ICSI the apical region of the sperm nuclei remains condensed surrounded by the peri- 
nuclear theca, a unique cytoskeleton. structure important in stabilizing sperm structure in 
mammalian sperm (Sutovsky et al., 2003). This structure begins to dissassemble during 
incorporation into the egg (hence in natural conception and in IVF), however this 
structure remains intact in ICSI resulting in atypical decondensation. Terada et al. 
(2000) hypothesise that the unusual nuclear remodelling in the first cell cycle of ICSI 
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may prevent the synchronised decondensation of all chromosomes. This in turn may 
result in increased ICSI derived chromosome anomalies (for chromosomes located 
within this apical region) by delaying the S-phase entry and hence leading to mitotic 
errors during the first cleavage. In light of this data several studies have investigated the 
position of chromosomes 18 and that of the sex chromosomes (due to the increased rate 
of sex chromosome aneuploidy in ICSI offspring) within sperm nuclei (Luetjens et al., 
1999; Sbracia et al., 2002; Terada et al., 2000). The study carried out by Leutjens et al. 
(1999) reported that chromosome 18 was located in the tail region in 60% of the 190 
sperin nuclei analysed, in contrast we found an average of only 33% of chromosome 18 
territories within the tail region. Sbracia et al. (2002) reported rates for chromosome 18 
of 14.49%, 31.35% and 54.36% in the head, middle and tail region, in contrast we 
report a more equal distribution throughout all three areas with respective rates of 35%, 
32% and 33%. The same study also reported rates of 40.94%, 50.29% and 8.77% for 
chromosome X and 52.94%, 3 8.14% and 8.93% for Y chromosome (in head middle and 
tail regions respectively). In agreement we report similar rates of 45%, 45% and 10% 
for chromosome X and 44%, 45% and I I% for chromosome Y. The study carried out 
by Luetjens et al. (1999) reported much higher rates of chromosome X position within 
the tail region with >40% of 230 sperm nuclei, compared to the results generated in this 
study with an average of 10% located in the tail region and around 45% located in both 
the head and middle region. All studies including this one report provide evidence for 
the preferential location of the sex chromosomes within the head and middle region of 
the spenn nucleus with significantly lower levels found within the tail region (except for 
that of the Leutjens study). This is of relevance as the study carried out by Terada et al. 
(2000), analysed the postion. of the sex chromosomes in 12 sperm after ICSI injection 
into hamster eggs, at 2 and 6 hours. Of these 12 three had a sex chromosome located in 
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the apical region, in contrast to the other nine analysed, after six hours these sex 
chromosomes remained condensed. These findings along with the evidence of increased 
rates of ICSI derived sex chromosomes aneuploidy (Bonduelle et al., 1996; 1999; 2002) 
have serious implications and suggest that the technique itself may play an important 
role in the increased rates of aneuploidy seen. Clearly further research should be 
initiated to determine if this is the case and whether males with compromised semen 
parameters are at any increased risks. Also these studies have not investigated genome 
organisation other than in reference to the head, middle or tail region it occupies and 
make no inference as to whether chromosomes occupy discrete domains and in relation 
to each other whether specific chromosomes are more peripherally located etc. This is 
clearly of importance especially given the fact that genome organisation in diseases 
such as EDMD have been shown to altered (Meaburn and Bridger., 2001). Future 
studies should be undertaken to determine the "normal situation" in control males with 
normal semen parameters and those with compromised semen parameters. 
Investigations should also be investigated in other testicular cells derived from testicular 
biopsies which will provide us with important information how the genome is organised 
throughout spermatogenesis. 
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Chapter 7: General discussion 
7.1 Project outcomes relative to specific aims 
In general terms, the work in this thesis has been largely successful in the completion of 
the specific aims set out in section 1.8. Significant steps have been made towards 
establishing the need for, and implementation of a pre-ICSI aneuploidy screening kit. 
Clues to the aetiology of the phenomenon of sperm aneuploidy has been provided 
through the analysis of semen parameters and genome organisation. Furthermore to the 
best of our knowledge we have provided the first report of a reduction in sperm 
aneuploidy levels coincident with any medical intervention. Specifically the following 
has been achieved: 
* Statistical analysis of cxisting qucstionnairc data, has rcvealcd that spcnn aneuploidy 
is perceived as a serious problem in infertility clinics. 
e Statistical analysis of the existing questionnaire data, also established that the majority 
of individuals surveyed believe there to be merit in pre-screening men for levels of 
sperin aneuploidy prior to treatment of ICSI. 
* Significant steps have been taken towards the development and implementation of a 
kit that will allow the screening of sperm aneuploidy in males undergoing ICSI. 
* Evidence is presented that sperm aneuploidy levels can vary significantly between 
samples in infertile men. 
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9 Preliminary evidence has been provided that suggests chromosome-specific and 
parameters-specific mechanisms with regard to sperm aneuploidy. 
9 Evidence is presented that, in 6 males, sperm aneuploidy levels have reduced 
significantly coincident with traditional Chinese herbal medicine treatment. 
9 Evidence has been provided for the anti-oestrogenic and anti-oxidant activities of the 
individual herbs used in the TCM treatment of these six individuals. 
* Evidence, has also been provided for the anti-oestrogenic and anti-oxidant activities of 
the herb mixtures used in the TCM treatment of two of the six individuals. 
* Evidence that chromosomes 18, X and Y occupy discrete domains within human 
spermatozoa is presented. 
9 Finally evidence is presented that selected chromosomal domains may occupy 
different positions in some infertile males. 
7.2 Development of a sperm aneuploidy screening kit for clinical use 
Within chapter 2, the development of the sperm screening kit is detailed, with the 
concentration and incubation times established for the decondensation buffers and 
denaturation. During the development of the technique for the screening kit two probe 
protocols were tested within the development of the screening kit, at the onset of the 
study the combinatorial probe approach was utilised, this entailed a four probe 
approach. In this case chromosome Y was labelled in Spectrum Green, chromosome 21 
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in Spectrum Orange and chromosome X used a combination of two probes labelled with 
different fluorochromes to produce a third colour (Spectrum Green and Spectrum 
Orange to produce a yellow colour), (figures 2.1,2.2 and 2.3). This approach however, 
produced several issues with regards to use within a screening kit. The first of which 
was the fact that it was not reproducible, in that the combination of the two X 
chromosome probes did not always produce a yellow colour, at times it would be 
difficult to distinguish it from chromosomes X and 21 as the probe was either more 
green or red in colour. This probe protocol was hence not suitable for incorporation into 
such a screening kit. Secondly the fact that it required 4 probes, which would make it 
more costly, again not ideal for a screening kit. Latterly within this study we switched to 
a three probe non-combinatorial approach (figure 8.5) using probes labelled in Spectrum 
Orange (2 1), Spectrum Green (X). and Spectrum Aqua figure (Y), to eliminate the 
reproducibility issues found with the first probe protocol. This probe protocol was not 
used at the outset of the study as the Leica microscope system used did not have the 
appropriate filter sets for analysis of these fluorochromes. At first we tested the new 
probe system with a quad band pass (including DAPI, Spectrum Orange, Spectrum 
Green and Aqua), however we encountered problems identifying the Aqua Y probe 
from the DAPI counterstain. More recently we have obtained a triple band pass 
(containing a Spectrum Orange, Spectrum Green and Aqua filters), to eliminate this 
problem. Since switching to this three-colour probe system we have attracted the 
interest of a company Stretton Scientific LTD, who are interested in commercialising 
this kit. Initial studies however still suggest a difficulty in distinguishing the Aqua probe 
from the DAPI counterstain though this may be the fault of our current filter. At present 
a number of issues remain that need to be resolved, these include the probe approach 
used, firstly we need to identify if there is a problem distinguishing the aqua probe from 
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the DAPI background through the rigorous testing of this protocol on a wide range of 
samples. Once the new probe protocol has been established and thoroughly tested, we 
would want to send the protocol and probes out to at least five other laboratories to test 
the reproducibility and robustness of the kit. 
We realise that the implementation of such a test within infertility clinics will not be 
possible to be undertaken unless it is in conjunction with an automated scoring system 
(due to the time constraints imposed by the sheer number of cells required to be scored). 
Within the past year we have tested several automated dot counters (from Applied 
Imaging and Imaging Associates), both companies have produced systems that are 
capable of undertaking such analysis reliably. The implementation of an automated 
scoring system would have many benefits, including: significantly reduced analysis 
time, analysis that can be carried out 24 hours a day. It will also enable identical scoring 
criteria to be programmed and set up for each infertility clinic eliminating the potential 
problems of observer bias that may contribute in part to some of the significant 
differences in aneuploidy levels found between studies (refer to section 1.5). It will also 
eliminate any potential problems of not being able to identify the Aqua Y probe from 
that of the DAPI counterstain. In conjunction with Stretton Scientific LTD, we hope to 
distribute this screening kit to infertility clinics, enabling some of the questions to be 
answered from chapter 1. Including the risk of chromosome aneuploidy in children 
conceived through ICSI, those individuals with high levels of sperm aneuploidy can opt 
for further follow-up in any conceptions with amniocentesis and the karyotyping of 
children conceived through ICSI. 
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7.3 Evidence of a correlation between semen parameters and sperm aneuploidy 
As seen in chapter 3 we have provided preliminary evidence of correlations between 
individual semen parameters and increased disomy of individual chromosome pairs, 
while statistically significant, warrants further investigation. Closer correlations of 
disomy rates in men with defects in only one of the three criteria used to measure semen 
quality will fonn the basis of future investigations, however this was not possible within 
this study as no individuals were identified with reduced semen quality in only one 
parameter. Through these studies, a closer understanding of the mechanistic basis of the 
relationship between chromosome segregation and infertility will be achieved. Further 
confin-nation of this could also be obtained utilising probes for different autosomes, 
hence establishing for example if aneuploidy in any other autosome pairs are 
significantly increased in individuals with reduced sperin count (as established for 
chromosome 21 disomy but not for the sex chromosomes). 
In the light of our results it is possible that a common mechanism leading to 
oligozoospennia and increased levels of XY disomy involves a perturbation in the 
mechanisms of synapsis and/or recombination in the XY paring region. These results 
generated in this study have formed part of a successfully funded Wellcome grant, in 
which to further test this hypothesis, single sperm PCR (Huang et al., 1995) will be 
used. In 10 severely oligozoospermic males and 10 controls, primers located within and 
outside the XY paring region will be used in these studies to determine whether there is 
evidence to support the absence or reduction of recombination within the X-Y pairing 
region. A significant difference between oligozoospermic males compared to controls 
would provide evidence to support our hypothesis. Clearly there is plenty of scope for 
further investigation based upon these preliminary observations, however one of the 
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shortcomings of the current study as it stands (presented in chapter 3) there is the lack 
of a second control group (men of proven fertility). The basis of the study was to 
compare individuals with reduced semen quality for specific semen parameters, against 
those that are within the normal range (however, in the majority of cases these 
individuals had reduced semen quality in the other parameters investigated). Clearly we 
realise the importance of having a second control group (consisting of individuals of 
proven fertility) and is something that is lacking from this study, however this was due 
to difficulties in recruiting control subjects. As part of future studies, such a control 
group, from which we will obtain at least four repeat samples. At present we have 
recruited four such individuals, however due to time constraints it was not possible to 
perform and include the analysis of these individuals. 
7.4 Evidence of reduction of sperm ancuploidy levels for chromosomes 21, X and Y 
in males coincident with TCM treatment and biological activity of TCM 
prescriptions 
We have provided novel evidence of the efficacy of TCM in the treatment of male 
infertility specifically that of reductions within disomy frequencies for the investigated 
chromosomes coincident with treatment. Within the past few years there has been an 
increasing use of TCM (including individuals within the medical profession), to date 
several studies have been published assessing people's views and attitudes towards 
TCM. Koh et al. (2003) questioned pharmacists attending the 61" International 
Congress of the International Pharmaceutical Federation, on their knowledge and 
attitudes towards complementary alternative medicine (CAM) including that of TCM. 
In total 84% of the 420 individuals asked revealed that at some point they themselves 
had used CAM in the treatment of both acute and chronic conditions. Receiving 
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information on these therapies from a range of sources including: books and magazines, 
friends and family and the Internet. Of these individuals 79% would recommend CAM 
treatment to friends and family. This study also indicated that 81% of these individuals 
felt they had inadequate knowledge to use these treatments in patients, however, of 
interest is that over 90% felt that the professional curricula should contain more CAM 
components. Fontanarosa and Lundberg, (1998) reported that the fundamental issue is 
not Western medicine versus TCM, but medical practice supported by clinical and 
scientific evidence. 
In Western medicine over half of the drugs used in the treatment of illnesses has been 
derived from plants (New Scientist, 2001; Yuan and Lin, 2000), therefore it is likely 
that the plant based herbs as used in TCM are likely to contain components that have 
medicinal benefit. The herbal combinations that are used, in TCM remains an untapped 
source for the discovery of new drugs. Traditionally Western drug discovery focuses on 
one plant type at a time in order to identify single active compounds, whereas TCM 
uses 10-20 different plants within prescriptions, therefore it is likely that in many cases 
the activity of these plants are based on the interactions of different compounds (Yuan 
and Lin, 2000). 
As reviewed in chapter 4 there have been a number of successful randomised clinical 
trials that have provided evidence of the efficacy of TCM treatment in a range of 
diseases including: atopic dermatitis; atopic eczema; bronchial asthma and irritable 
bowel syndrome. Clearly it is beyond the scope of this study to determine if the effects 
seen are due to a placebo effect or improvements in lifestyle for example, however we 
have provided evidence of the biological activities (including that of endocrine and anti- 
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oxidant activity) of the herbs used in TCM treatment. We have provided strong 
preliminary evidence to support the potential efficacy of TCM in the treatment of male 
infertility, clearly much more research is required and warranted. Over the last decade a 
great deal of pharmacological research has been undertaken to further our understanding 
and establish reliable composite formulae of TCM natural products (Wang, Z. T et al., 
1995). Further research needs to be carried out to detennine the principal active 
components of the investigated herbs; this would be possible through the separation of 
components through counter-current chromatography (CCC). We have initiated a 
potential collaboration with Brunel Institute for Bioengineering to use this technique to 
isolate the individual components of the herbs. These investigations will lead to the 
isolation and characterisation of the active components of the herbs, which in turn will 
lead to a better understanding of the chemical properties in the herbs that appear to be 
effective in the treatment of infertility. The technique of CCC will also establish a 
generic method for the purification of TCMs, hence providing samples for detailed 
chemical and biological analysis. It is also clear that the integration of Chinese TCM 
and western pharmacology constitutes a potentially rich source for drug discovery and 
development (Gong and Sucher., 1999). The therapeutic efficacy of isolated compounds 
may be related to the possible interactions of the individual ingredients, or even through 
the metabolism of these compounds within the body that may be responsible for the 
resultant activities. Therefore a barrage of tests must be undertaken to investigate the 
effects of such complex TCM preparations. 
Based on our findings of a reduction in sperm aneuploidy coincident with TCM 
treatment and evidence of the biological activity, we feel there is enough preliminary 
evidence to justify continuation to a double-blind placebo controlled clinical trial. This 
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would begin the address the question of whether the evidence provided in this study is 
as a result of the TCM treatment and will enable the existence of placebo effects and 
lifestyle changes. A detailed clinical trial will also enable more patient access and 
produce large amounts of data hence making it possible to determine how these may be 
acting i. e. the pathways through which these herbs may be acting. It would be possible 
to produce data on reactive oxidant species (ROS) within spenn (therefore individuals 
identified with high ROS in sperm, levels could be monitored to determine if this 
improves with the treatment of anti-oxidant herbs for example). A clinical trial may 
make it possible to monitor hormone levels coincident with treatment to determine if 
there are any changes, also possibly measure concentrations of known xenoestrogens 
e. g. PCB and PE in seminal plasma as in the study carried out by Rozati et al. (2002). 
This may provide a correlation either providing evidence of a potential link with 
environmental oestrogens or ruling it out as a possibility. Gathering of detailed patient 
data such as these are not possible in open-label studies such as these therefore 
hopefully will detennine how these are working if it is through these routes or whether 
it is through an alternative route. 
7.5 Chromosome positioning 
The research presented within chapter 6, illustrates that as in other cell types (including 
lymphoblastoid and fibroblast cells) there is evidence that the investigated 
chromosomes (18, X and Y) occupy discrete chromosome domains within sperm nuclei. 
The results presented within this chapter form the basis of preliminary evidence, a pilot 
study to detennine if there is evidence of genome organisation within sperin for 
chromosomes 18, X and Y. Clearly the evidence provided of genome organisation 
requires further investigation especially with regards to correlating the data with 
253 
aneuploidy frequencies for the investigated chromosomes, it is also clear that more 
controls and patients need to be recruited. Despite the relative small numbers of 
individuals investigated the results of this study provide evidence for the genome 
organisation of chromosomes 18, X and Y in tenns of location relative to the centre of 
the nucleus with chromosome 18 located more peripherally and chromosome X located 
more towards the interior. We also provided evidence of the preferential location of the 
sex chromosomes within the head and middle region of spenn. nuclei with intact sperm 
tails, whilst the location of chromosome 18 appeared to be equally distributed 
throughout the head, middle and tail region. Preliminary evidence was also provided for 
differences in chromosome location within the nucleus in several of the infertile patients 
investigated compared to that of the control population. The results presented in chapter 
6 suggesting evidence of preferential location within the sperm nucleus in terms of both 
that of peripheral and interior, and in polarity in terms of head middle and tail, for 
chromosomes 18, X and Y and differences found between a small number of 
individuals clearly demonstrate the requirement for further analysis. Future 
investigations should extend these studies to a larger patient and control cohort, 
preferably in patients for which significantly increased aneuploid levels have been 
identified in the sperm for the investigated chromosomes compared to controls. They 
should also include several other autosomes that are known to be gene rich and gene 
poor chromosomes (located in the interior of the nucleus and the periphery of nuclei 
respectively in lymphoblastoid and fibroblast cells investigated). This will determine if 
chromosome territory position is organised, if there is evidence of organisation, whether 
it is organised as in the somatic cells previously investigated, or whether genome 
organisation within genn cells is different. Studies investigating the position of 
chromosome territories within other testicular cells derived from testicular biopsies will 
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also generate important information on how the genome is organised throughout the 
process of spennatogenesis. This is likely to provide evidence as to what stage within 
spermatogenesis genome organisation may become perturbed, enabling not only spatial 
errors of genome organisation of infertile males but also the identification of the stage at 
which these errors occur. 
At present our understanding of what structures are responsible for genome organisation 
in germ cells is limited, however a number of structures of the nuclear envelope and 
proteins including the nuclear lamina, integral membrane proteins (Alsheimer et al., 
1996a) and the nuclear matrix that binds active regions of the nuclear matrix (Vclek et 
al., 200 1) have all been implicated. The nuclear structure of cells undergoing 
spennatogenesis has been demonstrated to undergo fundamental changes throughout 
this process. Examples of this is the expression of B3 and C2 lamins in spermatocytes 
only, and that the constituents and structure of the nuclear matrix changes throughout 
spennatogenesis, which are likely to be as a result of an adaptation to meiosis-specific 
nuclear function (Alsheimer et al., 1996b). Alsheimer et al. (1999) determined that 
lamin C2 is localised at segregated regions of the nuclear envelope in male meiotic 
cells, with chromosome ends, bound through synaptonernal complexes, associated with 
these C2 dense regions. Meaburn and Bridger, (2001) report the strict genome 
organisation found in somatic cells is absent in cells derived from individuals with 
EDMD, found to have proteins implicated in genome organisation either mutated or 
lacking. Therefore it would be reasonable to suggest that if nuclear structures and 
proteins within the cell types undergoing spermatogenesis was altered from that found 
in the normal situation, may lead to altered genome organisation. This could also result 
in abberant chromosome segregation which may in turn be responsible for some of the 
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increases in aneuploidy within the sperm of males with compromised semen 
parameters. Clearly further studies need to be carried out in normal and severely 
infertile males with significantly higher levels of chromosome aneuploidy. In order to 
identify if the preliminary evidence provided here of strict organisation (in terms of 
peripheral or interior location) is found for all chromosomes and what positions these 
occupy. Once determined if there is evidence of strict organisation, it will be possible to 
identify if this is perturbed in males with compromised semen parameters, and enable us 
to examine the role of these proteins in these patients. 
7.6 Self-criticisms of the project 
In retrospect there are a number of subjects that could have been dealt with differently, 
firstly with regards to the screening kit, given the opportunity we should have switched 
from the combinatorial (four) probe approach to the three colour approach, earlier on in 
the study, as it was clear, due to the lack of reproducibility of this probe approach that it 
would not be suitable for use within a screening kit. The reasons for not switching to the 
three colour approach was due to the fact that the fluoresent microscope did not have 
the appropriate filters. Switching to the three colour approach earlier would have meant 
that we could have generated more patient data using this approach and invested more 
time in resolving the issues that have arisen as a result of this protocol. The 
development of the screening kit would, hence have been further along through to the 
testing stages by now. 
Secondly, recruitment of patients was also a difficult issue and also for different control 
groups for the various studies. We have managed to recruit a number of controls for this 
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study, however for several investigations we could have done with more controls. In 
particular for the study into correlations between semen parameters and sperm 
aneuploidy (refer to section 7.3) and also for the studies into genome, organisation. The 
controls used in previous studies could not be used as they were stored in the sperm 
buffer at 4C, which may have affected the genome organisation in the sperm nuclei. In 
this study new control samples had to be used that were fixed and stored at -201C to 
prevent this, as a result we were only able to obtain three samples. Given more time it 
would have been possible to recruit and investigate more patients in each of the studies 
reported within this thesis particularly for the positioning and TCM aneuploidy studies, 
however due to time constraints this was not possible. 
Thirdly one of the major issues is the lack of karyotype analysis performed. The ideal 
situation would have been to perform this analysis on all the patients enrolled in the 
studies. This, however, was not possible due to the consent not given by patients to 
perform such analyses in the vast majority of individuals with a few rare exceptions. 
The occurrence of chromosome abnormalities has indeed been reported to be 
significantly higher within infertile males than that of their normal fertile counterparts 
(refer to section 1.5). The increased rate of such abnormalities however, is mainly 
associated with severe oligozoospermic males (those with <5 million/ml) (Patrizio and 
Broomfield, 1999), within these studies there were no males classified as severely 
oligozoospermic. Even if karyotype analysis had been performed in each of the patients 
it is unlikely that any chromosomal aberration identified would have altered any of the 
conclusions reached in these studies. For example in the TCM studies it is unlikely that 
even if a karyotype abnonnality was identified in one of the patients that it would have 
altered our conclusions that there is preliminary evidence of the efficacy of TCM in the 
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treatment of male infertility. Given more time it would have also been possible to carry 
out Y deletion analysis and analysis of CF mutations (refer to sections 1.3 and 1.2.1.1.1 
respectively) however, as with karyotype analysis these existence of these would have 
been unlikely to affect our conclusions. These karyotype analyses would have enabled 
us to present a more complete patient assessment and would have ruled out these 
aberrations as the cause of the infertility. Given the time and opportunity, within these 
studies these would have been perfonned. 
Fourthly, in retrospect and given more time we should have created detailed lifestyle 
questionnaires, that should have been completed at the time of each semen assessment 
(especially for repeat samples). This is of particular importance with regards to the 
TCM study, and would have enabled us to discount individuals or perhaps provide a 
possible explanation that may account for the reductions seen in disomy levels if, for 
example individuals had significantly reduced their dietary intake of cigarettes and 
alcohol. Future studies will include a well designed lifestyle questionnaire that should 
be completed by patients throughout treatment. It should be noted that in all cases 
individuals were required to provide detailed lifestyle questionnaires at the time of the 
first semen assessment, however, any changes in the lifestyle of these individuals were 
not monitored. It is unlikely though that changes in dietary factors such as smoking and 
alcohol would have caused the significant reductions in aneuploidy in these six patients 
as initial lifestyle questionnaires revealed, that none smoke and all consumed under the 
recommended allowance of alcohol units per week. 
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7.7 Concluding remarks 
At present there are many questions that arise over the apparent increase in infertility, 
particularly within Western populations, at present our knowledge and understanding of 
the mechanisms behind this is limited. Yet we have created radical treatment regimes 
for infertility (without, in many cases, knowing the cause for this infertility). 
Indisputably this is a cause for concern, indeed ICSI has raised concerns over the 
increased genetic risks to unborn children and transmission of infertility. Within these 
studies we have demonstrated significant differences in aneuploidy levels within the 
gametes of infertile males, ranging from individuals with levels comaprable to controls 
and individuals with up to 15 fold increases compared to controls. The differences 
observed between infertile males clearly have clinical ramifications, with the outcomes 
of ICSI being monitored carefully especially with regards to the karyotype of offspring 
and the careful monitoring of the fertility of these individuals. The results presented in 
this thesis hopefully shed some light onto some of the potential mechanisms that may be 
involved in infertility, for example the identification of chromosome specific semen 
parameter correlations and the preliminary investigations into genome organisation. 
Clearly it is essential for the further understanding of infertility that these studies are 
continued. Futher research is also warranted in alternative treatments to ICSI, treatments 
that are less radical and invasive without the potential risks associated such as TCM. 
We arc still a long way from understanding the mechanisms of infertility and only 
through further research and understanding of these factors will safe and reliable 
methods be available for the treatment of infertility. 
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Chapter 8: Materials and methods 
Within this materials and methods section, unless stated otherwise all chemicals were 
research grade and were purchased from Sigma-Aldrich Ltd. (Poole, UK). All 
sterilisation was undertaken by one of two methods, either through filtration (disposable 
filters with a pore size of 0.2[tm Whatman Puradisc) or through the process of 
autoclaving, heating up to 12PC for 10-15 minutes. From herein sterilisation is 
specified as being carried out by either filtration or autoclaving. 
8.1 Karyotyping 
8.1.1 Preparation of human chromosomes from blood 
This procedure was carried out in a BSB 3A Gelaire@ laminar flow cabinet type. A 
total of I ml of human blood was transferred into a sterile plastic tissue culture flask, to 
this flask 19ml of PB-Karyomax medium (Invitrogen, Paisley, UK) was added. The 
flask (containing blood and growth medium) was subsequently transferred to a 37C 
incubator for 72 hours. 
8.1.2 Harvesting of human chromosomes 
As before this procedure was carried out in a BSB 3A GelaireQD laminar flow cabinet. 
After the 72-hour incubation period, 200ýd of 50ýtg/ml colcemid (Invitrogen, Paisley, 
UK) was added to the flask to arrest the cells in metaphase, the flask was then returned 
to the 37T for 40-60 minutes. Meanwhile a 75mM KCI hypotonic solution was 
prepared and pre-warmed to 37C. 
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After the 40-60 minute incubation, the culture was removed from the 37'C incubator 
gently mixed and equally transferred to two 15ml centrifuge tubes. These tubes were 
then centrifuged at 1200 rpm for 5-7 minutes, after centrifugation the supernatant was 
removed and the pellet gently re-suspended (in a drop wise manner) in approximately 
I Oml of the 75mM KCI hypotonic solution (pre-wartned to 37C) these centrifuge tubes 
were then returned to the 371C incubator for a further 12 minutes. Following this 
incubation period 5ml of fixative (3: 1 methanol: acetic acid) (BDH, Dorset, UK) was 
added to the centrifuge tube and the tube was inverted to mix. The centrifuge tube was 
centrifuged as before (1200 rpm for 5-7 minutes), after centrifugation the supernatant 
was removed and the pellet re-suspended (drop wise) in 5ml of fixative (3: 1 methanol: 
acetic acid). Following the addition of the fixative the centrifuge tube was centrifuged at 
1200 rpm for 5-7 minutes, and the process of adding fixative drop wise followed by 
centrifugation was repeated a further 4-6 times. Subsequently chromosomes are stored 
at -20"C until required. 
8.1.3 Preparation of slides 
Centrifuge tubes containing harvested chromosomes are removed from -20'C and 
centrifuged as before, the supernatant is then removed and the appropriate volume 
(usually between 0.5-3ml) of fresh fixative is added to the centrifuge tube, to obtain the 
correct cell density. Using a pipette approximately 15-20pl of the cell suspension was 
dropped onto a clean glass slide (from a height of between 10-20crns to aid in 
disrupting cell membranes). On top of this cell suspension two drops of fresh fixative 
was added to aid in spreading and fixing chromosomes to the slide. The slide was then 
checked under phase contrast (x 10 magnification) to check for the presence of adequate 
numbers of metaphase spreads and ensuring that metaphases were well spread with little 
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or no crossovers as possible. Slides were then dehydrated through an ethanol series of 
(70,80 and 100%) and placed in a 37'C incubator overnight to age (to harden the 
chromosomes). 
8.1.4 Staining of slides with Vectasheild DAPI 
Slides were removed from the 37C incubator the following day, to each slide 50-1 00ýtl 
of anti-fade Vectasheild mounting medium with DAPI (Vector Laboratories, 
Peterborough, UK) was added and a coverslip placed on top. 
8.1.5 Microscopy and karyotype analysis 
Metaphases were analysed using a Leica DM 35 fluorescence microscope and captured 
using Smart Capture version 3.2 (Vysis Digital Scientific, UK). In total for each patient 
a minimum of 10 metaphases were karyotyped and the number of chromosomes were 
counted in at least 30 metaphases (to exclude the likelihood of chromosomal 
mosaicism). Images to be karyotyped were then exported into Quips CGH Karyotyper 
(version 3.1.1, Vysis, UK), the image of the DAPI banded chromosomes was then 
inverted to give a grey scale reverse DAPI banded image (figure 8.1). The metaphase 
was then karyotyped using the various tools available within the CGH karyotyper 
package. 
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Figure 8.1- illustrates the reverse DAPI banded karyotype of a normal 46, XY male 
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8.2 Methods for determining aneuploidy levels within spermatozoa 
8.2.1 Preparation of reagents for sperm FISH analysis: 
8.2.1.1 Sperm buffer used for storage of samples: 
Preparation of the sperm storage buffer lOmM Tris HCl (BDH, Poole, UK), lOmM 
NaCl (BDH, Poole, UK) (pH 8.0), was performed as follows: glass bottles were 
sterilised prior to use by filling with ddH20 and autoclaving. Once autoclaved the 
ddH20 was removed, the sperm buffer was prepared and transferred to the sterilised 
glass bottles and sterilised as before through autoclaving. Once autoclaved the sperm 
buffer was stored at room temperature (RT) until use. 
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8.2.1.2 DecOndensation buffers: 
Preparation'of decondensation and denaturation buffers: these were all carried out on 
the day unless specified otherwise. Decondensation of the sperm heads prior to 
denaturation and probe hybridisation is a critical step within sperm FISH as DNA 
within sperm nuclei is tightly packed with the use of interprotarnine disulphide bridges 
resulting in a high degree of DNA condensation. Appropriate decondensation of the 
sperm heads is required as the type and quality of the decondensation treatment is 
critical, as it is likely to affect the hybridisation and interpretation of the results (Rives 
et al., 1998). 
Two types of decondensation. buffers were utilised, swelling buffer I was a 0.1 M Tris 
buffer (pH 8.0) containing dithiothreitol (DTT). The DTT and 0.1 M Tris buffer were 
made up separately and combined prior to use on the day. AIM stock of DTT was 
prepared and transferred into sterile eppendorfs in aliquots of 400pl, and stored at - 
201C, the 0.1 M Tris buffer (pH 8.0) was prepared in sterile glass bottles and stored at 
RT. Prior to use the IM DTT aliquot was removed from -201C and thawed slowly at RT 
(in the dark, light sensitive), once thawed this was added to 40ml of 0.1 M Tris and 
placed in the dark until use. Swelling buffer 2 was used in addition to swelling buffer I 
in samples that had reduced/poor hybridisation as we found that it further aided 
permeabilisation of the sperm head to enable probes to further access the DNA within 
the sperm head producing more intense hybridisation signals. Swelling buffer 2 
comprised of 0.1 M Tris buffer (pH 8.0) and lithium salt (LIS). Aliquots of IM (LIS) 
was prepared and stored in a sterile universal at 4'C in the dark, on the day of use a 
25mM LIS/O. IM Tris buffer (pH 8.0) was prepared and then stored in the dark. 
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8.2.1.3 Preparation of denaturation solution, probes and post hybridisation washes 
A stock of 20x concentrate of SSC was prepared by adding the following components to 
IL ddH20: 175.3g sodium chloride and 88.2g sodium citrate dihydrate, once made up 
the 20xSSC was transferred to a sterile glass bottle and the pH was adjusted to 7.0 and 
stored at RT. A 2xSSC buffer was prepared by diluting the 20xSSC stock solution by I 
in 10 with ddH20 (pH 7.0). 
8.2.1.4 Preparation of denaturation solution: 
The denaturation solution (70%formamide/2xSSC) was prepared on the day by taking 
35 ml of formarnicle (BDH, Poole, UK), 10ml of 20xSSC and 20ml of ddH20 mixed 
well and the pH was then adjusted to 7.0. 
8.2.1.5 Probe preparation: 
Three colour FISH was carried out for chromosomes 2 1, X and Y in each patient using 
directly labelled commercially available probes (Vysis Inc., Downers Grove, Ilinois, 
USA). 
The probe preparations and denaturation for both protocol I and 2 are essentially the 
same with differences only in the specific probes used. All probe preparation and 
denaturation was carried out as according to manufacturers guidelines unless stated 
otherwise. The preparation and denaturation of the probes for both protocols were 
carried out prior to immediate use and details are included in the sperm FISH protocol. 
Figure 8.2 illustrates examples of the two probe approaches used. 
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Figure 8.2- panel A probe protocol I and panel B probe protocol 2 
Figure 8.2- Panel A- probe protocol I- green-Y, red-21 and green and red- X 
Panel B- probe protocol 2- green-X, red-21 and aqua-Y (shown without DAPI 
ounterstain to enable aqua Y to be seen). 
8.2.5.6 Post hybridisation washes: 
All post hybridisation washes were prepared on the day according to guidelines 
recommended by the probe manufacturer (Vysis, Downers Grove, Illinois, USA) pre- 
warmed to 45'C (+ I 'C per slide) and the pH adjusted to 7.0. Tbree post hybridisation 
washes were prepared, the first of which was a 50%formamide/2xSSC, the second a 
2xSSC and finally a 2xSSC/0. I% tween2O (BDH, Poole, UK). 
8.2.3 Sperm FISH protocol 
The preparation of semen samples for FISH use was carried out in a Laminar air flow 
cabinet type 11 under containment level 2+. Semen samples were immediately washed in 
I OmM Tris HCI, I OmM NaCl (pH 8.0) (sperm buffer) once received (approximately 1-2 
hours after production). Semen samples were transferred to 15ml centrifuge tubes and a 
total of I Omls of sperm buffer was added to each semen sample. The tubes containing 
the sample and sperm buffer were then centrifuged at 1200 rpm for 5 minutes, after 
each centrifugation the pellet was carefully re-suspended in I Omls of fresh sperm buffer. 
The centrifugation step, removal of the supernatant and re-suspension of the pellet in 
fresh sperm buffer was then repeated twice, this process was undertaken to remove the 
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seminal fluid and retain the sperm cells only. Samples were subsequently stored at 4'C 
(slides can be stored for up to one year) until required for FISH analysis. 
8.2.3.1 Slide preparation of sperm samples for FISH analysis (Day 1) 
Once ready for analysis sperm samples were centrifuged at 1200 rpm for 5 minutes, the 
supernatant was carefully removed ensuring the pellet was not disturbed. The pellet was 
then re-suspended in 0.5-Iml of fresh spenn buffer (dependant on the size of the pellet) 
until a semi-translucent suspension was achieved. Slides were then prepared by 
spreading 10-20pl of the cell suspension onto a clean glass slide using a plastic 
coversliP, air-dried and the appropriate cell density required was checked on a phase 
contrast microscope, ensuring cell density is approximately 70-80%. Slides were then 
dehydrated and fixed through an ethanol series of 70,80 and 100% for 5 minutes in 
each. It is essential to ensure that there were adequate numbers of cells on the slide to 
score the number of sperm required and that the density of these cells were not too 
sparse (to be able to score as many as possible within one field of view, reducing 
scoring time). It was also important to check that the cell density of the slide was not 
too high or that too many clumps were found (as overlapping sperm heads are not 
scored). The process of spreading sperm onto slides was repeated until the correct cell 
density required was achieved, adjusting the volume of the sperm sample added to the 
slide accordingly. Slides were then stored at RT overnight to age. 
8.2.3.3 Decondensation and Denaturation of sperm nuclei (Day 2) 
The aged slides, prior to hybridisation were decondensed for 30 minutes in swelling 
buffer 1. (N. B. Ifsamples were not adequately decondensed the FISH was repeated with 
the addition of the second swelling step, however, the majority of cases did not require 
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this additional step. In these cases this step comprised of the immediate transfer after 
incubation in swelling buffer I to swelling buffer 2for aI hour incubation). All 
incubations in the swelling buffer(s) took place at RT in the dark due the light 
sensitivity of the buffer(s). After decondensation the slides were briefly rinsed 
(approximately I minute) in 2xSSC pH 7.0 and air dried, and subsequently dehydrated 
in an ethanol series of 70,80 and 100% (incubated for 5 minutes in each) and air dried. 
Once air dried slides were denatured for II minutes in 70% formamide/2xSSC at 72'C 
I IC per slide (taking into account the drop in temperature the slides will cause to the 
denaturation solution). After denaturation slides were quenched in ice cold 70% ethanol 
(-20'C) for 2 minutes, followed by 2 minutes each in 80% and 100% ethanol to 
dehydrate the slide. Slides were then air dried before the probe was applied. 
8.2.3.4 Probe preparation and denaturation (Day 2) 
According to manufacturers guidelines, the probes were pre-warmed to 37'C and the 
following amounts of each of the above probes was aliquoted into an eppendorf for 
every slide to be hybridised: 
Protocol 1: 1.5pl of the LSI 21 probe (Spectrum Orange); 0.5pl CEP Y probe 
(Spectrum Green); 0.5pl of CEP X probe (Spectrum Orange); I pl of the CEP X probe 
(Spectrum Green). 
Protocol 2: 1.5 pl of the LSI 21 probe (Spectrum Orange); I pl CEP Y probe (Spectrum 
Aqua); I ýtl of CEP X probe (Spectrum Green). 
In both protocols a total of 7pl of the manufacturers hybridisation mix was added to 
each eppendorf. Once added the probes and hybridisation mix were added they were 
then vortexed to mix, pulse centrifuged, vortexed again, and subsequently denatured for 
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5 minutes at 70'C. The total volume of the probe mix (10.5 gl) was then added to the air 
dried slides, and then a 22 x 22mm coverslip was carefully placed on to the slide 
avoiding air bubbles. The coverslip was then sealed to the slide using rubber solution 
(Halfords, Redditch UK) in order to prevent evaporation of the probes, and slides were 
then placed in a humidified chamber overnight at 37'C. 
8.2.3.5 Post Hybridisation Washes (Day 3) 
Post hybridisation washes were carried out as specified by the manufacturers guidelines, 
briefly this included washes at 45C (+ PC per slide), 3x 10 minute washes in 
50%formamide/2xSSC, Ix 10 minute wash in 2xSSC followed by aIx5 minute 
incubation in 2xSSC/0. I %tween 20. After these washes at 450C slides were briefly 
rinsed in ddH20 and left to air dry in the dark, once dry slides were mounted in anti- 
fade mountant (Vectasheild) containing a DAPI counterstain (Vector laboratories, 
Peterborough, UK). 
8.2.4 Microscopy and scoring criteria 
Slides were observed using the Leica. fluorescence microscope with appropriate filter 
sets (Vysis, Downers Grove, IL, USA), triple band pass filter (DAPI/ Orange and 
Green), dual band pass filter (Orange/ Green) and single pass filters for (DAPI, Orange 
and Green). Images were captured using Smart Capture (Q-2). 
Approximately 5000 spen-n nuclei were scored per patient (or the maximum that could 
be counted in patients with severe oligozoospen-nia) triple colour FISH was always 
undertaken to enable disomic spermatozoa to be distinguished from diploid ones. For 
scoring slides a stringent criteria was applied: Spen-n. nuclei were only scored if 
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spermatozoa were intact, displaying a similar degree of decondensation and clear 
hybridisation signals; disrupted or overlapping spermatozoa were excluded from 
analysis. Spermatozoa were regarded as abnormal if two copies of the same 
chromosome (disomic) were found within the sperm nuclei. Sperm cells were scored as 
disomic if two signals recorded for the same chromosome were clear, similar in size and 
intensity, and separated from each other by at least one signal domain and clearly 
positioned within the sperm nuclei, (therefore excluding divided (split) signals being 
wrongly scored as disomies). Spermatozoa exhibiting two signals (as above) for each 
chromosome 21 and the sex chromosomes were counted as diploid. Cells that presented 
with an absence of either a sex chromosome or chromosome 21 were not counted as 
nullisomic as it is not possible to distinguish whether this is true nullisomy or failure of 
the probe to hybridise, therefore nullisomic spermatozoa were not included in analyses 
(Griffin et al., 1995; 1996). Examples of non-nal and aneuploid spermatozoa for 
chromosomes X, Y and 21 (using protocol I combination probe approach) are presented 
in figure 8.3. 
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Figure 8.3- examples of normal and abnormal spermatozoa using the FISH probe protocol I 
83 chromosomes X (labelled in yellow, produced by a combination of red and green), Y 
d in green) and 21 (labelled in red). Image A and B= normal X and Y bearing sperm 
: ively) for the chromosomes investigated with the presence of one sex chromosome and one 
some 2 1. Images C-H are all examples of aneuploid sperm, images C and D=Y and X 
sperm with disomy 21; images E-G are all examples of sex chromosome disomies (E = 
X, F= XY disomy, G= YY disomy) and image H= disomic for chromosome 21 and also 
s2 sex chromosomes (X and Y), hence is likely to be a diploid spermatozoa. 
8.3 Preparation of herbal extracts: 
We obtained 37 plant based herbs (figure 8.4 and table 8.1) used in the treatment of 
male infertility by traditional Chinese herbal medicine. The recommended preparation 
of the herbal prescriptions was to add water (an exact amount is not specified), ensuring 
that all the herbs were covered (with at least aI cm excess coverage). This infusion was 
then left overnight and boiled the following day for 30 minutes. The herbal infusion is 
then left to cool down and is then taken as a tea. The standard preparation of each of the 
herbs for all assays assessing herbal activities followed the same protocol given to 
patients. The herbs were prepared for each assay as follows: pyrex boiling tubes were 
rinsed with 100% ethanol followed by ddH20 and sterilised by autoclaving. Once 
sterilised 0.1 5g of each herb to be investigated was weighed out and transferred to these 
boiling tubes, following this 1ml of ddH20 was added to the boiling tube (more than 
enough to cover the herbs). The boiling tube was then covered with parafilm and 
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aluminium foil and were left to infuse over night at RT. Following overnight incubation 
the herbs were then boiled for 30 minutes at I OOOC. 
Figure 8.4- showing the 37 different herbs used in the treatment of infertility 
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Table 8.1- Pin-Yin, latin and common names of each of the 37 individual herbs where possible 
Herb 
No. 
Pin Yin Name Latin Name Common Name 
Herb I Chi Shao Radix paeoniae rubrae Red peony root 
Herb 2 Chuan Niu Xi Radix cyathula officinalis_ Cyathula root 
Herb 3 Fu Ling Sclerotium poriae cocos Poria 
Herb 4 Gou Qi Zi Fructus tycii chinensis Lycium fruit 
Herb 5 Huang Bi Cortex phellodendri Phellodrendron bark 
Herb 6 Mu Dan Pi Cortex moudan radicis Moutan 
Herb 7 Nu Zhen Zi Fructus ligustri lucidi Ligustrum seed / glossy privet fruit 
Herb 81 Shu Du 
Herb 9 Shan Yao Rhizoma dioscoreae Chinese yam 
Herb 10 Shan Zhu Yu Fructus corni officinalis Comus fruit / dogwood fruit 
Herb II Tao Ren Semen persicae Persica 
Herb 12 Tu Si Zi Semen cuscutae Dadder seed/ cuscuta seed 
Her 13 Ze Me Rhizoma alismatis plantago- 
aquaticae 
Alismatis rhizome/ water plantain 
tuber 
Herb 14 I Zhi Mu Rhizoma anemarrhenae 
asphod loidis 
Anemarrhena 
Herb 15 Ba Ji Tian Radix moridae officinalis Morinda root 
Herb 16 BaiZhu Rhizoma atractylodis 
macrocephalae 
Alba atractylocles 
Herb 17 Cbe Qian Zi Semen plantaginis Plantago seed 
Herb 18 Dang Shen Radix codonopsis pilosulae Codonopsis 
Herb 19 Fu Pen Zi Fructus rubi Rubus 
Herb 20 Gan Cao Radix glycyrrhizae uralensis Liquorice root 
Herb 21 Hong Hua Flos carthami tinctorii Safflower flower 
Herb 22 Wang Bu. Liu Xing 
Zi 
Semen varricariae pyramidata 
medic 
Vaccaria seed 
Herb 23 WU Wei Zi Fructus schisandrae chinensis Schisandra fruit 
Herb 24 Zhi Ke Aurantii tructus Aurantium fruit 
Herb 25 Shi Chang Pu Acod graminei rhizoma Acorus rhizome 
Herb 26 Lian Zi Xin Nelumbinis embryo Lotus embryo 
Herb 27 Bi Xic Rhizoma dioscoreae 
septemlobae 
Hypoglauca yam 
Herb 28 Cang Zhu Rhizoma atractylodis attractylocles 
Herb 29 Chai Hu Radix bypteuri chinensis Bupleurum 
Herb 30 Sheng Ma Rhizoma cimicifugae Bugbane rhizome 
Herb 31 Huang Qi H Radix astragali seuhedysari Astragalus root 
Herb 32 Sheng Di Huang S Radix rehmanniae glutinosae Fresh rehmannia 
Herb 33 Chen Pi Pericarpium citri reticulata 
blanco 
Citrus peel 
Herb 34 Han Lian Cao Eclipta 
Herb 35 Jin Yin Hua Flos toniceraejaponkae Lonicera flower 
Herb 36 Vin Yang Huo Herba epimedii Epimedium 
Hr erb 37 Yi Yi Ren Semen coicis Coix seed / jobs tear seed 
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8.4 Methods for determining endocrine activities including: 
oestrogenic, androgenic, anti-oestrogenic and anti-androgenic 
The purpose of this assay was to test plant extracts (boiled in water) (refer to section 8.3 
for preparation) for oestrogenic, androgenic, anti-oestrogenic and anti-androgenic 
activities. 
8.4.1 Preparation of and storage of medium components: 
Prior to use all glassware was rinsed twice with methanol (BDH, UK), followed by a 
final rinse in ethanol (Hayman, Essex, UK). 
8.4.1.1 Preparation of sterile minimal medium: 
The minimal medium was prepared by the addition of the following chemicals to IL of 
double-distilled water: KH2PO4 13.61g, (NH4)2SO4 1.98g, KOH pellets 4.2g, MgS04 
0.2g, Fe2 (S04)3 solution (20mg/ml ddH20) Iml, L-leucine 50mg, L-histidine 50mg, 
adenine 50mg, L-argenine-HCI 20mg, L-methionine 20mg, L-tyrosine 30mg, L- 
isoleucine 30mg, L-lycine-HCI 30mg, L-phenylalanine 25mg, L-glutamic acid 100mg, 
L-valine 150mg, L-serine 375mg. Once all components were added the medium was 
placed on a heated stirrer in order to ensure that all components had dissolved and that 
the medium was well mixed. Subsequently 45ml aliquots of the medium were measured 
out and placed into glass bottles, these were then autoclaved and stored at RT. 
8.4.1.2 Preparation of components for addition to minimal medium 
Copper (11) sulphate solution (20mM) was prepared, and filter sterilised, into sterile 
glass bottles and stored at RT. 
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L-aspartic acid stock solution was prepared by adding 4mg/mI (ddH20). this was then 
transferred to sterile glass bottles in aliquots of 20ml and sterilised by autoclaving and 
stored at RT. 
L-threonine stock solution was prepared by adding 24mg/ml (ddH20), this was then 
transferred to sterile glass bottles in aliquots of 5ml and sterilised by autoclaving and 
stored at 41C. 
The vitamin solution was prepared by the addition of the following components to 
180ml of ddH20: panthothenic acid (8mg), pyridoxine (8mg), thiamine (8mg), inositol 
(40mg) and biotin solution (2mg/100ml ddH20) (20ml). The vitamin solution once 
prepared was sterilised by filtration and transferred to sterile glass bottles in 10ml 
aliquots and stored at 4'C. 
A 20% glucose solution was prepared by making a 20%w/v solution of D-(+)-glucose, 
which was transferred to sterile glass bottles in 20ml aliquots, sterilised by autoclaving 
and stored at RT 
A 10mg/ml stock solution of CPRG was prepared and sterilised through filtration, 
aliquots of 2ml were transferred to sterile glass jars and stored at 4*C. 
8.4.1.3 Growth Medium preparation 
This segment of the assay was undertaken in a Laminar air flow cabinet type 11 (Flow 
laboratories Gelaire, class 100, Irvine). The growth medium was prepared by adding the 
following to 45ml of minimal medium: 5ml of glucose (20%w/v), 1.25ml of L-alanine, 
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0.5ml vitamins, 0.4ml L-threonine, 125pl Of CUS04. For the preparation of growth 
medium for the oestrogen or androgen yeast assay 125gl of the human oestrogen 
receptor (HER) yeast stock or the 125pl of the human androgen receptor (HAR) was 
added respectively. The culture flask was then swirled to mix and placed on an 
incubated shaker (250rpm) at 28'C overnight for 24 hours. 
8.4.1.4 Preparation of recombinant yeast assay media 
As with the preparation of the growth media this part of the assay was undertaken in a 
Laminar air flow cabinet type 11. The assay medium was prepared by adding the 
following to 45ml of minimal medium: 5ml of glucose (20%w/v), 1.25ml of L-alanine, 
0.5ml of CPRG, 0.5ml vitamins, 0.4ml L-threonine, 125gl Of CUS04. 
Once the assay medium was prepared it was necessary to add the appropriate amount of 
yeast from the cultures derived from the cultures grown overnight. The assay requires 
an amount of 4x 107 cells per 50ml. The amount of yeast to add was determined by 
taking two 100ýd aliquots from each growth culture, this was then transferred onto a 96 
well microtitre plate (Linbro, ICI Biomedicals, Ohio, USA). The turbidity of each of 
these aliquots was determined by the use of a spectrophotometer plate reader 
(Molecular Devices, California, USA) at the wavelength of 620nm. These absorbance's 
were noted and utilised to estimate the number of cells per ml by reading off from a 
yeast growth curve (figure 8.5). Using the following equation it was then possible to 
determine the amount of the growth culture that was required to be added to the assay 
medium to give the required 4x 107 cells per 50ml. 
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Volume of the growth culture =4x 107 
No. of cells calculated from growth curve 
Figure 8.5 illustrates the yeast growth curve used to calculate the number of cells per n-d present in the 
overnight (growth) culture. 
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Once calculated the appropriate aliquots were removed from the growth culture and 
added to the assay medium. 
8.4.2 Recombinant yeast screen assay procedure 
This part of the assay was undertaken in a Larninar air flow cabinet type 11. For each 
assay carried out a 96 well microtitre plate containing positive and negative controls, 
including: a standard curve (positive control), a row of ethanol blanks and a row of the 
yeast medium alone (both negative controls to check for contaminants. In the case of 
the oestrogen screen the standard utillsed was 17p-oestrodiol (covering the range of 1.3- 
2724ng/1), and for the androgen screen dihydro-testoterone (DHT) (covering the range 
of 7-14520ng/1) was used. Each of the standards were serially diluted in absolute 
ethanol in a 96 well microtitre plate, for each dilution a total of I Ogl was added to the 
assay plate using a multichannel pipette. Two sample plates were prepared to cover a 
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larger concentration range. The first of these was prepared in the same way as the 
standard curve with the sample extract being serially diluted in absolute ethanol 
covering a range of 5x I 0-3_ 1 Oýtl' with I Opt being transferred to the assay plate, these 
plates will be referred to as the dilution plate from herein. For the second plate samples 
were not serially diluted with absolute ethanol but were directly pipetted (spotted) onto 
the 96 well microtitre plate, with 1.25pl added to the first well, this amount was then 
doubled to 2.5pI and so on until the final volume of 40pl was reached in well 6, these 
plates will be referred to as spot plates from herein. Once all standards, ethanol blanks, 
yeast medium alone and samples were pipetted onto the assay plates these were left in 
the Laminar air flow cabinet type 11 to evaporate (until dry). Subsequently 200gl of the 
assay media, containing either oestrogen or androgen receptor carrying yeast 
(dependant on the screen being carried out) was pipetted into each of the wells on the 
assay plate using a multichannel pipette. Plates were subsequently sealed with autoclave 
tape (to prevent evaporation), and were shaken for 2-3 minutes on a microtitre shaker 
(Lab Plant, Huddersfield, UK), once shaken plates were placed into an incubator 
ovemight at 32T. 
Day 2 
All assay plates were removed from the 32'C incubator and shaken on the microtitre 
shaker as before, oestrogen screen plates were subsequently returned to the 321C 
incubator, androgen screen plates were then placed in an incubator at 28"C. 
Day 3 
As before the assay plates were removed from the incubators and shaken on the 
microtitre plate shaker. The plates for both screens were then left out overnight at RT, 
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to prevent the yeast cells from growing too rapidly, thus ensuring that the chromogenic 
substate (CPRG) change did not develop too rapidly. 
Day 4 
Assay plates were shaken on the microtitre plate shaker as before. The assay plates were 
then analysed using the spectrophotometer plate reader. All assay plates were measured 
at two wavelengths, the first of which was 540nm. (to measure colour change) and the 
second wavelength of 620nm to measure the turbidity of the medium (providing an 
estimate of yeast growth rate). 
In order for the accurate measurements for colour change, the amount of turbidity has to 
be corrected for, this is done by the following equation: 
Corrected value = chem.. abs. (540nm)- [chem. Abs. (620mu)-blank abs. (620nm)]. 
The plates were read on a spectrophotometer plate reader, the software used to analyse 
the data was that of Softmax pro, this calculation has been entered into the software and 
hence automatically takes into account the yeast turbidity. The values calculated could 
then be plotted showing the endocrine response of the investigated herbal extracts. 
8.5 Antagonist assays (anti-oestrogen and anti-androgen yeast based 
assays). 
8.5.1 Assay procedure: 
Growth medium for the yeast cells were prepared as stated before section 
8.4.1.3 
:iI 
' 
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8.5.1.1 Preparation of assay medium (Day 1): 
The assay medium was prepared as stated previously in section 8.4.1.4, however prior 
to the medium being transferred to the assay plates the agonist was added. In the anti- 
oestrogen assay 17P-oestrodiol was added to the medium to produce a final 
concentration of 2.5x 10" 0, to the anti-androgen assay DHT was added to produce a 
final concentration of 2.5x 10-9. To the medium the appropriate amount of yeast cells 
was added to the culture (described in section 8.4.1.4) and the chromogenic substrate 
CPRG was added. Once prepared the assay plates were prepared with standards, 
samples and controls. 
8.5.1.2 Preparation of standards and samples: 
The assay was undertaken in a Laminar air flow cabinet type 11, samples were prepared 
as stated before in section 8.4.2, in brief samples were either serially diluted (dilution 
plates) or aliquoted directly onto assay plates, (spot plates) covering a range of 1.25pl to 
40pl. As with previously described oestrogen and androgen yeast based assays a 
standard curve along with several negative controls are prepared (including an ethanol 
blank and yeast medium alone). In the case of the anti-oestrogen screen the standard 
used was hydroxy-tamoxifen (OHT) (covering the range of 8.4 to 19375 ng/1), the 
standard used for the anti-androgen screen was that of flutamide (covering the range of 
7-13810 ng/L) as before these were all serially diluted and 10ýtl transferred to the assay 
plates. As before all samples and standards were left to evaporate to dryness, once 
complete 200gl of the assay medium was transferred to each of the wells on the assay 
plates. Once complete the lids to the assay plates were placed on and were sealed with 
autoclave tape, assay plates were then vigorously shaken on a microtitre plate shaker for 
2 minutes and transferred to a 32'C incubator overnight. 
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Day 2: 
All assay plates were removed form the 32'C incubator and vigorously shaken on the 
microtitre plate shaker for 2 minutes, ensuring that the yeast cells are thoroughly mixed 
and dispersed throughout the wells. Anti-oestrogen screen plates were then placed back 
in the 32'C incubator, while anti-androgen screen plates were placed in a 28'C 
incubator overnight. 
Day 3: 
As before all plates were removed from the incubators (28'C and 32'Q and vigorously 
shaken on the microtitre plate shaker for 2 minutes, once shaken assay plates were left 
at RT ovemight. 
Day 4: 
All assay plates were vigorously shaken on the microtitre plate shaker for 2 minutes, 
assay plates were then analysed using a spectrophotometer plate reader at two 
wavelengths. The first of which was 540nm (to measure colour change) and the second 
"I 
at 620nm (measuring the turbidity of the medium and hence providing an estimate of 
the growth rate of the yeast cells). 
As before for accurate analysis of the rate of colour change the amount of turbidity had 
to be corrected for, the following equation took this into account: 
Corrected value = chem.. abs. (540nm)- [chem. Abs. (620nm)-blank abs. (620nm)]. 
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8.6 FRAP assay to determine anti-oxidant activity 
For this section of work it was necessary to have an assay system that would enable us 
to test plant extracts (boiled in water) (see section 8.3 for preparation) for antioxidant I 
activity. 
8.6.1 Preparation of the FRAP assay components: 
The FRAP assay requires three components (A, B and Q to make the working reagent, 
these are made up as follows: 
Reagent A- is a3 OOmM acetate buffer pH 3.6, and is prepared as follows: (3.1 g sodium 
acetate, 16 ml of glacial acetic acid (BDH, Poole, UK) made up to IL with ddH20, once 
made up this reagent is stored at RT. 
Reagent B- is made up on the day and consists of I OmM TPTZ (2,4,6-tripyridyl-s- 
triazine) in 40mM HCI (3.1 mg/ml). 
Reagent C- is also made up on the day and consists of 20mM FeC136H20, in ddH20 
(5.4mg/ml). 
Reagent A, B and C are then mixed in a 10: 1: 1 ratio respectively to produce the 
working FRAP reagent. 
8.6.2 FRAP assay protocol: 
For this assay all the individual and herb mixes were prepared as stated in section 8.3, a 
standard of I mM Ascorbic acid was also prepared (0.176mg/ml) in ddH20, as in section 
8.4 the anti-oxidant potential of herbs and standards were tested at a variety of 
concentrations, (1.25,2.5,5,10,20 and 40ýtl), with boiled ddH20 used as a negative 
control. 
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Each of the herb and standard concentrations were added to I ml of the working FRAP 
reagent at time intervals of I minute, each sample was then incubated in the dark at RT 
for 10 minutes. Following the 10 minute incubation the absorption was measured on a 
spectrophotometer at a wavelength of 593nm, that was first blanked against a sample 
containing I ml of FRAP and 40ýtl of ddH20, following this the wavelength of each of 
the herbs, standards and negative controls were measured and recorded after the 10 
minute incubation. 
8.7 Chromosome positioning in human sperm nuclei 
8.7.1 Preparation of sperm nuclei 
This was carried out as in section 8.2.3, briefly semen samples were washed three times 
in I OmM Tris HCI, I OmM NaCl (pH 8.0) by centrifugation (1200 rpm for 5 minutes) 
after each centrifugation the pellet was carefully resuspended. After the final 
centrifugation the majority of the supernatant was then removed (to give the correct cell 
density for FISH). Slides were then prepared by spreading 10-20ýtl of the cell 
suspension onto a clean glass slide and air-dried. Slides were then fixed for two hours in 
3: 1 methanol: acetic acid (BDH, Poole, UK) in order to flatten the sperm nuclei, once 
fixed the slides were air dried and then dehydrated through an ethanol series 70,80 and 
100% for 5 minutes in each. Slides were then stored at -20"C until further required. 
8.7.2 Preparation of denaturation solution, probes and post hybridisation washes: 
Please refer to section 8.2.1.2 for details on the preparations of decondensation buffers 
and denaturation solutions. 
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8.7.2.1 Probe preparation: 
Commercially available directly labelled whole chromosome paints (WCP probes) 
specific for chromosomes X, Y and 18 were utilised in this assay. Paints were obtained 
from Q-Biogene (Livingston, UK). Probes and all post hybridisation washes were 
carried out according to manufacturers guidelines. 
8.7.2.2 Post hybridisation washes: 
All post hybridisation washes were prepared on the day according to guidelines 
recommended by the probe manufacturer (Q-Biogene) and the pH adjusted to 7.0. 
These probes required 2 post hybridisation buffers to be prepared, and included: 
50%formamide/2xSSC, and 0.1 xSSC. For both washes 150mls of each was prepared 
(enough for three washes in each), the 50%forinamide/2xSSC was prepared as 
described in section 8.2.5.6, and the 0.1 xSSC was prepared from the 20xSSC stock 
(refer to section 8.2.1.3 for stock preparation). 
8.7.3 Chromosome positioning sperm FISH protocol: 
8.7.3.1 Slide preparation (Day 1) 
For chromosome positioning slides have previously been prepared and stored at -20"C, 
prior to use these were removed from and left at RT overnight to age ready for use. 
8.7.3.2 Sperm nuclei decondensation and denaturation (Day 2) 
Once aged the slides were decondensed and denatured as in section 8.2.3.3 (sperm FISH 
segment). However, in the chromosome positioning assay the second swelling buffer 
(LIS) was omitted as this is used to salt out DNA in DNA halo preparations and hence 
is likely to effect DNA organisation within the spenn nuclei. 
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8.7.3.3 Probe preparation (Day 2) 
FISH was carried out using directly labelled commercially available whole chromosome 
paints (WCP) for chromosomes X, Y and 18, unlike the Vysis probes the Q-Biogene 
probes come already mixed with the hybridisation buffer, therefore an aliquot of the 
total amount needed is taken directly from the tube. For each slide a total of 4.5pl of the 
probe (and hybridisation mix) was transferred into a sterile eppendorf and were placed 
at 371C for 5 minutes, denatured at 72"C for 5 minutes followed by being incubated at 
371C for 30-60 minutes to preanneal. Once the slide had been decondensed, denatured, 
dehydrated through an ethanol series 70,80 and 100%, air dried and the probe 
preparation finished 4.5[il of the probe was applied directly to the slide and a 13x I 3mm 
coverslip placed on top. As in section 8.2.3.4 the coverslips were then sealed with 
rubber cement and placed in a humidified chamber overnight at 37"C. 
8.7.3.4 Post Hybridisatioti Washes (Day 3) 
The two post hybridisation washes were pre-wanned in water baths to the following 
temperatures: 50%fonnamide/2xSSC at 451C (+ I IC per slide) and 0.1 xSSC at 60'C 
I `C per slide). Once these washes reached the required temperatures, the slides were 
removed from the (ovemight) humidified chamber and the rubber cement was carefully 
removed with forceps taking care not to disturb the coverslip. The slide was then briefly 
placed in 2xSSC to float the coverslip off, the slides were immediately placed in the 
first of three 5 minute 50%fonnamide/2xSSC washes (451C +I *C per slide). Once this 
wash was complete the slides were then immediately transferred to 
50%formamide/2xSSC washes for 5 minutes for a further two times. Once the third 
wash was complete the slides were directly transferred to the first of three 5 minute 
washes in 0.1 xSSC (60*C +I I'C per slide), this process was then repeated for the final 
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two washes. Once the final wash was complete slides were then briefly rinsed in ddH20 
and left to air dry in the dark before being counterstained with anti-fade mountant 
containing DAPI (Vector Laboratories). 
8.7.4 Microscopy and analysis of chromosome position in sperm nuclei 
Slides were observed using the same fluorescent microscope and image capture 
programme as reported in section 8.3. For positioning analysis a total of 50 sperm 
nuclei were captured for each slide, spermatozoa, considered had to follow strict criteria. 
Spennatozoa had to exhibit a similar degree of decondensation, only clear hybridisation 
signals located clearly and completely within the sperrn nuclei were considered, any 
disrupted or overlapping spermatozoa, were excluded from analysis. Two types of 
analysis were made with regards to chromosome territory position relative to the centre 
and chromosome territory position relative to the polarity of the sperm nucleus (i. e. in 
relation to head and tail). 
8.7.4.1 Chromosome positioning analysis within sperm nuclei: 
8.7.4.1.1 Collection of data with regards to chromosome territory position relative 
to the centre of the sperm nuclei 
In order to undertake the analysis of these 50 nuclei images were captured in smart 
capture and exported as TIFF files and imported into Adobe Photoshop v5.2. Using 
Adobe Photoshop the sperm nuclei was enlarged to three times its original size (300%), 
and the longest point of the sperm nuclei (from edge to edge) was measured by hand on 
the screen using a ruler. The position of the chromosome territory was then measured 
by measuring the distance from the centre of the chromosome territory to the nearest 
edge of the sperm nuclei, and also the length of the chromosome territory as stated 
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previously (Bridger, personal communication), see figure 8.6 for diagrammatic 
explanation. These measurements were directly recorded onto an excel spreadsheet. 
[ igure 8.6- two sperm nuclei (magnified 3 times the original size are shown), a whole 
01 0 
ss 
hromosome paint probe for chromosome X has been hybridised (red). The two panels A and B 
how chro mosome X to be centrally located (A) and peripherally located (B). The first step of the 
he 
r co 
nalysis is to measure the longest point of the sperm nuclei, as illustrated with the yellow line this 
s then recorded (i. e 5.5cm in A), the next step is to then measure the distance from the cen e of 
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chromosome territory to the nearest edge, as illustrated with the ý, thus providing the 
v 
neasurement for the location (i. e. more interior or peripheral). 
This was repeated for 50 nuclei per chromosome per patient, each chromosome and 
patient was also repeated (therefore 100 nuclei in total were analysed per patient per 
chromosome). At the same magnification an image of a graticule (figure 8.7) with I Oýtni 
sections was captured, this image was also exported as a Tiff file and imported into 
Adobe Photoshop, the image as with the spenn nuclei was magnified to 300% and using 
a ruler the length of aI OýLm section was measured in centimetres, based on this 6cm 
was equivalent to I Oýtm. This enabled the measurements calculated for sperm length and 
centre of the chromosome territory to the nearest edge of the sperm nuclei to be 
converted into microns. 
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Figure 8.6- diagrammatic explanation of the protocol used to measure the location of chromosome 
Figure 8.7- Picture of the graticule with I Oýim markings. 
0 ure 
8.7- image (taken at the same magnification of 
sperm nuclei) of the graticule measuring I OýLm, as 
h the sperm nuclei this was imported into Adobe 
toshop, and was enlarged to the same magnitude as 
&s -m nuclei. A l0lim section (as indicated by the 
), was then measured =6cm, enabling the 
isurements (in cms) to be converted into microns. 
8.7.4.1.2 Collection of data with regards to chromosome territory position relative 
to the polarity of the sperm nuclei 
The position of the sperm tail was also noted if still present and visible after the FISH 
procedure. This enabled us to determine whether chromosomes preferentially locate 
within head, middle or tail region of the sperm nuclei. The sperm head nuclei were 
divided into three equal parts along the longest length of the sperm (figure 8.8). The 
location of the chromosome territory was determined by which of the three regions the 
majority of the chromosome territory localised to, i. e. head middle or tail region (figure 
8.8) (Bridger, personal communication). 
289 
Figure 8.8- illustrating how chromosome territories were determined to be located in the head middle or 
8.7.4.2 Analysis of the data generated by chromosome positioning study 
The position of the chromosome territory was established (relative to the centre of the 
sperm nuclei as described in section 8.7.4.1.1). All measurements were converted to 
microns, and the data was normalised to take into account the varying sizes of sperm 
nuclei. This was carried out by dividing the number of microns from the centre of the 
chromosome territory to the nearest edge of the sperm nuclei by total length of the 
sperm nuclei at the longest point (also in microns) (Bridger, personal communication. 
The value obtained from this calculation is the value used to detennine the location of 
the chromosome territory (relative to the centre of the sperm nuclei). 
Analysis of the location of the chromosome territory in respect to polarity was made 
possible with respect to head, middle or tail position, whenever the tail was still present 
after the FISH procedure (refer to section 8.7.4.1.2). In these cases a note was made for 
each sperm as to whether the majority of the chromosome territory was located in either 
the head, middle or tail region. 
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The Incidence of aneupUdy In gametes of men undergoing ICSI has raised the prospect of there being risks associ- 
ated with ICSI and the question of whether or not to screen men for sperm aneuploidy before treatment. We report 
results of a questionnaire undertaken to address how lVF staff perceive this problem, whether ICSI men are already 
being screened for sperm aneuploldy and the extent to %hich 1VF specialists feel that there is merit In such a test. 
The results suggest that this is seen as a problem but most feel the risks outweigh the benefits. Most claimed their 
clinics do not screen sperm for aneuploidy but feel that there Is merit in doing so. There are considerable benefits to 
screening Le. couples would get additional Information about the genetic repercussions or icsi and could make 
Informed decisions before treatment; screening would also facilitate the design of a large research study to give 
clearer answers on the safety of ICS1. However, we acknowledge counter arguments Le. families would not necessar- 
lly benefit as most would have the ICSI procedure regardless of screen results; sex chromosome trisomies clinically 
are not severe enough to worry about In this context and there are other potential risks of ICS1 that screening 
would not address. 
Key words: aneuploidy/ICSIIOAT/opinion4sperm 
Introduction 
The proportion of aneuploid sperm (i. e. with extra Or missing 
chromosomes) in males with severe defects in the conventional 
parameters of semen quality, has been the topic of numerous 
studies in recent years (Lahdetie et al., 1997; Calogero et al., 
2001; Hansen et al., 2002; Healy and Saunders., 2002). Severe 
oligozoospermia has been associated with ancuploidy levels of 
up to 70% (Pang et al., 1999; Pfeffer et al., 1999. Ohashi et al., 
2001), i. e. extrapolations from sperm fluorescent in-situ 
hybridization (FISH) studies involving a few chromosomes at 
a time have indicated that the most severely affected males 
may have up to 70% of sperm that have at least one extra or one 
missing chromosome (Pang et al.. 1999; Pfeffer er al.. 1999). 
The vast majority of studies have provided evidence for a 
highly significant relationship between decreased semen qual- 
ity parameters and increased sperm aneuploidy (Bernardini., 
1997. Lahdetie er al.. 1997; U and Hoshiai, 1998; Martin, 
1998; McInnes et al., 1998, Aran er al., 1999; Colombcro et al.. 
1999; Nishikawa et al., 2000; Shi and Martin, 2000; Ushijimal 
er al., 2000; Vegetti et al., 2000). In other words. we are aware 
of -50 studies that address this issue, and the vast majority 
suggest that men with severe reductions in the usual criteria 
used to measure sperm have significantly elevated levels of 
sperm disomy. In our own experience, we have found up to a 
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15-fold increase in sperm aneuploidy for the chromosomes 
thought to be most prone to non-disjunction i. e. chromosomes 
X. Y and 21 (H. G. Tempest, unpublished data) in men with sub- 
optimal semen parameters. However. the magnitude of the 
increase varies from laboratory to laboratory and from patient 
to patient, indeed we are aware of about four studies. including 
Guttenbach et al., that show no relationship at all (GULtcnbach 
er at., 1997). The apparent discrepancy between reports may be 
explained by technical reasons (e. g. laboratory specific differ- 
ences in stringency of scoring criteria) or there may be genuine 
differences depending on the population of males studied. 
Specifically, intrinsic (e. g. DNA polymorphisms) or extrinsic 
(e. g. environmental pollutant%) factors may influence sperm 
aneuploidy depending on the patient cohort studied. 
Differences in aneuploidy among populations are not widely 
reported, however both intrinsic and extrinsic factors have been 
linked to errors in chromosome segregation. For example. 
cigarette smoke. alcohol and chemotherapy regimes can all 
cause increased sperm aneuploidy (Robbins et al., 1997, Rubes 
et al., 1998. Shi el al.. 2001) while factors such as age have 
been clearly associated with increased aneuploidy in both 
males and females (Griffin et al.. 1995. Hassold et al.. 1996). 
Moreover, a recent report has identified a genetic polymorph- 
ism as a significant risk factor for Down's syndrome (Hobbs 
et al., 2000). 
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Men with severe oligozoospermia are usually treated by 
ICSI. Therefore this raises the question of whether. in cases 
where men have significantly elevated levels of sperm 
aneuploidy, there is an increased risk of producing aneuploid 
offspring. This is of especial concern for trisomies of the sex 
chromosomes that arise 50% of the time in the sperm. Studies 
that have been performed examining the chromosomal consti- 
tution of ICS1 conceptions suggest that there is some cause for 
concern. Bonduelle et al. reported that 9/1084 ICSI concep. 
tuses respectively had sex chromosome abnormalities 
(Bonduelle et al., 1999a); this is 5-10 times the published 
population frequency (Hassold er al., 1996). More recently 
Bonduelle et al. compared outcomes of ICSI versus neonate 
pregnancies and found that 611000 had sex chromosome 
abnormalities in the ICS1 group compared with 2/1000 in the 
control grour-a small yet statistically significant increase 
(Bonduelle et al., 2002). 
Given the level of interest in the literature it seems 
reasonable to suggest that the increase in sperm aneuploidy 
associated with male infertility is of significant concern for 
infertility clinics and families embarking upon ICSI treatment. 
The question then arises 'should the male partner be screened 
for sperm aneuploidy prior to ICSIT-at least for the sex 
chromosomes. In our opinion, before this question can be 
discussed fully, a number of questions remain that. to the best 
of our knowledge, have hitherto been poorly investigated; these 
include the extent to which: (i) sperm ancuploidy for ICSI 
males is perceived as a problem in infertility clinics; (ii) men 
are already screened for sperm aneuploidy in IVF clinics. and 
(iii) specialists in infertility clinics feel that there is merit in 
screening ICSI males for sperm aneuploidy by molecular 
cytogenetic techniques. 
In the first part of this debate we report and discuss the 
results of a questionnaire-based study in which specialists in 
infertility clinics were surveyed with these questions in mind. 
They suggest that there is sufficient interest in this issue to 
warrant investment in molecular cytogenetic technology in 
infertility clinics to screen males for levels of aneuploidy as an 
adjunct to conventional semen analysis. In the second part we 
place these results in the wider context of a debate on the pros 
and cons of implementing a sperm ancuploidy screening 
service for ICSI couples. 
Materials and methods 
A one-page questionnaire was sent to scientists, clinicians. nurses and 
counsellors to all infertility clinics operating in the UK (Figure 1). In 
total 590 questionnaires were sent. the questionnaire was made 
deliberately short (consisting of only 5 questions) in order to 
maximize the return. For this reason, a self-addressed envelope was 
also included. In order to avoid leading questions, participants were 
asked about a number of genetic factors associated with male 
infertility e. g. constitutional chromosome abnormalities and Y- 
chromosome deletions. I'lic brief covering letter accompanying the 
questionnaire explained the purpose of the study. The questionnaire 
was anonymous. 
Statistical analysis 
In order to establish whether the responses were btatislically 
significant. standard X2-analysis was used. 
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Results 
Of the 590 questionnaires sent, 190 (32.2%) were completed 
and returned; 78 (13.2%) were returned as "no longer known at 
this address". In order to maximize return, the respondents 
were not asked to give their name. It was therefore difficult to 
determine accurately what proportion of UK clinics were 
represented; however analysis of the postmark on the return 
envelopes suggested that 55-70% of all UK clinics were 
represented by at least one respondent. Figure I also shows the 
number of answers obtained for each question in this study. 
All individuals questioned were invited to state their position 
in the infertility clinic-, however the majority declined to do so: 
thus the analysis is based on the cohort in general rather than 
opinions among individual career groups within IVF clinics. 
However, of the 49 that did state their occupation. 21 gave their 
job description as *consultant' suggesting that the 'decision 
makers' of the IVF clinics were represented significantly in the 
study. 
Approximately 82% U56) of respondents worked at clinics 
where ICST was routinely performed. Of these, 126 (80.7%) 
indicated that their clinics routinely performed karyotype 
analysis on patients undergoing ICSI, 65 (41.7%) performed 
Y-chromosome deletion analysis and 18 (11.5%) of the 
participants worked in clinics where chromosome analysis of 
sperm before treatment was performed. 
Approximately half (49.5%) of the respondents felt there 
was an increased risk of a child being born with congenital 
abnormalities when conceived by ICSI versus standard IVF 
treatment. This was significantly more than the 54 (28.4%) 
(P < O. W5 by X2-teSt) who felt there was no increased risk of 
congenital abnormalities in babies conceived by ICSI versus 
standard IVF treatment [42 respondents (22.1%) were unsure]. 
Of the participants who felt that there was an increased risk 
of congenital abnormalities associated with ICSI, 61, by far the 
largest majority (64.9%), felt this risk was due to chromosomal 
abnormalities in the sperm used for the procedure. Of the 
remainder. 11 (11.7%) felt it was due to the actual ICSI 
procedure itself and 14 (14.9%) were unsure of the cause. 
Around 8 (8.5%) respondents felt other factors were respon- 
sible for the increase and, when invited to comment on what 
they thought they were, responses included "chromosomal 
abnormalities in the egg used for the procedure", "artificial 
selection of sperm" and "individual circumstances- Thus a 
significant majority (P < 0.0005) cited chromosome abnor- 
malities in the sperm as the major risk factor (in their opinion) 
for ICSI treatment. 
When asked to choose a statement that best described their 
current opinion about ICSI, 122, the significant majority 
(64.2%) (P < 0.0005), felt there were minimal risks with ICSI 
but that the risks were outweighed by the benefits. Of the 
remainder, 35 (18.4%) required further information before 
forming an opinion; 17 (8.9%) felt there were no additional 
risks with ICSI over standard IVF treatment. 10 (5.3%) felt that 
there were considerable risks with ICSI but that it was still a 
worthwhile treatment overall. Significantly, none of the 
respondents felt the risks of ICS1 outweighed the benefits and 
they would therefore recommend it to patients. Of the 6 (3.2%) 
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Sperm chromosome screening before ICSI 
Please state your current job title: 
QUESTIONNAIRE 
1. Does your clinic currently perform intracytoplasmic sperm Injection (ICSI)? 
Ycs 156 No 34 
In. If Yes, does your clinic counsel and arrange for patients to have: 
Karyotype analysis? Yes 126 No 28 Unsure 2 
Ycbromosomedeletion analysis? Yes 65 No 55 Unsure 6 
Chromosome analysis of 
sperm before treatment? Yes 18 No 128 Unsure 10 
L In your opinion, is there an Increased risk ofcongenital abnormalities In babies conceived by ICSI 
versus standard is vitro fertillsation (IVF) treatment? 
Yes 94 No 54 Unsurc 42 
2a. If VM what do you feel causes this increase? 
Chromosomal abnormalities ICSI procedure itself II 
in sperm used for procedure 61 Other (Pleaso, specify) 8 
Unsure 14 
3. WbIels of the following statements beg applies to your opinion about ICSI? 
No additional risks with ICSI Minimal risks with ICSI 
over standard lVF 17 but outweighed by benefits 122 
Considerable risks with ICSI Risks outweigh benefits 
but still worthwhile overall 10 would not recommend to patients 0 
Further informittion required Othcr (please specify) 6 
before forrning opinion 35 
4. Are patients In your clinic currently counselled about potential risks of ICSI? 
Yes 184 No 6 Not applicable 0 
S. Do you think there is merit In pre-screening sperm o(ICSI males for chromosomal abnormalities 
prior to treatment? 
Yes 97 No 43 Unsure 50 
'Mank you for your help in complcting this questionnaire. If you have any (urther comments please reel free to 
write them on the reverse of this sheCL Please return completed questionnaire in the stamped envelope providcd. 
Figure 1. Questionnaire sent to clinics and number of responses for each question. 
that held opinions described as 'other' responses included 
"safety depends on indication for ICSP and "individual 
circumstances must be taken into account". 
Our results demonstrate that counselling about the risks of 
ICSI is widespread in IVF clinics as 184 (96.8%) indicated 
their patients were counselled and just 6 (3.2%) suggested they 
were not. 
Finally, we were interested to note that 97, a significant 
majority (5 1.1 %). felt that there was merit in pre-screening the 
sperm for chromosomal abnormalities prior to ICSI. This 
compared with 43 (22.6%) who felt there was no merit in so 
doing and 50 (26.3%) who were unsure. In other words over 
twice as many IVF specialists are supportive of our hypothesis 
that such a screen should be implemented in addition to 
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assessing regular semen parameters. compared with those who 
were not. This is highly significant (P < 0.0005) by X2-analysis. 
Discussion 
Questionnaire results 
The non-Mendelian transmission of aneuploidy to the offspring 
of couples undergoing ICST is a serious medical issue and one 
of considerable debate among the scientific community 
(Lahdctic et al.. 1997; Calogero et al., 2001: Hansen et al.. 
2002; Healy and Saunders, 2002). The results of the question- 
nairc part of this study seem to suggest that there is enough 
concern about sperm aneuploidy in infertility clinics to warrant 
inclusion of a screen for sperm aneuploidy prior to ICSI. It 
seems that. for the most part, these opinions are made on the 
basis that the majority of INT specialists questioned believe 
that there is an increased risk associated with ICS] (most likely 
to do with increased sperm aneuploidy) compared with 
standard IVF, but that the risks outweigh the benefits. They 
also indicate that screening for sperm aneuploidy is no( a 
practice that is widespread with only 18 (11.4%) of the 
respondents suggesting that this occurs in their clinics 
compared with 126 (80.7%) who said that constitutional 
karyotyping was commonplace. Of these 18, nine were almost 
certainly from the same clinic as they were returned in the same 
envelope with a 'with compliments' slip attached. Further 
questioning of a senior member of that particular laboratory 
(results not shown) revealed that information gleaned from 
screening sperm for ancupluidy beforehand was used for 
research purposes only and information was not Yet passed on 
to patients. Informal discussions with colleagues suggest that 
this is also the case in other clinics that examine sperm for 
aneuploidy. Thus. although 18 respondents said that their clinic 
counselled and arranged for patients to have sperm chrorm- 
some analysis. it seems certain that some (if not most) are 
counselled about the risks of ICSI and then given the 
opportunity to take part in an anonymous research programme. 
A further possibility is that some respondents did not under. 
stand the term chromosome analysis of sperm in this context. 
At this time therefore we are not aware of any clinic in the UK 
which screens for sperm aneuploidy and then uses that 
information as a means for genetic counselling of patients. It 
is clear that about twice as many respondents of this 
questionnaire think it is a good idea compared with those 
who do not. Clearly however. while very important. the 
opinions of IVF specialists are only one part of the decision- 
making process on this issue and the hard scientific facts should 
be considered in context. 
Pros and cons of screening ICSI males for sperm 
aneuploidy 
Screening for sex chromosome aneuploidy in sperm before 
ICSI might allow genetic counsellors to allay the fears of those 
families who are at low fisk (i. e. those that have low levels of 
sperm aneuploidy). 'Normal' levels of sex chromosome 
aneuploidy are thought to be around 0.3% i. e. 2-4 sperm 
with an extra or missing sex chromosome in every 1000 
(Griffin et at.. 1995). Men about to embark upon ICSI with 
similar levels should be, theoretically, at no increased risk of 
producing offspring with sex chromosome ancuploidy. In some 
men however. sex chromosome aneuploidy in sperm may be 
10-30 times that of normal levels (Pang ei at.. 1999). In this 
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scenario. based on existing data regarding the matemal versus 
paternal contribution tosex chromosome aneuploidy Massold 
et al., 1996), reasonably accurate estimates of potential risk of 
transmission can be made by genetic counsellors. Equipped 
with this information families can then make informed 
decisions about whether or not to continue with ICSI and. if 
they do. whether to have prenatal diagnosis of any subsequent 
pregnancy. The question of where to draw the line between 
'high risk' and 'low risk' is, however likely to be a contentious 
one. An interesting analogy is that of the triple screen test for 
pregnant women. On the whole, families who arc given a risk 
of around I in 250 as a result of the triple screen are offered 
amniocentesis (Wellesley et al., 2002). The figure of I in 250 
has been chosen on the balance of several lines of evidence as 
the most appropriate threshold point. Perhaps therefore a 
threshold based on similar levels of risk should be established 
for ICSI men with elevated levels of sperm ancuploidy, 
An additional benefit of providing an assessment of spcm 
aneuploidy to a large number patients is that it would be the 
first stage in which a very large number of ICS] males could be 
screened as part of a research study, Pregnancies could be 
followed up subsequently in order to establish more accurate 
estimates of the risk of transmitting trisomy through 1CSI. The 
purpose of this study would be. ultimately, to generate enough 
data to provide even more accurate assessments of the risk of 
transmitting trisomy for ICSI couples. In particular. the issue of 
whether ICSI perpetuates the risk of trisomy 21 could be 
addressed. A further advantage of such a technology being 
widespread is that the regular screening of sex chromosome 
aneuploidy might provide a means by which the efficacy of any 
new chemotherapeutic treatment regimes might be monitored. 
This would be particularly applicable if any pharmacogenomic 
approaches that addressed the problems of chromosome 
segregation directly were developed. Should such approaches 
prove effective, they might then provide means of treating male 
infertility that arc less labour intensive and do not have the 
risks associated with producing ancuploid offspring as has been 
suggested for ICSI. 
It is often argued that there is an apparent discrepancy 
between the high levels of sperm aneuploidy in ICSI males and 
the relatively reassuring figures for ICSI outcome. However. 
closer analysis of the data might suggest that this is not 
necessarily the case. Klinefelter syndrome (47. XXY) arises as 
a result of XY sperm disomy -50% of the time whereas a 
47. XYY karyotype is 100% paternally derived (Hassold et al., 
1996). Thus, a significant increase in sperm ancuploidy should. 
in theory, lead to an increased risk of these and other disorders 
in ICSI offspring. Recent work provides significant evidence 
that there is a several fold increase in sex chromosome 
abnormalities as%ociated with ICSI treatment (Bonductle, 
1999a, b, 2002) however, to the best of our knowledge these 
men were not screened for the incidence of sex chromosome 
abnormalities in their sperm beforehand. Had this been the 
casc, then a more accurate correlation between the incidence of 
sex chromosome aneuploidy in sperm and the karyotype of the 
child might have been possible and we suggest that then there 
would have been a very close correlation. Indeed to the best of 
our knowledge, there have been no large controlled studies that 
have screened sperm aneuploidy before ICSI, then monitored 
pregnancies throughout and then estimated the levels of 
paternally derived ancuploidy in the subsequent offspring. 
Clearly such a project would be an extremely difficult 
undertaking but it would help us resolve more fully the 
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question of the relationship between sex chromosome sperm 
ancuploidy and ICSI outcome. In this case, we might expect a 
very close correlation between the level of YY disomy and 
XYY children (since all XYY conceptuses are paternally 
derived). We might expect a slightly lower but nonetheless 
significant correlation between Klinefelter syndrome and XY 
sperm disomy since -50% of these errors ordinarily arise in the 
sperm. However we would expect only a weak correlation 
between XX disomy and XXX conceptuscs as the majority of 
these normally arise as a non-disjunction event in the ovary 
(Hassold et al., 1996). In order to screen for sex chromosome 
abnormalities in sperm. it is necessary to look at at least one 
autosome to distinguish disomic from diploid sperm: i. e. a 
sperm with two sex chromosomes and one autosome is 
assumed to be disomic whereas a sperm with two sex 
chromosomes and two autosomes is assumed to be diploid 
(Griffin et al., 1995). In this case it seems reasonable to suggest 
that the autosome screened should be chromosome 2 1. While 
Down's syndrome (trisomy 21) is predominantly (-90%) 
maternally derived (Hassold et al., 1996), a tenfold increase in 
the incidence of disomy 21 in the sperm could potentially 
double overall risk of trisomy 21 in the offspring. We are not 
aware of any studies demonstrating an increased risk of 
Down's syndrome associated with ICSI. However any increaw 
would be unlikely to have been seen using the methodologies 
of current studies (Bonduelle et al., 1999a, b, 2002). This is for 
two reasons: 6) because of the relatively small number of live 
births studied (around 1000 each. in test and control groups). 
and (ii) because the parental origin of the aberrant chromosome 
was not determined. As a comparison, had the same approach 
been used to address the question of whether Down's syndrome 
(incidence I in 700 live births) was associated with maternal 
age, it is questionable whether a statistically significant 
difference would have been seen between the two groups. 
Paternally-derived Down's syndrome accounts for about I in 
7000-14 000 live births; while this cannot be thought of as 
common, its incidence is similar to that of myotonic dystrophy 
and Edward's Syndrome. It is therefore reasonable to suggest 
that any significant increase in this disorder associated with the 
use of ICSI treatment might be of clinical concern. It is 
questionable however whether clinicians and patients would 
necessarily distinguish between the maternally. and paternally- 
derived forms given that the clinical feature% are identical, 
Nevertheless given that screening sperm for sex chromosome 
abnormalities requires the examination of at least one 
autosome, we propose that this autosome should be chromo- 
some 21. In fact, the majority of aneuploid conceptuses 
(including presumably those that arise as a result of injection of 
an aneuplold sperm) are thought not to reach the stage of 
clinical recognition (Hassold et al.. 1996). Of those in which a 
pregnancy is demonstrabley established. the majority result in 
spontaneous abortions. In fact only cases of sex chromosome 
aneuploidy or trisomy 21 can usually result in live births (with 
very rate exceptions e. g. trisomies 18 and 13). While spontan- 
eous abortions can be very stressful for families (particularly if 
there have already been several pregnancy losses). it is. in our 
experience, the prospect of having aneuploid offspring (even 
with mild clinical features) that is of most concern to ICSI 
families. Thus, we propose that. at the moment, if sperm 
ancuploidy screening of ICSI men is to go ahead, the sex 
chromosomes and chromosome 21 should be screened alone. 
To conclude, the increased risk of transmitting trisomy through 
ICSI is therefore quite well established for the sex chromo- 
somes but not for chromosome 21. There is. theoretically. an 
increased risk of transmitting paternally derived trisomy 21 
although this has yet to be determined on a large cohort of ICSI 
outcomes. Moreover. an increase in sperm aneuploidy for the 
'non-21' autosomes is of less concern in terms of screening in 
ICSI males but could. theoretically, lead to increased incidence 
of spontaneous abortion (Hassold et al.. 1996) thus further 
limiting the chances of a live birth. 
If a screen for sperm aneuploidy were implemented, 
appropriately trained individuals could estimate the potential 
of conceiving aneuploid offspring by performing FISH and 
counting the proportion of aneuploid sperm in the male partner. 
The test could be done at the same time as the semen 
assessment and. probably, could be organized in order not to 
delay the progress of the ICSI cycle. This procedure is 
nevertheless costly in that it involves development or procure- 
ment of high quality fluorescent probes. staff training, the cost 
of each individual test. the purchase of a high specification 
epifluorcscence microscope and the costs involved in estab- 
lishing the technique as routine. A number of clinical 
laboratories, however, now already have epifluorescence 
microscopes and the cost of the test. if bome by the patient. 
would be minor in comparison with the total cost of the ICSI 
procedure. A second drawback of implementing the procedure 
is that scoring about 5000 sperm per patient is very time 
consuming. This problem may ultimately be circumvented by 
automated approaches for the scoring of sperm aneuploidy that 
should be leqs labour intensive: these are under development in 
a number of laboratories. Thus, before such a service is offered. 
it needs to be established that these and other drawbacks are 
outweighed by the benefits. 
What is not clear (and, possibly. is unlikely to be so until 
such a service is implemented) is how patients would respond 
given the information that they were at high risk of transmitting 
aneuploidy to their offspring. Giltay et al. (1999) reported that 
a significant majority 142 out of 75 (56%) Dutch couples] 
continued with ICSI even though they were carrying consti- 
tutional chromosome abnormalities and were counselled 
extensively that they were at a significant risk of having an 
affected child (Giltay et al., 1999). It could be argued however 
that the patients in that study benefited from the information 
that they were at risk of an affected child so that they could 
come to an informed decision, indeed nearly half of these opted 
for amniocentesis given this information. If this were the caie. 
then it would be a strong argument in favour of screening 
sperm for aneuploidy levels prior to ICSI. An alternative 
interpretation however is that the results suggest that. even 
given information about elevated sperm ancuploidy. families 
would, on the whole. go ahead with ICSI anyway and thus 
screening for sperm aneuploidy would be a fruitless exercise. 
We have difficulty with this second viewpoint for the following 
reasons: closer analysis of the data by Giltay er al. (1999) 
reveals that 31% of the patients in the study declined ICS1 
given the information about their genetic risk. It is, in fact 
highly unlikely for a sub-fertile man to decline ICSI under 
normal circumstances (S. T. Homa, personal communication). 
This leads us to conclude that a significant proportion may take 
the decision to refrain from ICSI if they were identified as high 
risk whereas more still would opt for prenatal diagnosis with a 
view to either terminating or preparing for an affected child. In 
either case. therefore, the information is highly valuable to the 
patients and their reproductive planning. 
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A further issue is that factors other than elevated sperm 
aneuploidy may lead to an increased risk of trisomic offspring 
as a result of ICSI. These include the disruption of the meJoEic 
spindle during the injection process (e. g. Pang et aL, 1999) and 
inadequate decondensation of the sex chromosomes in the sub- 
acrosomal region (Sbracia et al.. 2002). If either of these 
hypotheses prove to at least contribute to the observed increase 
in sex chromosome abnormalities in ICSI children then this 
might lessen the need to screen ICSI males for aneuploidy. 
However. given that sex chromosome aneuploidy levels are 
elevated in ICSI males and elevated levels of sex chromosome 
abnormalities have been reported in ICSI children it seems 
unlikely that there would not be at least some relationship 
between the two findings. 
A final consideration is whether sex chromosome abnor- 
malities are clinically severe enough to be of sufficient concern 
for ICSI clinics and families. The majority of sex chromosome 
abnormalities are only diagnosed if they are picked up 
prenatally or when affected individuals are having reproductive 
problems. Indeed, most are not detected at all and fewer 
couples are opting for a therapeutic abortion when a sex 
chromosome abnormality is diagnosed (Abramsky et al., 
2001). In the context of this study then it raises the question 
of whether these relatively mild symptoms, during childhood 
warrant investing in an extensive screening programme for 
sperm aneuploidy. On one side of the argument. if couples 
would mostly continue with ICSI anyway and the disorder 
would be unlikely to be detected unless it was looked for 
specifically, then there is little point in implementing the 
screen. On the other, the reproductive and secondary sexual 
development problems associated with sex chromosome 
abnormalities vary from individual to individual und can be 
quite severe. We should therefore inform couples (to the best of 
the genetic counsellor's knowledge) of the risk of having an 
affected child, particularly if they are willing to pay for the test. 
Moreover, although the risk of patcmally-dcrived trisomy 21 is- 
only theoretical at this stage, it may be argued that it is of 
sufficient concern to warrant further investigation. This could 
be achieved by screening a large number of ICSI males for 
disomy 21 levels in sperm and monitoring obstetric outcome by 
karyotyping. 
In conclusion, screening for sperm aneuploidy is not 
commonly practised in IVF clinics. There are pros and cons 
of implementing such a screen, and, in our experience, about 
twice as many IVF specialists favour the idea compared with 
those who do not. The benefits of screening at least for 
chromosomes X. Y and 21 include the added information it 
gives to families about their reproductive health and the fact 
that it can be implemented without delaying ICST. With this 
knowledge. the patients can then make informed decisions 
regarding their treatment, and whether they wish to opt for 
prenatal diagnosis and/or plan for a potentially affected child. 
There is a further benefit that it would allow a larger research 
programme that would ultimately give clearer answers on the 
safety of ICST e. g. with regard to the risk of transmitting 
Down's syndrome. Indeed. it could be argued that. if 
karyotyping is recommended for these men (in which an 
abnormality is found in about 12% of ICSI men. Nakamura 
et al.. 2001) then sperm aneuploidy certainly should be 
implemented as abnormal levels are likely to be found in far 
more infertile men. On the other hand the following can be 
argued in response: 6) families would not benefit from such a 
screen as the majority would go ahead with ICSI regardless of 
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the information given; (ii) sex chromosome abnormalities are 
clinically not severe enough to worry about in this context and 
(iii) even if we do screen for sperm aneuploidy it would not 
take into account other associated risks of the ICSI procedure. 
In our opinion the first point is questionable given a closer 
analysis of the data (Giltay et al., 1999). The second point is 
central to the debate and is likely to be resolved more clearly 
when the question of the ri%k of transmitting Down's syndrome 
is more clearly established. The third point is theoretical at this 
stage and it seems likely that there is at least some significant 
relationship between levels of sperm aneuploidy and incidence 
of trisomic offspring in ICSI couples. The only certainty is that 
the debate will continue for some time befoTe the test becomes 
widespread. 
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Appendix B: 
Online Table: Mouse mutations causing reproductive defects. Only single mutant defects are described. Fertility defects of unknown gene 
origin are not described. M, male; F, female; Iletero, heterozygote phenotype taken from Matzuk and Lamb, (2002). 
Mutant gene Male/ Reproductive Phenotype Fertility Status 
. Fernal 
Acrosin (Acr) M Sperm are capable of binding and penetrating the zona pellucida Delayed 
fertility 
Activin receptor-type IIA (Acvr2) B Antral follicle block in females, small testes, delayed fertility in Infertility F 
males Subfertility M 
Activin/inhibin PB subunit (Inlibb) F Delivery and nursing defects Subl'ertility 
Acyl-CoA synthetase 4 (ACS4; I'll Enlarged uteri with prostaglandin accumulation Subfertility 
Facl4) 
Adamtsl (a disintegrinlike and F Cystic formations in uteri; defects in precivulatory follicle Subl'ertility 
metalloprotease with development 
thrombospondin type I motif, 1) 
Adamts2 (procollagen N- M Defects in spermatogenesis; marked decrease in sperm within Infertility 
proteinase) testes tubules 
ADP-ribosylation factor-like 4 M Significantly reduced testicular weights and sperm counts Normal 
(Arl4) fertility 
Alpha I microglobulin/bikunin F Defects in ovulation and cumulusoocytes complex (COC) Subfertility 
(Ambp; Urinary trypsin inhibitor) integrity 
Angiotensin-converting enzyme M Compromised ability of sperm to fertilize ova Subfcrtility 
(Ace) 
Androgen receptor (Ar; tfm or M Feminized external genitalia; hypogonadal; cryptorchidism with Infertility 
Teslicular feminization) a block in spermatogenesis 
Anti-MOllerian hormone (Amh) B Uteri development in males causes obstruction and secondary Secondary 
infertility; females exhibit early delpetion of primordial follicles Infertility 
AMI I receptor (Amhr2) M Uteri development in males causes obstruction and secondary Secondary 
infertility Infertility 
Apal'I (Apoptotic protease M Spermatogonial degeneration Variable lethality; Infertility 
activating factor I) 
Apolipoprotein B (Apob) M11 I Decreased sperm count, motility, survival time, and ability to Infertility 
feililizeova 
Aryl-hydrocarbon receptor (Ahr) F Early development of primordial follicles; decreased numbers of Subfertility 
antral follicles 
Ataxia telangiectasia (Atm) B Germ cells degenerate; disruptions evident in meiosis I Infertility 
ATP-binding cassette transporter I F Placental malformations leading to impaired embryo growth, Subfertility 
(Abcal) embryo loss and neonatal death 
Basigin (Bsg) B Defects in fertilization and implantation (F); block in Partial 
spermatogenesis at metaphase I (M) lethality; 
Infertility 
Bax (Bcl2-associatcd X protein) B Premeicitic arrest of spermatogenesis; increased oocytes and Infertility M 
primordial follicles postnatally 
Bcl2 (B-cell leukemia/ lymphoma F Fewer oocytes/primordial follicles in the post-natal ovary Subfertility 
2) 
1306 M Apoptosis in metaphase I spermatocytes Subfertility 
13clX (13021) hypomorph B PGCs are lost by E 15.5 Infertility 
Bclw (Bcl2l2, Bcl2-like 2) B Late meiotic arrest with loss of germ cells (M) and reduced PGC Infertility M 
survival (F) Subfertility F 
Bone morphogenetic protein 4 B Absent primordial germ cell (PGC) population; defect in PGC Lethal 
(Bmp4) development 
Bmp8a M Degeneration of germ cells and epididymis Progressive 
Infertility 
Bmp8b B Reduced or absent PGCs (developmental defect); Postnatal male Subfertility/ 
germ cell proliferation/differentiation defect and spermatocyte Infertility 
apoptosis 
Bmpl5 F Defects in cumulus-oocyte complex (COC) formation and Subfertility 
ovulation 
BM P receptor, type IB (Bmpr I b) F Defects in estrous cyclicity, cumulus expansion, and endometrial Subfertility 
gland development 
Calmegin (Cign) M Defect in sperm-zona pellucida. binding Infertility 
Camk4(calcium/calmodulindepend M Impaired chromatin packaging during spermiogensis Infertility 
ent protein kinase IV) 
I 
cAMP-responsive element M Defective spermiogenesis with aberrant post-meiotic gene I Infertility 
ix 
( 
modulator Wrem) expression 
cAMP-specific phosphodiesterase F Diminished sensitivity of the granulosa cells to gonadotropins Subfertility 
type 4 (Pdc4d) 
Casein kinase 111 (Csnk2a2) M Glohozoospermia (no acrosomal cap) Infertility 
Caspase-2 (Casp2) F Decreased apoptosis of female germ cells Increased 
Fertility 
CatSpcr (putative sperm cation M I Defects in motility and fertilization Infertility 
channel) 
CD9 antigen (Cd9) F Spe -egg binding defect Subfertility 
Cell division cycle 25 homolog B F Oocytes are arrested in meiotic prophase, with defects in Infertility 
(Cdc25b) (Cdc25b phosphatase) maturation promoting factor activity 
Centromere protein B (Cenpb) B Males are hypogonadal and have low sperm counts; females Subfertility F 
have straindependent uterine epithelium defects 
C/EPBP (CCAAT/enhancerbindin F Reduced ovulation and block in CL differentiation Infertility 
g protein 0) 
Claudin II (Odril 1; Osp-I 1) M No light junctions between Sertoli cells Infertilitv 
Colony stimulating factor B Males have reduced testosterone; females have implantation and Sublertility 
(macrophage) (Csn) lactation defects 
Colony stimulating factor B Mean litter size decrease with disproportionate loss of males Intercrossing 
(granulocytemacrophage) (Csf2) pups (F); maternal effects most pronounced in intercrosses with Subrertility 
knockout males 
Connexin 37 (Gia4; Cx37) F Defects in late folliculogenesis and oocyle meiosis Infertility 
Connexin 43 (Gja I; Cx43) B Small ovaries and testes; decreased numbers of germ cells from Neonatal 
E 11.5 lethality 
Cpcb (cytoplasmic B Disrupted germ cell differentiation and meiosis I synaptonernal Infertility 
polyadenylation element binding complex formation 
protein) 
Cut-like I (Cutl 1; CDP/Cux) M Severely reduced male fertility Subl'ertility 
truncation mutant 
Cyclin Al (Ccnal) M Block in spermatogenesis before the first meiotic division Infertility 
Cyclin D2 (Ccnd2) B Failure of granulosa cell proliferation (F); males fertile with Infertility F 
decreased testis size 
Cyclin dependent kinase 4 (Cdk4) I. - Defects in the hypoihalamic-pituitarygonadal axis Infertility 
Cyclooxygenase 2 Ptgs2) F Defects in ovulation and implantation Most Infertile 
Cyp IIa (Cytochrome 450,11 a, B Males fen-dnized with female external genitalia, underdeveloped Lethal 
cholesterol side chain cleavage) sex organs-, gonads degenerate 
Cyp 19 (Cytochrome P450,19, B Early spermatogonial arrest, Leydig cell hyperplasia, and defects Progressive 
aromatase) in sexual behavior (M); folliculogenesis block and ovulation Infertility M; 
defects Infertility F 
Cyp, 40 (P450 25-hydroxyvitamin F Uterme hypoplasia and absence of CL Infertility 
D-I(. hydroxylase) 
Cyritestin (Adam3) M Altered sperm protein expression and adhesion defects during Infertility 
fertilization 
Daxl (NrObl) M Progressive degeneration of the germinal epithelium Infertility 
DazI (Deleted in azoospermia-like) B Reduced germ cells; differentiation failure and degeneration of Infertility 
germ cells 
Desert hedgehog (Dhh) M Complete absence of mature sperm; defects in Sertoli-to-Leydig Infertility 
cell signaling 
Dmc I It (Disrupted meiotic cDNA B Defects in chromosome synapsis in meiosis; female germ cells Infertility 
I homolog) degenerate during embryogenesis 
Dnmt Io (DNA methyltransferase) F Embryos of knockout females die during gestation due to Subfertility 
imprinting defects; maternal effect gene 
DNA polymerase X M Immotile spermatozoa Lethality; 
Infertility 
Doublesex and mab-3 related M Defects in post-natal testes differentiation; disorganized Infertility 
transcription factor I (DmrtI) seminiferous tubules and absence of germ cells 
Dyncin heavy chain 7 (Dnahc I) M Defects in sperm flagellar motility Infertility 
Early growth response I (Egrl; B Lack of LH (M); downregulation of LHR, not remedied with Infertility 
NGFI-A) targEted lacZ insertion 
_ 
gonadotropin treatment (F) 
Early growth response I (Egrl) F LI I insufficiency; loss of estrous cyclicity, no CL; rescued by Infertility 
targeted nco insertion treatment with gonadotropins 
Early growth response 4 (Egr4) M Germ cells undergo apoptosis during pachytene stage Infertility 
ELKL motif kinase (Emk) B fl-gal gene trap insertion creates a null allcle; homozygotes Intercrossing 
intercrossed are not fertile Infertility 
Empty spiracles homolog 2 B Defective development of gonads and urogenital tracts Lethal 
(Emx2) 
Estrogen receptor ot (Eltot)(Esrl) B Females have hemorrhagic ovarian cysts and uterine defects, l7fýertihty 
x 
-- . ---. -------- --- 
decreased lordosis response; males develop disruptions of the 
seminiferous epithelium due to abnormal epididymal function, 
no ejaculat ions 
Estrogen receptor P (ERP)(Esr2) B Females are subfertile; males are fertile, but develop prostate Sublertility 
hyperplasia 
Fanconi anemia complementation B I lypogonadism. reduced fertility, more dramatic and progressive Subtertility 
group A (Fanca) in females 
Fanconi anemia complementation B Hypogonadism. compromised gametogenesis Subl'ertility 
group C (Fancc) 
Fanconi anemia complementation B I lypogonadism, compromised gametogenesis Subfertility 
group 0 (Faneg) 
Fcrtilin P (Adam2) M Altered sperm protein expression and adhesion defects during Infertility 
fertilization 
Fibroblast growth factor 9 (Fgf9) M XY male-to-female sex reversal; phenotype ranges from Lethal 
testicular hypoplasia to complete sex reversal 
Figla or FIGa (Factor in the F No primordial follicles develop at birth and oocytes die Infertility 
germline. a) 
Fragile-X mental retardation M Macroorchidism 
syndrome I homolog (Fmrl) 
FS1 I hormone P-subunit (Fshb) B Female pre-antral block in folliculogenesis; males decreased Infertility F 
testis Si7e 
FS1 I receptor (Fshr) B Female pre-antral block in folliculogenesis; males decreased Infertility F 
testis size 
Fusl (translocated in liposarcoma; M Defects in spermalocyte chromosome pairing Infertility 
TLS) 
pl, 4-Galactosyltransferase B Male infertility; defects in sperm-egg interaction; females Variable 
Exhibit defects in delivery and lactation lethality 
I-Glutamyl transpeptidase (Ggtp) B Both males and females are hypogonadal and infertile; Infertility 
phenotype corrected by feeding mice Nacetylcysteine 
Gdi I (guanosine diphosphate B B Impaired spermatogenesis, vaculolar degeneration in males; Infertility 
dissociation ihibitor 1; Rho GDIa) postimplantation pregnancy defects in females 
tic Glial cell line-derived neurotrophic N MH Depletion of stem cell reserves; spermatogonia differentiate Fertile 
factor (Gdnf) 
Glycoprotein hormone a-subunit B I Hypogonadal due to FSI I and Ll I deficiency Infertility 
(Cga) 
Gpr106 (G proteincoupled receptor M Crsp males homozygous for transgene integration exhibit a high Infertility 
106) intraabdominal position of the testes, complete sterility 
Growth differentiation factor-7 M Defects in seminal vesicle development Infertility 
(Gd 17) 
Growth differentiation factor-9 F Folliculogenesis arrest at the one-layer follicle stage Infertility 
(Od 19) 
Growth hormone receptor (Ghr) F Delayed puberty and prolonged pregnancy 
Ing F11 Loss of maternal allele in developing embryos causes somatic 
overgrowth due to loss of IGF2 imprinting 
I feat shock protein 70-2 (Iisp70-2) M Meiosis defects and germ cell apoptosis Infertility 
I leatshock transcription factor I F Maternal effect gene; pre- and postimplantation defects Infertility 
(Ilsfl) 
I lepatocyte nuclear factor (HNF- B Infantile uterus; normal ovarian histology (F); vestigial vas Infertility 
I a)(transcription factor 1; TcfI) deferens, seminal vesicles and prostate, impaired 
spermatogenesis, no mating behavior (M) 
I ligh mobility group box 2 M Sertoli and gerrn cell degeneration and immotile spermatozoa. Subfertility 
(Ilmgb2) 
I listone 112A family, member X M Pachytene stage arrest in spermatogenesis; defects in Infertile 
(112afx) chromosome segregation and MLI II foci formation 
II istone 3.3A gene (Wf3a) M P-gal gene trap insertion creates a hypornorphic allele; Subfiertility 
Insertional mutation homozygous males have reduced copulatory activity and fewer 
matings result in pregnancy 
I lomeobox A 10 (1 loxa 10) B Variable infertility; males have cryptorchidism and females have Progressive, 
frequent embryo loss prior to implantation infertility M; 
subfertility F 
I lomeobox AII (I loxa 11) B Females have uterine defects; males have malformed vas Infertility 
deferens and undescended testes 
I Irb (IIIV-1 Rev binding protein) M Round-headed spermatozoa lack an acrosome Infertility 
(RAB/Rip) ( lobozoospermia) 
Inhibin a (Inha) B Granulosa/Sertoli tumors, gonadotropin hormone-dependent Infertility F 
Secondary 
infertilit M 
Inositol polyphosphate- 5- M Sperm have reduced motility and reduced ability to fertilize Infertility 
xi 
---. - :----. - 
phosphatase (Inpp5b) eggs, defects in fertilin P processing 
Insulin-like growth factor I (IgfI) B I lypogonadal and infertile; disrupted spermatogenesis and Infertility 
vestigial ductal system, defects in mating behavior (M); 
impaired antral follicle formation (F) 
Insulin-like growth factor 2 I'll Mutation of maternal allele in pups causes developmental Lethality; 
receptor (lgf2r); T-associated defects and cmbryonic/peri natal death maternal effect 
matemal effect (Tme) mutation 
Insulin-like hormone 3 (Ins13) B Bilateral cryptorchidism results in abnormal spcrmatogenesis in Subfertility 
males; female subfertility associated with irregular estrous 
cycles 
Insulin receptor substrate 2 (Irs2) F Small, anovulatory ovaries with reduced numbers of follicles Infertility 
Interleukin II (1111) F Compromised implantation and decidualization Infertility 
JunD (Jundl) M Anomalous hormone levels and sperm structural defects Infertility 
Kit ligand (Kitl) B I steel defect mutation causes defect in PGC migration/survival; Infertility 
panda mutation causes blocks in folliculogenesis in females 
Kit receptor (Kit) B White spotting null mutation causes PGC defects Infertility 
Leptin (Lep; ob/ob) mutant B Obese and infertile with hypogonadotropic hypogonadism Infertility 
Leptin receptor (Lepr, db/db) B Obese and infertile with hypogonadotropic hypogonadism Infertility 
mutant 
Leukemia inhibitory factor (Lif) F Failed implantation Infertility 
Limk2 (LIM motif containing M Degeneration of spermatogenic cells in the seminiferous tubules; 
protein kinase 2) 
_ 
increased apoptosis 
Lipase, hormone sensitive (IISLý M Multiple abnormalities in spermatogcnesis Infertility 
(Lipe) 
Luteinizing Hormone Receptor B Underdeveloped sex organs and infertility in both males and Infertility 
(Lhegr) females; spermatogenesis arrested at round spermatid stage; 
preantral 
folliculogenesis block 
Man2a2 (a-mannosidase lix) M Defect in adherence of spermatogenic cells to Sertoli cells; germ Mostly infertile 
cells prematurely released from the testis 
Mater (materrial antigen that F Development beyond the two-cell stage is blocked; Maternal Infertility 
embryos require) effect gene 
M Ih IýM ut L homologue 1) B Meiotic arrest and genomic instability Infertility 
Mos (Moloney sarcoma oncogene) F Parthenogenetic activation, cysts and teratomas Subfiertility 
Msh4 (MutS homologue 4) B Prophase I mciotic defects apparent at the zygotene/pachytene Infertility 
stage; germ cells lost within a few days post-parturn 
Msh5 (MutS homologue 5) B Zygotene/pachytcne meiotic defects with aberrant chromosome Infertility 
., vnaT)-, i% and an 
Microtubule-associated protein 1, A M Abnormal microtubules in germ cells and Sertoli cells Infertility 
(Mtap7)(EMAP- 115) insertional 
mutation 
More (microrchidia) insertional M Early arrest in meiosis and germ cell apoplosis Infertility 
mutation 
MybI I (A-myb) myeloblastosis M Germ cell mciotic arrest at the pachytene stage Infertility 
oncogene-like I 
Na(+)-K(+)-2CI(-) cotransporter M Low spermatid counts and compromised sperm transport Infertility 
(NKCCI) solute carrier family 12, 
member 2 (Sle I 2a2) 
Neuronal Ilclix-Loop- Ifelix 2 B Males are infertile and hypogonadal; females are fertile when Infertility 
(Nhlh2) reared with males 
Neuronal insulin receptor (NIR) B Hypothalamic hypogonadism; impaired spermatogenesis and Infertility 
follicle maturation 
Nitric oxide synthase 3, F Compromised ovulation, delayed meiotic progression from Subfertility 
endothelial cell (Nos3; eNos) metaphase I 
Nuclear receptor coactivator B Decreased responsiveness to steroid hormones in uterus, Fertile 
(Ncoal); steroid receptor mammary glands (F), testes and prostate (M) 
coactivator-I (SRCI) 
Nuclear receptor corepressor F Ovulation defect; ovaries accumulate luteinized, unruptured Infertility 
RIP40 (Nripl) follicles 
Nuclear receptor subfamily 5, B Gonadal agenesis in both sexes Lethal 
group A, member I (Nr5a I); 
Steroidogenic factor- I (SF- I) 
Otx I (orthodenticle homolog 1) B Prepubescent dwarfism and hypogonadism; progressive recovery I Delayed 
of follicular development and sperm development and fertility fertility 
Ovo M Reduced fertility and underdeveloped genitalia Sublertility 
P2X I receptor (P2rx I) M Oligospermia and defective vas deferens contraction Infertility 
p 181 nk4c (Cdkn2c) M Leydig cell hypetplasia and reduced testosterone production Fertile_ 
x1i 
I I'A'en '-! 
pl9lnk4d (Cdkn2d) M Testicular atrophy and gerrn cell apopiosis Fertile 
p27KipI (CdknIb) B CL differentiation failure and granulosa cell hyperplasia (F), Infertility F 
males fertile with testicular hyperplasia 
p57 Kip2 (Cdkn I c) B Surviving mice show sexual immaturity Mostly lethal 
PACI; adenylate cyclase F Prolonged and irregular diestrous phase Subfertility 
activating TK)Iypeptide I receptor I 
(Adcyapirl) 
PC4 (testicular germ cell protease) M Sperm have impaired fertilization ability Infertility 
(Pcsk4) 
Pcntraxin 3 (Ptx3) F Defects in cumulus-oocyte complex (COC) integrity and Subfertility 
ovulation 
Phosphatidylinositol 3'- kinase M Defects in proliferation and increased apoptosis of Infertility 
(Pi3k) 
--- 
spermatogonia 
Phosphatidylinositol glycan, class CM Abnormal testes, epididymis and seminal vesicles Variable 
A (Piga) Infertility; no 
allele 
transmission 
PH (pituitary specific B Snell dwarf mice have multiple anterior pituitary hormone Infertility 
transcription factor I) deficiencies and hypogonadism 
Polyomavirus enhancer activator 3 M Normal mating behavior, but males do not set plugs or release Infertility 
(Pea3) 
Postmeiotic segregation increased B Abnormal chromosome synapsis in meiosis (M); female Infertility M 
2 (Pms2) knockout zygotes have microsatellite instability in both maternal 
and paternal genomes, Materrial efTect gene 
Progesterone receptor (Pgr) F Defects in ovulation, implantation, sexual behavior, and Infertility 
mammary gland development 
Prolactin (PrO F Females are infertile with irregular estrus cycles Infertility 
Prolactin receptor (Prlr) B Compromised ovulation, fertilization and preimplantation Infertility F, 
development in knockouts (F); defects in maternal behavior in Subfertility M 
knockouts and heterozygotes (F); variable infertility and 
subfertility in males 
Prop I (paired like homeodomain B Ames dwarf mice have multiple anterior pituitary hormone Infertility 
factor 1; prophet of Pit I) deficiencies and hypogonadism 
Prostaglandin E2 EP2 receptor F Decreased fertilization and defects in cumulus expansion Subfertility 
(Ptger2) 
Prostaglandin F receptor ftfir) F Females do not undergo parturition, failed lutcolysis Infertility 
Protamine I (Prml) CM Protamine haploinsufficiency; abnormal spcrmatogenesis Infertility 
Protamine 2 (Prm2) CM Protamine haploinsufficiency; abnormal spermatogenesis Infertility 
Protease inhibitor protcase nexin-I M Abnormal seminal vesicle morphology and altered semen Subl'ertility 
(PN- I) knockout (Serpine2) protein composition 
Protein kinase A, catalytic subunit M Most mice die; few viable mice have sperm motility defects Mostly lethal 
a (Prkaca) 
Protein phosphatase I catalytic M Defects in spermiogenesis Infertility 
subunit 7 (Ppp I cc) 
_ Protein phosphatase I regulatory F Knockouts exhibited defects in progesterone facilitated sexual Not reported 
subunit IB (Ppp] rl b)(DARPP-32) receptivity 
Puromycin-sensitive F Lack of CL formation and prolactin production cause early Infertility 
aminopeptidase (Psa) - 
pregnancy loss 
Rctinoic Acid Receptor alpha M Complete arrest and degeneration or germ cell depletion Infertility 
(Rara) 
Retinoic acid receptor y (Rarg) M Squamous metaplasia of the seminal vesicles and prostate Infertility 
Rctinoid X receptors (Rxrb) M Germ cell maturation defects and tubular degeneration Infertility 
__ Rosl (c-ros) protoncogene) M Sperm motility defects Infertility 
Scavenger receptor, class BI F Defects in oocyte maturation and early embryo development due Infertility 
(Srbl) to abnormal lipoprotein metabolism 
ScrpinaS (Scrine proteinase M Sertoli cell destruction Infertility 
inhibitor A 5; Protein C inhibitor) 
S112-B B Males have small testes and reduced sperm count; females have Subfertility M 
small, anovulatory ovaries with reduced numbers of developing Infertility F 
follicles 
Smad I (MAD homolog 1; Madhl) B Developing embryos lose PGCs Lethal 
Smad5 (MAD homolog 5; Madh5) B Developing embryos lose PGCs Lethal 
Sp4 trans-acting transcription M Defects in reproductive behavior Infertility 
factor (Sp4) 
Spaml. (sperm adhesion molecule) F Sperm defects in hyaluronic-acid binding su-bfiertility 
mutations 
Sperni-I M Defect in haploid sperm function Subfertility 
xill 
'H 
Sperm mitochondrionassociated M Defects in sperm motility and migration into the oviduct; defects Subfertility and 
cysteine-rich protein (SMCP) in fertilization Infertility 
Spermatid perinuclear RNA- M Defects in seminiferous epithelium and spermatogenesis Subfertility 
binding protein (Spnr) insertional 
mutation 
_ SPO II homolog (Spo 11) B Defects in meiosis, oocytes lost soon after birth Infertility 
_ Steroid 5a-reductase type I F Defects in parturition Infertility 
(Srd5al) 
_ Steroidogenic acute regulatory B Males have female external genitalia; both sexes die of Lethal 
_protein 
(Star) adrcnocortical insufficiency 
Styx (phosphoserine/ M Defects in round and elongating spermatid development Infertility 
threonine/tyrosine interaction 
protein) 
Supcroxidedismutase I (Sodi) F Folliculogenesis defect, failure to maintain pregnancy Subfertility 
Sycp3 (synaptonemal complex B Defects in chromosome synapsis during meiosis; germ cell Infertility M, 
protein 3) anontmiq in ma' .. s in females due to aneuploidy Subfertility F 
_ Taf4b (TAF4B RNA polymerase F Defects in follicular development, oocyte Infertility 
11, TATA box binding maturation/fertilization 
proteinassociated factor, 
TAF11105) 
_ TATA-binding proteinlike protein M Post-mciotie spcrmiogenesis block (defective acrosome Infertility 
(Tip; TRF2) formation in early stage spermatids) 
_ Telomerase reverse transcriptase B Progressive infertility in both sexes; females have few oocytes Progressive 
(Tert) and uterine abnormalities Infertility 
Theg (kisimo) (Transgene M Abnormal elongated spermatids, asthenospermia Infertility 
intejention) 
_ Thyroid stimulating hormone F I lypothyroid; females show continuous dioestrus, and poor Infertility 
0 (Tshb, hyt/hyt) mutant response to gonadotropin-induced superovulation 
_ Tial I (cytotoxic granule-associated B PGCs lost by E 13.5 Infertility 
RNA binding proteinlike 1) 
_ TnpI (transition protein 1) M Abnormal chromosome condensation, sperm motility Subfertilitv 
_ Tnp2 (transition protein 2) M Abnormal chromosome condensation Subfertility 
Tumor necrosis factor type I F Enhanced prepubertal response to gonadotropins; early ovarian Subl'ertility 
receptor (Tn frsfl a) senescence 
Ubc2b (E2B ubiquitinconjugating M Alterations in sperm chromatin structure, an incomplete mciotic Infertility 
enzyme, IIR6B) arrest, abnormal sperm morphology 
Ubiquitin-like DNA repair gene M Most knockouts die during development or shortly after birth; Variable 
1IR23B (Rad23b) surviving mice have multiple abnormalities and male sterility lethality, 
Infertility 
Ubiquitin protein ligase E3A B Testicular hypoplasia, defects in spermatogenesis and prostate Subfertility 
(Ube3a; E6-AP ubiquitin protein gland development (M); ovarian hypoplasia, defects in ovulation 
jigase) and uterine development (F) 
Ubiquitin protein ligase seven in M Block in spermatogenesis and germ cell apoptosis; failure to Partially lethal; 
absentia IA (Siah I a) complete transition to telophase of meiosis I Infertility 
_ VASA homolog (Ddx4; DEAD M Defective proliferation/differentiation of PGCs Infertility 
_box 
polypeptide 4 
Vitamin D receptor (Vdr) B Defects in estrogen biosynthesis in males and females; elevated Infertility 
knockout serum gonadotropins 
Voltage-dependent Anion Channel M Immotile sperm; axonemal defects 
Tith 
sperm maturation Infertility 
_Type 
3 (Vdac3) 
Wilms tumor homolog (Wt 1) B Gonadal agenesis Lethal 
Wipl (p53-induced phosphatasc) M Runting and testicular atrophy Subfertility 
_ Wingless-related MMTV F Ovaries depleted ofoocytes; MUllerian ducts do not form Infertility 
integration site 4 (Wnt4) 
Wnt7a B Females show abnormal development of oviducts and uterus, Infertility 
males do not have Millierian duct regression 
Zf: x (Zinc finger protein X-linked) B Reduced germ cell numbers; males have reduced sperm, but are Subfertility F 
fertile, females subfertile 
Zona pellucida protein I (Zp 1) F Defects in fertilization u erti itv 
Zp2 F Fragile oocytes with defects in developmental competence Infertility 
Zp3 F Fragile oocytes Infertility 
x1v 
Appendix C: 
The following tables include the semen assessments for each sample from each of the six 
patients (NLCL, IDSS, PHEH, ALTAL, JFEF and SGSW) undergoing TCM treatment. 
Semen assessment results for seven consecutive samples from patient NLCL undergoing TCM 
treatment 
Patient: NLCL Sample 
1 
Sample 
2 
Sample 
3 
Sample 
4 
Sample 
5 
Sample 
6 
Sample 
7 
Date 8/12/99 19/l/00 8/3/00 16/5/00 8/8/00 7/11/00 3/7/01 
Appearance N N N N N N N 
Volume (ml) 2.8 2.5 2.0 2.3 3.5 3.0 2.1 
Viscosity SV N N N N N SV 
Liquefaction C C C C C C P 
PH 8.0 8.0 8.0 8.0 8.0 8.0 8.4 
Agglutination NS NS NS NS NS NS NS 
_ M. A. R test BD <10% <10% <10% <10% <10% <10% 
Sperm concentration/H ()6 69x I -. 7-. -7- IOXIO ---5.5-xj--O6- . 5xlO 
-T3j x 
-1-0-7-- ()6 32xI 57xlO6 24x 10" 
Total no. sperm 26 19 145 112 170 50 
motility % 10% 26% 11% 17% 41% 37% 58% 
Progression (overall) G2- 
slow 
GI-2 G2 G2 G2 G2 
I 
GI-2 
I- rapid, I inear (good) 0% 46% 15% 28% 28% 6% 30% 
2- slow linear or non- 
linear (weak) 56% 22% 30% 44% 44% 52% 42% 
3- very limited forward 
progression 
32% 22% 40% 12% 16% 22% 16% 
4- locally sluggish 12% 10% 15% 12% 12% 18% 8% 
5- locally quickly 
shaking 
0% 0% 0% 4% 0% 4% 4% 
Abnormal forms % 91% 87% 97% 97% 96% 96% 87% 
Head defects - 
amorphous 
14% 4% 0% 2% 3% 2% 10% 
- tapered 11% 1% 3% 3% 6% 3% 1% 
- pyriform 2% 10% 8% 5% 6% 9% 5% 
- large 4% 4% 3% 3% 2% 2% 10% 
- round 10% 19% 26% 17% 29% 30% 20% 
- other 1% 18% 26% 19% 8% 11% 1 7% 
Tail defects 
- coiled 
35% 13% 5% 30% 23% 23% 22% 
- double 0% 0% 2% 0% 0% 1% 1% 
Mid-piece defects 14% 18% 24% 1 19% 19% 15% 11% 
Comments I I 
N= normal, C= complete, SV= slightly viscous, BD= beyond detection, G= gelatinous, NS= non-specific, P=partial 
xv 
I. e n'4 
Semen assessment results for six consecutive samples received from patient IDSS undergoing TCM 
treatment 
Patient: IDSS Sam le I Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 
Date 8/12/99 19/1/00 23/2/00 29/3/00 2/5/00 13/6/00 
Appearance N 
T 
N N N N N 
_ Volume (ml) 3.8 4.0 4.5 2.75 4.5 4.2 
_ Viscosity N N N N N 
Liquefaction C C C C C C 
_ PH 8.0 8.0 8.0 8.0 8.0 8.0 
Agglutination NS NS NS NS NS NS 
_ M. A. R test BD <10% <10% <10% <10% <10% 
Sperm concentration/H 17x 10" IWO" , 21xlO" 8OX 101, 13x 
106 7.9xlO" 
_ Total no. sperm 48 95 220 60 33 
Motility % 18% 11% 30% 8% 26% 42% 
Progression (overall) G3- v ltd G2-3 G2 G3 G3 G 1-2 
_ 1- rapid, linear (good) 0% 12% 8% 3% 0% 26% 
2- slow linear or non-linear 
(weak) 
_ 
28% 38% 
1 
56% 23% 27% 38% 
_ 3- very limited forward 
progression 
60% 29% 26% 30% 43% 22% 
_ 4- locally sluggish 12% 21% 10% 44% 30% 14% 
5- locally quickly shaking 0% 0% 0% 0% 0% 0% 
Abnormal forms % 96% 97% 96% 98% 97% 98% 
Head defects - amorphous 20% 8% 6% 2% 2% 4% 
- tapered 8% 5% 2% 2% 4% 0% 
- pyriform 4% 0% 4% 5% 3% 1% 
- large 4% 4% 8% 11% 6% 7% 
- round 28% 42% 19% 24% 16% 34% 
- other 8% 28% 1 29% 23% 26% 28% 
Tail defects 
- coiled 
0% 2% 4% 3% 7% 1% 
- double 0% 4% 0% 16% 0% 8% 
Mid-piece defects 24% 4% 24% 1 
14% 34% 15% 
Comments 
I 
I I II 
N= normal, C= complete, SV= slightly viscous, BD= beyond detection, G= gelatinous, NS= non-specific 
xvi 
Semen assessment results for rive consecutive samples received from patient PHEH undergoing TCNI 
treatment 
Patient: PHEH Sample I Sample 2 Sample 3 Sample 4 Sample 5 
Date 12/1/00 16/2/00 22/3/00 16/5/00 30/6/00 
Appearance N N N N N 
Volume (n-d) 4.6 4.0 4.5 3.2 3.2 
Viscosity N N Sv N Sv 
Liquefaction C C C C C 
PH 8.0 8.0 8.0 8.5 8.0 
Agglutination + NS + NS + 
MAR test BD <10% <10% <10% <10% 
Spenn concentration/mil l2xlO6 7.5xlO6 37xW 16xlGb 30xlO" 
Total no. sperm x 10' 55 30 167 51 96 
motility % 36% 53% 27% 45% 40% 
Progression (overall) G2 G2 GI-2 G 1-2 G3 
1- rapid, linear (good) 28% 20% 32% 16% 6% 
2- slow linear or non-linear (weak) 34% 37% 36% 36% 26% 
3- very limited forward progression 14% 33% 12% 10% 32% 
4- locally sluggish 20% 10% 16% 20% 28% 
5- locally quickly shaking 4% 0% 4% 18% 8% 
Abnormal forms % 97% 99% 97% 98% 100% 
Head defects - amorphous 3% 6% 0% 1% 7% 
tapered I% 3% 0% 3% 1% 
- pyriform 5% 0% 0% 1% 2% 
- large 2% 3% 5% 4% 15% 
- round 10% 36% 19% 14% 30% 
- other 64% 38% 64% 59% 19% 
Tail defects 
- coiled 
2% 5% 1% 0% 0% 
- double 2% 3% 9% 9% 
1 Mid-piece d fects 1 10% 1 6% 1 5% 1 7% 18% 
F-o q_mrnents 
normal, C= complete, SV= slightly viscous, BD= beyond detection, G= gelatinous, NS= non-specific 
xvil 
1 
Semen assessment results for four consecutive samples received from patient ALTAL undergoing TCI%I 
treatment 
Patient: ALTAL Sample I Sample 2 Sample 3 Sample 4 
Date 15/12/99 19/1/00 16/2/00 22/3/00 
Appearance N N N N 
Volume (n-J) 1.8 3.0 1.8 1.5 
Viscosity N N N N 
Liquefaction C C C C 
PH 8.0 7.5 8.0 8.0 
Agglutination NS NS NS NS 
MAR test >99% >99% >99% >99% 
Spenn concentration/n-d 61 X106 37xlOý 22x 106 63xlO" 
Total no. spenn x 10' 110 113 40 95 
__ motility % 24% 7% 45% 13% 
Progression (overall) G3 G3 G34 G34 
__ I- rapid, linear (good) 0% 0% 0% 1% 
2- slow linear or non-linear (weak) 4% 17% 4% 3% 
3- very limited forward progression 56% 53% 64% 61% 
4- locally sluggish 40% 30% 32% 35% 
5- localIV quickly shaking 0% 0% 0% 0% 
Abnormal forms % 95% 95% 99% 94% 
Head defects - amorphous 20% 11% 6% 4% 
- tapered 7% 6% 5% 4% 
- pyrifonn 17% 19% 5% 00/0 
- large 5% 6% 1% 2% 
- round 20% 6% 17% 14% 
- other 8% 19% 8% 16% 
Tail defects 
- coiled 
5% 11% 2% 18% 
- double 0% 4% 2% 2% 
Mid-piece defects 13% 13% 53% 34% 
Comments 
normal, C= complete, SV= slightly viscous, BD= beyond detection, G= gelatinous NS= non-specific 
xvill 
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Semen assessment results for three consecutive samples received from patient JFEF undergoing TCM 
treatment 
Patient: JFEF Sample I Sample 2 Sample 3 
Date 5/4/00 1/8/00 26/9/00 
Appearance G N G 
Volume (n-J) 4.25 3.2 5.8 
Viscosity N N 
Liquefaction C C C 
PH 8.0 8.0 8.0 
Agglutination + Slight Slight 
M. A. R test 50% 80% 20% IgG 10%]gA 
Sperm concentration/H 25xlO6 MW 22x I Cý 
Total no. sperm X106 106 26 128 
motility % 48% 38% 41% 
Progression (overall) G4 G2-3 G2 
I- rapid, linear (good) 0% 10% 22% 
_ 2- slow linear or non-linear (weak) 5% 36% 44% 
3- very limited forward progression 35% 23% 20% 
4- locally sluggish 60% 31% 12% 
5- locally quickly shaking 0% 0% 4% 
Abnormal forms % 99% 97% 98% 
Head defects - amorphous 5% 17% 9% 
tapered 11% 13% 2% 
pyriform 4% 4% 7% 
large 2% 4% 2% 
round 33% 29% 29% 
other 24% 10% 11% 
Tail defects 
- coiled 
11% 6% 13% 
. double 2% 1% 5% 
Mid-piece defects 1 8% 1 13% 20% 
Comments I I 
N= normal, C= complete, SV= slightly viscous, BD= beyond detection, G- gelatinous NS- non-specific 
xix 
Semen assessment results for three consecutive samples received from patient SGSW undergoing TCM 
treatment 
Patient: SGSW Sample I Sample 2 Sample 3 
Date 16/2/00 22/3/00 18/7/00 
Appearance N N N 
_ Volume (rnl) 3.2 4.0 3.1 
_ Viscosity Viscous Viscous Viscous 
Liquefaction C IC IC 
_ PH 8.0 8.0 9.0 
Agglutination NS NS NS 
MAR test BD <10% <10% 
Sperm concentration/nil 18XI06 49x 10" 44x 10' 
Total no. sperm x 10" 58 196 136 
motility % 53% 44% 56% 
- Progression (overall) G4 G3 GI-2 
I- rapid, linear (good) 0% 0% 42% 
2- slow linear or non-linear (weak) 17% 31% 40% 
3- very limited forward progression 24% 31% 1 01YO 
4- locally sluggish 59% 31% 4% 
5- locally quickly shaking 0% 7% 4% 
Abnormal forrns % 92% 96% 92% 
Head defects - amorphous 4% 20% 9% 
tapered - 9% 16% 13% 
- 
- pyriform 8% 12% 8% 
- large 1% 8% 1% 
- round 13% 8% 9% 
- other 20% 20% 15% 
Tail defects 
- coiled 
2% 4% 9% 
- double 9% 0% 0% 
Mid-piece defects 26% 12% 280% 
Comments 
N= normal, C= complete, IC= incomplete, BD= beyond detection, G= gelatinous NS= non-speciric 
xx 
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